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FROM POLIO EPIDEMIC TO COVID-19 PANDEMIC
Invasive mechanical ventilation is the mainstay of treatment for many patients with acute 
respiratory failure. It is used to improve gas exchange, to reduce the work of breathing, 
and to prevent further organ failure and death [1]. The polio epidemic of 1952 marked the 
start of intensive care units (ICUs), characterized by the continuous and prolonged use of 
artificial ventilation outside of the operating room [2]. Until that time, the only clinically 
used ventilators were huge metal tanks in which the body was enclosed almost entirely, 
except for the patient’s head [3]. Negative pressure inside the tank was created by bellows 
that allowed the chest to expand and the lungs to inflate with air. Still, many patients with 
paralytic poliomyelitis died. Caring for patients in these iron lungs was challenging, and a 
shortage of iron lungs as well as the lack of airway protection preventing from aspiration 
mostly contributed to the high mortality. On August 25 in 1952, the anaesthesiologist Bjørn 
Ibsen proposed tracheostomy and positive pressure ventilation in these patients [4]. As a 
result, several hundred medical students were employed to provide manual and continuous 
bag ventilation every day, for several weeks [5]. All patients were placed in same room and 
were under constant observation by a clinical team – this can be considered as the first 
ICU [1]. This simple and relatively inexpensive solution quickly and drastically improved 
outcomes, as mortality for bulbar cases of poliomyelitis decreased to 38% against 78% of 
the year before [5]. A strong need for automated delivery of positive pressure arose, and the 
first artificial respirators were introduced soon after [6]. The polio epidemic also stimulated 
the invention of arterial blood gas analysers for better assessment of cardiorespiratory 
physiology in addition to clinical observation [7].
Over the last decades, sophisticated technology has immensely improved the 
monitoring of the patient’s respiratory physiology and the delivery of mechanical ventilation. 
Nowadays, positive pressure is provided via an endotracheal or tracheostomy tube (invasive 
ventilation) or face mask (noninvasive ventilation) in two main modes: controlled and 
partially-assisted ventilation. In controlled modes, the timing and duration of pressurization 
are fully regulated by the ventilator. Sedation with or without paralysis is often needed to 
sufficiently decrease or suppress the patient’s breathing effort as a means to provide lung-
protective ventilation and to optimize patient-ventilator interaction. In assisted modes, the 
patient is allowed to breathe spontaneously while inspiration is supported by the ventilator; 
the patient determines the timing of the mechanical delivery of breaths (“triggering”). The 
choice of timing and interface to deliver mechanical ventilation depends on the underlying 
cause of respiratory failure. Main indications for the initiation of mechanical ventilation 
include acute hypoxemic respiratory failure due to ventilation/perfusion mismatch, shunt, or 
diffusion limitations (e.g., with pulmonary infection, congestive heart failure, or pulmonary 
capillary leak), acute hypercapnic respiratory failure as a result of an imbalance between 
the load, capacity and drive of the respiratory muscle pump (e.g., with obstructive lung 
disease, chest wall disorders, neuromuscular respiratory dysfunction, or phrenic nerve 
conduction impairment), and circulatory failure with the goal to stabilize gas exchange 
and to unload the respiratory muscle pump. In addition, intubation is indicated in patients 
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with an inability to maintain airway patency because of upper airway obstruction, to 
manage secretions, or to protect the airway from aspiration (e.g., with decreased levels of 
consciousness).
Today, the use of modern mechanical ventilators is at the heart of abating the 
coronavirus disease 2019 (COVID-19) pandemic that resulted in an unprecedented number 
of complex patients with life-threatening hypoxemic respiratory failure [8–10]. Situations of 
surge also motivated clinicians and researchers to create “simple” and innovative ventilation 
solutions, some even similar to the concepts described in the 1950s. At the same time, the 
current pandemic stresses the importance of a proper understanding of the challenges and 
complications of mechanical ventilation, including how, when and where a safe delivery of 
ventilation can be achieved.
CHALLENGES AND COMPLICATIONS OF MECHANICAL VENTILATION
Protecting the lungs
Despite being life-saving, mechanical ventilation can also be a major source of harm with 
a profound impact on patient outcomes, including the duration of hospital and ICU stay, 
survival and long-term quality of life [11–13]. Physiological and biological insights from 
the past years have demonstrated that inadequate mechanical ventilation can cause and 
potentiate lung injury and inflammation. This is the result of excessive lung stress and strain, 
also known as ventilator-induced lung injury (VILI) [11]. Advances in the understanding of 
mechanical ventilation and how to safely manage ventilated patients have resulted in the 
development of lung-protective ventilation strategies for patients with (and without) the 
acute respiratory distress syndrome (ARDS) [12]. These strategies aim at minimizing the 
stress and strain applied to the lungs while maintaining adequate gas exchange, and are 
characterized by limiting tidal volumes and lowering end-inspiratory (plateau) pressure 
and driving pressures [13, 14]. Next to ventilatory strategies, many studies in the last 20 
years have focused on evaluating adjunctive VILI minimization approaches, including 
prone positioning [15, 16], pharmacologic interventions (e.g., neuromuscular blockade [17, 
18]), and lung support therapies such as extracorporeal membrane oxygenation [19, 20]. 
Nonetheless, short-term mortality of patients with ARDS remains high (around 40–46% 
for moderate to severe ARDS [21]) and additional evidence is needed to clarify whether 
combined lung-protective strategies can improve outcomes.
Maintaining respiratory muscle function
Most patients receiving invasive mechanical ventilation are readily liberated from the 
ventilator upon recovery from their life-threatening condition. For some patients, however, 
the transition from mechanical ventilator support to unassisted breathing and liberation 
from the endotracheal tube – a process called weaning – can be rather challenging [22, 
23]. According to a new definition of weaning outcomes, almost 25% of patients entering 




[22]. Factors associated with prolonged weaning duration include older age, higher severity 
of illness, admission for medical reasons and emergent surgery, and longer duration of 
mechanical ventilation before the first separation attempt [22]. The pathophysiology of 
weaning failure is complex and often multifactorial, but one of the main contributing factors 
is diaphragm weakness [23–25]. This is associated with prolonged ICU stay, a higher risk 
of complications and increased mortality [26–28].
The diaphragm is the main respiratory muscle that drives alveolar ventilation. There is 
accumulating evidence of an important loss of diaphragm function in patients exposed 
to mechanical ventilation [29–32]. Although a range of factors could impair diaphragm 
function in critically ill patients, mechanical ventilation itself plays a crucial role. While 
mechanical ventilation partially or completely unloads the respiratory muscle pump, 
excessive ventilator unloading is associated with diaphragm disuse atrophy and a loss of 
muscle strength [29–33]. Maintaining diaphragm activity under mechanical ventilation may 
be protective for preventing atrophy, however, excessive breathing efforts due to insufficient 
ventilator support or excessive respiratory drive could further impair diaphragm function 
[34, 35]. In addition, excessive breathing effort may also result in high lung stress with or 
without increases in tidal volumes, which could worsen lung injury [36, 37]. Because of 
these insights, many experts have recently recognized the need for a diaphragm-protective 
ventilation strategy in addition to lung-protective ventilation, aiming to simultaneously 
protect both organs [38–40]. However, this poses new challenges at the bedside since it 
remains uncertain what the optimal balance is between breathing effort and the level and 
timing of ventilatory assist – including a feasible and safe transition from controlled to 
partially-assisted ventilation modes.
Over the last years, research in respiratory muscle dysfunction during ICU stay has 
mainly focused on the diaphragm. However, the respiratory muscle pump is much more than 
just the diaphragm and the interplay between various respiratory muscle groups is highly 
complex. In conditions of low diaphragm capacity or high respiratory loading, accessory 
inspiratory muscles (parasternal, external intercostal, scalene, and sternocleidomastoid 
muscles) are activated. When the (relative) load imposed on the inspiratory muscles 
further increases, the expiratory muscles are frequently recruited in critically ill patients 
[41, 42], of which the most important ones are the lateral abdominal wall muscles. Their 
role during mechanical ventilation and weaning thereof is largely neglected in literature, 
but could be of clinical relevance as increasing evidence demonstrates expiratory 
muscle weakness at the time of ventilator weaning [43–46], likely as a consequence of 
muscle disuse. This predisposes patients to difficult weaning and/or reintubation due to 
respiratory complications related to insufficient secretion clearance, such as pneumonia 
and atelectasis. Thus, similar as for the diaphragm, maintaining physiological levels of 
expiratory muscle activity under mechanical ventilation may prevent and treat prolonged 
ventilator-dependence. Once we gain a better understanding of the role and function 
of the extra-diaphragmatic inspiratory and expiratory muscles during ICU stay, a shift in 
research efforts and ventilation strategies targeting the complete respiratory muscle pump 
is expected to emerge.
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RATIONALE AND RESEARCH AIM
Individualization of safe mechanical ventilation is needed to prevent or attenuate 
the development of lung and respiratory muscle injury. This requires a thorough 
understanding of the patient’s drive to breathe and respiratory (muscle) mechanics 
under mechanical ventilation. However, the diaphragm remains poorly monitored 
at the bedside, mainly because of a lack of simple and feasible modalities for this 
purpose. This is a significant contrast to the numerous tools available to monitor 
and support other organ functions in the ICU. Furthermore, monitoring breathing 
effort during current clinical practices is crucial to better understand the impact 
of mechanical ventilation on the lungs and diaphragm, and to identify targets 
for optimal levels of breathing effort. In addition, while preventing injury of the 
respiratory muscle pump under mechanical ventilation is a key priority, strategies 
for assisting and restoring respiratory muscle function during mechanical ventilation 
are clinically not available.
Therefore, the overall aims of this thesis were:
1. to identify and improve monitoring modalities for the diaphragm
2. to better understand the impact of mechanical ventilation on the respiratory 
pump, especially on the diaphragm
3. to evaluate strategies for preventing respiratory muscle dysfunction, with a 
specific focus on the expiratory muscles
OUTLINE OF THE THESIS
This thesis combines various original investigations, concise clinical review and opinion 
articles, and research letters to address the above aims. The preamble serves as an 
extensive background section for the overall thesis. In chapter 2, we explain the physiology 
of the respiratory drive as relevant for critically ill patients, the impact of low and excessive 
respiratory drive on the lungs and the diaphragm, and currently available monitoring 
techniques to assess respiratory drive at the bedside. In chapter 3, we outline the 
prevalence of diaphragm weakness in ventilated ICU patients and mechanical ventilation-
related mechanisms that contribute to the development of diaphragm dysfunction. 
In addition, monitoring techniques and potential preventive and therapeutic strategies 
to limit the development of diaphragm weakness are discussed. The main body of the 
thesis is then divided into three parts according to the above thesis aims: monitoring the 




and treatment of expiratory muscle dysfunction (part 3). Each part starts with a 
narrative review for an in-depth introduction on the particular section.
Part 1 - Monitoring the diaphragm
We first describe the state-of-the-art techniques for assessing the diaphragm and breathing 
effort and their clinical implications (chapter 4). One of these techniques, monitoring of the 
diaphragm electrical activity (EAdi) is of particular interest. EAdi is measured via a dedicated 
nasogastric catheter embedded with electrodes that are positioned at the level of the 
diaphragm [47]. In chapters 5 and 6, we investigated two EAdi-derived indices that were 
recently introduced in the literature: 1) the neuromechanical efficiency (NME) index [48], 
which quantifies the amount of pressure generated by the inspiratory muscles normalized to 
EAdi amplitude (NME = pressure (cmH2O) / EAdi (µV)), and 2) the patient-ventilator breath 
contribution (PVBC) index [49, 50], which provides an estimation of the fraction of breathing 
effort that is generated by the patient compared to the total work of breathing (patient + 
ventilator). Both indices were previously evaluated in limited numbers of patients [48, 49], 
and the repeatability – an essential characteristic for any diagnostic tool – was not assessed 
at all. Therefore, we assessed the test-retest reliability of the NME (chapter 5) and the 
PVBC (chapter 6) indices by performing repeated measurements per patient within a short 
time interval and under equal circumstances. Variability between repeated measurements 
should be low before clinical implementation of new bedside indices is justified.
In these chapters, we propose that the presence of non-physiological EAdi waveforms 
may compromise the reliability of the NME and PVBC. Signal processing algorithms within 
the ventilator software continuously filter out interferences, such as cardiac electrical 
activity. Inadequate filtering of cardiac activity-related noise impacts the EAdi signal 
quality and could therefore affect the reliability of EAdi-derived parameters. However, 
proving the impact of suboptimal EAdi signal filtering is rather challenging, because of the 
uncertainty with regard to how the EAdi signal is processed within the ventilator (“black 
box”), and because direct acquisition of the raw diaphragm electromyogram (EMGdi) is 
not available on the ventilator. Therefore, we designed a Y-splitting cable which allowed us 
to simultaneously measure the raw EMGdi (using our own dedicated measurement setup) 
and the ventilator-processed EAdi signal from one nasogastric catheter. This was used in 
chapter 7, where we present two clinical cases to illustrate the impact of inadequate EAdi 
signal filtering on the assessment of the diaphragm and patient-ventilator interaction. 
Additionally, in this chapter we used waveform data from a previous study [51] to assess 
the incidence of cardiac activity-related artifacts in the EAdi signal. To be more specific, 
we wanted to raise the concern that cardiac activity-related artifacts may be mistakenly 
detected as ineffective respiratory efforts (one of the most common forms of patient-
ventilator asynchrony, i.e., when inspiratory effort is insufficient to trigger the ventilator 
during the expiratory phase of ventilation [52]). Our work was recognized by another 
research group, who thoughtfully reanalyzed the performance of their previously published 
algorithm [53] for automatic detection of ineffective efforts. We replied to their work and 
added our correspondence to chapter 7.
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Another clinical illustration of how breathing effort monitoring can aid in a better 
understanding of patient-ventilator interaction is presented in chapter 8. In this example, 
we used esophageal manometry – a technique that is further detailed in chapter 4 – to 
demonstrate the presence and impact of reverse triggering. This is an interesting and likely 
under-recognized form of asynchrony that is characterized by a patient effort that occurs 
after (“is triggered by”) the initiation of a ventilator insufflation (passive breath) [54].
The importance of diaphragm monitoring, together with the current limitations related 
to EAdi signal processing, motivated us to develop a new and improved algorithm for 
attenuation of the echocardiogram (ECG) interference in the EMGdi signal. This technical 
work is presented in chapter 9. We designed and evaluated a modified template subtraction 
method (Estimated ECG Subtraction method) for processing a clean EMGdi signal without 
the need for a reference ECG channel.
Next, to illustrate how diaphragm monitoring can be incorporated directly in the delivery 
of mechanical ventilation assist, we provide a narrative review on proportional modes of 
ventilation (chapter 10). Proportional modes of ventilation deliver inspiratory assist in 
proportion to the patient’s effort, either measured with EAdi (in neurally adjusted ventilatory 
assist (NAVA)), or based on estimates of the respiratory muscular pressure (Pmus, in 
proportional assist ventilation with load-adjustable gain factors (PAV+)). In this chapter, 
we first discuss the principles of NAVA and PAV+ and how these modes could provide lung 
and diaphragm-protective ventilation. We also provide clinical recommendations for how 
to titrate inspiratory assist at the bedside based on EAdi-derived parameters and/or Pmus.
The last two chapters of this section focus on ultrasound. Besides monitoring of 
respiratory effort by means of physiological signals, ultrasound is increasingly employed 
at the bedside as it is noninvasive and relatively easy to perform. Ultrasound plays an 
important role in some chapters of the remaining of this thesis (chapters 15, 19 and 20). 
First, we describe the methodology, principles and clinical applications of respiratory 
muscle ultrasound in chapter 11. We also provide a systematic approach for ultrasound-
based evaluation of the respiratory muscle pump (including the diaphragm, parasternal 
intercostal muscle and the expiratory muscles) and discuss new modalities for functional 
imaging and quantification of tissue properties. One of these new ultrasound modalities 
is tissue Doppler imaging (TDI), which could quantify the velocity of muscle contraction. 
The use of this robust technique in ventilated patients to evaluate the diaphragm was 
recently published [55]. However, we challenged some of these findings from a technical 
and physiological perspective, and addressed our concerns in a correspondence letter that 
is provided in chapter 12.
Part 2 – Impact of mechanical ventilation on the respiratory pump
The chapters grouped in Part 2 focus on the impact of mechanical ventilation on the lungs 
and the diaphragm, all from a different perspective and in a different research setting: it 
includes observational physiological studies in ICU patients and healthy volunteers, but 
also experimental work in a bench and porcine model of lung injury. The section starts 




ventilation, and clinical strategies and monitoring methods to facilitate such ventilation 
approach (chapter 13).
While the impact of inspiratory ventilator assist on lung and diaphragm function are 
well known (detailed in chapters 2 and 3), the effect of expiratory ventilator assist (positive 
end-expiratory pressure (PEEP)) on the diaphragm remains uncertain. PEEP increases 
end-expiratory lung volume and could thereby impact diaphragm geometry and function. 
Chapter 14 is a physiological and imaging study in healthy volunteers, which builds upon 
previous work in rats where it was demonstrated that prolonged PEEP application causes 
remodeling of the diaphragm, resulting in longitudinal atrophy [56]. We aimed to investigate 
the acute in vivo effects of PEEP on the human diaphragm, as this is a prerequisite for 
diaphragm remodeling. In 19 healthy volunteers, we performed various robust physiological 
measurements to study the functional effects of PEEP on respiratory mechanics and muscle 
function, and we developed a novel high-resolution magnetic resonance imaging (MRI) 
protocol to study PEEP-induced effects on diaphragm geometry, including assessment of 
diaphragm length and muscle thickness.
Before considering implementing new clinical strategies to mitigate the risks of 
mechanical ventilation on the lungs and diaphragm in critically ill patients, the effects of 
current ICU practices should be better understood. This is first addressed in chapter 15: in 
a single center prospective observational study, we investigated the duration of absent or 
excessively low EAdi after endotracheal intubation in a mixed ICU population. We evaluated 
the temporal pattern of EAdi resumption and risk factors contributing to prolonged disuse 
of the diaphragm after intubation. We also aimed to quantify the incidence of reverse 
triggering in this cohort. In chapter 16, respiratory and diaphragm function was evaluated 
in ventilated brain-injured ICU patients during the weaning phase. This is a population that 
is of particular interest, as weaning protocols including the use of spontaneous breathing 
trials (SBT) are less well established in this patient group. During an SBT, the patient is 
challenged to breathe with no or minimal ventilator support for a certain amount of time 
(mostly 30–120 minutes). In the general ICU population, the use of an SBT has shown to 
improve outcomes [57, 58], and completion of an SBT is used to predict ventilator liberation 
success [59, 60]. In addition, measurements of respiratory mechanics and muscle function 
during an SBT could provide important insights as to why patients fail at weaning from 
mechanical ventilation [23, 41]. We wanted to assess the role of a successful SBT in brain-
injured patients and performed respiratory mechanics and breathing effort monitoring 
aiming to identify patients at risk for ventilator liberation failure.
Last, the work presented in chapter 17 was designed and performed during the first 
COVID-19 wave in early 2020, when a need for innovative and simple ventilation solutions 
for mass use emerged [8, 9]. This pandemic encouraged us to investigate whether the 
Oxylator, a fist-size portable ventilation device for out-of-hospital emergency ventilation 
[61, 62], could be used reliably and safely in conditions of severe lung injury. We tested 
these aims on a bench simulation and porcine model of lung injury. In addition, we wanted 
to derive monitoring methods allowing the delivery of safe and individualized ventilation 
during situations of surge.
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Part 3 – Treatment of expiratory muscle dysfunction
Part 3 of this thesis focuses on the expiratory muscles, which is a largely neglected 
component of the respiratory muscle pump. In chapter 18, we summarize the current 
knowledge on the role of the expiratory muscles in critically ill patients and the functional 
implications of expiratory muscle dysfunction. In addition, we discuss risk factors for 
development of expiratory muscle weakness during ICU stay, and potential strategies for 
maintaining or improving expiratory muscle strength. One potential treatment modality is 
neuromuscular stimulation. There is a growing interest in stimulation strategies to preserve 
or restore muscle activity in ICU patients, but protocols targeting the expiratory muscles are 
less well studied. This is surprising, as stimulation of the expiratory abdominal wall muscles 
can be employed noninvasively via surface electrodes placed over the lateral abdominal 
wall. In chapters 19 and 20, we assessed the feasibility, efficacy and safety of a prototype 
breath-synchronized expiratory muscle stimulator during the early phase of mechanical 
ventilation in a mixed ICU population. We performed an international randomized controlled 
pilot study in three centers in the Netherlands and one center in Australia; results of the 
Australian study are described in chapter 19, whereas chapter 20 presents the Holland 
study as well as a pooled analysis of the Australian and Holland studies that we performed 
to estimate potential clinical effects in a larger group.
Part 4 – Synthesis
This thesis is closed with a synthesis, which provides a summary of chapters 4–20, the 
general discussion of key findings, and future directions. In all, the work that I present 
in this thesis describes innovative techniques for monitoring and assisting respiratory 
muscle physiology in critically ill ventilated patients. At the same time, it can be seen 
as a constructive critical appraisal of the current state-of-the-art technology, aiming 
at avoiding that technology is over-enthusiastically adopted in clinical practice without 
addressing a clear clinical problem or pursuing a potential patient benefit. Advanced 
technology is certainly not always a panacea, but can definitely aid in the delivery of 
safe and personalized mechanical ventilation once we gain a thorough understanding 
of the capabilities and limitations. This thesis reflects an enormous team effort from 
many international collaborators; I hope that it offers new and exciting opportunities for 
technological applications and knowledge generation in the ICU, and encourages clinicians 
to incorporate routine monitoring of respiratory drive and effort in their clinical practice for 
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INTRODUCTION
The primary goal of the respiratory system is gas exchange, especially the uptake of oxygen 
and elimination of carbon dioxide. The latter plays an important role in maintaining acid-
base homeostasis. This requires tight control of ventilation by the respiratory centers in the 
brain stem. The respiratory drive is the intensity of the output of the respiratory centers, 
and determines the mechanical output of the respiratory muscles (also known as breathing 
effort) [1, 2].
Detrimental respiratory drive is an important contributor to inadequate mechanical 
output of the respiratory muscles, and may therefore contribute to the onset, duration, 
and recovery from acute respiratory failure. Studies in mechanically ventilated patients 
have demonstrated detrimental effects of both high and low breathing effort, including 
patient self-inflicted lung injury (P-SILI), critical illness-associated diaphragm weakness, 
hemodynamic compromise, and poor patient-ventilator interaction [3, 4]. Strategies that 
prevent the detrimental effects of both high and low respiratory drive might therefore 
improve patient outcome [5].
Such strategies require a thorough understanding of the physiology of respiratory drive. 
The aim of this chapter is to discuss the (patho)physiology of respiratory drive, as relevant 
to critically ill ventilated patients. We discuss the clinical consequences of high and low 
respiratory drive and evaluate techniques that can be used to assess respiratory drive at 
the bedside. Finally, we propose optimal ranges for respiratory drive and breathing effort, 
and discuss interventions that can be used to modulate a patient’s respiratory drive.
DEFINITION OF RESPIRATORY DRIVE
The term “respiratory drive” is frequently used, but is rarely precisely defined. It is important 
to stress that the activity of the respiratory centers cannot be measured directly, and 
therefore the physiological consequences are used to quantify respiratory drive. Most 
authors define respiratory drive as the intensity of the output of the respiratory centers 
[3], using the amplitude of a physiological signal as a measure for intensity. Alternatively, 
we consider the respiratory centers to act as oscillatory neuronal networks that generate 
rhythmic, wavelike signals. The intensity of such a signal depends on several components, 
including its amplitude and frequency. Accordingly, we propose a more precise but clinically 
useful definition of respiratory drive: the time integral of the neuronal network output of the 
respiratory centers, derived from estimates of breathing effort. As such, a high respiratory 
drive may mean that the output of the respiratory centers has a higher amplitude, a higher 
frequency, or both.
The respiratory drive directly determines breathing effort when the neuromuscular 
transmission and respiratory muscle function are intact. We define breathing effort as 
the mechanical output of the respiratory muscles, including both the magnitude and the 




WHAT DETERMINES THE RESPIRATORY DRIVE?
Neuroanatomy and physiology of the respiratory control centers
The respiratory drive originates from clusters of interneurons (respiratory centers) located 
in the brainstem (Figure 1) [2]. These centers receive continuous information from sources 
sensitive to chemical, mechanical, behavioral and emotional stimuli. The respiratory 
centers integrate this information and generate a neural signal. The amplitude of this signal 
determines the mechanical output of the respiratory muscles (and thus tidal volume). The 
frequency and timing of the neural pattern relates to the breathing frequency and the 
duration of the different phases of the breathing cycle. Three phases can be distinguished 
in the human breathing cycle: inspiration, post-inspiration, and expiration (Figure 2). Each 
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Figure 1. Schematic representation of the anatomy and physiology of respiratory drive. The re-
spiratory centers are located in the medulla and the pons and consist of groups of interneurons 
that receive information from sources sensitive to chemical, mechanical, behavioral, and emotional 
stimuli. Important central chemoreceptors are located near the ventral parafacial nucleus (pFV) and 
are sensitive to direct changes in pH of the cerebrospinal fluid. Peripheral chemoreceptors in the 
carotid bodies are the primary site sensitive to changes in PaO2, and moderately sensitive to changes 
in pH and PaCO2. Mechano and irritant receptors are located in the chest wall, airways, lungs, and 
respiratory muscles. Emotional and behavioral feedback originate in the cerebral cortex and hypo-
thalamus. The pre-Bötzinger complex (preBötC) is the main control center of inspiration, located 
between the ventral respiratory group (VRG) and the Bötzinger complex (BötC). The post-inspiratory 
complex (PiCo) is located near the Bötzinger complex. The lateral parafacial nucleus (pFL) controls 
expiratory activity and has continuous interaction with the pre-Bötzinger complex, to prevent inef-
ficient concomitant activation of inspiratory and expiratory muscle groups: lung inflation depresses 
inspiratory activity and enhances expiratory activity, which ultimately results in lung deflation. Lung 
deflation has the opposite effect on these centers.
Inspiration
Inspiration is an active process that requires neural activation and subsequent contraction 
(and energy expenditure) of the inspiratory muscles. The pre-Bötzinger complex, a group of 
interneurons positioned between the ventral respiratory group and the Bötzinger complex 
in the brain stem (Figure 1), is the main control center of inspiration [2]. The output of the 
pre-Bötzinger complex increases gradually during inspiration and rapidly declines when 
expiration commences. Axons of the pre-Bötzinger complex project to premotor and 
motor neurons that drive the inspiratory muscles and the muscles of the upper airways. 
The pre-Bötzinger complex has multiple connections to the other respiratory centers, which 
is thought to ensure a smooth transition between the different breathing phases and to 
prevent concomitant activation of opposing muscle groups [6].
Post-inspiration
The aptly named post-inspiratory center controls the transitional phase between 
inspiration and expiration by reducing expiratory flow. This is achieved by gradually 
lowering the excitation (and thus contraction) of the inspiratory muscles, which leads 
to active lengthening (i.e., eccentric contractions) of the diaphragm [2, 7]. Additionally, 
the post-inspiratory center controls the upper airway muscles. Contraction of the upper 
airway muscles increase expiratory flow resistance, effectively reducing expiratory flow. 
Post-inspiratory activity increases the time before the respiratory system reaches end-
expiratory lung volume. This can lead to a more laminar expiratory flow and might prevent 
alveolar collapse, while also increasing the duration of gas exchange in the alveoli [2]. Post-
inspiration is a common part of the breathing cycle in healthy subjects at rest, but disappears 
rapidly when respiratory demands increase, to favor faster expiration [8] (Figure 2).
The importance of the post-inspiratory phase in mechanically ventilated patients 




predominantly on the interplay between ventilator settings (e.g., cycle criteria, breathing 
frequency, ventilator mode) and the respiratory mechanics of the patient. Additionally, 
the endotracheal tube bypasses the actions of the upper airway muscles. Experimental 
data in piglets suggest that post-inspiratory activity of the diaphragm prevents atelectasis 
and possibly cyclic alveolar recruitment [9], although a study in patients weaning from 































Figure 2. Breathing phases. Flow, transdiaphragmatic pressure (Pdi) and electromyography of the 
rectus abdominal muscle (EMGRA, in arbitrary units (a.u.); note that this signal is disturbed with elec-
trocardiogram artifacts) during tidal breathing at rest (a) and during high resistive loading (b) in one 
healthy subject. Vertical dashed lines mark the onset of the different breathing phases. Inspiration 
(I) is characterized by a steady increase in Pdi and positive flow, and is present during both tidal 
breathing and high loading. The gradual decrease in Pdi during expiratory flow in (a) is consistent 
with post-inspiration (PI). Note that the rate of decline in Pdi is much more rapid during high loading. 
During tidal breathing (a), expiration (E) is characterized by the absence of Pdi and EMGRA activity 
and occurs after post-inspiration. High loading (b) leads to active expiration (AE), which can be 
recognized by the increase in EMGRA activity. Also, expiration directly follows the inspiratory phase.
Expiration
Expiration is generally a passive event during tidal breathing. The elastic recoil pressure 
of the lungs and chest wall will drive expiratory flow until the lung and chest wall recoil 
pressures are in equilibrium at functional residual capacity, or at the level of positive end-
expiratory pressure (PEEP) in mechanically ventilated patients. In passive conditions, 
expiratory flow depends solely on the time constant (i.e., the product of compliance 
and resistance) of the respiratory system. The expiratory muscles are recruited with high 
metabolic demands, low inspiratory muscle capacity, increased end-expiratory lung volume 
and/or increased expiratory resistance [11].
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The lateral parafacial nucleus controls the expiratory phase of breathing. An increased 
respiratory drive leads to late-expiratory bursts, and consequent recruitment of the 
expiratory muscles (extensively reviewed in [11]). Several inhibitory connections exist 
between the inspiratory pre-Bötzinger complex and the expiratory lateral parafacial 
nucleus, which prevent concomitant activation of inspiratory and expiratory muscle groups 
(Figure 1) [2, 6].
FEEDBACK TO THE RESPIRATORY CONTROL CENTERS
Central chemoreceptors
The most important chemoreceptors in the central nervous system are positioned on 
the ventral surface of the medulla and near the ventral parafacial nucleus (also referred 
to as the retrotrapezoid nucleus). These receptors are sensitive to the hydrogen proton 
concentration ([H+]) of the cerebrospinal fluid (CSF), commonly known as pH [12]. Because 
CO2 can rapidly diffuse across the blood-brain barrier, changes in PaCO2 quickly affect the 
pH of the CSF. A set point exists in the control centers, which keeps pH (and PaCO2) within 
a relatively tight range. A slight increase in PaCO2 above this set point provides a powerful 
stimulus to breathe: a change in PaCO2 of 5 mmHg can already double minute ventilation 
in healthy subjects. When PaCO2 decreases only a few mmHg below the set point, the 
respiratory drive lowers gradually [13] and can abruptly disappear causing apnea, especially 
during sleep. In contrast, metabolic changes in pH are sensed less rapidly because it takes 
several hours before the electrolyte composition of the CSF is affected by changes in 
metabolic acid-base conditions.
Peripheral chemoreceptors
The carotid bodies are positioned close to the carotid bifurcation and are the primary sites 
sensitive to PaO2, PaCO2, and pH of the arterial blood. The aortic bodies contribute to 
respiratory drive in infants, but their importance in adults is probably minor [14]. The output 
of the carotid bodies in healthy subjects remains relatively stable over a wide range of PaO2 
values; their output increases gradually below a PaO2 of 80 mmHg and then rises steeply 
when PaO2 falls below 60 mmHg [15]. Their contribution to respiratory drive in healthy 
subjects is therefore probably modest. However, concomitant hypercapnia and acidosis 
have a synergistic effect on the response of the carotid bodies, meaning that their output 
is increased by more than the sum of the individual parts. This makes the carotid bodies in 
theory more relevant in ventilated patients in whom hypoxemia, hypercapnia, and acidosis 
are more common.
Thoracic receptors
Several receptors have been identified in the chest wall, lungs, respiratory muscles, and 
airways that provide sensory feedback to the respiratory centers on mechanical and 




the chest wall, respiratory muscles, upper airways, and terminal bronchioles, and provide 
information on stretch and volume of the respiratory system through vagal fibers [2]. 
These receptors are well known for their contribution to the Hering-Breuer reflexes, which 
terminate inspiration and facilitate expiration at high tidal volumes (Figure 1). Irritant 
receptors line the epithelium of the proximal airways, and are sensitive to irritant gases and 
local inflammation. These sensors promote mucus production, coughing, and expiration. 
C-fibers are found inside the lung tissue and might be activated by local congestion causing 
dyspnea, rapid breathing, and coughing [16].
The relative contribution of these receptors to the respiratory drive of critically ill patients 
is uncertain. Feedback from these sensors may explain the hyperventilation observed in 
pulmonary fibrosis, pulmonary edema, interstitial lung disease, and pulmonary embolism, 
which persists even in the absence of hypoxemia or hypercapnia. Further research into the 
contribution of these sensors during mechanical ventilation is warranted.
Cortical and emotional feedback
Stimuli based on emotional and behavioral feedback, originating in the cerebral cortex 
and hypothalamus, modulate the respiratory drive. Pain, agitation, delirium, and fear are 
common in mechanically ventilated patients and can increase respiratory drive [17]. The 
role of the cortex and hypothalamus in the respiratory drive of critically ill patients has 
rarely been studied and requires more attention before recommendations can be made.
There is some evidence that the cerebral cortex has an inhibitory influence on breathing. 
Damage to the cortex might dampen this inhibitory effect, which could explain the 
hyperventilation sometimes observed in patients with severe neurotrauma [18].
WHAT IS THE EFFECT OF NON-PHYSIOLOGICAL RESPIRATORY DRIVE 
ON MY PATIENTS?
Consequences of excessive respiratory drive
Patient self-inflicted lung injury
Excessive respiratory drive could promote lung injury through several mechanisms. In the 
absence of (severe) respiratory muscle weakness, high respiratory drive leads to vigorous 
inspiratory efforts, resulting in injurious lung distending pressures. Recent experimental 
studies demonstrate that this may worsen lung injury, especially when the underlying injury 
is more severe [19, 20]. Particularly in patients with acute respiratory failure, large inspiratory 
efforts could result in global and regional overdistention of alveoli and cyclic recruitment 
of collapsed lung areas, due to an inhomogeneous and transient transmission of stress 
and strain (so-called P-SILI) [3, 21]. Large efforts may cause “pendelluft”: air redistributes 
from nondependent to dependent lung regions, even before the start of mechanical 
insufflation, and hence, without a change in tidal volume [20]. Excessive respiratory drive 
may overwhelm lung-protective reflexes (e.g., Hering-Breuer inflation-inhibition reflex), 
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which in turn leads to high tidal volumes and promotes further lung injury and inflammation 
[3]. In addition, large inspiratory efforts could result in negative pressure pulmonary edema, 
especially in patients with lung injury and/or capillary leaks [21]. As such, a high respiratory 
drive is potentially harmful in spontaneously breathing mechanically ventilated patients 
with lung injury. Applying and maintaining a lung-protective ventilation strategy (i.e., low 
tidal volumes and low plateau pressures) is challenging in these patients and may often 
lead to the development of patient-ventilator dyssynchronies, such as double triggering 
and breath stacking, again leading to high tidal volumes and increased lung stress. 
Furthermore, maintaining low plateau pressures and low tidal volumes does not guarantee 
lung-protective ventilation in patients with high respiratory drive.
Diaphragm load-induced injury
In non-ventilated patients, excessive inspiratory loading can result in diaphragm fatigue 
and injury as demonstrated by sarcomere disruption in diaphragm biopsies [5]. Whether 
this occurs in critically ill ventilated patients is less clear, although we have reported 
evidence of diaphragm injury, including sarcomere disruption [22]. The concept of 
load-induced diaphragm injury may explain recent ultrasound findings demonstrating 
increased diaphragm thickness during the course of mechanical ventilation in patients 
with high inspiratory efforts [23]. In addition to high breathing effort, patient-ventilator 
dyssynchronies, especially eccentric (lengthening) contractions, may promote load-induced 
diaphragm injury [24]. Whether eccentric contractions are sufficiently severe and frequent 
to contribute to diaphragm injury in intensive care unit (ICU) patients is not yet known.
Weaning and extubation failure
During ventilator weaning, high ventilatory demands with high respiratory drive increase 
dyspnea, which is associated with anxiety and impacts weaning outcome [25]. “Air hunger” 
is probably the most distressing form of dyspnea sensation, which occurs in particular when 
inspiratory flow rate is insufficient (“flow starvation”), or when tidal volumes are decreased 
under mechanical ventilation while the PaCO2 level is held constant [25]. In patients with 
decreased respiratory muscle strength and excessive respiratory drive, the muscle’s ability 
to respond to neural demands is insufficient; dyspnea is then characteristically experienced 
as a form of excessive breathing effort. Activation of accessory respiratory muscles was 
found to be strongly related to the intensity of dyspnea [26], and can lead to weaning and/
or extubation failure [10]. In addition, dyspnea impacts ICU outcome and may contribute 
to ICU-related post-traumatic stress disorders.
Consequences of low respiratory drive
In ventilated patients, a low respiratory drive due to excessive ventilator assistance and/or 
sedation is a critical contributor to diaphragm weakness. The effects of diaphragm inactivity 
have been demonstrated both in vivo and in vitro in the form of myofibrillar atrophy and 
contractile force reduction [22, 27]. Diaphragm weakness is associated with prolonged 




mortality [28]. In addition, low respiratory drive can lead to patient-ventilator dyssynchronies, 
such as ineffective efforts, central apneas, auto-triggering, and reverse triggering [29]. 
Excessive ventilator assistance may result in dynamic hyperinflation, particularly in patients 
with obstructive airway diseases. Dynamic hyperinflation reduces respiratory drive and 
promotes ineffective efforts (i.e., a patient’s effort becomes insufficient to overcome 
intrinsic PEEP). Although asynchronies have been associated with worse outcome, whether 
this is a causal relationship requires further investigation.
HOW CAN WE ASSESS RESPIRATORY DRIVE?
Because the respiratory center output cannot be measured directly, several indirect 
measurements have been described to assess respiratory drive. It follows that the more 
proximal these parameters are to the respiratory centers in the respiratory feedback loop, 
the better they reflect respiratory drive. This includes, from proximal to distal: diaphragm 
electromyography, mechanical output of the respiratory muscles, and clinical evaluation.
Clinical signs and breathing frequency
Clinical signs, such as dyspnea and activation of accessory respiratory muscles, strongly 
support the presence of high respiratory drive, but do not allow for quantification. Although 
respiratory drive comprises a frequency component, respiratory rate alone is a rather 
insensitive parameter for the assessment of respiratory drive; respiratory rate varies within 
and between subjects, depends on respiratory mechanics, and can be influenced by several 
factors independent of the status of respiratory drive, such as opioids [30] or the level of 
pressure support ventilation. We therefore need to evaluate more sensitive parameters of 
respiratory drive.
Diaphragm electrical activity
Diaphragm electrical activity (EAdi) reflects the strength of the electrical field produced 
by the diaphragm and, hence, the relative change in discharge of motor neurons over time. 
Provided that the neuromuscular transmission and muscle fiber membrane excitability are 
intact, EAdi is a valid measure of phrenic nerve output and thus the most precise estimation 
of respiratory drive [7, 31]. Real-time recording of the EAdi signal is readily available on a 
specific type of ICU ventilator (Servo–I/U, Getinge, Solna, Sweden). The EAdi signal is 
acquired using a dedicated nasogastric (feeding) catheter with nine ring-shaped electrodes 
positioned at the level of the diaphragm [31]. Computer algorithms within the ventilator 
software continuously select the electrode pair that is closest to the diaphragm, and correct 
for disturbances such as motion artifacts, esophageal peristalsis, and interference from 
the electrocardiogram or other nearby muscles. EAdi reflects crural diaphragm activity and 
is representative of activity from the costal parts of the diaphragm (and thus the whole 
diaphragm). In addition, the EAdi signal remains reliable at different lung volumes and was 
found to correlate well with transdiaphragmatic pressure (Pdi) in healthy individuals and ICU 
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patients [32, 33]. As respiratory drive comprises both an amplitude and duration component, 
the inspiratory EAdi integral may better reflect respiratory drive than EAdi amplitude alone.
Reference values
Normal values for EAdi are not yet known, but it is proposed that an amplitude of at least 
5 μV per breath in ICU patients is likely sufficient to prevent development of diaphragmatic 
disuse atrophy [1].
Limitations
As the EAdi amplitude varies considerably between individuals and normal values are 
unknown, recordings are mainly used to evaluate changes in respiratory drive in the same 
patient. EAdi during tidal breathing is often standardized to respiratory muscle pressure (i.e., 
neuromechanical efficiency index) [34] or to that observed during a maximum inspiratory 
contraction (i.e., EAdi%max) [7]. Although the latter was shown to correlate with the intensity 
of breathlessness in non-ventilated patients with chronic obstructive pulmonary disease 
(COPD) [35], it is generally not feasible to perform maximum inspiratory maneuvers in ICU 
patients. In addition, recruitment of accessory respiratory muscles is not reflected in the 
EAdi signal. Finally, suboptimal filtering of the raw diaphragm electromyography signal may 
affect validity to quantify respiratory drive with EAdi [34].
Airway occlusion pressure
The airway occlusion pressure at 100 milliseconds (P0.1) is a readily accessible and 
noninvasive measurement that reflects output of the respiratory centers. The P0.1 is the 
static pressure generated by all inspiratory muscles against an occluded airway at 0.1 
seconds after the onset of inspiration. The P0.1 was described over 40 years ago as an 
indirect measurement of drive that increases proportionally to an increase in inspiratory 
CO2 and directly depends on a neural stimulus (i.e., diaphragm electromyography or 
phrenic nerve activity) [36]. Advantages of P0.1 are that short and unexpected occlusions 
are performed at irregular intervals such that there is no conscious reaction (normal 
reaction time is >0.15 seconds) [36]. Second, the maneuver itself is relatively independent 
of respiratory mechanics, for the following reasons: 1) P0.1 starts from end-expiratory lung 
volume, meaning that the drop in airway pressure is independent of the recoil pressures of 
the lung or chest wall; 2) since there is no flow during the maneuver, P0.1 is not affected 
by flow resistance; and 3) lung volume during an occlusion does not change (with the 
exception of a small change due to gas decompression), which makes it unlikely that vagal 
volume-related reflexes or force-velocity relations of the respiratory muscles influence 
the measured pressure [7, 36]. In addition, the maneuver remains reliable in patients with 
respiratory muscle weakness [37], and in patients with various levels of intrinsic PEEP and 
dynamic hyperinflation [38]. Although the latter patient category shows an important delay 
between the onset of inspiratory activity at the alveolar level (estimated by esophageal 
pressure (Pes)) and the drop in airway pressure during an end-expiratory occlusion, Conti 




at the mouth and the drop in Pes at the first 0.1 seconds of the inspiratory effort (r = 0.92, 
bias 0.3 ± 0.5 cmH2O) [38]. The P0.1 can therefore be considered as a valuable index for 
the estimation of respiratory drive.
Reference values
During tidal breathing in healthy subjects, P0.1 varies between 0.5 and 1.5 cmH2O with an 
intra-subject breath-to-breath variability of 50%. Due to this variation, it is recommended 
to use an average of three or four P0.1 measurements for a reliable estimation of respiratory 
drive. In stable, non-intubated patients with COPD, P0.1 values between 2.4 and 5 cmH2O 
have been reported [7], and from 3 to 6 cmH2O in patients with the acute respiratory distress 
syndrome (ARDS) receiving mechanical ventilation [39]. An optimal upper threshold for P0.1 
was 3.5 cmH2O in mechanically ventilated patients; a P0.1 above this level is associated 
with increased respiratory muscle effort (i.e., an esophageal pressure-time product (PTP) 
>200 cmH2O∙s/min [40]).
Limitations
Although the P0.1 is readily available on most modern mechanical ventilators, each 
ventilator type has a different algorithm to calculate P0.1; some require manual activation 
of the maneuver, others continuously display an estimated value based on the ventilator 
trigger phase (i.e., the measured pressure decrease before the ventilator is triggered, 
extrapolated to 0.1 seconds), whether or not averaged over a few consecutive breaths. 
Considering that the trigger phase is often shorter than 0.05 seconds, P0.1 is likely to 
underestimate true respiratory drive, especially in patients with high drive [39]. The accuracy 
of the different calculation methods remains to be investigated.
In addition, extra caution is required when interpreting the P0.1 in patients with expiratory 
muscle activity; since recruitment of expiratory muscles results in an end-expiratory lung 
volume that may fall below functional residual capacity, the initial decrease in P0.1 during 
the next inspiration may not reflect inspiratory muscle activity solely, but comprises the 
relaxation of the expiratory muscles and recoil of the chest wall as well [7].
Inspiratory effort
Respiratory drive may also be inferred from inspiratory effort measured with esophageal 
and gastric pressure sensors. The derivative of Pdi (dPdi/dt) reflects respiratory drive only if 
both the neural transmission and diaphragm muscle function are intact. As such, high dPdi/
dt values reflect high respiratory drive. In healthy subjects, dPdi/dt values of 5 cmH2O/s are 
observed during quiet breathing [4]. dPdi/dt is often normalized to the maximum Pdi, but 
maximum inspiratory maneuvers are rarely feasible in ventilated ICU patients. A limitation 
of using Pdi-derived parameters is that Pdi is specific to the diaphragm and therefore 
does not include accessory inspiratory muscles, which are often recruited when respiratory 
drive is high. Calculating the pressure developed by all inspiratory muscles (Pmus) may 
overcome this. Pmus is defined as the difference between Pes (i.e., surrogate of pleural 
pressure) and the estimated pressure gradient over the chest wall. Other measurements 
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of inspiratory effort are the work of breathing and the PTP, which have been shown to 
correlate closely with P0.1 [41, 42]. However, all the above measurements require esophageal 
manometry, a technique that demands expertise in positioning of the esophageal catheter 
and interpretation of waveforms, making it less suitable for daily clinical practice. Another 
major limitation is the risk of underestimating respiratory drive in patients with respiratory 
muscle weakness; despite a high neural drive, inspiratory effort might be low.
A noninvasive estimate of inspiratory effort can be derived with diaphragm 
ultrasound. Diaphragm thickening during inspiration (i.e., thickening fraction) has shown 
fair correlation with the diaphragmatic PTP [43]. However, diaphragm ultrasound does 
not account for recruitment of accessory inspiratory and expiratory muscles, and the 
determinants of diaphragm thickening fraction require further investigation. Nonetheless, 
diaphragm ultrasound is readily available at the bedside, of relatively low cost and is 
noninvasive, and may therefore be a potential promising technique for the evaluation of 
respiratory drive.
STRATEGIES TO MODULATE RESPIRATORY DRIVE
Targeting physiological levels of respiratory drive or breathing effort may limit the impact 
of inadequate respiratory drive on the lungs, diaphragm, dyspnea sensation, and patient 
outcome. However, optimal targets and upper safe limits for respiratory drive and inspiratory 
effort may vary among patients, depending on factors such as the severity and type of lung 
injury (e.g., inhomogeneity of lung injury), the patient’s maximum diaphragm strength, 
and the presence and degree of systemic inflammation [3, 19]. In this section, we discuss 
the role of ventilator support, medication, and extracorporeal CO2 removal (ECCO2R) as 
potential clinical strategies for modulation of respiratory drive.
Modulation of ventilator support
Mechanical ventilation provides a unique opportunity to modulate respiratory drive by 
changing the level of inspiratory assist and PEEP. Ventilator settings directly influence 
PaO2, PaCO2, and mechanical deformation of the lungs and the chest wall, which are the 
main determinants of respiratory drive. Titrating the level of inspiratory support to obtain 
adequate respiratory drive and breathing effort might thus be an effective method to 
prevent the negative consequences of both high and low breathing effort on the lungs 
and diaphragm [44], although more research is required to determine optimal targets and 
the impact of such a strategy on patient outcomes.
Several studies have evaluated the effect of different ventilator support levels on 
respiratory drive during partially-supported mechanical ventilation [45, 46]. Increasing 
inspiratory support reduces respiratory drive, most evidently seen as reduction in EAdi 
amplitude (Figure 3) or in the force exerted by the respiratory muscles per breath. With high 
inspiratory assistance the patient’s respiratory effort may even decrease to virtually zero. 




If changing inspiratory support level has little to no influence on the patient’s respiratory 
drive, a clinician should consider whether the elevated respiratory drive originates from 








Figure 3. Influence of inspiratory support levels on the electrical activity of the diaphragm (EAdi). 
Example of a representative patient showing a decrease in EAdi in response to increasing levels of 
inspiratory pressure support (PS).
Medication
Drugs can affect the respiratory centers directly, or act by modulating the afferent signals 
that contribute to respiratory drive [2]. Opioids such as remifentanil act on the μ-receptors 
in the pre-Bötzinger complex. Remifentanil was shown to reduce the respiratory rate, while 
having little effect on the amplitude of the respiratory drive [30]. The effect of propofol 
and benzodiazepines is likely mediated by gamma-aminobutyric acid (GABA) receptors, 
which are widely distributed in the central nervous system. In contrast to opioids, these 
drugs reduce the amplitude of the respiratory drive while having little effect on respiratory 
rate [47].
Neuromuscular blocking agents (NMBA) block the signal transmission at the 
neuromuscular junction. These agents do not control drive per se, but can be used to reduce 
the mechanical output of the respiratory muscles. High doses of NMBA completely prevent 
breathing effort, which might protect against the effects of detrimentally high breathing 
effort, but could also contribute to diaphragm atrophy [5]. A strategy using low-dose NMBA 
to induce partial neuromuscular blockade allows for effective unloading of the respiratory 
muscles without causing muscle inactivity. Short-term partial neuromuscular blockade 
is feasible in ventilated patients [48]. The feasibility and safety of prolonged (24 hours) 
partial neuromuscular blockade and the effects of this strategy on respiratory drive and 
diaphragm function are currently under investigation (ClinicalTrials.gov: NCT03646266).
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Extracorporeal CO2 removal
ECCO2R (also known as low-flow extracorporeal membrane oxygenation) can be applied 
to facilitate lung-protective ventilation in patients with hypoxemic failure and respiratory 
acidosis due to low tidal volumes [49]. ECCO2R has been shown to reduce respiratory drive 
(EAdi and Pmus) in patients with ARDS and in patients with acute exacerbation of COPD 
[49, 50]. The feasibility, safety, and effectiveness of awake ECCO2R in patients with acute 
respiratory failure in order to limit excessive respiratory drive need further investigation. 
An ECCO2R strategy is probably more complex in this group, as the control of drive may be 
partly independent of PaCO2 (e.g., if the Hering-Breuer reflex is overwhelmed), and other 
organ dysfunctions and sepsis may complicate the clinical picture [49, 50].
CONCLUSION
Respiratory drive is the intensity of the output by the respiratory centers and determines 
the effort of the respiratory muscles. A combination of chemical, mechanical, behavioral, 
and emotional factors contribute to the respiratory drive. High and low respiratory drive in 
patients under mechanical ventilation may worsen or even cause lung injury and diaphragm 
injury, and should thus be prevented. Several techniques and interventions are available to 
monitor and modulate respiratory drive in critically ill patients. The impact of preventing 
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KEY POINTS
• Diaphragm weakness occurs rapidly during invasive ventilation and is associated with 
prolonged ventilator weaning and poor outcome.
• Prolonged low diaphragm activity can lead to disuse atrophy. Excessive respiratory 
muscle loading can cause diaphragm injury.
• A diaphragm-protective ventilation strategy enables a new opportunity to minimize, 
prevent or recover from the effects of invasive ventilation on the diaphragm.
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Effects of invasive ventilation on the respiratory muscles
INTRODUCTION
A disturbance in the balance between the capacity and loading of the respiratory muscles 
may result in respiratory failure. For these patients, invasive ventilation is a life-saving 
intervention that aims to reduce the work of breathing and improve gas exchange. While 
invasive ventilation can partially or completely unload the respiratory muscles, respiratory 
muscle function may deteriorate in ventilator-bound intensive care unit (ICU) patients. 
Compared to peripheral skeletal muscles, the diaphragm appears more affected by critical 
illness and invasive ventilation. Diaphragm weakness is associated with prolonged ventilator 
weaning, increased risks of ICU readmission and hospital readmission, and mortality. 
Therefore, it is of crucial importance to limit the detrimental effects of critical illness and 
invasive ventilation on the respiratory muscles.
While the respiratory muscle pump consists of multiple inspiratory and expiratory muscles, 
this chapter focuses on the diaphragm, the main muscle for inspiration. We summarize 
the prevalence of diaphragm muscle weakness in ventilated ICU patients and potential 
mechanisms causing ventilator-induced diaphragm dysfunction. Clinical implications of 
diaphragm dysfunction are discussed, as well as monitoring techniques and potential 
preventive and therapeutic strategies to limit the development of diaphragm weakness.
DEFINITION AND PREVALENCE OF DIAPHRAGM MUSCLE WEAKNESS 
IN ICU PATIENTS
The gold standard to assess in vivo diaphragm strength in ventilated patients is to measure the 
change in transdiaphragmatic pressure induced by magnetic stimulation of the phrenic nerves 
(Pdi,tw). This assessment provides a standardized measure of contractility, because it does not 
need the patient’s cooperation. As this technique requires invasive pressure measurements 
of the diaphragm using gastric and esophageal balloons, the change in twitch pressure 
generated at the outside tip of the endotracheal tube (Pet,tw) is proposed as a noninvasive 
surrogate. Using Pet,tw, diaphragm weakness has been defined as Pet,tw <11 cmH2O. With 
this definition, diaphragm weakness is already present within 24 hours after intubation in up to 
64% of ventilated patients, meaning that critical illness can impair diaphragm function at a very 
early stage, probably even before the patient is admitted to the ICU and exposed to invasive 
ventilation. At the time of initiation of ventilator weaning, incidence is even higher (63–80%).
A more feasible and readily available bedside technique to measure inspiratory 
muscle strength is the assessment of maximal inspiratory pressure (Pi,max). Pi,max can 
be measured in selected cooperative patients following a maximum inspiratory effort 
against a closed airway, using a hand-held device connected to the endotracheal tube 
or tracheostomy tube. Alternatively, in poorly cooperative patients, pressures can be 
assessed by performing a 20-second end-expiratory hold maneuver. Although Pi,max is 
poorly correlated with Pet,tw, high values for Pi,max exclude inspiratory muscle weakness, 




Ultrasound can be used to evaluate diaphragm function. Thickness of the diaphragm is best 
visualized at the zone of apposition (lateral rib cage between the 8th and 10th ribs). During 
inspiration, the diaphragm contracts and thickens. The magnitude of thickening (thickening 
fraction (TFdi)) during tidal breathing reflects the activity of the diaphragm. The TFdi during 
a maximal inspiratory effort (TFdi,max) has been used to estimate strength, in which a 
TFdi,max <20% was found indicative of severe diaphragm weakness. Using this definition, 
studies have shown that diaphragm weakness is present in 29% of patients at the time 
of the first spontaneous breathing trial and in 36% of patients at the time of extubation. 
In addition, changes in diaphragm end-expiratory thickness were observed over the first 
week of ventilation in 56% of patients. About 80% of these patients showed a decrease 
in thickness of >10%, which was associated with increased risk of delayed extubation.
CAUSES AND MECHANISMS
In this section we summarize three mechanisms by which invasive ventilation contributes 








Atrophy Injury / dysfunction
Diaphragm weakness
Sarcomere disruptionLoss of mass
Over-assistance
Eccentric contractions
Figure 1. Schematic illustration of invasive ventilation-related mechanisms involved in the devel-
opment of diaphragm weakness. Dashed lines represent uncertain causation.
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Disuse atrophy
There is strong evidence that disuse of the diaphragm due to ventilator over-assist is the 
critical contributor to diaphragm weakness. This has been demonstrated both in vivo 
and in vitro. Diaphragm inactivity is associated with activation of proteolytic pathways, 
which results in myofibrillar atrophy and contractile force reduction. Studies in animals 
and brain-dead patients suggest an important role for oxidative stress and mitochondrial 
dysfunction in the development of diaphragm weakness. However, recent studies 
investigating diaphragm biopsies from ICU patients showed significant diaphragm fiber 
atrophy and weakness in the absence of mitochondrial dysfunction and oxidative stress. 
Further research is required to understand the cellular mechanisms causing disuse atrophy. 
Importantly, ultrasound studies indicate that diaphragm atrophy occurs rapidly (<4 days) 
and that the change in diaphragm thickness (i.e., rate and magnitude) is correlated with 
the extent to which respiratory effort is suppressed by the ventilator.
Excessive loading
It has been demonstrated that, in non-ventilated patients, excessive inspiratory loading 
can result in diaphragm muscle injury and prolonged loss of force production. Whether 
inadequate ventilator support also results in diaphragm injury in critically ill patients is 
less clear. However, strong breathing efforts are common in patients on partially-assisted 
modes. In addition, histological patterns in the diaphragm muscle of these patients are 
consistent with load-induced injury. In addition to high breathing effort, patient-ventilator 
dyssynchrony, especially eccentric (lengthening) contractions, may promote load-induced 
diaphragm injury. Whether eccentric contractions are sufficiently severe and frequent 
to contribute to diaphragm weakness in ICU patients is yet unknown. Nevertheless, 
this emphasizes the importance of good patient-ventilator synchrony during invasive 
ventilation, which is another rationale for monitoring patient effort. The concept of load-
induced diaphragm injury may explain recent ultrasound findings in which an increase in 
diaphragm thickness of >10% during the course of invasive ventilation was associated 
with high levels of patient inspiratory effort and decreased likelihood of extubation. This 
increase in thickness possibly reflects muscle inflammation and edema.
Longitudinal atrophy
Diaphragm muscle loss affecting the length of muscle fibers was recently described as an 
effect of excessive positive end-expiratory pressure (PEEP). An increase in PEEP applied 
during invasive ventilation results in a larger end-expiratory lung volume and, consequently, 
shorter diaphragm length at the zone of apposition. Experimental work showed that PEEP 
results in a loss of sarcomeres, resulting in a decreased optimal length for force generation. 
If similar effects occur in the human diaphragm, an acute reduction in PEEP (i.e., during a 
spontaneous breathing trial) would result in an overstretched diaphragm above its adapted 
optimal length and, consequently, result in diaphragm dysfunction. The clinical relevance 





In critically ill patients, it is likely that multiple factors play a role in the development or 
aggravation of diaphragm weakness. Next to the mechanisms related to invasive ventilation, 
the diaphragm can be involved in shock-related organ failure present at the time of ICU 
admission. For instance, animal studies have demonstrated that cardiogenic shock is 
associated with contractile impairment and fatigue of the respiratory muscles, resulting from 
increase in diaphragm work and reduction in diaphragm oxygen delivery. In addition, sepsis 
could impair diaphragm force through activation of inflammation in the muscle. There is some 
evidence that medication such as sedatives, neuromuscular blockers and corticosteroids 
affect the severity of diaphragm weakness, but this is beyond the scope of this chapter.
DIAPHRAGM-PROTECTIVE VENTILATION
Considering the potentially detrimental effects of controlled invasive ventilation on the 
diaphragm, there is a strong rationale for applying partially-assisted ventilator modes when 
feasible and safe. Maintaining spontaneous breathing under invasive ventilation should 
minimize disuse atrophy, and avoiding excessive spontaneous inspiratory efforts potentially 
limits the development of load-induced diaphragm injury. In clinical practice, we should 
aim to titrate inspiratory support and sedation to maintain levels of inspiratory effort that 
are considered physiological (Figure 2).
Further research is needed to define the optimal level of inspiratory effort in critically 
ill patients. This probably depends on the underlying condition, the maximal strength of 
the diaphragm, and respiratory rate. Until further data are available, it seems reasonable 
from a physiological perspective to maintain a breathing effort similar to that of healthy 
subjects at rest. A study in patients weaning from invasive ventilation showed that patients 
who were successfully weaned from the ventilator exhibited inspiratory effort within this 
physiological range (approximately 4–8 cmH2O). In addition, using ultrasound, patients 
with a TFdi of 15–30% during the first 72 hours of invasive ventilation had the shortest 
duration of ventilation.
A diaphragm-protective ventilation strategy enables a new opportunity to minimize, 
prevent or recover from the effects of invasive ventilation on the diaphragm. To apply such 
a strategy, bedside monitoring of breathing effort is required.
Atrophy InjuryPhysiological range
 Diaphragm activity
Figure 2. Concept of diaphragm-protective ventilation: aiming to keep diaphragm activity within 
physiological range and preventing muscle atrophy and injury.
53
Effects of invasive ventilation on the respiratory muscles
MONITORING TECHNIQUES FOR THE DIAPHRAGM
Today, the state-of-the-art method for monitoring respiratory muscle effort is assessment 
of changes in pleural pressure using an esophageal balloon catheter. This enables direct and 
continuous measurement of inspiratory effort. However, this technique requires expertise 
in positioning of the catheter and interpretation of waveforms. Recommended reading 
regarding this monitoring technique is provided in the reading list at the end of this chapter.
With the introduction of neurally adjusted ventilatory assist (NAVA), a mode for 
partially-assisted ventilation that synchronizes ventilation to diaphragm electrical activity 
(EAdi), continuous monitoring of crural EAdi has become available for ICU patients. EAdi 
is measured using a dedicated nasogastric feeding tube with embedded electrodes at the 
level of the diaphragm. The EAdi curve can be displayed during any mode of ventilation 
and is a valuable tool for detecting diaphragm inactivity, ventilator over-assistance and 
patient-ventilator asynchronies.
Ultrasound is a noninvasive and feasible bedside technique for assessment of 
diaphragm excursions, thickness and thickening. Detailed information on diaphragm 
ultrasound is provided elsewhere in this book.
PREVENTION AND THERAPEUTIC STRATEGIES
Few studies have evaluated strategies to improve respiratory muscle function in patients 
with critical illness-associated diaphragm weakness. This section will summarize the role 
of pharmacological interventions and training of inspiratory muscles.
Today, no drug is approved to improve respiratory muscle function. There has been 
interest in improving contractile efficiency of muscle fibers by using phosphodiesterase-4 
inhibitors or the calcium sensitizer levosimendan. In a retrospective cohort study, 
improvement in diaphragm movement was found in 21 out of 40 patients with ventilator-
induced diaphragm dysfunction after receiving a low dose of theophylline. However, 
theophylline has a narrow non-toxic therapeutic range, which limits its applicability and 
safety in clinical practice. Levosimendan has been shown to enhance contractile efficiency 
of muscle fibers isolated from the diaphragm of healthy subjects and patients with COPD. 
In addition, in healthy volunteers it was demonstrated that levosimendan improved 
neuromuscular efficiency of the diaphragm and reversed fatigue. The effect of this drug 
on the diaphragm function of ICU patients remains to be investigated.
Inspiratory muscle training (IMT) is safe and feasible in ICU patients. A typical hand-held 
inspiratory threshold device that can be used for IMT is shown in Figure 3. Patients should be 
sufficiently alert to cooperate with the training method. When performing IMT, the patient is 
disconnected from the ventilator and the device is connected to the tracheostomy tube or 
endotracheal tube with the cuff inflated. Different loading protocols have been applied. We 
use the protocol applied by Martin et al. (2011): four sets of 6–10 loaded breaths. Loading 




gradually increased daily as tolerated. This strategy has been shown to improve Pi,max 
and to reduce the duration of ventilator weaning. Optimal training protocols should be 
further developed and the impact of IMT on clinical outcomes requires future studies. Other 
strategies that are currently being investigated are phrenic nerve pacing for the prevention 
of disuse and restoring diaphragm function. Phrenic nerve pacing has been applied in 
experimental and human studies, using a transvenous phrenic nerve pacing system designed 
to be applied percutaneously in the left subclavian vein. Whether there is a potential role of 
phrenic nerve pacing in difficult-to-wean ICU patients will be determined in the near future.
Figure 3. Threshold IMT device. The threshold can be increased by adjusting the spring length.
SUMMARY
Invasive ventilation may have detrimental effects on the respiratory muscles. A diaphragm-
protective ventilation strategy therefore has great potential for improving patient outcomes. 
Clinicians should consider monitoring respiratory muscle effort during the course of invasive 
ventilation. The right balance between lung-protective ventilation, adequate gas exchange, 
patient comfort and maintaining inspiratory effort may be challenging to achieve. Further 
studies are needed to determine the optimal level for inspiratory effort and the effects of 
a diaphragm-protective ventilation strategy on patient outcomes.
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ABSTRACT
Recent studies have shown both beneficial and detrimental effects of patient breathing 
effort in mechanical ventilation. Quantification of breathing effort may allow the clinician 
to titrate ventilator support to physiological levels of respiratory muscle activity. In this 
review we will describe the physiological background and methodological issues of the 
most frequently used methods to quantify breathing effort, including esophageal pressure 
measurements, the work of breathing, the pressure-time product, electromyography and 
ultrasound. We will also discuss the level of breathing effort that may be considered optimal 
during mechanical ventilation at different stages of critical illness.
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INTRODUCTION
In the past decade, multiple important studies have underlined that maintaining patient 
breathing effort during mechanical ventilation is a double-edged sword [1–5]. Positive 
effects of patient breathing effort may include improved recruitment of basal lung fields and 
facilitated oxygenation [5, 6]. Furthermore, preserving patient breathing effort might protect 
against the development of diaphragm atrophy and contractile dysfunction resulting from 
disuse [2]. On the other hand, patients with high respiratory drive can generate pressures 
that are incompatible with lung-protective ventilation, a phenomenon termed patient 
self-inflicted lung injury (P-SILI) [7]. Additionally, studies in the early course of the acute 
respiratory distress syndrome (ARDS) have demonstrated that continuous infusion of the 
neuromuscular blocker cisatracurium improves survival, possibly by abolishing breathing 
effort [4]. Striking a balance between the beneficial and detrimental effects of breathing 
effort is one of the contemporary challenges in mechanical ventilation management [8]. 
It has been proposed that ventilator assist should be titrated to the individual patient’s 
disease state, based on the respiratory drive, pressure output of the respiratory muscles, 
and lung mechanics [5, 8–10].
However, it is difficult to assess activity of the respiratory muscle pump during 
mechanical ventilation without specific diagnostic techniques [11]. The “gold standard” 
parameters are the work of breathing (WOB) and the pressure-time product (PTP), which 
are based on pressure measurements [12]. These measurements can be difficult to obtain 
and interpret. As such, the PTP and WOB are rarely used in clinical care and are mostly 
considered to be a research tool [13]. Recently, diaphragm electromyography [9] and 
ultrasound [14] have become increasingly popular to assess breathing effort in research and 
clinical care. The aim of this review is to describe the physiological basis of breathing effort 
assessment. We will discuss how esophageal pressure (Pes), gastric pressure (Pga), PTP, 
WOB, ultrasound and electromyography can be used to quantify breathing effort during 
mechanical ventilation, and highlight the technical issues related to these measurements. 
Furthermore, we will discuss which levels of breathing effort may be considered desirable 
during mechanical ventilation at different stages of critical illness.
PHYSIOLOGY
Definition of breathing effort
Although the term breathing effort feels intuitive, there is no clear definition, and many 
authors and textbooks define it differently. In this review we have defined breathing effort 
as any energy-consuming activity of the respiratory muscles aimed at driving respiration.
Function of the respiratory muscle pump
The respiratory muscle pump compromises multiple skeletal muscles that act in a 




Breathing effort is tightly controlled to match the respiratory demands of the body. An 
imbalance between breathing effort and the respiratory demands of the body will result in 
respiratory failure. Mechanical ventilation is life-saving in respiratory failure by taking over 
the patient’s WOB, restoring the balance between respiratory load and capacity. During 
partially-supported ventilation, the WOB is shared by the patient and the ventilator. To 
assess the patient’s relative contribution to ventilation, it is useful to separate the inspiratory 
and expiratory muscle pump. See Figure 1 and Table 1 for a schematic representation of 
the respiratory system, muscle pressures and pressure gradients.
Inspiratory muscle pump
Inspiration is mainly driven by the diaphragm in healthy individuals during tidal breathing 
[15]. The diaphragm is a thin (±2.0 mm) dome-shaped muscle that forms the boundary 
between the thorax and the abdomen [16]. The muscle fibers are conventionally divided 
into two main components: the crural portion inserts into the first three lumbar vertebrae, 
and the costal portion projects onto the rib cage and xiphoid process. The muscle fibers 
of the costal diaphragm that directly appose to the lower rib cage constitute the “zone 
of apposition” [16–18]. In simplified form, the diaphragm acts like a piston in a barrel. 
Shortening of the muscle fibers in the zone of apposition descends the dome of the 
diaphragm, increasing the size of the thoracic cavity and compressing the abdominal cavity. 
Consequently, intrapleural pressure (Ppl) falls and abdominal pressure (Pab) rises, creating 
a pressure gradient called the transdiaphragmatic pressure (Pdi) [19,20]:
Pdi (cmH2O) = Pab (cmH2O) – Ppl (cmH2O)    (1)
The drop in pleural pressure will generate a pressure gradient over the lungs, the 
transpulmonary pressure (PL), which can be calculated by subtracting Ppl from the airway 
opening pressure (Pao):
PL (cmH2O) = Pao (cmH2O) – Ppl (cmH2O)     (2)
The cyclic rises and falls in PL ultimately drive alveolar ventilation.
Clinically, Ppl and Pab are often estimated by Pes and Pga. The assessment of Ppl and 
Pab requires placement of esophageal and/or gastric balloons (Figure 1), which may be 
perceived as too invasive for some patients. Today, balloon catheters are available that can 
be used for gastric feeding as well; thus, assessing Pes and/or Pga is not more invasive 
than routine clinical care [13]. It is important to note that the balloon catheters provide 
an estimation of pleural pressure, but the actual pressure in the pleural space differs 
from region to region due to gravity and differences in spatial respiratory mechanics [21]. 
Nevertheless, Pes measurements provide a useful estimation of the mean pleural pressure 
at the dependent lung regions [21, 22]. The advantages, limitations and technical aspects 
of Pes and Pga measurements in critically ill patients have been discussed in two excellent 
review articles [23, 24].
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Figure 1. Schematic representation of the respiratory system and relevant pressures. Note the single 
catheter equipped with an esophageal pressure balloon, gastric pressure balloon and an electrode 
array in between the two balloons. For calculations of the pressure gradients, we refer to the text. 
Abbreviations: Palv, alveolar pressure; Pao, airway opening pressure; Paw, airway pressure; Pbs, 
pressure at the body surface; Pes, esophageal pressure; Pga, gastric pressure; Ppl, pleural pressure.
Table 1. Pressure gradients of the respiratory system.
Gradient name Abbreviation Formula Clinical assessment
Transpulmonary pressure PL Pao – Ppl Paw – Pes
Transalveolar pressure/elastic recoil 
pressure of the lung
Pel(L) Palv – Ppl Paw (zero flow) – Pes
Transdiaphragmatic pressure Pdi Pab – Ppl Pga – Pes
Pressure gradient over the chest wall Pcw Ppl – Pbs Pes (as Pbs is conventionally 0)
Pressure gradient over the respiratory 
system
Prs Pao – Pbs Paw (as Pbs is conventionally 0)
Abbreviations: Pab, abdominal pressure; Palv, alveolar pressure; Pao, airway opening pressure; Paw, 





Additional muscle groups are recruited when the respiratory load is elevated. The most 
important accessory inspiratory muscles are the sternocleidomastoid, parasternal, scalene 
and rib cage muscles [25]. Like the diaphragm, contraction of the accessory inspiratory 
muscles expands the thorax and lowers Ppl, promoting a rise in PL and subsequent lung 
inflation. Contraction of accessory inspiratory muscles does not generate a pressure 
gradient between the abdominal and thoracic compartment if the diaphragm is relaxed 
[12]. At any time, Ppl depends on the pressure generated by all the respiratory muscles 
(Pmus) and the pressure gradient over the chest wall (Pcw):
Ppl (cmH2O) = Pmus (cmH2O) + Pcw (cmH2O)    (3)
Accordingly,
Pmus (cmH2O) = Ppl (cmH2O) – Pcw (cmH2O)    (4)
Pmus provides a global assessment of all inspiratory muscles, while Pdi is specific to the 
diaphragm [12, 26]. Pcw is often calculated by dividing the inspired volume by the theoretical 
compliance of the chest wall (Ccw), estimated as 4% of vital capacity. Accordingly, a 
(predicted) vital capacity of 4000 mL will reveal an estimated Ccw of 160 mL/cmH2O [12]. 
Reference values for Ccw are between 150 and 200 mL/cmH2O [12]. However, these values 
were obtained in healthy subjects and might not be accurate in critical illness. The actual 
Ccw of a patient can be determined by constructing a pressure-volume curve for Pes during 
passive inflation; Pmus is zero during passive inflation and muscle paralysis, meaning that 
the observed Pes is completely determined by Pcw (see Equation 3) [26].
Expiratory muscle pump
Expiration is a passive process during quiet breathing [19, 26, 27]. When the inspiratory 
muscles relax, the elastic energy build up in the structures of the respiratory system drives 
lung deflation. The expiratory muscles are recruited to assist in expiration when the load 
imposed on the inspiratory muscles is elevated [28]. Additionally, the expiratory muscles 
are recruited when passive expiration is hampered by reduced elasticity of the lungs (e.g., 
emphysema) or elevated expiratory resistance (e.g., exacerbation of chronic obstructive 
pulmonary disease (COPD)) [29]. The abdominal wall muscles are the principal muscles 
of expiration. The internal interosseous intercostal and the triangularis sterni muscles are 
accessory expiratory muscles [25]. Contraction of the abdominal wall muscles compresses 
the abdominal compartment, increasing Pab. If the diaphragm is relaxed, the increased 
Pab will be transmitted to the thorax and will increase Ppl, facilitating lung deflation. 
Contraction of the accessory expiratory muscles directly increases Ppl by compressing 
the thorax. Notably, the expiratory muscles can also facilitate inspiration. By contracting 
during the expiratory phase, lung volume is reduced below functional residual capacity and 
the diaphragm is shifted cephalad to a more optimal position [30, 31]. When the expiratory 
muscles relax during the subsequent inspiration, the diaphragm will descend and Ppl will 
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fall, facilitating lung inflation [30]. During high respiratory loads, the expiratory muscles 
might generate more pressure than the diaphragm [32]. Therefore, assessment of breathing 
effort at high loads should also take the expiratory muscles into account.
QUANTIFYING BREATHING EFFORT
Physical examination and graphical inspection of ventilator waveforms
Physicians may rely on physical examination to assess breathing effort in clinical practice. 
For instance, recruitment of accessory muscles is a sign of increased respiratory workload 
[32]. Inward movement of the abdomen during inspiration (abdominal paradox) means that 
the accessory muscles exert more force than the diaphragm, which is often interpreted as 
a sign of impending diaphragm fatigue [33]. Most patients develop a breathing pattern 
characterized by low tidal volumes and high respiratory frequency during prolonged 
fatiguing loads [34]. However, these breathing patterns suggest an increased workload and 
impending fatigue, but do not allow quantitative assessment of breathing effort [35]. The 
pressure and flow waveforms displayed on the ventilator are also inadequate in assessing 
breathing effort during partially-supported ventilation, as they cannot distinguish between 
patient breathing effort and the work of the ventilator [11].
Pressure-based quantification of breathing effort
Because the respiratory muscles exert their function by generating pressure, breathing 
effort can be assessed by analysis of these pressures. The requirements and reference 
values of pressure-based assessment of breathing effort are summarized in Table 2.
Pressure amplitudes
If an esophageal and a gastric balloon are present, the amplitude of tidal swings in Pes, 
Pdi and Pga can be studied during partially supported ventilation by using the following 
calculation:
ΔP (cmH2O) = P,expiration (cmH2O) – P,inspiration (cmH2O)   (5)
The formula can be used with Pes, Pga and Pdi to obtain their respective amplitude during 
inspiration and expiration. If the patient’s respiratory muscles are active, Pes will fall and 
Pga and Pdi will rise during inspiration (Figure 2a-d). A rise in Pga during expiration is a sign 
of expiratory muscle recruitment.
Pressure amplitude assessment is relatively straightforward and can be performed 
real-time at the bedside, making it especially useful to observe trends within a patient. 
However, there are several limitations to assessment of breathing effort based on Pes 
and Pga swings solely. Amplitude of pressure swings neglects the duration and frequency 
of muscle contractions. Additionally, Pes swings are usually not corrected for the recoil 




can result in both underestimation and overestimation of Pmus. Consequently, pressure 
swings show a rather poor correlation to energy expenditure [35]. More in-depth analysis 
of breathing effort may be warranted in selected critically ill patients.
Table 2. Techniques for the assessment of breathing effort.
Technique Parameters Reference values Comments
Pressure 
amplitudes
Pes, Pga, Pdi Pdi and Pes: absolute 
differences of 5–10 
cmH2O per breath in 
healthy subjects at rest 
[10, 20, 36, 37]
Suitable for bedside 
evaluation without the 






Further analysis: Ccw, CL,dyn
2.4–4 J/min [38, 39] 
and 0.35–0.7 J/L [12, 




Can be divided into 
elastic, resistive and 
PEEP components
Viable during high 
minute ventilation and 
flow





Further analysis: Ccw, CL,dyn
50–150 cmH2O∙s/min 
in healthy subjects at 
rest [23, 40, 41]
Advanced breathing 
effort assessment
Can be divided into 
elastic, resistive and 
PEEP components




Pes, Pga, Pdi, Pi,max, Ti/Ttot 0.03 in healthy 
subjects at rest [42]
TTIdi up to 0.15–0.18 
can be continued 
indefinitely [43]
Useful to predict 
whether the observed 
effort can be sustained
Corrects for reduced 
muscle efficiency
Pi,max can be difficult 
to obtain in ICU 
patients
Abbreviations: Ccw, compliance of the chest wall; CL,dyn, dynamic lung compliance; ICU, intensive 
care unit; PEEP, positive end-expiratory pressure; Pdi, transdiaphragmatic pressure; Pes, esophageal 
pressure; Pga, gastric pressure; Pi,max, maximal inspiratory pressure; Ti, inspiratory time; TTIdi, 
diaphragmatic tension-time index; Ttot, total respiratory cycle time.
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Figure 2. Pressure-based assessment of inspiratory breathing effort. Dashed lines in the flow-time 
and pressure-time curves represent moments of zero flow. (a) Flow waveform. (b) Gastric pressure 
(Pga) waveform. (c) Transdiaphragmatic pressure (Pdi) waveform, calculated as Pga minus esoph-
ageal pressure (Pes). The gray area represents the pressure-time product (PTP) of the diaphragm 
during inspiration. Note the presence of Pdi increase before the onset of inspiratory flow; a sign of 
intrinsic positive end-expiratory pressure (PEEPi). (d) Pes waveform. The recoil pressure of the chest 
wall (Pcw), estimated at 4% of vital capacity, has been superimposed on the Pes tracing at the onset 
of the decrease in Pes (upper bound of Pcw) and at the onset of inspiratory flow generation (lower 
bound of Pcw), as well as the lung recoil pressure as derived from the dynamic lung compliance 
(CL,dyn). The colored area comprises the total PTP of respiratory muscle pressure (Pmus): the dark 
green area represents the PTPmus attributed to PEEPi, the light green area represents the elastic 
PTPmus, and the light blue area represents the resistive PTPmus. (e) Pressure-volume loop of the 
changes in Pes and lung volume during the presented breath, also known as the Campbell diagram. 
The chest wall compliance (Ccw) curve and CL,dyn curve intersect at functional residual capacity 
(FRC). The dark green area represents the WOB attributed to PEEPi, the light green area represents 
the elastic WOB, and the light blue area represents the resistive WOB.
Pressure-time product (PTP)
A more sophisticated parameter to quantify breathing effort is the PTP. The PTP is 
calculated as the time integral of the Pmus [12]:
PTP = P (cmH2O) × t (s) = ∫ Pdt (cmH2O·s)     (6)
PTP is commonly reported over a 1-minute interval. The PTP of the respiratory muscle pressure 




respiratory muscle activity (Figure 2d). If Pga is also available, the PTP of the diaphragm 
pressure (PTPdi) can be constructed as a specific measurement of diaphragm effort (Figure 
2c). Because the PTP is sensitive to the frequency and duration of contractions, it correlates 
well with energy expenditure during a broad range of inspiratory loadings [44]. The PTP is 
insensitive to changes in volume, meaning that it is also valid when effort does not result in 
volume generation, such as during isometric contractions. This is especially relevant in ICU 
patients with PEEPi and poor interaction with the ventilator, that exhibit ineffective efforts [45]. 
The PTP of the esophageal pressure (PTPes) can be divided into parts to overcome elastic, 
resistive and threshold (i.e., PEEPi) forces (Figure 2d). This subdivision may be of clinical 
interest in patients who are difficult to wean off the ventilator, or to monitor effects of ventilator 
management and pharmacological interventions. The technical aspects of measuring the 
PTP have been covered recently [23, 24]. It is also possible to construct a PTP of the expiratory 
muscles (PTPex) [46], but this technique is seldom used and reference values are not 
available. More research is required before overall recommendations on PTPex can be made.
There are limitations to the PTP. First, volume and flow are not considered, even though 
contractions at higher flows and volumes are less efficient and thus require more effort. This 
has been demonstrated in studies where equal PTPs were generated at different flows and 
volumes. This resulted in widely different levels of the oxygen cost of breathing at equal 
PTPs [44, 47]. Furthermore, calculation of PTPmus requires measurement of Ccw, which 
is cumbersome in patient on partially-supported ventilation as it requires passive inflation 
and muscle paralysis [12]. Despite these limitations, the PTP is very useful as it is linearly 
related to activity and energy expenditure of the respiratory muscle pump during relatively 
constant ventilation. This was demonstrated in conditions of flow below 1 L/s [48] and duty 
cycles between 0.3 and 0.6 [44], which is applicable to most ICU patients [36].
Tension-time index (TTI)
Another method to assess breathing effort is the TTI, which relates the average inspiratory 
pressure (Pi,mean) to the maximal inspiratory pressure (Pi,max) that a patient can generate:
TTI = (Pi,mean/Pi,max) × (Ti/Ttot)     (7)
in which Pi,mean can be either Pdi,mean or Pmus,mean, and Ti/Ttot is the relative duration 
of inspiration to a full breath cycle. For example, generating a Pdi,mean equal to 30% of 
Pdi,max at a duty cycle of 0.5 would yield a diaphragmatic TTI (TTIdi) of 0.15.
Some ventilators can calculate Pi,mean over a time period of a few breaths. Additionally, 
it is possible to obtain the Pi,mean by dividing the inspiratory PTP by the sampling period 
[12]. The advantage of TTI over other indices is that the TTI partially corrects for reductions 
in muscle efficiency and weakness by relating the observed pressures to the maximal 
pressures. The TTI correlates well with oxygen consumption of the respiratory muscle pump 
[43, 44]. The TTI is also correlated with the time that a certain load can be upheld by the 
diaphragm. In healthy individuals a TTIdi below 0.15–0.18 can be sustained indefinitely, 
while higher values will eventually lead to fatigue and task failure [43, 49].
69
Assessing breathing effort in mechanical ventilation: physiology and clinical implications
There are some technical and theoretical limitations of the TTI. Technically, it is difficult to 
obtain reliable Pi,max measurements in critically ill patients as it requires maximal voluntary 
efforts which is hindered by sedation and motivation [12]. Furthermore, the TTI does not 
take volume and flow into account. This was illustrated in two studies where the maximal 
sustained TTIdi ranged from 0.11 to 0.22 and the maximal sustained TTI of the respiratory 
muscles ranged from 0.16 to 0.32 within the same subject, depending on flow, volume 
and duty cycles [50, 51]. Despite these limitations, the TTI is a clinically useful parameter, 
especially to assess whether a load imposed on the patient’s respiratory muscle pump is 
sustained.
Work of breathing (WOB)
The classic method to assess breathing effort is the WOB. Work is done when a force moves 
its point of application over a distance. In case of the respiratory system work is done when 
a pressure changes the volume of the system [26]:
WOB = P (cmH2O) × V (L) = ∫ PdV (J)     (8)
WOB is often reported as work per liter (J/L), obtained by dividing the work per breathing 
cycle by the tidal volume. Increased work per liter means that more pressure is required 
to generate an equal volume. This can be caused by several factors, such as reduced lung 
compliance or the presence of PEEPi [52]. Detailed analysis of the WOB is possible using the 
Campbell diagram to divide work into resistive, elastic and PEEPi components (Figure 2e) 
[23, 26, 52]. Furthermore, WOB of the expiratory muscles can be assessed by attributing any 
observed Pes exceeding the Ccw curve to expiratory muscle activity. Additionally, work per 
breathing cycle can be multiplied by the respiratory rate (in breaths per minute) to obtain the 
power of breathing, or work rate [12]. This is an interesting parameter from a physiological 
point of view, as it combines time and volume dimensions. Work rate correlates closely to 
oxygen consumption of the respiratory muscles in a wide range of flows, volumes and duty 
cycles [44, 47]. It has been proposed that the work rate, or mechanical power, is a unifying 
factor that might predict development of ventilator-induced lung injury (VILI) [53, 54].
There are limitations to WOB. First, as work is only performed when a volume is 
displaced, the WOB is insensitive to isometric contractions. Second, duration and frequency 
of contractions are also not considered. For example, the same breath might generate 
the same tidal volume at the same Pes, but could take twice as long. Work would not 
be different between these two breaths, even though the longer breath will consume 
substantially more energy.
Other methods to quantify breathing effort
Other techniques to quantify breathing effort that do not depend on direct assessment of 
pressure have been developed, including the electrical activity of the diaphragm (EAdi) and 





Neural control of breathing effort is tightly matched to the respiratory demands of the body. 
As such, both surface electrodes and electrodes placed on a nasogastric tube have been 
used to acquire electromyography signals of the respiratory muscles in order to assess 
breathing effort in research and clinical care.
Surface electrodes have been used to measure activity of the diaphragm, accessory 
respiratory muscles and expiratory muscles. Although noninvasive, the quality of the 
recordings can be heavily impaired by cross-talk of adjacent muscles and other factors 
such as fat, edema and movement artifacts [60, 61]. Furthermore, there are no standardized 
procedures for placement and analysis of the surface electrode signals and no reliable 
reference values are available. Therefore, further study is required before this technique 
can be used to quantify breathing effort in clinical care.
The EAdi signal circumvents some of the technical difficulties of surface electromyo-
graphy. EAdi can be monitored real-time using a dedicated nasogastric tube with wired 
electrodes positioned at the level of the crural diaphragm (Figure 1) [62]. This catheter was 
originally designed to control the ventilator in a specific ventilation mode (neurally adjusted 
ventilatory assist (NAVA)), but recent reports indicate that EAdi recordings are also useful to 
monitor breathing effort and patient-ventilator interaction [63–65]. Measurement of EAdi 
does generally not require additional invasive procedures as most ventilated ICU patients 
are instrumented with a feeding tube for regular care. The electrodes acquire the spatial 
and temporal summation of action potentials from the motor units in the crural diaphragm. 
There is a close correlation between electrical activity from the crural and costal parts of the 
diaphragm [66]. Furthermore, the EAdi signal is independent of changes in lung volume [67]. 
EAdi correlates well to Pdi in healthy individuals and ICU patients [67]. Thus, EAdi appears 
to be a reliable estimate of global diaphragm muscle activity in ICU patients [68–70].
Electrical activity is not synonymous with muscle contraction and force generation. 
The coupling between electrical activity and pressure is expressed as the neuromuscular 
efficiency (NME) index:
NME (cmH2O/μV) = Pdi (cmH2O) / EAdi (μV)    (9)
The NME can be used to calculate pressure from EAdi when assuming constant coupling 
over time. NME obtained during expiratory holds and multiplied by the observed EAdi 
appeared to be a reliable estimation of Pmus under different conditions of ventilator 
assistance [9]. Another index derived from the EAdi is the patient-ventilator breath 
contribution (PVBC) index. The PVBC estimates the patient’s relative contribution to tidal 
volume generation during NAVA by comparing EAdi peaks with tidal volume in assisted 
and non-assisted breaths [71]. The PVBC reliably predicted the fraction of breathing effort 
generated by the patient in a small group of ARDS patients [72].
Although promising, there are still limitations of EAdi-derived parameters to assess 
breathing effort: EAdi-derived parameters are not necessarily a direct measure of breathing 
effort, but are more closely related to neural drive. In addition, EAdi is insensitive to 
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recruitment of accessory muscles, making it less suited to assess breathing effort at high 
workloads. Furthermore, reference values for EAdi-derived parameters are not yet known. 
NME and PVBC indices need to be further evaluated in larger ICU populations before both 
indices can be widely implemented in daily clinical practice.
Table 3. Parameters, reference values, and comments of electromyographic assessment of breathing 
effort.
Technique Parameters Reference values Comments
Electrical activity of the 
diaphragm (EAdi)
EAdi amplitude Amplitude of 5–20 
μV per breath in ICU 
patients (expert 
opinion)
Parameter of respiratory 
drive





EAdi, Pes, Pga 0.5–2 cmH2O/μV in 
ICU patients
(expert opinion)




EAdi and Vt during 
assisted and 
unassisted breaths
Unavailable Not yet validated in larger 
ICU cohorts
Surface electromyography Electrical activity
during inspiration 
and expiration
Unavailable Noninvasive, but 
hampered by cross-talk of
adjacent muscles and 
movement artifacts
Abbreviations: EAdi, electrical activity of the diaphragm; EMG, electromyography; NME, neuromuscular 
efficiency; Pes, esophageal pressure; Pga, gastric pressure; PVBC, patient-ventilator breath 
contribution; Vt, tidal volume.
Ultrasound
Ultrasound has gained in popularity as a diagnostic tool in clinical management and 
research in the ICU [14]. The role of ultrasound to evaluate respiratory muscle function 
and effort have been discussed in recent articles [65, 73]. Components of the respiratory 
muscle pump, including the diaphragm, abdominal wall muscles and accessory muscles, 
are positioned relatively superficial and are readily accessible for ultrasound. Changes in 
the absolute thickness of the respiratory muscles over time within a patient can be used to 
recognize the development of atrophy [2, 74, 75]. The thickening fraction of the diaphragm 
(TFdi) in the zone of apposition during inspiration can be used as a measure of contractile 
activity [76, 77]. This requires measurement of diaphragm thickness (Tdi) at end-expiration 
(Tdi,ee) and end-inspiration (Tdi,ei) [73]:
TFdi = (Tdi,ei − Tdi,ee) / Tdi,ee × 100%     (10)
TFdi has shown fair correlation to the Pdi [78], PTPdi and PTPes [76, 77] in some studies, 




Movement of the diaphragm dome during inspiration has also been used to evaluate 
diaphragm function and reference values are available (Table 4). To study diaphragm 
movement, the ultrasound probe is placed at the subcostal position, using the liver as a 
window on the right side and the spleen on the left side. In contrast to the TFdi, assessment 
of diaphragm movement should only be conducted in patients disconnected from the 
ventilator, as ventilator assistance will result in caudal movement of the diaphragm, even 
in a patient on neuromuscular blockers. As such, there is a poor correlation between 
diaphragm excursion and TFdi, PTPes and PTPdi during partially-supported ventilation [77].
Advantages of ultrasound include the noninvasive nature, low costs, steep learning curve 
and straightforward calculations which allows bedside evaluation of breathing effort [73]. 
However, several technical and methodological limitations apply to ultrasound assessment 
of breathing effort. Because the diaphragm is very thin, small errors in measurement can 
result in large overestimation and underestimation of thickness and thickening fraction 
[73]. Additionally, the left hemidiaphragm is harder to visualize than the right side [78]. 
Furthermore, TFdi is insensitive to duration and frequency of contractions and does not 
account for recruitment of accessory and expiratory muscles [59]. Despite these limitations, 
ultrasound is a very promising technique in clinical care, especially as a bedside evaluation tool.
Table 4. Parameters, reference values, and comments of ultrasound assessment of breathing effort.
Technique Parameters Reference values Comments
Diaphragm thickness (Tdi) Diaphragm thickness 
at end-expiration
1.5–2.4 mm [55, 56] Noninvasive and useful 
to assess development 
of atrophy
Not a measurement of 
effort per se
Left hemidiaphragm 
may be difficult to 
visualize
Thickening fraction (TFdi) TFdi = (Tdi,ei − Tdi,ee) 
/ Tdi,ee × 100%
24–53% during 
quiet breathing [57], 
up to 157% during 
vigorous effort [58]
Does not allow for 
direct quantification of 
muscle pressures
Caudal displacement M-mode diaphragm 
displacement during 
tidal breathing
1.6–1.8 cm during 
quiet breathing, up 
to 7.5 cm during 
deep breathing [59]
Cannot distinguish 
patient work from 
ventilator work during 
partially-supported 
ventilation
Abbreviations: Tdi (ee/ei), diaphragm thickness (at end-expiration/end-inspiration); TFdi, thickening 
fraction of the diaphragm.
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CLINICAL IMPLICATIONS
Although assessment of breathing effort has been applied in physiological research and 
clinical studies for decades, the optimal range of breathing effort in critically ill patients 
remains to be established. Trials that compare different levels of effort have not been 
published so far. Therefore, we are dependent on physiological principles and reasoning 
to guide lung-protective and diaphragm-protective ventilation [79].
Insufficient breathing effort
Studies in the past decade have promoted the idea that insufficient breathing effort leads 
to atrophy and weakness of the diaphragm, a process termed ventilator-induced diaphragm 
dysfunction (VIDD) [80, 81]. For instance, significant diaphragm atrophy has been observed 
after complete inactivity of the diaphragm for 18 to 69 hours in brain-dead organ donors 
[1]. Subsequent studies demonstrated that diaphragm atrophy also occurs during partially-
supported ventilation [82–85], and that the extent of atrophy is related to the level of 
assistance provided by the ventilator [2]. Recently, development of diaphragm atrophy has 
been associated with prolonged ICU admission and an increased risk of complications [86], 
further supporting the idea of ventilator over-assistance and VIDD.
Additional factors can play a role in the development of muscle weakness and atrophy 
in ICU patients, including inflammation [87], myotoxic drugs [88], nutritional deficiency and 
catabolic state [89]. The term critical illness-associated diaphragm weakness (CIADW) is 
now preferred over VIDD to describe respiratory muscle weakness in critically ill patients [90]. 
Remarkably, clinical studies have shown that neuromuscular blockers administered in the first 
48 hours of moderate to severe ARDS improves outcome without the development of clinically 
relevant muscle weakness [4, 91–93]. Recently, it was observed that patients on assist-control 
ventilation regularly exhibited contractions of the diaphragm, a type of asynchrony called 
reversed triggering [94]. This mechanism prevents complete inactivity of the diaphragm, and 
possibly hampers the development of disuse atrophy during controlled ventilation. Indeed, short 
daily sessions of low-frequency pacing prevents development of disuse atrophy in peripheral 
skeletal muscles of ICU patients [95, 96]. In a case study on a single patient receiving controlled 
ventilation for eight months, pacing one hemidiaphragm for 30 minutes a day prevented 
the development of disuse atrophy [97]. Although further study is warranted, it is possible 
that levels below resting breathing effort can prevent development of disuse atrophy [40].
Excessive breathing effort
Prevention of excessive breathing effort by unloading the respiratory muscles is a 
cornerstone of mechanical ventilation. Excessive effort can be detrimental to lung 
mechanics and the function of the respiratory muscle pump.
Detrimental effects on the lungs
Vigorous efforts can generate substantial negative pleural pressures [98], potentially 




the peak PL below 25 cmH2O and tidal amplitude swings below 12 cmH2O based on the 
physiological principles of stress and strain [23, 102]. Furthermore, vigorous patient effort 
could result in poor synchrony with the ventilator and impairs oxygenation and comfort 
[103], warranting sedation and paralysis [91]. Reduced Ppl can cause intrapulmonary 
air shifts from nondependent to dependent regions (pendelluft), potentially leading to 
injurious alveolar overdistention and rupture [3]. Additionally, the reduced Ppl brought 
on by vigorous patient effort increases the vascular transmural pressure and can lead to 
elevated lung perfusion and development of alveolar edema [22, 23]. Increased activity 
of the expiratory muscles could result in elevated Ppl during expiration. If the Ppl is higher 
than alveolar pressure (Palv) the alveoli have a tendency to collapse, promoting atelectasis 
and possibly cyclic recruitment of alveoli (atelectrauma) [99, 104]. It is possible that the 
beneficial effects of muscle relaxants during the early course of ARDS can be attributed 
to the prevention of excessive muscle effort [4, 92, 93], although effort was not measured 
in these studies.
Detrimental effects on the respiratory muscles
Excessive breathing effort could incite eccentric contractions of antagonizing muscle 
groups, for example concomitant activation of the diaphragm and abdominal muscles. 
Eccentric contractions were found to cause sarcolemmal disruption and inflammation 
on a microscopic level in animal models [105, 106]. Furthermore, sarcolemmal disruption 
has been observed in animal models of mechanical ventilation after high breathing effort 
[107–109] and in patients with COPD [110]. Infiltration of inflammatory cells has been 
observed in diaphragm fibers obtained from ventilated ICU patients [83]. Additionally, 
patients exhibiting high efforts as assessed by diaphragm ultrasound showed increased 
Tdi,ee over time, which could be a sign of muscle inflammation and/or injury [2]. However, 
both studies were observational, so whether vigorous breathing effort leads to sarcolemmal 
damage in critically ill patients, and at which levels of effort this occurs, warrants further 
study.
Appropriate effort during different stages of illness
Based on the aforementioned considerations we recommend monitoring of breathing 
effort in selected mechanically ventilated patients [65, 111]. During the very early course 
of critical illness respiratory drive can be excessive, leading to injurious respiratory muscle 
contractions and damaging PL, especially in ARDS [98]. In this early phase, high effort occurs 
in a “muscle hostile environment” characterized by systemic and local inflammation. It is 
reasonable to prioritize unloading of the respiratory muscles to prevent lung injury and 
diaphragm dysfunction under these conditions [7, 79]. Employing a partially-supported 
mode to regain patient breathing activity is advisable after the initial phase of critical 
illness, although strenuous efforts should still be prevented [79, 101]. This strategy 
has the potential to allow simultaneous lung-protective and diaphragm-protective 
ventilation.
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CONCLUSIONS
Both ventilator over-assistance and under-assistance may have adverse effects on 
respiratory muscle function. As outlined in this review, the desired level of respiratory muscle 
effort depends on patient characteristics, in particular the phase of critical illness and 
mechanical output of the respiratory muscles. Quantification of breathing effort requires 
specific monitoring techniques and calculations. This is a developing field, and new studies 
will help us to better define optimal levels of respiratory muscle activity in ICU patients. 
The fact that we do not have clinical studies to demonstrate that monitoring of respiratory 
muscle function improves outcome should not be used as a reason to withhold such 
techniques in selected patients. Future clinical trials will provide data if guiding ventilator 
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ABSTRACT
Background
Diaphragm dysfunction develops frequently in ventilated intensive care unit (ICU) patients. 
Both disuse atrophy (ventilator over-assist) and high respiratory muscle effort (ventilator 
under-assist) seem to be involved. A strong rationale exists to monitor diaphragm effort and 
to titrate ventilator assist to maintain respiratory muscle activity within physiological limits. 
Diaphragm electromyography is used to quantify breathing effort and has been correlated 
with transdiaphragmatic pressure and esophageal pressure. The neuromuscular efficiency 
(NME) index can be used to estimate inspiratory effort; however, its repeatability has not 
been investigated yet. Our goal is to evaluate NME repeatability during an end-expiratory 
occlusion (NMEoccl) and its use to estimate the pressure generated by the inspiratory 
muscles (Pmus).
Methods
This is a prospective cohort study, performed in a medical-surgical ICU. A total of 31 adult 
patients were included, all ventilated in neurally adjusted ventilatory assist (NAVA) mode 
with an electrical activity of the diaphragm (EAdi) catheter in situ. At four time points within 
72 hours, five repeated end-expiratory occlusion maneuvers were performed. NMEoccl was 
calculated as delta airway pressure (ΔPaw)/ΔEAdi and was used to estimate Pmus. The 
repeatability coefficient (RC) was calculated to investigate the NMEoccl variability.
Results
A total number of 459 maneuvers were obtained. At time T=0, mean NMEoccl was 1.22 ± 
0.86 cmH2O/μV with a RC of 82.6%. This implies that when NMEoccl is 1.22 cmH2O/μV, 
it is expected with a probability of 95% that the subsequent measured NMEoccl will be 
between 2.22 and 0.22 cmH2O/μV. Additional EAdi waveform analysis to correct for non-
physiological appearing waveforms did not improve NMEoccl variability. Selecting three out 
of five occlusions with the lowest variability in NMEoccl reduced the RC to 29.8%.
Conclusions
Repeated measurements of NMEoccl exhibit high variability, limiting the ability of a single 
NMEoccl maneuver to estimate neuromuscular efficiency and therefore the pressure 
generated by the inspiratory muscles based on EAdi.
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BACKGROUND
Diaphragm dysfunction frequently develops in mechanically ventilated intensive 
care unit (ICU) patients and is associated with adverse clinical outcomes including 
prolonged mechanical ventilation and mortality [1–7]. It appears that non-physiological 
diaphragm activity plays an important role [8], in which both disuse atrophy resulting from 
ventilator over-assist [3, 9, 10] and high respiratory muscle effort resulting from ventilator 
under-assist [11–13] have been associated with diaphragm dysfunction in ICU patients. 
Therefore, there is a strong physiological rationale for monitoring diaphragm effort [14–16] 
and titrating ventilator assist to maintain respiratory muscle activity within physiological 
limits [17].
Variations in esophageal pressure (Pes) during breathing have been used for decades 
to quantify breathing effort. Recently, two state-of-the-art papers reviewed the technical 
and clinical aspects of Pes monitoring in ICU patients [18, 19]. Limitations of this technique 
include strict control of balloon inflation volume and complexity of signal interpretation, in 
particular when expiratory muscles are recruited.
Diaphragm electromyography (EMG) is an alternative technique used to quantify 
breathing effort in ICU patients [15]. Strong correlation has been reported between the 
electrical activity of the diaphragm (EAdi) and the transdiaphragmatic pressure (Pdi) or Pes 
[20, 21]. The neuromechanical efficiency (NMEoccl), defined as delta airway pressure (ΔPaw) 
divided by ΔEAdi measured during an end-expiratory occlusion, has been used to estimate 
the inspiratory effort breath by breath [21, 22]. This ratio describes how much pressure can 
be generated for each microvolt of EAdi signal; in other words, how efficient the diaphragm 
is in generating pressure for a certain amount of electrical activity. This is of potential 
interest for monitoring diaphragm function (over time) and helps to titrate ventilator assist 
in order to minimize diaphragm dysfunction resulting from ventilator over-assist and under-
assist [17]. Today, this index has only been evaluated in studies with limited numbers of 
patients [21–24] and the repeatability, an essential characteristic for a diagnostic tool, has 
not been investigated at all. Therefore, the aim of our study was to evaluate the NMEoccl 
repeatability in mechanically ventilated ICU patients and its use to estimate the maximum 
inspiratory pressure generated by the inspiratory muscles (Pmus).
METHODS
Study design and population
This prospective cohort study was performed in an academic ICU. Adult patients with a 
dedicated EAdi catheter (Maquet Critical Care, Solna, Sweden) in situ and mechanically 
ventilated in neurally adjusted ventilatory assist (NAVA) mode were eligible for inclusion. 
The institutional ethical committee approved the study protocol and informed consent was 





The EAdi catheter was positioned according to the manufacturer’s instructions using a 
dedicated software tool on the Servo-I ventilator (Maquet Critical Care, Solna, Sweden). 
The catheter position was verified before data acquisition. When patients exhibited a stable 
breathing pattern (i.e., no coughing, hiccups, or disproportional differences in respiratory 
rate), the following measurements to assess respiratory muscle function were performed: 
1) an end-expiratory occlusion maneuver (obtained by activating the expiratory hold button 
on the ventilator for one inspiratory effort) for measurement of NMEoccl; and 2) a “zero-
assist breath” in which inspiratory assist level was decreased to zero for one single breath to 
calculate the patient-ventilator breath contribution (PVBC) index [25, 26]. Both maneuvers 
were repeated five times with at least a 1-minute interval in between. The number of breaths 
between maneuvers was variable to prevent anticipation by the patient. Measurements 
were recorded and stored for offline analysis at time T=0 (baseline), and after 12 hours 
(T=12), 24 hours (T=24) and 72 hours (T=72).
Data acquisition
EAdi, flow and Paw waveforms were acquired from the ventilator via a RS232 serial port 
connected to a laptop with dedicated software (Servo Tracker version 4.1, Maquet Critical 
Care, Solna, Sweden). Maximum inspiratory pressure (MIP) measurements were performed 
with a manovacumeter (Micro Respiratory Pressure Meter, Carefusion, Yorba Linda, CA, 
USA) connected to the endotracheal tube [27].
Data analysis
A software routine developed for MATLAB (version R2016b, MathWorks Inc., Natick, MA, 
USA) was used for offline analysis. NMEoccl was calculated in three different ways (see 
Figure 1):
1. by dividing ΔPaw by ΔEAdi [21], in which ΔPaw was calculated as the difference 
in pressure between the Paw nadir during an end-expiratory occlusion and the 
preceding end-expiratory pressure level,
2. by dividing the area under the curve (AUC) of Paw by the AUC of EAdi, and
3. by dividing Paw by EAdi at fixed points (steps of 3 μV) on the EAdi waveform.
The inspiratory time (Ti) was defined as the period between the onset of EAdi and the time 
point when EAdi amplitude falls at 70% of its peak value (cycle-off criterion in NAVA). To 
investigate the effect of an occlusion maneuver on Ti, we compared Ti during the occluded 
breath with the Ti of the three preceding unloaded breaths. To estimate Pmus under clinical 
conditions, the mean EAdi amplitude of five tidal breaths (before the end-expiratory 
occlusion) was multiplied by NMEoccl/1.5 [21]. The correction factor of 1.5 compensates for 
the fact that in the presence of flow, the diaphragm generates less pressure for the same 
EAdi than during an occluded breath [21]. The tension-time index (TTI) was calculated as 
Pmus/MIP multiplied by the ratio of Ti to total respiratory cycle time (Ttot) [28].
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Figure 1. Example of a neuromechanical efficiency index calculation during an end-expiratory oc-
clusion maneuver (NMEoccl). The lighter blue line represents the electrical activity of the diaphragm 
(EAdi) signal expressed in μV. The darker blue line represents the delta airway pressure (ΔPaw) 
expressed in cmH2O. The NMEoccl was calculated in three different ways: 1) by dividing ΔPaw by 
ΔEAdi, shown as arrows; 2) by dividing the area under the curve (AUC) of Paw by the AUC of EAdi, 
represented by the filled areas, and 3) by dividing Paw by EAdi at fixed points (steps of 3 μV) on the 
inspiratory EAdi curve, as demonstrated by the dots.
Statistical analysis
Statistical analysis was performed with GraphPad Prism (version 5.03, GraphPad Software, 
San Diego, USA). Data were analyzed as median [interquartile range (IQR)], except as stated 
otherwise. Statistical significance was indicated by a p value < 0.05.
The repeatability coefficient (RC) represents the absolute value by which two repeated 
measurements in one subject will differ in 95% of cases. The formula developed by Bland 
and Altman was used to calculated RC: 1.96 × √2 × within-subject standard deviation (SD) 
[29]. One-way analysis of variance (ANOVA) was used to obtain the within-subject SD with 
the subject as independent factor and the repeated NMEoccl measurements as dependent 
factors. Since the NMEoccl variability increased as the magnitude of NMEoccl increased, the 
ratio of a single NMEoccl measurement to the mean NMEoccl of five repeated measurements 
was used (see Supplemental file 1) [29]. The correlation coefficient measured for repeated 
observations was used to investigate the within-subject correlation between Paw and EAdi 
[30, 31], using SPSS Statistics (version 22, IBM Corp., USA).
In addition, to obtain the within-subject NMEoccl variability, per patient and for each time 
point a coefficient of variation (CoV) was calculated as the ratio of the within-subject SD to the 
mean NMEoccl. The median CoV of the study population was used to divide the study population 
into two groups with CoV higher or lower than median. The paired t-test was used to test for 
differences in clinical parameters (that might affect NMEoccl variability) between both groups.
The Pearson correlation coefficient was calculated to test the correlation between Ti 
and NMEoccl, and between TTI and Pmus. One-way ANOVA was used to investigate the 





Table 1 shows the main characteristics of the study population. A total of 459 occlusions 
were performed (see Supplemental file 2). In 19 patients, the measurements could not 
be obtained at all four time points due to various reasons: extubation (n=7), agitation 
(n=2), low EAdi (n=3), return to controlled ventilation mode (n=2), death (n=1), and 
others (n=4).
NMEoccl variability
A representative NMEoccl maneuver is shown in Figure 1. At T=0, 149 maneuvers were 
obtained in 31 patients, 6 maneuvers were lost due to technical issues. Mean ΔPaw was 
14.1 ± 7.9 cmH2O and mean ΔEAdi was 14.8 ± 9.9 μV. Mean NMEoccl was 1.22 ± 0.86 cmH2O/
μV (ranging from 0.41 to 3.56 cmH2O/μV), with a RC of 82.6%. This RC implies that when 
NMEoccl is 1.0 cmH2O/μV, it is expected with a probability of 95% that the subsequent 
measured NMEoccl will be between 0.17 and 1.83 cmH2O/μV. When the EAdi of this patient 
during normal tidal breathing is 10 μV, the estimated Pmus would be somewhere between 
1.1 cmH2O and 12.2 cmH2O (calculated as EAdi × NMEoccl/1.5, see Methods section). In 
addition, the RC of the NMEoccl calculated as per the AUC of the Paw and EAdi, and at 
fixed points on the EAdi curve (Figure 1) remained high: 87.7% for the AUC method, and 
85.5–175.9% at fixed points. The RC of the separate components of NMEoccl was 95.7% for 
EAdi, and 73.9% for Paw. Figure 2 shows that there was a moderate correlation between 
ΔEAdi and ΔPaw during the occlusion for the individual patients (average r = 0.52, p < 
0.0005; ranging from r = -0.90 to r = 1.0).
Upon visual inspection, it appeared that some of the EAdi tracings exhibited a rather 
non-physiological shape: a plateau during inspiration (while an increase would be expected) 
or at maximum inspiration, or a delayed increase in EAdi relative to the decrease in Paw 
(Figure 3). It was reasoned that such non-physiological-appearing EAdi waveforms 
contributed to the high NMEoccl variability. Supplemental file 2 shows every occlusion 
maneuver obtained in this study. Different mathematical approaches were used in order to 
try to objectively detect and exclude non-physiological EAdi waveforms (see Supplemental 
file 3). Despite these mathematical approaches, the NMEoccl repeatability remained high 
with a RC of 63.4%. Finally, we pragmatically selected three out of five occlusion maneuvers 
with the lowest variability and averaged the three NMEoccl values to obtain a single, average 
NMEoccl for each individual patient. This approach reduces the influence of erroneous 
values, irrespective of the origin, and will result in a more reproducible NMEoccl value per 
patient. As a result, the RC improved to 29.8%. This approach was used for subsequent 
analysis.
Correlation of NMEoccl variability with clinical parameters and inspiratory time
The median CoV NMEoccl at T=0 was 23.1 [18.7–29.9] %. After dividing the study population 
into two groups with CoV higher or lower than median, respectively, no significant differences 
in clinical parameters were found (see Supplemental file 4). Median Ti during the occlusion 
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was 0.51 [0.35–0.65] seconds and of the preceding breaths 0.65 [0.48–0.84] seconds. 
On average, in 48% of the measurements within a patient, Ti of the occluded breath was 
longer than the Ti of the preceding breaths. Only a moderate negative correlation was 
found between Ti and NMEoccl (r = -0.219).
Table 1. Main characteristics of the study population (n=31).
Characteristics
Age (years), median [IQR] 69 [55.5–72]
Sex (male/female), n 22/9
BMI (kg/m2), median [IQR] 24.7 [21.6–26.0]
Comorbidity, n (%)
Cardiac diseases 9 (29%)
Diabetes mellitus 6 (19%)
COPD 4 (13%)





ARDS at admission, n (%) 9 (29%)
Sepsis during admission, n (%) 6 (19%)
Duration of MV on T=0 (days), median [IQR] 10 [8.5–18.5]
Partially-assisted mode before T=0 9 [4–14]
Controlled mode before T=0 1 [0–3.5]
Total days of MV (days), median [IQR] 24 [14.5–29.5]
NAVA level (cmH2O/µV), median [IQR] 0.7 [0.5–1.2]
Tidal volume (ml), median [IQR] 450 [381–554]
Respiratory rate (min-1), median [IQR] 25 [18–30]
PEEP level (cmH2O), median [IQR] 8 [6–10]
Use of opioids or sedatives, n (%) 16 (51.6%)
Total LOS ICU (days), median [IQR] 26 [20–34]
Total LOS hospital (days), median [IQR] 41 [23–52.5]
Died within the study period, n (%) 1 (3%)
Abbreviations: ARDS, acute respiratory distress syndrome; BMI, body mass index, COPD, chronic 
obstructive pulmonary disease; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; 
















Figure 2. Correlation of delta airway pressure (ΔPaw) and electrical activity of the diaphragm (EAdi) 
of all maneuvers at T=0. Each line represents the correlation for an individual patient with five repeat-











Figure 3. Four examples of electrical activity of the diaphragm (EAdi) waveform irregularities during 
an end-expiratory occlusion. The lighter blue line represents the EAdi signal, the darker blue line 
represents the delta airway pressure (ΔPaw). (a) Negative slope during the inspiratory part of the 
EAdi waveform. (b) Delay in onset of EAdi. (c) EAdi peak that is cut off. (d) Split EAdi peak.
Changes in NMEoccl over time
Twelve patients completed the 72-hour study period. In these patients, NMEoccl at T=0 was 
0.8 [0.7–1.1] cmH2O/μV and did not change over time (p = 0.75): 0.7 [0.4–0.9] cmH2O/μV, 
0.8 [0.6–1.1] cmH2O/μV, and 0.9 [0.6–1.3] cmH2O/μV for T=12, T=24, and T=72, respectively.
Diaphragm muscle effort
The mean EAdi of five unloaded breaths before the end-expiratory occlusion was used 
to calculate Pmus. At T=0, Pmus was 9.4 [6.0–12.8] cmH2O and did not change over time 
(p = 0.58): 10.4 [5.4–15.4] cmH2O, 10.7 [4.8–13.1] cmH2O, and 8.2 [6.0–15.9] cmH2O for T=12, 
T=24, and T=72, respectively. The median Pmus varied widely among patients, ranging from 1.8 
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to 36.0 cmH2O. Based on previous literature [21, 23], we defined a physiological Pmus between 
5 and 10 cmH2O. At T=0, 6 patients (19.4%) had a mean Pmus <5 cmH2O and 12 patients 
(38.7%) had a Pmus >10 cmH2O, indicating ventilator over-assist or under-assist, respectively.
MIP was obtained in 15 patients in the week before or after the NMEoccl measurements, 
which allowed us to calculate TTI. Median MIP was 29 [24–38] cmH2O and median TTI was 






















Figure 4. Inspiratory muscle pressure (Pmus) versus the Tension Time Index for 15 patients in whom 
maximum inspiratory pressure was measured. The dotted line represents the threshold for dia-
phragm fatigue [36].
DISCUSSION
The main findings of the present study can be summarized as follows: 1) repeated 
measurements of NMEoccl within an individual patient exhibited unacceptably high variability, 
indicating that a single NMEoccl cannot be used to estimate the pressure generated by the 
inspiratory muscles; 2) no correlation was found between NMEoccl variability and clinical 
parameters; 3) extensive waveform analyses did not improve the repeatability of NMEoccl; 
4) NMEoccl and Pmus remain stable over time in a heterogeneous group of patients; and 
5) both low and high diaphragm effort are common in this cohort of patients on partially-
assisted ventilation mode.
NMEoccl variability
Variability of both components of NMEoccl (Paw and EAdi) is expected given the variability 
in inspiratory drive, even during occlusions. However, NMEoccl itself is independent from 
respiratory drive and should therefore be more stable from breath to breath. Beck and 
colleagues reported a linear relationship between EAdi and Pdi in healthy subjects, at 




linear relationship between EAdi and Pdi in patients with acute respiratory failure [20]. 
Bellani et al. showed that NMEoccl derived from Paw closely reflects NME during normal tidal 
breathing derived from Pes, and concluded that calculation of NMEoccl allows a clinically 
valuable estimate of inspiratory effort [21]. In this latter study, two end-expiratory occlusions 
were obtained in each patient, but repeatability was not reported. Furthermore, they 
report that despite changes in the level of ventilator assist, NMEoccl remained rather stable 
within individual patients, as supported by the linear relationship between Pmus and EAdi 
(r2 = 0.78) [21]. This is in apparent contrast with our findings, as we found only a moderate 
correlation between Pmus and EAdi. However, differences in data analysis should be 
acknowledged. Bellani et al. used the Pearson correlation coefficient to test the correlation 
between Paw and EAdi, in which all measurements from different patients were analyzed 
together as if they were from a single patient. However, the variability in between-subject 
measurements is different compared to the variability in within-subject measurements [33]. 
Therefore, calculating the correlation coefficient of repeated observations, as done in the 
current study, seems more appropriate [30, 31]. Indeed, Figure 2 demonstrates that the 
slope of the Paw-EAdi relationship in individual patients is highly variable. This is consistent 
with the results of Bellani et al., exhibiting high inter-individual variability [21].
The high NMEoccl repeatability reported in the current study precludes its application 
in clinical practice. Based on visual inspection of the EAdi waveforms, we proposed that 
suboptimal filtering and replacement of cardiac electrical activity by the ventilator software 
is an important contributor. Several techniques for waveform analyses were applied, but did 
not improve repeatability, suggesting that in addition to suboptimal filtering other factors 
might be involved. Beck et al. showed that an increase in lung volume from functional 
reserve capacity to total lung capacity reduces Pdi by 60% for a given EAdi [34]. Similarly, 
muscle weakness may affect NMEoccl, but both are unlikely to explain the high variability in 
our study, given that all measurements were obtained in a time window of 5–10 minutes.
As none of the techniques for waveform analyses resulted in improved NMEoccl 
repeatability, a more pragmatic approach was explored that is also feasible in clinical 
practice. In thermodilution cardiac output measurements, three repeated measurements 
are averaged, provided that these values are within 10% of their average. If not, a total of 
five measurements are performed in which the lowest and highest value are eliminated [35]. 
In our study, this strategy reduced the influence of erroneous NMEoccl values, irrespective 
of the cause, and will result in a more reproducible value of NMEoccl.
NMEoccl as monitoring tool
Theoretically, the NMEoccl could be helpful to titrate ventilator assist in patients on partially-
assisted modes. NMEoccl is calculated by dividing ΔPaw by ΔEAdi during an end-expiratory 
occlusion. During an occlusion, ΔPaw equals ΔPmus and therefore NMEoccl can be obtained 
without direct measurement of Pmus (requiring an esophageal balloon). Rearranging 
this formula to Pmus = NMEoccl × EAdi allows calculation of Pmus breath by breath, after 
dividing this value by 1.5 to correct for differences in NME obtained under static and dynamic 
conditions [21]. Interestingly, NMEoccl may be used to evaluate respiratory muscle function 
93
Estimation of the diaphragm neuromuscular efficiency index in mechanically ventilated critically ill patients
over time. A decrease in NMEoccl indicates that the respiratory muscles are less efficient in 
converting electrical activity into pressure. Possible causes for variability in NMEoccl require 
further studies, but may include intrinsic positive end-expiratory pressure and impaired 
function of the contractile proteins.
In our study population, there were no significant changes in NMEoccl over time 
(p = 0.75), which corresponds to the results of Bellani et al. [23]. However, it should be 
noted that during our study period the ventilatory settings were not fixed, which might 
explain why NMEoccl did not change over time.
In our study, Pmus varied among patients but remained relatively stable in individual 
patients over time. In some patients the estimated inspiratory effort was >20 cmH2O. 
An important question is whether a relatively high inspiratory pressure generated by the 
respiratory muscles may result in the development of contractile fatigue. A TTI ≥0.15 puts 
the diaphragm at risk of development of fatigue [36]. In our study, all patients except for 
two, with a Pmus <12 cmH2O, had a TTI <0.15. This might suggest that titration of ventilatory 
assist to a Pmus <12 cmH2O could limit the risk of fatigue development. However, this has 
to be studied before it can be applied in clinical practice.
Strengths and limitations
The strengths of our study are the high number of occlusions analyzed and the fact that 
at each time point five repeated occlusions were obtained. This allows a thorough analysis 
of the repeatability of NMEoccl and provides methods to improve its variability under clinical 
conditions. In addition, several waveform analysis techniques were performed to evaluate 
the high NMEoccl variability; however, this did not improve the RC for NMEoccl. It was suggested 
that suboptimal filtering of the EAdi by the ventilator software might be important. 
Software engineers should further improve ventilator software for EAdi signal filtering.
Several limitations should be acknowledged. First, patients in our study did not have an 
esophageal balloon in situ; therefore, we could not validate our measurements against the 
gold standard. However, previous studies have shown excellent correlation between ΔPaw 
and ΔPes during an occlusion maneuver [37–39]. Second, our study was conducted in a 
single center and in a selected group of ICU patients. The generalizability of the findings 
needs to be assessed.
CONCLUSION
An end-expiratory occlusion maneuver allows measurement of the static change in EAdi 
and Paw for the calculation of NMEoccl. This maneuver is simple to conduct and safe in ICU 
patients ventilated in a partially-assisted mode. However, the present study demonstrates 
that a single maneuver cannot be used to calculate NMEoccl, given the unacceptably high 
variability. Further studies should be conducted to improve software for EAdi analysis 
for this specific purpose. For now, selecting three out of five occlusions with the lowest 
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SUPPLEMENTAL FILES
Supplemental file 1: NMEoccl calculated as a ratio
Since the variability of NMEoccl increased as the magnitude of the NMEoccl increased, the ratio 
of a single NMEoccl value to the mean NMEoccl of five repeated measurements was used to 

















































E-Figure 1. (a) The difference in NMEoccl expressed against the mean NMEoccl, and (b) the ratio of
NMEoccl expressed against the mean NMEoccl.
Supplemental file 2: Individual NMEoccl data
An overview of the five repeated occlusions for each individual patient is accessible online: 
https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-2172-0.
Supplemental file 3: Extensive waveform analysis
The repeatability coefficient (RC) of NMEoccl of 82.6% was deemed insufficient for clinical 




non-physiological shape: a plateau during inspiration (while an increase would be expected) 
or at maximum inspiration, or a delay in the increase in EAdi compared to the decrease in 
Paw (see Figure 3 of the main manuscript). It was assumed that this might be the result of 
suboptimal ventilator software for EAdi processing and filtering, based on electrocardiogram 
(ECG) replacements, which might contribute to the high variability in NMEoccl.
Figure 3 of the main manuscript shows the most common non-physiological EAdi 
waveforms that were observed during the end-expiratory occlusions. Often, a certain change 
in the slope was observed at random time points during the inspiratory phase (Figure 3a-d 
of the main manuscript). In addition, it was demonstrated that the EAdi and Paw signals did 
not always start at the same time point. Most of the time this was due to an apparent “delay” 
in the EAdi signal (Figure 3b of the main manuscript), which differed in duration and timing 
between the five repeated measurements within a patient (see for example patient 4, T=12 
hours in Supplemental file 2). Therefore, this delay could not be the result of a technical 
problem with the data acquisition.
It was reasoned that the non-physiological EAdi waveforms were the result of 
inappropriate processing of EAdi recordings within the ventilator software. Besides 
measuring the diaphragmatic electrical activity, the sensors embedded in the EAdi 
catheter measure other electrical activity nearby as well, such as cardiac electrical activity 
and esophageal movement. Since the cardiac electrical activity is much stronger than 
the diaphragm electrical activity, additional measures must be taken to subtract the ECG 
signal (mainly the QRS complex) from the EAdi signal to ensure accurate diaphragm activity 
recordings. Computer algorithms within the ventilator software (patented by Maquet Critical 
Care, no details available) are responsible for this filtering process. Inappropriate filtering 
could lead to a certain loss of data. Since we did not have access to the raw EAdi data, it was 
impossible to make assumptions about the underlying raw data, i.e., about the true course 
or peak of the EAdi signal. Calculating NMEoccl using inappropriately filtered EAdi waveforms 
will lead to incorrect NMEoccl values and thereby to a variability that is disproportionally 
high. Therefore, we aimed to develop criteria to mathematically detect and exclude these 
non-physiological EAdi waveforms in order to improve NMEoccl variability.
Mathematical approaches to detect and exclude non-physiological EAdi waveforms
It was hypothesized that all zero or negative EAdi slopes with a certain sample length 
anytime during the inspiratory phase are “non-physiological” and should therefore 
be excluded for further analysis. First, to detect these zero or negative EAdi slopes, a 
continuous slope of the inspiratory increase in EAdi was calculated (i.e., the derivative of the 
EAdi). Then, it was tried to objectively detect zero or negative EAdi slopes with a predefined 
sample length. However, due to a wide variation in the duration of the irregularities between 
maneuvers and patients, it was not possible to objectively define this “sample length” and 
thereby to exclude maneuvers based on these criteria. In addition, sometimes a sudden 
change in slope of the inspiratory EAdi waveform was seen (not accompanied by a change 
in Paw) while the slope remained positive (see E-Figure 2). These factors together ensured 
that it was impossible to define or standardize “change in slope”.
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E-Figure 2. Example of a subtle change in slope of the diaphragm electrical activity (EAdi) wave-
form, not accompanied by a change in slope of the delta airway pressure (∆Paw).
Apparently, it was possible to objectively identify rough irregularities such as deep 
inflections of the EAdi waveform during the inspiratory phase, or EAdi peaks that were 
horizontal for a certain time period during the maneuver (Figure 3c of the main manuscript). 
However, removing these waveforms in the analyses did not improve the variability in NMEoccl 
sufficiently, as numerous artifacts could not be objectively detected using mathematical 
approaches. Simply excluding all waveforms with any kind of subtle irregularities will lead 
to an unacceptable low number of remaining waveforms and to observer bias.
From a physiological perspective, EAdi should increase during an inspiratory effort 
and Paw should decrease. Therefore, it is reasonable to remove only parts of the EAdi 
and corresponding Paw waveforms that did not meet this theory, instead of excluding the 
whole maneuver from the analyses. Hence, parts of the waveform that did not meet the 
following criteria were removed: 1) a difference between the current and previous sample of 
EAdi (EAdix – Eadix-1) >0 μV; and 2) similarly, Pawx – Pawx-1 <0 cmH2O. It was hypothesized 
that with this method, ECG replacements could be eliminated and thereby reducing the 
variability between occlusion maneuvers. After removing the parts of both Paw and EAdi 
waveforms that did not meet these criteria, the remaining parts of both waveforms were 
plotted against each other and the slope was considered to represent NMEoccl. This slope 
was estimated using a linear regression analysis according to the following equation, in 
which a is the slope of the linear regression which can be considered the NME:
Paw = a × EAdi + b
This method represents a time-independent relation of EAdi and Paw, in which only 
artifacts were eliminated. However, this method did not improve the RC of the NMEoccl: 
90.9%. After including only those slopes with a determination coefficient >80%, NMEoccl 




In conclusion, different mathematical approaches were invented and tested, but did not 
reduce NMEoccl variability to acceptable values. Therefore, we pragmatically continued with 
the method described in the main manuscript.
Supplemental file 4: Extended results
Correlation of clinical parameters and NMEoccl variability at T=0
First, the coefficient of variation (CoV) was calculated for each patient. The median CoV 
for NMEoccl at T=0 hours was 23.1 [18.7–29.9] %. The study population was divided in two 
groups, with the CoV higher or lower than the median, respectively, and clinical parameters 
were compared between groups (Table E1).
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ABSTRACT
The patient-ventilator breath contribution (PVBC) index estimates the relative contribution 
of the patient to total tidal volume (Vtinsp) during mechanical ventilation in neurally adjusted 
ventilatory assist mode and has been used to titrate ventilator support. The reliability of 
this index in ventilated patients is unknown and was investigated in this study. PVBC was 
calculated by comparing tidal volume (Vtinsp) and diaphragm electrical activity (EAdi) during 
assisted breaths (Vtinsp/EAdi)assist and unassisted breaths (Vtinsp/EAdi)no-assist. Vtinsp was 
normalized to peak EAdi (EAdipeak) using 1) one assisted breath, 2) five consecutive assisted 
breaths, or 3) five assisted breaths with matching EAdi preceding the unassisted breath 
(N1PVBC2, X5PVBC2, and X5PVBC2EAdi-matching, respectively). In addition, PVBC was calculated 
by comparing only Vtinsp for breaths with matching EAdi (PVBCβ
2). Test-retest reliability 
of the different PVBC calculation methods was evaluated with the intraclass correlation 
coefficient (ICC) using five repeated PVBC maneuvers performed with a 1-minute interval. 
In total, 125 PVBC maneuvers were analyzed in 25 patients. ICC [95% confidence interval] 
values were 0.46 [0.23–0.66], 0.51 [0.33–0.70] and 0.42 [0.14–0.69] for N1PVBC2, X5PVBC2 
and X5PVBC2EAdi-matching, respectively. Complex waveform analyses showed that insufficient 
EAdi filtering by the ventilator software affects reliability of PVBC calculation. With our 
new EAdi matching techniques reliability improved (PVBCβ2 ICC: 0.78 [0.60–0.90]). We 
conclude that current techniques to calculate PVBC exhibit low reliability and that our newly 
developed criteria and estimation of PVBC – using Vtinsp of assisted breaths and unassisted 
breaths with matching EAdi – improves reliability. This may help implementation of PVBC 
in clinical practice.
NEW & NOTEWORTHY
The patient-ventilator breath contribution (PVBC) index estimates the relative contribution of 
the patient to the tidal volume generated by the patient and the ventilator during mechanical 
ventilation in neurally adjusted ventilatory assist (NAVA) mode. It could be used to titrate 
ventilator support and thus to limit development of diaphragm dysfunction in intensive care 
unit patients. Currently available methods for bedside assessment of PVBC are unreliable. 
Our newly developed criteria and estimation of PVBC largely improved reliability and help 
to quantify patient contribution to total inspiratory effort.
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INTRODUCTION
Mechanically ventilated intensive care unit (ICU) patients are prone to develop diaphragm 
weakness, which is associated with difficult weaning, prolonged duration of mechanical 
ventilation, and ICU mortality [5, 7, 10, 11, 13, 16–18]. Potential mechanisms include the 
development of diaphragm muscle atrophy as a result of ventilator over-assist and 
diaphragmatic injury as a consequence of ventilator under-assist [8, 9, 11, 18, 22, 28]. 
Especially in partially-supported modes of ventilation, where the work of breathing is shared 
between the patient and ventilator, there appears a strong rationale to monitor diaphragm 
effort and to titrate the level of ventilator assist to allow patient breathing effort within 
physiological range [6, 14, 15, 20]. It should be noted that monitoring patient breathing 
effort is unreliable with standard ventilator waveforms such as airway pressure or flow 
[3]. Esophageal pressure (Pes) monitoring is considered the state-of-the-art technique 
to monitor breathing effort in ventilated patients, but this technique is invasive, and 
interpretation of waveforms may be complex [4, 26]. Diaphragm electromyography (EMGdi) 
is used to quantify neural breathing effort [2, 6], but the calculation of muscle pressure 
from EMGdi amplitude should be done with caution as high within-patient variability was 
recently described [19].
The neuroventilatory efficiency index defines the ability to generate tidal volumes (Vtinsp) 
per microvolt of diaphragm electrical activity (EAdi) [23, 29]. The patient-ventilator breath 
contribution (PVBC) index estimates the relative contribution of the patient to the total 
Vtinsp generated by the patient and the ventilator together. As this index requires a strong 
correlation between the change in Vtinsp and the change in EAdi (i.e., proportionality), it 
has only been studied in neurally adjusted ventilatory assist (NAVA) mode [12, 24]. The 
PVBC index is obtained by comparing a breath without ventilator assistance (patient effort 
only) to assisted breaths (patient effort + ventilator effort) and can be calculated with 
different approaches: either by normalizing Vtinsp to EAdi, or by comparing Vtinsp for breaths 
with similar EAdi [12, 24]. A PVBC value of 1.0 indicates that Vtinsp is fully generated by the 
patient, whereas a PVBC value of 0.0 suggests that Vtinsp is completely generated by the 
ventilator.
Validation of the PVBC has been tested by using the patient’s contribution to total 
transpulmonary pressure as the gold standard in both animals and humans [12, 24]. 
Accordingly, the PVBC index may be useful to titrate ventilator support and thus to limit 
the consequences of ventilator over-assist or under-assist. However, the reliability of PVBC 
measurements at the bedside has not been evaluated yet. Therefore, the aim of the present 
study was to investigate the test-retest reliability of the PVBC index in a heterogeneous 
cohort of ICU patients ventilated in NAVA mode. Test-retest reliability was assessed for 
the different approaches to calculate PVBC. We hypothesized that reliability of PVBC 
improves when comparing Vtinsp for breaths with similar EAdi. In addition, methods were 
developed to further improve the applicability of the PVBC index as a bedside monitoring 






Study design and population
This prospective cohort study was conducted at the ICU of the Radboudumc in Nijmegen. 
Data are part of a larger study evaluating the reliability of diaphragm monitoring techniques 
in mechanically ventilated patients [19]. Adult patients with an EAdi catheter in situ and 
ventilated in NAVA mode (Servo-I ventilator, Maquet Critical Care, Solna, Sweden) were 
eligible for inclusion.
Ethics approval and consent to participate
The institutional ethical committee (CMO Region Arnhem-Nijmegen) approved the study 
protocol (case no. 2015-1799). Informed consent was waived because of to the noninvasive 
nature of the study and negligible risks.
Study protocol
Before data acquisition the EAdi catheter position was verified with dedicated software 
available on the ventilator. When patients exhibited a stable breathing pattern (i.e., no 
coughing, hiccups) inspiratory support (NAVA level) was abruptly decreased to zero to 
obtain the first single unassisted breath for analysis. This “zero-assist maneuver” was 
repeated five times with an ~1-minute interval. The number of breaths between maneuvers 
was variable, to prevent the patient’s anticipation.
Data acquisition
Ventilator flow, airway pressure (Paw), and EAdi waveforms were sampled at 100 Hz and 
obtained via the RS232 serial port connected to a laptop with dedicated software (Servo 
Tracker version 4.1, Maquet Critical Care, Solna, Sweden). Data were stored for offline 
analysis in a software routine developed in Microsoft Visual Basic (Microsoft, 2010) and 
MATLAB (R2017a; MathWorks, Natick, MA, USA).
Offline signal processing
Neural inspiratory time (EAdi-Ti) was defined as the period from increasing EAdi >0.5 µV 
above baseline until EAdi decreased to 70% of its peak (i.e., cycling-off criterion in NAVA). 
Vtinsp was calculated as the time integral of inspiratory ventilator flow. Events should meet 
the following criteria to be considered a patient effort and to be included in further analyses: 
Vtinsp ≥50 ml, EAdipeak ≥2 µV and EAdi-Ti >400 ms.
PVBC calculation methods
PVBC was calculated as the ratio of Vtinsp/EAdi during unassisted breaths to that during 
assisted breaths [(Vtinsp/EAdipeak)no-assist/(Vtinsp/EAdipeak)assist]. PVBC indices were squared 
because previous studies demonstrated improved agreement with relative breathing 
effort estimated from Pes measurements [24]. If PVBC2 values exceeded 1.0, which is 
mathematically possible but not conceptually, PVBC2 was considered 1.0.
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Single and averaged breaths
(Vtinsp/EAdipeak)assist was calculated in two ways (Figure 1), by using: 1) Vtinsp and EAdipeak of 
one breath (“N1”) preceding the unassisted breath (N1PVBC2), or 2) mean Vtinsp and EAdipeak 
of five consecutive breaths (“X5”) preceding the unassisted breath (X5PVBC2) [24].
21.6 µV19.1 µV
mean EAdipeak = 21.0 µV
226 ml
442 ml
mean Vtinsp = 458 ml
X5PVBC2 N1PVBC2
N1PVBC2 = ((226/21.6) / (442/19.1))2 = 0.20














Figure 1. A representative patient-ventilator breath contribution (PVBC) maneuver and calculation 
methods for N1PVBC2 and X5PVBC2. The dashed box represents waveforms of the unassisted breath. 
PVBC was calculated using peak electrical activity of the diaphragm (EAdipeak) and inspiratory tidal 
volume (Vtinsp) of 1 breath before the unassisted breath (
N1PVBC2), and based on the mean EAdipeak and 
Vtinsp of 5 breaths before to the unassisted breath (
X5PVBC2). For each patient 5 of these maneuvers 
were obtained per time point. *Paw represents the pressure above positive end-expiratory pressure.
Matching EAdi
Because initial results demonstrated poor reliability of N1PVBC2 and X5PVBC2, new analysis 
techniques were developed to match EAdi between the assisted breaths and the unassisted 
breath. To this end, five assisted breaths were selected for analysis only if they showed 
EAdi waveforms similar to the unassisted breath (X5PVBC2EAdi-matching). Breaths could be 
selected any time in the 1-minute interval before the unassisted breath. Matching was 
defined as similarity in the inspiratory increase of EAdi. This was tested mathematically by 
performing linear fitting to each EAdiassist-EAdino-assist curve. The determination coefficient 
(r2), regression slope and trend line intersection with the y-axis were computed (Figure 




criteria were met: 1) r2 ≥ 0.85, 2) regression slope between 0.75 and 1.33, and 3) trend 
line intersection between -1.5 µV and 1.5 µV. The averaged Vtinsp of five matched assisted 
breaths prior to the unassisted breath was used for Vtinsp,assist.
Matching EAdi of the assisted breaths and unassisted breath may eliminate the need for 
normalization of Vtinsp to EAdipeak. PVBC
2 could then be simply calculated as (Vtinsp,no-assist/
Vtinsp,assist)











































Figure 2. Matching algorithm explained to detect similarity in electrical activity of the diaphragm 
(EAdi) between assisted breaths and the unassisted breaths, using the same patient-ventilator 
breath contribution (PVBC) index maneuver as in Figure 1. Similarity in EAdi between each assisted 
breath and the unassisted breath was evaluated by performing a linear regression fitting for the 
EAdiassist-EAdino-assist curve. To correct for differences in EAdi inspiratory time between the assisted 
breath and the unassisted breath, similarity was evaluated from EAdi onset of both breaths until 
the time point where either EAdiassist or EAdino-assist reached its peak or plateau, whichever occurred 
first. The red bar below the EAdi of the assisted breaths indicates that there was no match with the 
unassisted EAdi. In this example, the slope parameter of the linear fit was too high (in red). The 
dark blue bar below the EAdi of the assisted breaths indicates a proper match with the unassisted 
breath (slope, intercept and determination coefficient (r2) parameters are within predefined range, 
see Methods). Mean EAdipeak and mean inspiratory tidal volume values of the 5 matching breaths 
were subsequently used in the calculation of X5PVBC2EAdi-matching and PVBCβ
2.
Additional techniques derived from X5PVBC2
As EAdi matching is not yet available in routine clinical practice, additional techniques that 
can be used at the bedside were developed post hoc as modifications of X5PVBC2. First, we 
pragmatically selected three out of five X5PVBC2 maneuvers with lowest variability, provided 
that these values were within 20% of their mean. Selection was done by calculating 
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the standard deviation (SD) of all possible combinations of three out of five X5PVBC2 
maneuvers for each patient. The combination with lowest SD was subsequently included 
in the statistical analysis if the variability of the three repeated X5PVBC2 measurements 
was <20%. This method is further referred to as X5PVBC23/5. Second, for reasons clarified 
in the Discussion section, we aimed to exclude the influence of non-physiological EAdi 
waveforms and calculated X5PVBC2 based on only Vtinsp of the five assisted breaths before 
to the unassisted breath (X5PVBC2Vt, no EAdi signal used). For clarity, Table 1 explains the 
different techniques used to calculate PVBC.
Table 1. Explanation of different methods used to calculate the PVBC index.
PVBC Patient-ventilator breath contribution: (Vtinsp/EAdipeak)no-assist/(Vtinsp/EAdipeak)assist
N1PVBC2 Squared PVBC based on Vtinsp and EAdipeak of the 1
st (“N1”) assisted breath 
before the unassisted breath
X5PVBC2 Squared PVBC based on the mean Vtinsp and mean EAdipeak of 5 consecutive 
(“X5”) assisted breaths before the unassisted breath
X5PVBC2EAdi-matching Squared PVBC using the mean Vtinsp and mean EAdipeak of 5 matching assisted 
breaths in the 1-minute interval preceding the unassisted breath; for EAdi 
matching criteria, see Methods
PVBCβ2 Squared PVBC using only the mean Vtinsp of 5 matching assisted breaths in the 
1-minute interval preceding the unassisted breath: (Vtinsp,no-assist/Vtinsp,assist)
2
X5PVBC23/5
X5PVBC2 using 3 out of 5 PVBC maneuvers with the lowest variability, provided 
that these values are within 20% of their average
X5PVBC2Vt
X5PVBC2 calculated based on mean Vtinsp of 5 assisted breaths just before the 
unassisted breath; no EAdi matching applied
Abbreviations: EAdipeak, peak electrical activity of the diaphragm; Vtinsp, inspiratory tidal volume.
Statistical analysis
Statistical analyses were performed using SPSS Statistics (version 22, IBM Corp., USA) 
and GraphPad Prism (version 7.04, GraphPad Software, CA, USA). Data were analyzed as 
median [interquartile range (IQR)], except as stated otherwise. Statistical significance was 
indicated by a p value < 0.05.
Test-retest reliability of PVBC was evaluated using the intraclass correlation coefficient 
(ICC), which is the ratio of between-subject variance to total variance (i.e., sum of between-
subject and within-subject variance) [1, 30]. Hence, high ICC indicates high similarity 
between measurements taken from the same subject. ICC values and their 95% confidence 
intervals (CI) were calculated based on an absolute agreement, two-way random effects 
model with random factors for subject and measurement index. Single measures ICC 
values were of primary interest, to evaluate whether a single PVBC measurement can be 




measures ICC was of interest, as this calculation method is in itself based on the average 
of repeated PVBC maneuvers. ICC values were interpreted as follows: <0.5: poor reliability, 
0.5–0.75: moderate reliability, 0.75–0.9: good reliability, and >0.9: excellent reliability [21]. 
To test for differences in ICC between the various PVBC calculation methods we calculated 
the 84% CI; no overlap in these CIs was considered corresponding to p < 0.05 [25].
ICC of X5PVBC2EAdi-matching and PVBCβ
2 was evaluated in patients with sufficient EAdi 
matching for at least three of the five unassisted breaths. Since ICC models cannot handle 
missing data, only the first three successful measurements were included. Second, the 
coefficient of variation (CoV) of repeated PVBC measurements for all individual patients was 
calculated as the ratio of the within-subject SD to the mean, in order to evaluate dispersion 
of the repeated PVBC measurements. The median of these individual CoVs was used as 
the overall within-subject CoV for a given PVBC calculation method. This median CoV of 
PVBCβ2 was used to divide the study population into two groups with CoV higher or lower 
than median. Paired t-tests and Chi-squared tests were performed to test for differences 
in clinical parameters between groups.
RESULTS
The main characteristics of the study population (n=25) are shown in Table 2. A total of 125 
PVBC maneuvers were analyzed. Reliability parameters of all PVBC calculation methods 
are presented in Table 3.
Single and average breaths
N1PVBC2 indicated poor reliability: ICC 0.46 [0.23–0.66] and median CoV 31.3% (Table 
3). The latter suggests that if the mean of five N1PVBC2 measurements was 0.6, the five 
repeated measurements itself would likely vary between 0.23 and 0.97 (95% interval range; 
i.e., N1PVBC2 ± 1.96 × 0.1 CoV), which is a clinically unacceptably wide range. One should also 
note that due to the nature of PVBC, this interval range is bounded by 0 and 1.
Figure 1 shows physiological variability in EAdipeak and thus in Paw and Vtinsp (i.e., 
proportionality of NAVA) of the assisted breaths before the unassisted breath. Median CoV 
of EAdipeak of the five assisted breaths before the unassisted breath was 20.9 [15.3–24.6] %. 
Given the poor reliability of N1PVBC2, it was reasoned that averaging five assisted breaths 
before the unassisted breath limits the variability of the repeated PVBC measurements. As 
shown in Table 3, reliability of X5PVBC2 did not improve compared with N1PVBC2.
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Table 2. Main characteristics of the study population (n=25).
Characteristics
Age (year), median [IQR] 69 [56–72]
Sex (male/female), n 19/6
BMI (kg/m2), median [IQR] 24.7 [21.8–26.0]
Comorbidity, n (%)
Cardiac diseases 14 (56%)
COPD 4 (16%)




ARDS at admission, n (%) 7 (28%)
Sepsis during admission, n (%) 3 (12%)
Duration of MV at measurement time point (days), median [IQR] 10 [7–16]
Partially-assisted mode 8 [4–12]
Controlled mode 1 [0–2.8]
Duration of MV on partially-assisted mode after measurement time point (days), 
median [IQR]*
13 [5–19]
Ventilation characteristics at measurement time point, median [IQR]
NAVA level (cmH2O/µV) 0.7 [0.5–1.1]
EAdi peak (µV) 11.3 [7.8–18.1]
Tidal volume (ml) 441 [352–472]
Respiratory rate (min-1) 23 [18–30]
PEEP level (cmH2O) 8 [6–10]
PaO2/FiO2 ratio (mmHg) 259 [220–311]
Use of opioids or sedatives, n (%) 17 (68%)
Within-hospital 30-day mortality, n (%) 6 (32%)
Abbreviations: ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary 
disease; EAdi, electrical activity of the diaphragm; FiO2, inspired oxygen fraction; IQR, interquartile 
range; MV, mechanical ventilation; NAVA, neurally adjusted ventilatory assist; PaO2, arterial partial 
pressure of oxygen; PEEP, positive end-expiratory pressure. *n=21: four patients were lost to follow-up; 
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Matching EAdi
Upon visual inspection, some EAdi waveforms exhibited a rather non-physiological shape: 
i.e., a plateau or decrease during inspiration (while an increase would be expected) or at 
maximum inspiration (see Figure 3). For reasons clarified in the Discussion section, these 
“non-physiological EAdi waveforms” may contribute to the poor reliability of N1PVBC2 and 
X5PVBC2, and we hypothesized that EAdi matching to select assisted and unassisted breaths 
with similar respiratory drive would improve reliability. Where X5PVBC2EAdi-matching did not 
improve reliability (Table 3), calculating PVBC based on only tidal volumes of these EAdi-
matched breaths (PVBCβ2) exhibited good reliability (ICC: 0.78 [0.60–0.90] and median 
CoV: 12.1%).
After dividing the study population into two groups with CoV of PVBCβ2 either lower 
or higher than median (14.2%), statistically significant differences were only found in 
mean unassisted Vtinsp (372 ± 100 ml vs. 278 ± 72 ml, respectively, p = 0.048) and CoV 
of unassisted Vtinsp (5.9 ± 7.9% vs. 14.4 ± 5.5%, respectively, p = 0.023). No differences in 
clinical characteristics were found between the two groups.
Additional techniques derived from X5PVBC2
Because EAdi matching precludes direct clinical implementation of PVBC, additional 
techniques that can be used at the bedside were developed. Reliability results of X5PVBC23/5 












Figure 3. Examples of diaphragm electrical activity (EAdi) waveforms and insufficient signal filtering. 
Tracings (a), (b) and (c) were obtained from three different patients. In each of these tracings the last 
breath represents an unassisted breath. Dark blue bar: effective matching (for criteria, see Methods) 
of assisted EAdi with unassisted EAdi. Red bar: no adequate matching between assisted EAdi and 
unassisted EAdi. (a) Proper EAdi matching: all assisted breaths match the unassisted EAdi. (b) Fil-
tering error in the unassisted EAdi (arrow, last breath), resulting in an abrupt change in slope during 
inspiration. In addition, the third assisted EAdi shows a non-physiological EAdi waveform (i.e., split 
peak, see arrow). Because of this filtering error in the unassisted EAdi, none of the assisted breaths 
match with the unassisted EAdi. (c) Minor filtering error in the unassisted EAdi (i.e., split peak, see 
arrow). Therefore, matching between the assisted and unassisted EAdi was only sufficient for those 
assisted breaths that show a similar EAdi shape. (d) Random examples of various non-physiological 
EAdi waveforms observed during the study; data are from different patients.
DISCUSSION
The aim of the present study was to investigate the test-retest reliability of the PVBC index 
in clinical practice. The main finding is that currently available bedside methods to assess 
the PVBC index in ICU patients are unreliable. However, we present a new algorithm for EAdi 
matching between assisted breaths and unassisted breaths, which increases the reliability 
of PVBC and thus its clinical value. Calculation of PVBC using our EAdi matching technique 
may be useful to monitor the relative contribution of the patient to total tidal volume during 
mechanical ventilation in NAVA mode.
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Validity of PVBC
Because NAVA is a proportional ventilation mode, Vtinsp,assist reflects the patient’s inspiratory 
effort (EAdi) plus the proportional ventilator effort (ΔPaw). Where Vtinsp,no-assist is generated 
by the patient’s effort solely, the Vtinsp,no-assist/Vtinsp,assist ratio should reflect the contribution 
of the patient versus that of the ventilator. In an animal study, Grasselli et al. [12] normalized 
Vtinsp to EAdipeak, to account for physiological variability in neural respiratory drive between 
consecutive breaths. They validated the PVBC index against the relative contribution of 
ΔPes to dynamic transpulmonary pressure (ΔPL,dyn). As ΔPes estimates patient’s inspiratory 
effort and ΔPL,dyn reflects total breathing effort (patient + ventilator), the ratio of ΔPes/
ΔPL,dyn is considered the gold standard for PVBC assessment. There was a near-perfect 
1:1 linear relationship between PVBC2 and ΔPes/ΔPL,dyn, which was confirmed in patients 
with acute respiratory failure [24]. Therefore, in the present study we did not validate PVBC 
to ΔPes/ΔPL,dyn measurements. Instead, we focused on the test-retest reliability of the 
PVBC index and developed techniques to improve its reliability.
Reliability of PVBC
Due to normalization of Vtinsp to EAdipeak, PVBC should be stable from breath to breath within 
a short time interval. Unexpectedly, we found a poor reliability of N1PVBC2. It was reasoned 
that the variability in Vtinsp and EAdipeak of the assisted breaths might have contributed to this 
low reliability. Averaging five assisted breaths just before the unassisted breath (X5PVBC2) 
only slightly improved reliability. This suggests that the within-subject variability is due 
to an erroneous measurement, as it is highly unlikely that this within-subject variability 
is related to altered neuroventilatory coupling in the short time period of measurements 
(five minutes). In light of the present findings, we propose that suboptimal acquisition 
and/or filtering of the EAdi signal plays an important role. Artifacts originating from e.g., 
cardiac electrical activity, crosstalk from other muscles, and esophageal peristalsis affect 
EAdi signal quality and are replaced by filtering algorithms within the ventilator software. 
Suboptimal filtering results in non-physiological EAdi waveforms and thereby introduces 
measurement errors (see Figure 3). Inadequate filtering of the EAdi signal affects the Vtinsp 
delivered by the ventilator, as in NAVA mode inspiratory support is determined by this 
filtered EAdi signal [31]. In contrast, during an unassisted breath the generated tidal volume 
is the result of the patient’s true respiratory drive, irrespective of EAdi filtering (there is no 
ventilator assist). Thus, a filtering artifact present in the unassisted EAdi results in a Vtinsp,no-
assist/EAdipeak,no-assist ratio that is not necessarily representative for that tidal volume (i.e., it is 
overestimated as inadequate filtering results in an EAdipeak lower than true EAdipeak). With 
our technique for EAdi matching, only breaths with similar EAdi waveforms are included in 
the PVBC calculation. This means that the inspiratory effort for the assisted and unassisted 
breaths of that patient are comparable and that the measurement error related to non-
physiological EAdi signals is reduced. With our criteria for detecting EAdi similarity (linear 
regression fit parameters: r2 ≥ 0.85, regression slope between 0.75 and 1.33, and trend line 
intersection between -1.5 µV and 1.5 µV) we indeed demonstrated improved reliability of 




of other techniques to calculate PVBC. As PVBCβ2 has already been validated against the 
gold standard (ΔPes/ΔPL,dyn) [24], our data indicate that a single PVBCβ
2 measurement 
as obtained with our newly developed EAdi matching criteria can be reliably used to assess 
the true contribution of the patient versus that of the ventilator.
The concept of EAdi matching has been used previously to improve the relationship between 
PVBC and ΔPes/ΔPL,dyn [24]. However, important differences in EAdi matching from our study 
should be acknowledged. First, Liu et al. [24] applied EAdi matching solely based on EAdipeak ratio 
of assisted and unassisted breaths, where a ratio between 0.8 and 1.3 was defined as a match. 
In contrast, our matching criteria were based on the inspiratory increase in EAdi. It was reasoned 
that this is more appropriate for limiting the influence of non-physiological EAdi waveforms. 
For instance, if cardiac artifact replacements are present in the inspiratory EAdi increase, the 
EAdipeak ratio might be within the 0.8–1.3 range while the peak value itself underestimates 
true EAdipeak. With our matching criteria, such breaths would be excluded. Second, in their 
study only the five assisted breaths preceding the unassisted breath were tested for similarity, 
while in our study breaths were selected in the 1-minute interval before the unassisted breath.
As our matching algorithm precludes direct bedside implementation of the PVBC index, 
we aimed to optimize the X5PVBC2 method by 1) pragmatically selecting three out of five PVBC 
maneuvers with the lowest variability (X5PVBC23/5) and 2) calculating 
X5PVBC2 based on tidal 
volumes only (X5PVBC2Vt). The first strategy is comparable to measurements of thermodilution 
cardiac output and to our proposed estimation of the neuromechanical efficiency index, 
where three repeated measurements were averaged, provided that these values are within 
15% of their median [19, 27]. X5PVBC23/5 showed excellent reliability (ICC: 0.99 [0.98–0.99]) 
whereas X5PVBC2Vt showed good reliability (ICC: 0.77 [0.58–0.88]) only for average measures.
Although both methods are more time-consuming because five unassisted maneuvers 
should be performed, no EAdi matching is required. It should, however, be noted that both 
methods are only statistical techniques to reduce measurement error, whereas with our 
EAdi matching technique reliability is improved by reducing influence of non-physiological 
EAdi waveforms. Therefore, it was reasoned that it was inappropriate to test agreement 
of PVBCβ2 with X5PVBC23/5 and 
X5PVBC2Vt in order to provide further conclusions about the 
validity of both methods. In contrast, validity of X5PVBC23/5 and 
X5PVBC2Vt should be further 
investigated by comparing these methods to ΔPes/ΔPL,dyn. In the meantime, software 
engineers should further improve ventilator software for EAdi filtering and implement a 
matching algorithm such as that developed in the current study, so that PVBCβ2 becomes 
available at the bedside as a sophisticated and reliable monitoring method for the relative 
contribution of the patient to total inspiratory volume during NAVA.
Clinical implications of PVBC
PVBC is potentially helpful in quantifying the patient’s contribution to total tidal volume 
(patient + ventilator) for patients ventilated in NAVA mode. This could help the clinician 
in adjusting ventilator assist without the need for Pes measurements. This is of clinical 
importance, given the adverse effects related to ventilator under-assist and ventilator 
over-assist [10, 14]. However, to limit the detrimental effects of mechanical ventilation 
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on the diaphragm, the PVBC index should always be interpreted in the light of absolute 
ventilator assist (inspiratory airway pressure) and patient effort (EAdi). For example, a high 
PVBC value may be found in patients with very high respiratory drive and in patients with 
low drive ready to be weaned. In the former, there is insufficient inspiratory assist by the 
ventilator (low inspiratory airway pressure) and high EAdi. In the latter, EAdi will be low, 
reflecting low patient effort, but the high PVBC indicates that still the majority of effort is 
generated by the patient, so most likely this patient is ready to be weaned off the ventilator. 
Accordingly, PVBC holds promise for future clinical application, but technical aspects should 
be improved as demonstrated in the present report and clinicians should be aware of the 
rather complex interpretation of the PVBC value.
Strengths and limitations
The strengths of our study are the high number of PVBC maneuvers performed within a 
short time period. This allows extensive waveform analysis such that different methods 
for PVBC calculation could be evaluated. In addition, an EAdi matching technique was 
developed to detect similarity in EAdi between assisted and unassisted breaths.
Some limitations should be addressed. First, we did not validate PVBC to Pes 
measurements, as this has been done previously [12, 24]. Second, six patients were excluded 
from the analysis of X5PVBC2EAdi-matching and PVBCβ
2 as predefined matching criteria were 
not met. This could have been anticipated by applying less stringent matching criteria; 
however, this subsequently increases the possibility of introducing measurement error. On 
the other hand, reasons for matching failure were identified and substantiate the need for 
improved EAdi signal processing, such that PVBC measurements could become available 
in all patients ventilated in NAVA mode. Finally, although the PVBC index is a promising 
monitoring technique that has been validated in experimental studies [12, 24], it was not 
the aim of the present study to provide clinical guidance regarding the interpretation of 
the PVBC index during the course of mechanical ventilation. Instead, we focused on the 
reliability of this index and found that improvement of current bedside techniques for PVBC 
calculation is required before this index can be reliably used for titrating ventilator support. 
This highlights the importance of reliability studies for new monitoring indices before 
implementation in clinical practice. Future clinical studies should focus on the diagnostic 
implications of PVBC during the course of mechanical ventilation and in weaning trials. 
Then, guidelines should be developed on how PVBC can be used as part of a diaphragm-
protective ventilation strategy.
In conclusion, this study shows that the methods currently available to assess the 
PVBC at the bedside are unreliable. Our newly developed criteria and estimation of PVBC 
(selecting only matching EAdi between the assisted and unassisted breaths) increased 
reliability. When an EAdi matching algorithm is implemented in the ventilator software, 
the PVBC index is continuously available at the bedside as a tool that helps the clinician 
in assessing the contribution of the patient versus that of the ventilator during NAVA. 
Future studies need to focus on the diagnostic implications of PVBC during the course of 
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To the Editor:
Monitoring diaphragm activity in mechanically ventilated patients is used to limit the 
adverse consequences of mechanical ventilation on the diaphragm [1]. Ventilator over-
assist may result in disuse atrophy and ventilator under-assist in load-induced injury 
[2]. In addition, monitoring diaphragm activity allows for detection of patient-ventilator 
asynchronies [1]. Esophageal pressure (Pes) measurement is the state-of-the-art technique 
to assess inspiratory muscle effort and patient-ventilator interaction but requires specific 
expertise and signals may be difficult to interpret [3], especially when expiratory muscles 
are activated [4]. Monitoring the electrical activity of the diaphragm (EAdi) with a dedicated 
nasogastric catheter (EAdi catheter, Getinge, Solna, Sweden) [5] is a valuable alternative 
for bedside assessment of patient-ventilator interaction [1]. The EAdi catheter contains nine 
ring-shaped electrodes positioned at the level of the diaphragm and was originally designed 
to control the ventilator in neurally adjusted ventilatory assist (NAVA) mode [5]. Ventilator 
algorithms continuously select the electrode pair closest to the diaphragm and correct 
for signal disturbances, such as interference from cardiac electrical activity and motion 
artifacts due to cardiac contractions and esophageal peristalsis. However, the reliability 
of EAdi-derived parameters to monitor the diaphragm (e.g., neuromechanical efficiency 
index and patient-ventilator breath contribution index) has been challenged recently due 
to possible artifacts in the EAdi signal as processed by the ventilator software [6, 7]. This 
is of potential clinical and scientific importance because inadequate EAdi filtering may 
underestimate or overestimate the severity of patient-ventilator asynchrony and result in 
inadequate modulation of ventilator settings.
Notably, the BetterCare® software was validated by using the EAdi signal as a reference 
standard to classify ineffective efforts during expiration [8]. Ineffective efforts were defined 
as EAdi peaks of >1 µV above basal EAdi during expiration, not followed by a ventilator 
breath. More recently, Rolland-Debord and colleagues used this same threshold of >1 µV 
for detection of ineffective efforts based on EAdi solely [9]. However, we challenge the 
origin of such small EAdi peaks and reason that EAdi peaks during expiration (example 
Figure 1, left) can also reflect filtering artifacts instead of ineffective efforts. The aim of 
the current study was to establish the origin of expiratory EAdi peaks in the EAdi signal as 
displayed by the ventilator software. We performed an in-depth signal analysis and explain 
















(PS 22 cmH₂O, PEEP 6 cmH₂O, RR 20/min)
NAVA mode









Figure 1. Left: Ventilator waveforms from a patient ventilated in pressure support (PS) mode with 
a PEEP of 6 cmH2O and PS level of 22 cmH2O. Respiratory rate (RR) was 20/min. Dashed vertical 
lines indicate the start and end of mechanical inspiration (i.e., flow zero-crossings). A catheter was 
placed to monitor electrical activity of the diaphragm (EAdi). Adequate catheter position was verified 
with chest X-ray and the manufacturer’s guidelines provided within the ventilator software. Arrows 
indicate small EAdi peaks during mechanical expiration. Right: After switching ventilator mode to 
NAVA, all EAdi peaks resulted in proportional ventilator assist, and ventilator-RR increased to 36/
min. Interestingly, no drop in Paw, indicating no patient effort, is observed for those breaths related to 
the smaller EAdi peaks (dashed circles), leading to the suspicion of cardiac activity-related artifacts 
and “EAdi auto-triggering”. Abbreviations: NAVA, neurally adjusted ventilatory assist; Paw, airway 
pressure; PEEP, positive end-expiratory pressure.
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METHODS
Seventeen patients were included in this study. First, to assess the origin of expiratory 
EAdi peaks of >1 µV, we performed measurements in two patients ventilated in pressure 
support mode who had an EAdi catheter and catheter for Pes and/or transdiaphragmatic 
pressure (Pdi) measurements in situ for clinical purposes. Ventilator flow, airway pressure, 
and EAdi waveforms were obtained (sample frequency, 100 Hz) from the Servo-U ventilator 
using Servo-tracker software (Servo-tracker release 4.2, Getinge, Solna, Sweden). 
Simultaneously, airway pressure, Pes and/or Pdi, ECG, and raw diaphragm electromyography 
(EMGdi) were acquired at 2 kHz using a dedicated measurement setup (Biopac MP160, 
BIOPAC Inc., USA). A Y-splitter cable (Telerex Nederland B.V., The Netherlands) allowed 
simultaneous acquisition of EMGdi and EAdi signals. Data were offline resampled to 2 kHz, 
synchronized based on airway pressure tracings that were acquired simultaneously using 
both measurement devices (i.e., an end-expiratory hold was performed at the start of a 
recording; the corresponding drop in airway pressure was used to synchronize the data) 
and processed using a software routine for MATLAB 2018b (Mathworks, Natick, MA, USA).
Additionally, we analyzed waveform data (EAdi, Pes, ventilator flow, and airway pressure) 
from 15 patients ventilated with continuous positive airway pressure (±10 minutes per 
patient; subset from Reference 10) to assess the incidence of expiratory EAdi peaks of >1 
µV. Expiration was defined based on flow zero-crossings. With Pes waveforms, we verified 
if expiratory EAdi peaks were true ineffective efforts.
RESULTS
Prospectively acquired waveforms from two patients are shown in Figure 2. EAdi peaks 
during expiration were not the result of patient effort (no decrease in Pes or increase in Pdi), 
but, instead, occurred simultaneously with cardiac activity. Also, cardiac activity present 
at the start of an inspiratory effort resulted in a delay between EAdi onset and the start of 
EMGdi increase (see Figure 2a).
In total, 4063 breaths from 15 patients (mean 271 ± 89 breaths per patient) were 
analyzed to describe the incidence of expiratory EAdi peaks. In total, 240 expiratory EAdi 
peaks were present in 12 patients (median number of expiratory EAdi peaks per patient 
per 10-min interval, 19 [minimum–maximum (min–max), 2–52]; median percentage of 
expiratory EAdi peaks with regard to total breaths per patient, 6.8% [min–max, 0.6–
23.6%]). Only 21/240 (8.8%) peaks were true ineffective efforts as confirmed with Pes. 
Ineffective efforts were present in only five patients. Cardiac activity-related EAdi peaks 
varied in amplitude (min–max, 1–20 µV, but mostly <4 µV) and were always lower than 








































Figure 2. (a) Airway pressure (Paw), electrical activity of the diaphragm (EAdi) as presented on the 
ventilator, raw diaphragm electromyography (EMGdi), and esophageal pressure (Pes) waveforms 
obtained from the same patient as in Figure 1, ventilated in pressure support mode. Cardiac electrical 
activity can be clearly observed as spike-shaped artifacts in the EMGdi signal. The two expiratory 
EAdi peaks that are marked with arrows occurred simultaneously with cardiac electrical activity 
while there was no patient effort (no drop in Pes). The expiratory EAdi peak at the second arrow 
occurred simultaneously with a ventricular extra systole. The small EAdi peaks during expiration that 
are marked with asterisks are reasoned to be the result of a mechanical artifact due to the absence 
of both spike-shaped cardiac electrical artifacts and patient effort at these moments. In addition, 
the second breath shows a delay between the start of EMGdi (black dashed line) and increase in 
EAdi (red dashed line), likely because of filtering cardiac electrical activity at the beginning of this 
breath. Note that the same phenomenon (but to a much lesser extent) can be observed for the 
first breath. The observation that there is a patient effort (drop in Pes) simultaneously with both 
the start of EMGdi and the start of EAdi for the other breaths strengthens the hypothesis that this 
“delay” might be a filtering artifact. (b) Flow, EAdi, EMGdi, and transdiaphragmatic pressure (Pdi) 
from a different patient. Pdi was obtained via a double-balloon catheter for Pes and gastric pressure 
measurements and was calculated as gastric pressure – Pes. Black dashed vertical lines reflect flow 
zero-crossings. Small EAdi peaks of about 3.5 µV are visible during expiratory flow (arrows in EAdi 
waveform), which coincide with cardiac activity in a relatively fixed pattern. Furthermore, the minor 
drops in Pdi at the time of expiratory EAdi peaks (arrows in Pdi waveform) confirm the absence of 
functional diaphragm contraction at these moments.
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DISCUSSION
In this study we clearly demonstrate that patient-ventilator interaction can be misinterpreted 
because of suboptimal EAdi filtering by the ventilator software. Possible explanations are 
as follows:
1. Electrical artifact: Ineffective filtering and replacement of QRS complexes can 
appear as EAdi peaks or can lead to a delayed onset of EAdi increase. The EMGdi 
frequency is from 20 to 250 Hz, whereas the ECG frequency is from 0 to 100 Hz (but 
mostly <25 Hz) [11]. Due to this frequency overlapping, it is difficult to fully eliminate 
cardiac activity from diaphragm activity, especially during real-time processing. 
Furthermore, removal of cardiac electrical activity is technically challenging in 
patients with arrhythmias, tachycardia, and/or low diaphragmatic activity (thus, 
low signal-to-noise ratio).
2. Mechanical artifact: Cardiac movement (contraction and filling of the heart) results 
in intrathoracic pressure changes and slight displacement of the EAdi catheter 
relative to the diaphragm. Insufficient filtering of these movement artifacts may 
result in EAdi peaks.
Recognizing filtering-related asynchrony is important for proper evaluation of patient-
ventilator interaction. First, inappropriate filtering affects the reliability of EAdi-derived 
monitoring indices, as we published earlier [6, 7]. Second, inadequate EAdi signal filtering 
at the start of inspiratory activity may cause a non-physiological delay between true neural 
inspiration and the start of EAdi-derived inspiration. Third, cardiac activity-related EAdi 
peaks during expiration result in an overestimation of the true number of ineffective efforts, 
when very sensitive criteria are used (e.g., increase in EAdi >1 µV). This may also explain the 
relatively low sensitivity (65.2%) of the BetterCare® algorithm when validating ineffective 
efforts with EAdi signal data as a reference standard [8]. Finally, cardiac activity-related 
EAdi peaks result in proportional ventilator assist during NAVA (see Figure 1, right). This 
“EAdi auto-triggering” leads to high ventilator respiratory rates, which may cause patient 
agitation and might needlessly alarm nurses and staff.
CONCLUSION
Cardiac activity-related artifacts are often present in the EAdi signal filtered by the ventilator 
software. This might lead to incorrect interpretation of patient-ventilator interaction and 
highlights the need for proper technical and physiological understanding of monitoring 
signals and software used for research and clinical decision-making. Future analysis 
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Response letter: Considerations for an optimal EAdi threshold for automatic detection of ineffective efforts
From the authors:
We greatly appreciate the interest of Dr. Aquino-Esperanza and colleagues in our research 
letter [1] regarding the influence of suboptimal filtering of the electrical activity of the 
diaphragm (EAdi) signal on the detection of patient-ventilator asynchronies. In that letter, 
we raised the concern that cardiac activity-related artifacts in the EAdi signal may be 
mistakenly detected as ineffective efforts when the EAdi threshold is too low. Based on 
this work, Aquino-Esperanza and colleagues have thoughtfully reanalyzed the performance 
of their BetterCare® algorithm [2] to find an appropriate EAdi threshold for automatic 
detection of ineffective efforts. They conclude that increasing the EAdi threshold from 1 
µV to 2.3 µV improved the sensitivity of their algorithm and maintained adequate specificity. 
We appreciate this careful reanalysis and agree with the authors that a threshold of >2 µV 
is reasonable. It should be noted that in our work [1], EAdi artifacts were mostly <4 µV, but 
we agree that a threshold of 4 µV would be clinically disproportionate and increase the 
false negative rate.
We also agree with the authors that a personalized adaptive EAdi threshold may improve 
the performance of automatic detection of true ineffective efforts. We considered testing 
this with our dataset; however, the incidence of true ineffective efforts was too low [1]. In 
contrast, because the processing of these EAdi artifacts is a technical issue, it might be 
rather impossible to distinguish between artifacts and true ineffective efforts based on a 
certain EAdi threshold solely. As part of our earlier work, we aimed to quantify waveform 
characteristics of the cardiac activity-related artifacts (i.e., slope of the inspiratory EAdi 
increase, timing, and amplitude) and predict the occurrence of these artifacts based on 
patient characteristics. For instance, we hypothesized that cardiac activity-related peaks 
had steeper increases (“sharp waves”, possibly consistent with fast cardiac depolarization); 
however, slopes of the artificial and true peaks were similar on average, and both artificial 
peaks with lower and higher slopes compared to true EAdi peaks were found within patients. 
Furthermore, factors such as the presence of ventricular hypertrophy were not related to 
the occurrence of these artifacts. We did not include these findings in our research letter, 
as this is clinically not very helpful at this time.
Importantly, the main challenge with developing a (personalized) EAdi threshold using 
signal characteristics is the uncertainty regarding how the ventilator algorithm processes 
the EAdi signal (“black box”). In addition, artifacts may look different when originating from 
cardiac or catheter movements (mechanical artifact) or when being secondary to inefficient 
filtering of the QRS complex (electrical artifact). This requires specific analysis of the raw 
diaphragm electromyography signal, and indeed, complex mathematical techniques might 
offer a solution. As the raw diaphragm electromyography is not available to the clinician 
to test this approach, we reason that using a threshold >2 µV as proposed by Aquino-
Esperanza and colleagues is an appropriate practical solution for automatic detecting 
of ineffective efforts in large datasets. However, one should keep in mind that artifacts 
of larger amplitudes can be present and that careful consideration of the EAdi catheter 
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Respiratory entrainment and reverse triggering in a mechanically ventilated patient
THE CLINICAL CHALLENGE
A 35-year-old man with no relevant past medical history was admitted to a community 
hospital with dyspnea, cough productive of purulent mucus, and fever. A chest radiograph 
showed bilateral basal consolidations, and he was diagnosed with community-acquired 
pneumonia. The patient did not improve with ceftriaxone and developed severe 
bronchospasm after bronchoalveolar lavage, leading to hypercapnic respiratory failure, 
and consequently, endotracheal intubation. Computed tomographic imaging of the chest 
revealed a tree-in-bud configuration without ground-glass opacifications, consolidations, 
pleural effusions, or signs of pulmonary embolism. Despite treatment with prednisolone 
and bronchodilators, the patient required increasing ventilatory support, and his peak 
airway pressure eventually reached 46 cmH2O (in pressure control mode) with 18 cmH2O 
of positive end-expiratory pressure. The patient was transferred to our hospital four days 
after intubation for possible extracorporeal CO2 removal or extracorporeal membrane 
oxygenation. An esophageal balloon was inserted to evaluate pulmonary mechanics (Table 
1), which revealed that the high airway pressure was mostly used to overcome resistance 
in the conducting airways. The true lung-distending pressure was within lung-protective 
range; as such, we continued ventilation with high inspiratory support levels. After results of 
cultures of blood and bronchial fluid were found to be negative, the patient was treated with 
1.0 g of methylprednisolone daily for three days for idiopathic interstitial lung disease. His 
condition improved steadily over the next seven days; his ratio of arterial oxygen pressure to 
fraction of inspired oxygen increased from 97 to 218 mmHg, and his arterial carbon dioxide 
pressure (PaCO2) decreased from 72 to 49 mmHg. On the patient’s eight day at our center, 
we observed a remarkable pattern of pressure and flow on the ventilator screen (Figure 
1), which we initially interpreted as “fighting the ventilator”. Increasing doses of sedatives 
did not abolish the pattern. The patient-ventilator interaction was subsequently identified 
and managed with esophageal pressure measurements and knowledge of respiratory 
physiology.
QUESTIONS
1. Which patient-ventilator interaction did the patient exhibit?
2. What is the pathophysiology of this patient-ventilator interaction?
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Figure 1. Airway pressure (Paw), flow, volume, esophageal pressure (Pes), and transpulmonary pres-
sure (PL) in 12 consecutive breaths. PL is calculated as Paw – Pes. Asterisks mark passive mandatory 
ventilator insufflations, as can be deduced from the rise in Pes during inspiration. The hash signs 
mark breaths that start as a passive insufflation but are rapidly followed by patient effort, as can 
be concluded from the drop in Pes. The decreases in Pes lower the Paw and trigger the ventilator 
before complete exhalation of the previous breath (arrows), leading to breath stacking with high tidal 
volumes (1.3 Liters). These breaths with patient effort are likely reverse triggered. That is, the man-
datory insufflations elicit a neural response leading to patient effort. There is a 2:1 ratio of mandatory 
to reverse-triggered breaths, which is consistent with respiratory entrainment.
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Inspiratory pressure support (cmH2O) 36
Positive end-expiratory pressure set (cmH2O) 12
Respiratory rate set (min-1) 30
Fraction of inspired oxygen 0.6
Respiratory mechanics
Tidal volume (ml) 502
Tidal volume (ml/kg predicted body weight) 5.7
Peak airway pressure (cmH2O) 43
Plateau pressure (cmH2O) 23
Total positive end-expiratory pressure (cmH2O) 13
Esophageal pressure at inspiratory occlusion (cmH2O) 14
Esophageal pressure at expiratory occlusion (cmH2O) 10
Compliance of the respiratory system (ml/cmH2O) 50
Lung compliance (ml/cmH2O) 83
Chest wall compliance (ml/cmH2O) 125
Inspiratory airway resistance (cmH2O/L/s) 22
Inspiratory transpulmonary pressure (cmH2O) 9
Expiratory transpulmonary pressure (cmH2O) 3







-, bicarbonate; PaCO2, arterial carbon dioxide pressure; PaO2, arterial oxygen 
pressure. The parameters of the respiratory mechanics were obtained during static conditions in volume 
control mode with constant flow rates. Plateau airway pressure was measured during an inspiratory 
hold. Total positive end-expiratory pressure was measured on the airway pressure curve during a 
prolonged expiratory hold. Inspiratory airway resistance was calculated by dividing the difference 
between peak airway pressure and plateau airway pressure by the end-inspiratory flow. Inspiratory 
and expiratory transpulmonary pressures were calculated by subtracting esophageal pressure from 
airway pressure during an end-inspiratory hold and an end-expiratory hold, respectively. Ideal body 





We reasoned that the observed patient-ventilator interaction was a typical example of 
respiratory entrainment with reverse triggering. Careful analysis of the airway pressure, 
the flow and esophageal pressure curves (Figure 1) revealed a fixed breathing pattern with 
two distinct types of breaths: 1) mandatory breaths (marked with asterisks in the figure) 
characterized by the absence of patient effort (esophageal pressure rises during inspiration), 
and 2) “reverse-triggered” breaths (marked with hash sign in the figure) characterized 
by the presence of patient effort after the start of the mandatory ventilator insufflation 
(esophageal pressure drops). It is reasoned that the pressure and flow in the mandatory 
breath stimulate the respiratory control center and produce involuntary patient effort in 
a process known as “respiratory entrainment”. Patient effort then lowers airway pressure 
below the ventilator trigger level (Figure 1, arrows), leading to a mandatory insufflation 
before expiration of the previous breath. This caused “breath stacking” in our patient, which 
led to volumes and pressures that were incompatible with lung-protective ventilation (Table 
2). We reasoned that breath stacking due to reverse triggering had to be abolished to limit 
the risk of ventilator-induced lung injury.
Table 2. Differences between respiratory mechanics in mandatory (passive) insufflations and reverse-







Volume (ml) 620 1413 530–710*
Volume (ml/kg predicted body weight) 7 16 6–8
Transpulmonary pressure (cmH2O) 9 23 <20
Plateau airway pressure (cmH2O) 30 36 <30
Driving pressure (cmH2O) 10 28
# <15
*Safe limit was calculated using the height of this patient (195 cm) and the Devine formula, assuming 6–8 
ml/kg predicted body weight to be lung protective. Transpulmonary pressure was obtained by subtracting 
esophageal pressure from airway pressure during an end-inspiratory hold. Driving pressure was obtained 
by subtracting the airway pressure during an expiratory hold from the airway pressure during an 
inspiratory hold. #Estimated by dividing the tidal volume by the compliance of the respiratory system.
CLINICAL SOLUTION
Respiratory entrainment produces involuntary inspiratory effort. As such, increasing the 
dose of sedatives is not expected to stop or prevent reverse triggering, and might even 
facilitate its occurrence. Because the first response to a patient “fighting the ventilator” 
is often to increase sedation, it is essential to recognize this form of patient-ventilator 
interaction. In fact, reducing sedation and changing respiratory rate, inspiratory pressure, 
and applied volume can disrupt entrainment and prevent reverse triggering. Unfortunately, 
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these measures were ineffective in our patient. Therefore, the neuromuscular blocker 
rocuronium was administered to abolish respiratory muscle output and prevent reverse-
triggered efforts with breath stacking.
THE SCIENCE BEHIND THE SOLUTION
The definition and origin of reverse triggering
“Reverse triggering” is a new term for a distinct type of patient-ventilator interaction. It is a 
consequence of respiratory entrainment, a physiological phenomenon that was described 
as early as the 19th century. Entrainment refers to the resetting of an oscillator’s period and 
phase to match an external stimulus. Respiratory entrainment exists when the rhythm 
imposed by the ventilator is matched by the patient’s respiratory center.
Respiratory entrainment can be induced in wakeful, sleeping, and anesthetized human 
subjects on mechanical ventilation, both in health and in disease. Entrainment most often 
occurs when tidal volumes and respiratory rates are close to a subject’s own respiratory 
rate and tidal volume (i.e., as observed during wakefulness). The leading theory is that the 
flow and pressure applied by the ventilator activate stretch receptors in the upper airways, 
lungs, and chest wall. Feedback by these receptors causes the respiratory control center to 
match the phase and frequency of the external stimulus, producing a repetitive respiratory 
pattern (Figure 2).
The term “reverse triggering” refers to the abnormal relationship between the ventilator 
and the patient. The external stimulus, in this case the mandatory breath applied by the 
ventilator, elicits a reflexive neural response from the patient. The ventilator seemingly 
“triggers” the patient. The resulting neural and muscular activity is “reverse-triggered” 
effort. A 1:1 ratio of mechanical to reverse-triggered breaths is most common, but other 
ratios, such as 2:1, 3:1, and 1:2 have been described as well. Our patient presented a 2:1 
ratio (one muscular effort for every two machine insufflations) for most of the 30-minute 
recording period.
The evolutionary benefit of the “reverse-triggering” reflex is unknown. Reacting to an 
external stimulus could merely be a feature common to other pattern-generating centers 

















Figure 2. Feedback loop leading to entrainment and reverse triggering. Starting upper left: the 
ventilator applies pressure and volume in a fixed and repetitive pattern. This acts as the external 
stimulus, leading to the activation of different receptors (in red) in the airways, lung tissue, and chest 
wall. These receptors provide neural feedback to the respiratory control center through vagal (and 
possibly other) fibers. The respiratory control centers in the brain stem (dark green) try to match the 
pattern generated by the ventilator. In this figure, a 1:1 entrainment ratio is generated (every manda-
tory insufflation is followed by phrenic nerve activity). The respiratory muscles contract according to 
this phrenic nerve activity output. This results in the drop in pleural (and esophageal) pressure. The 
timing, duration, and magnitude of the inspiratory muscle effort show little variation. The dotted 
arrow that goes back to the ventilator illustrates that the reverse-triggered effort may trigger the 
ventilator, leading to breath stacking.
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Recognizing reverse triggering
Clinically, it is important to differentiate reverse triggering from “spontaneous” (patient-
initiated) effort because pathophysiology and treatment strategies differ. There are 
two distinguishing characteristics of reverse-triggered breaths, and both are related to 
respiratory entrainment.
First, reverse-triggered breaths occur in a stable and repetitive pattern. It has been 
proposed that at least 5–10 breaths with a fixed mechanical/patient effort ratio (1:1, 1:2, 
or 2:1) must be present. Second, reverse-triggered breaths differ minimally in the timing, 
duration, and magnitude of inspiratory effort, which can be measured and quantified by 
either diaphragmatic electromyography or esophageal pressure measurements (Figure 
3). The duration of inspiratory effort equals the time between the drop in esophageal 
pressure and its return to baseline. The timing of inspiratory effort is quantified by the time 
difference (or phase delay) between the onset of the mandatory insufflation and the onset 
of subsequent patient effort. This is often expressed as the phase angle:
Phase angle (°) = [(inspiratory effort onset time – ventilator onset time) /
ventilator cycle duration] × 360°      (1)
where ventilator cycle duration is the time difference between the onset of two mandatory 
insufflations. A phase angle of 0 degrees would mean perfect synchronization between 
neural and mechanical effort; a phase angle of 180 degrees would mean patient effort 
commences exactly halfway between the onset of two mandatory insufflations. The 
magnitude of inspiratory effort can be quantified by subtracting the nadir esophageal 
pressure during the breath from the baseline esophageal pressure. The degree of variation 
of the phase angles, inspiratory duration, and magnitude of inspiratory effort can then be 
quantified by calculating the coefficient of variation for each parameter:
Coefficient of variation (%) = (standard deviation / mean) × 100%  (2)
We consider a coefficient of variation less than 15% to be consistent with respiratory 
entrainment, although there is no consensus in the literature. Spontaneous patient effort 
is more likely to vary in magnitude and timing and generally does not occur in a fixed 
pattern.
The response to a prolonged expiratory hold can also help to distinguish between 
respiratory entrainment with reverse triggering and spontaneous patient effort. A 
20-second expiratory hold suppresses the external stimulus that sustains respiratory 
entrainment and should prevent reverse triggering (Figure 4). Spontaneous patient effort 
is likely to continue during the expiratory hold and often becomes more vigorous.
Our patient demonstrated a 2:1 ratio of mechanical to reverse-triggered breaths. The 
phase angle, inspiratory activity duration, and magnitude of inspiratory effort demonstrated 
minimal variance, and patient effort ceased during a prolonged expiratory hold (Figure 




reverse triggering. This diagnosis would have been difficult to confirm without esophageal 
pressure measurements because the phase angle, inspiratory time, and magnitude of 

























Figure 3. Airway pressure (Paw), flow, and esophageal pressure (Pes) tracings for the measure-
ments and calculation of phase angle, inspiratory duration, and magnitude of inspiratory effort. 
Total ventilator cycle duration is the time (in ms) between the onset of two mandatory mechanical 
insufflations. Patient inspiratory time (Ti) is the time (in ms) between the drop in Pes until its return 
to baseline. The phase delay (dP; light blue area) is the time (in ms) between the onset of manda-
tory mechanical insufflation and the onset of patient effort (rapid drop in Pes). The phase angle is 
obtained by dividing the phase delay by ventilator cycle duration, multiplying by 360 degrees. The 
magnitude of inspiratory effort (∆Pes, in cmH2O) is calculated as the difference between the Pes at 
the onset of its rapid decline and its nadir.
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Figure 4. Elimination of reverse-triggered breaths during an end-expiratory hold: airway pressure 
(Paw), flow, esophageal pressure (Pes), and transpulmonary pressure (PL; calculated as Paw – Pes) 
during seven breaths and an expiratory hold. The first five breaths show signs of respiratory entrain-
ment: a 2:1 pattern of mandatory to reverse-triggered breaths, with the magnitude and duration of 
inspiratory effort very similar for both breaths. An end-expiratory occlusion was performed, which 
abolished respiratory muscle activity for more than 12 seconds. The arrow on the Pes curve marks the 
moment that inspiratory effort was expected if patient effort would have been generated sponta-
neously. After the expiratory hold, another mandatory insufflation was administered by the ventilator; 
patient effort immediately followed. This is suggestive of reverse triggering because the patient 
effort seems to depend on the external stimulus provided by the mandatory ventilator insufflation.
Consequences of reverse triggering
Potentially harmful effects on the lungs
The transpulmonary pressure is a clinical estimate of stress applied to the lungs:
Transpulmonary pressure = airway opening pressure – pleural pressure (3)
Esophageal pressure is often used to approximate pleural pressure in the clinical setting. 
Both high ventilator assistance (increased airway opening pressure) and elevated patient 
effort (lower pleural pressure) will increase the transpulmonary pressure and thus result in 
more lung stress. The negative intrathoracic pressures that accompany reverse-triggered 




pressure. In addition, strong inspiratory effort can cause a shift in the intrapulmonary air 
left over at end expiration, an effect known as “pendelluft” that increases lung stress on 
relatively healthy regions of lung tissue.
Reverse triggering may also result in breath stacking if the timing and magnitude 
of patient effort are sufficient to trigger the ventilator. Breath stacking can elevate 
transpulmonary pressures and increase tidal volumes to levels incompatible with lung- 
protective ventilation (Table 2), as illustrated in this case.
Potentially harmful effects on the respiratory muscles
On one hand, excessive respiratory muscle activity can damage the respiratory muscle 
fibers and thus contribute to respiratory muscle dysfunction and prolonged weaning. In 
addition, diaphragmatic contractions can become eccentric if reverse triggering occurs 
during expiration. Eccentric contractions are more injurious to muscle fibers than concentric 
contractions, although this has not been proven in the setting of reverse triggering. On the 
other hand, maintaining some respiratory muscle effort during mechanical ventilation (in this 
case due to reverse triggering) may protect against disuse atrophy of the inspiratory muscles. 
In our patient, the pressure-time product of the respiratory muscles due to reverse triggering 
was 172 cmH2O∙s/min (Figure 5), which is close to a physiological level of effort. However, we 
reasoned that in this case the potential harm to the lungs outweighed this potential benefit.
Potentially harmful effects on homeostasis and hemodynamics
The reverse-triggered patient effort might contribute significantly to CO2 production and 
oxygen demand, which could warrant a higher minute volume or result in an elevated PaCO2. 
The negative intrathoracic pressure can also increase the preload of the right ventricle and 
elevate the afterload of the left ventricle; both could contribute to cardiac failure.
Preventing and treating reverse triggering
Because reverse triggering originates from respiratory entrainment, interrupting or 
modifying the entrainment pattern can prevent or limit reverse triggering. Because 
entrainment is more likely to occur during sedation, it is unwise to increase sedatives as 
a treatment. One might be tempted to reduce the trigger sensitivity of the ventilator. 
Although this can effectively prevent breath stacking, it does not abolish the potentially 
injurious muscular effort or the harmful effects of negative intrathoracic pressure.
Instead, the entrainment between the ventilator and the patient can be disrupted by 
changing the tidal volume (or pressure) and the mandatory respiratory rate. In general, 
entrainment is more likely to occur during longer mechanical insufflations with lower 
flow rates and higher volumes. Reducing tidal volume can therefore break entrainment. 
In addition, increasing the mandatory respiratory rate can completely abolish a patient’s 
neural effort and disrupt respiratory entrainment. Lowering the mandatory respiratory rate 
might cause patient effort to commence before mechanical inflation, thereby effectively 
breaking entrainment. As a final option, a neuromuscular blocker can be administered to 
abort the mechanical consequences of reverse triggering.
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Figure 5. Advanced analysis of breathing effort: flow and esophageal pressure (Pes) during one 
breath with reverse triggering. The vertical dotted line crosses the flow curve at 0 L/s. The green 
area represents the pressure-time product of the respiratory muscles, calculated by integrating the 
area between the chest wall pressure (Pcw) curve and the Pes curve during inspiration. The Pcw 
curve was obtained by dividing the inhaled volume by the chest wall compliance (125 ml/cmH2O 
obtained during static measurements). The pressure-time product for this breath was 19.1 cmH2O∙s. 
At nine reverse-triggered breaths per minute, the pressure-time product due to reverse triggering 
was 172 cmH2O∙s/min.
CONCLUSIONS
Mechanical ventilation may entrain a patient’s respiratory rhythm, especially during deep 
sedation, and could lead to reverse triggering with potentially detrimental effects on 
the lungs, respiratory muscles, and hemodynamics. Recognizing this patient-ventilator 
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ABSTRACT
The accuracy of diaphragm electromyogram (EMGdi) derived parameters, as used in critically 
ill intensive care unit (ICU) patients, can be compromised due to electrocardiographic (ECG) 
interference in the EMGdi signal. Removal of ECG contamination from the esophageal 
recordings of the EMGdi is challenging due to spectral overlapping of EMG and ECG 
signals, and because of variability in artifact shape and amplitude. Therefore, we designed 
an Estimated ECG Subtraction (EES) method, based on three steps: 1) identification of 
the timing of the QRS artifact without an ECG reference channel, 2) estimation of the 
normalized ECG, considering the EMGdi as noise, and 3) subtraction of the denormalized 
ECG estimate from the EMGdi recordings. We evaluated the EES method against the use of 
a wavelet-based adaptive filter. Using EMGdi signals of ten ICU patients, we demonstrated 
that the EES method yields uncontaminated EMGdi, and showed that it is more effective 
than a wavelet-based adaptive filter only. Implementation of this technique may offer 
means to improve diaphragm activity monitoring and control in clinical practice.
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INTRODUCTION
The diaphragm is the most important respiratory muscle. Monitoring diaphragm activity 
in mechanically ventilated intensive care unit (ICU) patients is performed to facilitate 
diaphragm-protective ventilation, to assess patient-ventilator interaction and work of 
breathing, as well as to identify neuromuscular dysfunctions [1–4]. Bedside monitoring 
of the diaphragm electrical activity (EAdi) is available on a specific ventilator (Servo-
I/U, Getinge, Solna, Sweden) via a dedicated nasogastric (feeding) tube embedded with 
multiple ring-shaped electrodes positioned at the level of the diaphragm [5, 6]. EAdi 
reflects the spatial and temporal recruitment of the crural diaphragm motor units, and is 
the closest available signal to the neural respiratory center output [5, 7]. The EAdi catheter 
was originally designed to control the timing and level of ventilator pressurization in neurally 
adjusted ventilatory assist (NAVA) mode [5], but can also be used to monitor diaphragm 
activity in other ventilator modes or with unassisted breathing [1]. Signal processing 
algorithms within the ventilator continuously select the electrode pair closest to the 
diaphragm and filter out interferences, such as cardiac electrical activity (ECG), and motion 
artifacts due to cardiac contractions and esophageal peristalsis. However, we found that 
the reliability of EAdi-derived parameters to monitor diaphragm activity is compromised 
by these ventilator signal processing algorithms [8, 9]. Furthermore, we demonstrated that 
ineffective filtering and inadequate removal of QRS complexes that interfere with the raw 
diaphragm electromyogram (EMGdi) limits interpretation of patient-ventilator interaction 
and detection of neural inspiration onset [10]. Improved filtering methods are needed for 
optimal use of the EMGdi – and its processed EAdi signal – in clinical decision-making 
and research.
Removal of ECG contamination from any type of EMG is a major challenge because of 
spectral overlapping of the ECG (0–100 Hz) and the EMG (20–250 Hz, but mostly <150 
Hz) [11], causing an increase in power content of the EMG and distortion of its frequency 
information. Different methods for removal of ECG interference from the EMGdi have been 
described, using gating [12], subtraction techniques [13, 14], wavelets [15–17], and high-
pass [11] or adaptive filtering [18], but none of these methods were proven to fully eliminate 
cardiac activity without important information loss. In addition, clinical application of most 
of these methods is limited due to the need for a dedicated reference ECG recording. This 
is especially challenging with regard to esophageal recordings of the EMGdi, as the QRS 
complex may vary in shape and amplitude depending on the location of the electrode 
pairs relative to the heart.
In 2009, Zhan et al. described a wavelet-based adaptive filtering technique for removal 
of ECG contamination from esophageal EMGdi recordings without requiring extra channels 
as ECG reference [15]. This method performs well in general; however, it is less robust for 
removal of ECG artifacts that overlap with diaphragm contraction, and selection of the 
mother wavelet is challenging. Also without the need for a reference ECG channel, Costa 
Junior et al. recently demonstrated that a template subtraction method was effective in 




work, a template was directly constructed from the contaminated EMG. We figured that 
this method could also be applicable in EMGdi processing. However, in esophageal EMGdi 
signals the ECG contamination can be more pronounced and variable due to the close 
proximity of the EAdi catheter to the heart.
The aim of the current study is to design and evaluate a modified template subtraction 
method for offline attenuation of ECG interference in the EMGdi signal obtained with a 
nasogastric catheter in ICU patients. A second aim is to evaluate how this method compares 
with a wavelet-based adaptive filter.
MATERIALS AND METHODS
Subjects and signal acquisition
Data were part of a previous study in which diaphragm activity was measured when patients 
were disconnected from the ventilator (Servo-I, Getinge, Solna, Sweden) for performing a 
spontaneous breathing trial with T-tube and supplemental oxygen [20]. Recordings of raw 
EMGdi signals from ten ICU patients with varying amplitude and timing of diaphragm activity 
and ECG contamination were selected, aiming to represent the variety range that was 
observed in the study population. Because the duration of the spontaneous breathing trial 
varied among subjects, in that study [20] stable recordings during ventilator disconnection 
were divided into six epochs of at least one minute taken at equal time intervals in between. 
We randomly selected two of these epochs per patient to evaluate the performance of the 
filtering method. The average duration of these recordings per patient was 7.2 minutes 
(min–max, 3–8 minutes). EMGdi signals were acquired with a nasogastric catheter which 
was embedded with two balloons and a multiple-array electrode consisting of nine stainless 
steel rings (width, 2 mm; diameter, 2 mm) placed 10 mm apart, creating an array of eight 
sequential differential electrode pairs (NeuroVent Research Inc., Canada). Signals were 
amplified and digitized (Porti 7–16: 22 bits, 71.5 nV/least significant bit, noise level <1 
µV; TMSi B.V., The Netherlands) at a sampling frequency of 2000 Hz for each channel.
Signal pre-processing
All (offline) signal processing and analysis for this study was performed in MATLAB R2018b 
(Mathworks, Natick, USA). First, EMGdi recordings from all separate electrode pairs were 
bandpass filtered through a 2nd order Butterworth block with a frequency band of 30–400 
Hz, to remove low-frequency and high-frequency noise. Interference from the 50 Hz 
power line was removed with a Notch filter. Subsequently, a cross-correlation and double-
subtraction technique was applied to determine the center of the electrical active region 
of the contracting diaphragm (EARdi), as described in detail by Sinderby et al. [21]. The 
signal segments obtained from the electrode channel above and below this EARdi were 
subsequently subtracted from each other. This technique reduces influence of movement 
of the center of this EARdi relative to the electrode array and increases signal-to-noise ratio. 
The double-subtracted contaminated EMGdi signal is further referred to as the EMGdi-DS.
157
Estimated ECG Subtraction method to remove ECG artifacts from esophageal recordings of diaphragm EMG
Wavelet-based adaptive filter
To remove ECG interference from the EMGdi-DS, a wavelet-based adaptive filter as 
designed by Zhan et al. [15] was applied. By using the discrete wavelet transform, the 
EMGdi-DS was decomposed into details and approximation parts. We performed a wavelet 
decomposition to level 5 using a 4th order Daubechies (db4) wavelet, which qualitatively 
best matched the shape and form of the ECG artifacts, consistent with earlier work [15]. 
Then, the signal was filtered in the wavelet space by using an adaptive threshold (sigmoid 
function). This improves performance as compared to a fixed threshold as the EMGdi 
to ECG amplitude varies over time. Finally, the wavelet filtered signal (EMGdi-WA) was 
reconstructed using the inverse discrete wavelet transform.
Estimated ECG Subtraction method
Below, we describe a method, adapted from Costa Junior et al. [19], how to create an ECG 
template directly from the contaminated EMGdi-DS. Subsequently, this template is used 
to remove ECG artifacts from the EMGdi-DS.
The following steps are shown in Figure 1 and explain how the ECG template was 
constructed from the EMGdi-DS.
The first action is to identify the precise time instances at which ECG artifacts occur.
1. The EMGdi-DS signal (Figure 1, step 1) was bandpass filtered in the frequency 
band of the ECG interference (4–50 Hz) through a 4th order Butterworth filter 
to promote the ECG amplitude relative to the EMGdi (Figure 1, step 2). This is 
especially important for recordings where the EMGdi amplitude can be larger than 
the ECG artifact. The signal was then rectified (Figure 1, step 3), and filtered with a 
moving average filter with window width of 16.7 milliseconds and normalized to the 
amplitude of the EMGdi-DS (EMGdi-DS-A) (Figure 1, step 4). This yields an EMGdi-
DS-A signal required for detection of QRS segments.
2. A time-dependent threshold was implemented as the R wave amplitude could 
vary over time (e.g., due do slight movements of the EAdi catheter relative to the 
heart) (Figure 1, step 5). The threshold level was defined as the median value of the 
EMGdi-DS-A signal over a fixed interval of 0.5 seconds, which was subsequently 
interpolated and filtered with a moving average filter with a window width of 12.5 
milliseconds (chosen based on qualitative assessment). Start and end time points 
of potential QRS segments were defined by each crossing of the EMGdi-DS-A with 
this threshold level (Figure 1, step 6). The interval between potential QRS segments 
is further referred to as the inter-QRS interval.
3. It is likely that a small percentage of the identified potential QRS segments was 
wrongly detected (i.e., part of the EMGdi) due to spectral overlapping of the EMGdi 
in the 4–50 Hz frequency band. Therefore, incorrectly detected QRS segments 
were removed based on outliers in the inter-QRS interval length (Figure 1, step 7). 




the quasi-periodic nature of the ECG: starting from the first potential QRS segment 
and assuming a relatively constant inter-QRS interval, the expected location of the 
next segment was estimated based on the median inter-QRS length with a time 
window of 0.66 times this median length. If no QRS segment was found within this 
window, a new QRS segment was inserted at the location with the highest peak 
above the threshold in the EMGdi-DS-A signal. Regardless of whether or not a new 
QRS segment was inserted, the peak in that window was used as a starting point 
to repeat this process.
The next step is to construct an ECG template.
4. Knowing the locations of all QRS segments in the EMGdi-DS, the R wave was 
detected as the highest value (positive peak) present in that segment and the Q 
and S waves were detected as the lowest values (negative peaks) before and after 
the R wave present in that segment, respectively (Figure 1, step 8). After detecting 
these peaks, a 0.3 second window length around the R peak was selected to ensure 
that the complete ECG artifact was captured (Figure 1, step 9). This window duration 
was manually adapted if deemed necessary (e.g., in patients with prolonged PQ 
time, and/or large P waves, or large T waves, such as illustrated in Figure 2).
5. All QRS segments in the signal segment were captured and normalized to the peak 
values in the original EMGdi-DS to calculate an average QRS template (Figure 1, step 
10a-c); normalization to the Q, R and S peaks was performed since their relative 
amplitudes could vary over time. Local normalization to two negative peaks (Q and 
S waves) was performed upon dividing the QRS segment into QR and RS segments. 
As previously described [19], averaging all QRS segments retains the QRS pattern 
while reducing the stochastic elements in that segment. Since the EMG bursts are 
uncorrelated with the ECG, the EMGdi will present to this analysis as a stochastic 
signal.
The final action is to subtract the estimated ECGs from the EMGdi-DS.
6. A new time series was constructed starting with a zero-baseline signal. At each 
instance of an R peak, a QRS signal was constructed and added to the baseline. 
Each QRS complex was based on the average QRS template and amplified (i.e., 
denormalized) to its original amplitude (Figure 1, steps 10d and 11).
7. The new time series of the estimated ECG recording was then subtracted from the 
EMGdi-DS (Figure 1, step 12). As these constructed ECGs will never be a perfect 
copy of the original ECG (because of some variability in QR and RS duration, for 
instance), some residue of ECG noise could still be present. Residue noise was 
further attenuated by applying the wavelet-based adaptive filter as described 
earlier.
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7. Remove (and restore) wrongfully 
detected (or deleted) QRS segments
1. EMGdi-DS 2. Bandpass filter (4–50 Hz) to promote ECG amplitude 
3. Rectification 4. Moving average filter to create EMGdi-DS-A 
5. Apply threshold level 
6. Detect crossings with threshold level
start QRS segment end QRS segment
8. Detect QRS peaks in EMGdi-DS 
9. Select window length around R wave 



































































Figure 2. Example of an ECG template for which the duration of the template was manually pro-
longed in order to capture the complete artifact.
Evaluation of performance
The performance of the filtering technique was evaluated visually in the time domain and 
by quantitative analysis in the frequency domain. Spectral analysis of the EMGdi-DS, the 
EMGdi as processed with a wavelet-based adaptive filter only (EMGdi-WA) and by the 
Estimated ECG Subtraction method (EMGdi-EES) was performed using Welch’s averaged 
periodogram method with a frequency resolution of 0.5 Hz. As we cannot obtain the true 
clean EMGdi, it is not possible to assess signal-to-noise ratio or relative error of the power 
spectrum. Differences in power spectral densities between signals were quantitatively 
assessed by computing the total power and the median frequency for the full recordings. 
As we identified the location of the QRS artifacts, we also calculated the median frequency 
for those EMGdi-DS signal segments that were not contaminated with cardiac artifacts; 
results were compared with the median frequency obtained from the same ECG-free 
segments in the EMGdi-WA and EMGdi-EES signals. Differences in total power and 
median frequency between signals were analyzed with repeated measures ANOVA with 
Greenhouse-Geisser correction at the 95% significance level; pairwise comparison was 
performed after Bonferroni correction. Assumption of normality was assessed with the 
Shapiro-Wilk normality test and a log-transformation of the data was applied if deemed 
necessary. Statistical analysis was performed using SPSS (IBM SPSS Statistics, version 26, 
IBM Corp., USA). Data are presented as median [interquartile range (IQR)] unless otherwise 
stated.
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RESULTS
Figure 3 presents the results from three patients with different ECG to EMGdi intensities 
and timing, and demonstrates that the Estimated ECG Subtraction method was more 
successful in attenuating ECG contamination as compared to a wavelet-based adaptive 
filter only (Figure 3a-c). In addition, the EMGdi-WA recordings illustrate that cardiac activity-
related artifacts that are still present just before – or overlapping with – the start or end 
of diaphragm contraction may limit accuracy of neural inspiratory time detection. The 
periodogram of these examples (Figure 3d-f) clearly demonstrates spectral overlapping 
of the ECG and EMGdi in the EMGdi-DS, and a reduction in power for the lower frequencies 
with corresponding increase in median frequency for the EMGdi-WA and EMGdi-EES, with 
effects more pronounced for the EMGdi-EES.
Median frequencies and total power for the full recordings of the EMGdi-DS, EMGdi-WA 
and EMGdi-EES signals obtained from all patients are presented in Table 1. Post hoc tests 
revealed a significant increase in median frequency from 40.8 [35.7–51.4] to 66.3 [61.9–
69.2] to 68.8 [67.8–73.3] Hz, and a reduction in total power from 390 [264–530] to 196 
[157–236] to 167 [134–237] µV2, when comparing the full recordings of the contaminated 
EMGdi-DS to the EMGdi-WA and to the EMGdi-EES signals, respectively (p < 0.001 for 
both parameters). For those signal segments free of QRS artifacts, median frequency 
of the EMGdi-EES and EMGdi-WA was similar (69.7 [68.8–75.9] vs. 68.2 [64.2–75.9] Hz, 
respectively; p = 0.11), but significantly different from the median frequency of the EMGdi-
DS (65.6 [60.6–71.2] Hz; p = 0.001 for differences with the EMGdi-WA and the EMGdi-EES); 
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DISCUSSION
In the current study, we present a new method (template subtraction plus wavelet-based 
adaptive filtering technique) for removal of ECG artifacts from EMGdi recordings obtained 
with a nasogastric catheter in ICU patients. In recordings with different amplitudes 
and timing of EMGdi and ECG contamination, we demonstrate that the Estimated ECG 
Subtraction method is feasible and efficient in processing a clean EMGdi signal without 
the need for a dedicated reference ECG channel. Implementation of this technique could 
facilitate improved processing of the EMGdi and its derived parameters for diaphragm 
activity monitoring and control.
Development of the Estimated ECG Subtraction method
Template subtraction techniques for filtering ECG contamination from EMGdi recordings 
acquired with surface electrodes have been described previously, using different methods 
for template creation and QRS segment detection [11–13, 22]. In general, a template can be 
obtained from additional recordings of the contamination (i.e., from a separate reference 
ECG recording), from a pre-existing template, or by estimating the template from an 
EMG recording when the muscle is in a relaxed state. Such methods cannot be applied to 
esophageal recordings of the EMGdi, because the shape of the artifact depends on the 
position of the catheter electrodes near the heart, and varies among – and sometimes 
also within – patients; therefore, it will not match any artifact template when derived from 
a noninvasive simultaneous ECG recording or from a pre-existing ECG template. Moreover, 
obtaining a template from a recording with the muscle in a relaxed state (i.e., during 
expiration with very low amplitude of EMGdi as compared to ECG) could be challenging in 
ICU patients with high and variable respiratory rate, expiratory diaphragmatic activity or EMG 
interference from extra-diaphragmatic muscles. Such method could require recordings 
during apnea events or when diaphragm activity is temporarily artificially suppressed (i.e., 
recordings under deep sedation or neuromuscular blockade); however, such interventions 
may also change the shape and timing of the artifact, and do not outweigh the benefits 
of obtaining a cleaner signal with our Estimated ECG Subtraction method as compared to 
other available filtering techniques.
Costa Junior et al. were the first that estimated an ECG template directly from the 
complete recording of the contaminated EMG of the limb muscle [19]. The lack of need 
for an ECG reference channel is an important prerequisite for processing EMGdi signals 
using any template subtraction method. The core of this method is that, to estimate the 
ECG representation in the registration, first the EMG is considered as noise to estimate an 
ECG template from ensemble averaging over several heartbeats. With this template, the 
ECG artifacts can be almost completely eliminated by subtraction of this template from 
the EMGdi registration. The method presented in the current study was partially based on 
their work [19], but important differences and improvements should be mentioned. First, 
as ECG artifacts may vary in amplitude due to slight catheter motion relative to the heart, 




varying ECG to EMGdi ratio. Second, we implemented an algorithm to delete and restore 
any wrongfully detected or removed QRS segments utilizing the quasi-periodic nature of 
the ECG. Third, an average QRS complex segment was constructed after local normalization 
to the Q, R and S amplitudes (i.e., normalization to one maximum value (R wave) and to 
two local minima (Q and S waves)). Normalization to only the R wave has been described 
before [19, 22, 23], while our method takes into account the within-patient variability in 
relative QRS amplitudes. Fourth, we created a template of longer duration (default of 0.3 
seconds instead of 0.16 seconds, which was manually prolonged if deemed necessary) 
to enable removal of the complete ECG segment as substantial P and T waves could be 
present due to the close proximity of the catheter near the heart. In addition, Costa Junior 
et al. [19] did not evaluate the performance of their algorithm in clinical data, while we used 
EMGdi signals of ICU patients with varying intensity and timing of diaphragm activity and 
ECG contamination to design our method and to confirm its efficiency. Last, we additionally 
applied a wavelet-based adaptive filter to remove residual ECG noise, if present, since any 
estimated ECG template will never be the perfect copy of the original contamination.
Comparison with a wavelet-based filter
We demonstrated that the Estimated ECG Subtraction method was efficient in removing 
ECG artifacts from variable EMGdi recordings and yielded better performance as compared 
to a wavelet-based adaptive filtering technique only, as demonstrated visually, as well as 
indicated by the significant increase in median frequency from the Welch’s periodogram 
for the full signal recordings. Although we could not compare both techniques with a true 
clean EMGdi, this finding indicates that more lower frequencies (likely related to the ECG 
contamination) were present in the EMGdi-WA as compared to the EMGdi-EES.
Wavelet-based adaptive filters have been increasingly proposed for removal of ECG 
noise from EMG recordings of various muscles, including the diaphragm, and with and 
without the use of extra channels for ECG recording [15–17, 24–26]. This method performs 
well particularly when the ECG to EMG amplitude is high. However, obtaining a clean 
EMGdi can be difficult; for instance, when the ECG amplitude is similar to the EMGdi 
amplitude, when the artifact consistently overlaps with diaphragm contraction, or when 
the contamination cannot be fully captured in a wavelet. The current study clearly illustrates 
that residue ECG noise present in the EMGdi-WA – particularly when overlapping with 
the start or end of diaphragm contraction – may limit reliability of neural inspiratory time 
detection. In addition, robustness and efficiency of this method may be limited by the 
computational complexity of the technique, including defining the optimal threshold and 
wavelet type.
Limitations
Limitations of the Estimated ECG Subtraction method that should be mentioned are that 
our method would be less robust in the presence of changes in artifact shape within a 
recording (e.g., with arrhythmias, such as premature ventricular or atrial contractions); 
however, this is a common limitation for any EMG filtering method. Second, for adequate 
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ECG contamination detection and template creation, the R wave amplitude should be 
larger than the EMGdi amplitude after promoting the ECG in the 4–50 Hz frequency 
band. This is needed for detection of potential QRS segments using the crossing of the 
EMGdi-DS-A with a dynamic threshold level, and to avoid subsequent removal of important 
EMGdi information after template subtraction. In all ten patients with various EMGdi to 
ECG intensities, artifacts could be detected sufficiently after promoting the ECG frequency 
band. Last, the signals used for development and evaluation of the filtering technique 
were acquired with a nasogastric catheter embedded with both a multiple-array electrode 
and two pressure balloons, while the EAdi catheter (Getinge, Solna, Sweden) consists of 
electrodes only. Addition of these balloons may have affected the presence of motion 
artifacts in our recordings.
Future work
Although it was not the focus of the current study, it would be interesting to investigate 
whether a template subtraction filtering method can be applied at the bedside in real-time. 
We are not aware of such applications in the current EMG literature, and this requires an 
accurate estimation of future QRS artifact events. It should be explored whether advanced 
time series analyses, e.g., employing probability forecasts, could be applied.
In addition, a next study should evaluate the clinical impact of our filtering technique 
in a larger sample. For instance, it would be interesting to quantify whether assessment 
of patient-ventilator interaction or calculation of neural inspiratory time improves when 
directly comparing the EAdi signal as filtered by the ventilator software with the envelope 
signal of the EMGdi-EES. This should be studied prospectively, as it requires a simultaneous 
recording of the raw EMGdi and the ventilator-processed EAdi signal from one nasogastric 
catheter.
Clinical importance
Monitoring the respiratory drive and diaphragm activity in critically ill patients using the 
EMGdi (or its further processed EAdi signal) facilitates the implementation of a diaphragm-
protective ventilation strategy and assessment of neuromuscular dysfunctions [1–3]. 
Obtaining and interpreting adequate diaphragm activity signals requires specific expertise 
and may be challenging in ICU patients [4, 10]. We have previously demonstrated that 
reliability of EAdi-derived parameters and detection of neural inspiratory onset could 
be limited by suboptimal filtering of the ECG contamination from the EMGdi signal as 
processed by the ventilator software [8–10]. This could result in ventilator settings poorly 
adapted to the patient’s physiology. Adequate detection of neural inspiratory time promotes 
the identification and solving of patient-ventilator asynchronies, especially when expressed 
as the phase angle amongst the sequential onset or offset of the EMGdi and the start or 
end of ventilator pressurization (e.g., such as with premature cycling and reverse triggering) 
[27–29]. In addition, it is important for assessment of (changes in) the coordination and 
contribution of the diaphragm and extra-diaphragmatic muscles of the respiratory 




diaphragmatic activity [20, 32]. If translated into a (near) real-time algorithm for use at 
the bedside – ideally when implemented within the ventilator software – our proposed 
method could allow an important optimization for bedside monitoring of diaphragm 
activity. In addition, improved offline processing of the EMGdi signal will result in more 
accurate evaluation of the diaphragm for diagnostics and research purposes. Theoretically, 
the Estimated ECG Subtraction technique could allow application to EMG signals derived 
from any type of muscle, since the need for efficient removal of ECG contamination from 
EMG is not just limited to the diaphragm (motor control studies involving trunk muscles, 
for instance).
CONCLUSION
We present and confirmed efficiency of a new method, i.e., the Estimated ECG Subtraction 
method, for ECG contamination removal from the EMGdi that does not require a dedicated 
ECG reference channel and utilizes the quasi-periodic characteristics of the ECG for template 
creation. The Estimated ECG Subtraction method performs better to yield uncontaminated 
EMGdi as compared to a wavelet-based adaptive filter only. Implementation of this 
technique may offer means to improve diaphragm activity monitoring and control in clinical 
practice.
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ABSTRACT
Proportional modes of ventilation assist the patient by adapting to his/her effort, which 
contrasts with all other modes. The two proportional modes are referred to as neurally 
adjusted ventilatory assist (NAVA) and proportional assist ventilation with load-adjustable 
gain factors (PAV+): they deliver inspiratory assist in proportion to the patient’s effort, and 
hence directly respond to changes in ventilatory needs. Due to their working principles, 
NAVA and PAV+ have the ability to provide self-adjusted lung and diaphragm-protective 
ventilation. As these proportional modes differ from “classical” modes such as pressure 
support ventilation (PSV), setting the inspiratory assist level is often puzzling for clinicians at 
the bedside as it is not based on usual parameters such as tidal volumes and PaCO2 targets. 
This paper provides an in-depth overview of the working principles of NAVA and PAV+ and 
the physiological differences with PSV. Understanding these differences is fundamental 
for applying any assisted mode at the bedside. We review different methods for setting 
inspiratory assist during NAVA and PAV+, and (future) indices for monitoring of patient 
effort. Last, differences with automated modes are mentioned.
TAKE-HOME MESSAGE
This review explains how proportional ventilation modes improve the match between the 
patient and the ventilator and provide the potential for both lung and diaphragm-protective 
ventilation. We discuss different methods to titrate inspiratory assist levels, which is a key 
challenge at the bedside, as optimal targets of respiratory muscle effort may vary among 
patients and over the course of critical illness.
175
Proportional modes of ventilation: technology to assist physiology
INTRODUCTION
Proportional modes of ventilation work by amplifying the effort of the patient’s respiratory 
muscle activity, providing the necessary support to improve the imbalance between capacity 
and demand and to reach the patient’s ventilation goal at the same time. Proportional 
modes have the potential to provide lung and respiratory muscle-protective ventilation 
by maintaining the patient’s control mechanisms against both lung overdistention and 
ventilator over-assistance, and avoiding the development of diaphragm disuse atrophy [1, 
2]. Inspiratory assist is delivered in synchrony with patient effort during the total inspiratory 
cycle, and thus, by contrast with other modes, directly responds to changes in ventilatory 
demands [3, 4]. This is fundamentally different from conventional partially-supported 
modes of ventilation such as pressure support ventilation (PSV), where the same pressure 
is delivered by the ventilator for every breath and is independent of the metabolic needs 
and the magnitude of the patient’s effort and also, most often, of its timing. Hence, patient-
ventilator asynchrony and ventilator over-assistance are common and often unnoticed in 
conventional modes such as PSV [5–9].
Modes of proportional ventilation readily available in clinical practice on dedicated 
ventilators are neurally adjusted ventilatory assist (NAVA) [3], and proportional assist 
ventilation with load-adjustable gain factors (PAV+) [2]. Their physiological effects are very 
similar, but they differ in the signal used to control the ventilator. NAVA delivers inspiratory 
assist in proportion to the diaphragm electrical activity (EAdi), which closely reflects 
central respiratory drive and is measured via a dedicated nasogastric (feeding) tube with 
embedded electrodes [3]. PAV+ delivers assist in proportion to the instantaneous flow and 
volume generated by the patient’s inspiratory effort or muscular pressure (Pmus), which 
is estimated from semi-continuous automatic measurements of respiratory mechanics 
applying the equation of motion of the respiratory system [10, 11]. As patients tailor 
the amount of assist themselves, proportional modes simplify the implementation of 
assisted mechanical ventilation [12]. An important barrier to wide implementation of those 
modes, however, is the unfamiliarity with the settings and functioning, which differ from 
conventional modes. Real-time monitoring of respiratory drive (EAdi time course during 
NAVA) and patient effort (semi-continuous estimation of Pmus in PAV+) is also available 
in proportional modes and allows quantification of the physiological response to changes 
in ventilatory assist. Although proportional modes have been increasingly used, setting 
inspiratory assist levels remains a challenge at the bedside as it cannot be based on usual 
parameters such as tidal volumes and PaCO2 targets [13, 14]. Moreover, safe targets for 
respiratory effort may vary among patients, depending on the severity of lung injury and 
diaphragm function [15–17]. The uncertainty regarding titration of inspiratory support with 
NAVA and PAV+ might be one of the reasons why there is still limited data showing improved 
clinical outcomes when using proportional modes as compared to conventional modes [18, 
19], but clinical benefits of NAVA compared to PSV were recently demonstrated in difficult-




consequences, PSV maintains an appearance of simplicity and is the most frequently used 
partially-supported mode of ventilation [22].
This review provides a physiological understanding of proportional modes during 
invasive mechanical ventilation in the adult intensive care unit (ICU) population and their 
differences with PSV, which is fundamental to understand when applying any assisted mode 
at the bedside. We discuss methods for titrating inspiratory assist during NAVA and PAV+, 




Measured with a dedicated nasogastric feeding tube, EAdi reflects the intensity of the 
electrical field produced by the diaphragm contraction and is the closest available signal 
to the respiratory centers’ output. EAdi is the most precise surrogate of neural respiratory 
drive provided that neuromuscular transmission and muscle fiber membrane excitability 
are intact, and the diaphragm is used as the main inspiratory muscle (i.e., no significant 
difference across different accessory muscles) [3, 23, 24]. EAdi mainly reflects crural 
diaphragm activity, but is representative of activity from the costal parts of the diaphragm. 
EAdi correlates well to transdiaphragmatic pressure [25, 26] and the signal remains reliable at 
different lung volumes [27]. Ventilator algorithms continuously correct for interference from 
cardiac activity and motion artifacts due to cardiac contractions and esophageal peristalsis.
NAVA is unique compared to all other ventilator modes, as it uses EAdi to control the 
ventilator, especially triggering, the level of inspiratory assist, and cycle-off. Inspiratory 
pressure (Paw) applied above positive end-expiratory pressure (PEEP) during NAVA is 
determined by the proportionality gain (NAVA level, in cmH2O/µV) set by the clinician:
Paw = (NAVA level × EAdi) + PEEP     (1)
Thus, when the EAdi amplitude is 10 µV and the NAVA level 1.5 cmH2O/µV, peak Paw 
reaches 15 cmH2O above PEEP. Inspiratory assist is proportional to EAdi over the inspiratory 
cycle; it is triggered for every EAdi increase >0.5 µV above baseline and is terminated when 
EAdi amplitude falls at 70% of its peak value, which probably approximates reasonably 
the end of the active contraction. The EAdi signal is pneumatically independent and thus 
triggering is not directly affected by the presence of leaks or intrinsic PEEP; assisted breaths 
can be triggered either by EAdi, Paw or flow, according to a hierarchy that follows the “first 
come, first served” principle [3]. EAdi allows real-time monitoring of diaphragm activity, 
which is not limited to the use in NAVA mode and even possible in a non-intubated patient. 
When using EAdi for monitoring purposes, it is important to realize that an increase in EAdi 
can have many causes, such as an increased mechanical load imposed on the respiratory 
muscles (e.g., increase in resistance), an increased ventilatory demand (e.g., increase in 
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CO2 production), or an increase in drive unrelated to the load (e.g., inflammation) [28–30]. 
Because changes in tidal volume are controlled primarily by the brain stem respiratory 
centers, changing the level of assist may not affect tidal volume.
PAV+
In PAV+, the trigger functions similarly to other assisted modes of ventilation; the ventilator 
detects inspiratory effort by instantaneous measures of flow and volume that is pulled in by the 
patient and delivers pressure assist accordingly [10, 11]. The inspiratory assist is instantaneously 
calculated from the measured flow and volume using the equation of motion of the respiratory 
system and an adjustable gain that determines the percentage of the total pressure 
calculated to be delivered [2, 4]. The total pressure delivered to the respiratory system (Ptotal) 
is then the sum of Paw and Pmus and it overcomes both resistive and elastic recoil pressure:
Ptotal = Paw + Pmus = (flow × resistance) + (volume × elastance)  (2)
The ventilator automatically calculates respiratory system resistance [10] and elastance [11] 
by performing short end-inspiratory occlusions every 8–15 breaths (of note: this is specific 
to PAV+ and does not exist in simple “PAV” or in “proportional pressure support”) and uses 
the gain as %assist:
Paw = %assist × Ptotal       (3)
Using Equation 2, this relationship can be further written as:
Paw = Pmus × %assist / (100 – %assist)     (4)
Paw is thus a fraction of Ptotal and proportional to the instantaneous Pmus during the full 
inspiratory cycle (Figure 1); the gain indicates a percentage of respiratory muscle unloading, 
set by the clinician. Hence, if the gain is set at 75%, it means that the ventilator delivers 75% 
of the total pressure, the remaining 25% being assumed by the patient’s Pmus (Equation 
3): Paw equals three times Pmus along the inspiratory phase (Equation 4). Practically, 
this gain can be between 5% and 85%. Indeed, assist levels close to 100% would put 
the patient at risk of over-assistance in case of errors in the automated calculations of 
respiratory mechanics resulting in overestimation of the pressure needed. Similar to NAVA, 
because the patient’s brain controls the desired volume, the volume delivered to the patient 
may show little variations when varying the level of assist [31]. Inspiration is cycled-off 
when flow decreases to a low pre-set level (by default set to 3 L/min). This cycling-off 
mechanism usually makes the end of ventilator assistance extremely close to the end of the 
neural inspiration. PAV+ cannot be used during noninvasive ventilation, as end-inspiratory 
occlusions cannot be performed in the presence of leaks. In addition, estimations of Ptotal 
do not correct for intrinsic PEEP, if present, which may lead to an underestimation of the 



















Figure 1. Example of the working principle of proportional assist ventilation with load-adjustable 
gain factors (PAV+). Short inspiratory occlusions are automatically performed (indicated by * in the 
flow signal) for the calculation of respiratory system resistance and compliance. Arrows indicate that 
airway pressure (Paw) is delivered proportional to the patient’s effort (esophageal pressure (Pes)).
DIFFERENCES BETWEEN PROPORTIONAL MODES AND PSV
Patient-ventilator interactions: Pmus-Vt relationship and cycling-off criterion
The main physiological differences between PSV and proportional modes can be explained 
with the relationship between patient’s effort or Pmus and tidal volume (Vt) delivered 
by the ventilator (Figure 2a). During unassisted breathing, increases in Pmus result in 
a relatively linear increase in tidal volume (i.e., assuming a linear relationship between 
Pmus and PaCO2) [33, 34]. The slope of this relationship represents the efficiency of the 
respiratory muscles. With PSV, the Pmus-Vt curve is shifted upwards and, therefore, does 
not start from zero volume (Figure 2a); this is because a substantial tidal volume is still 
delivered despite minimal respiratory drive and no measurable effort (e.g., due to sedation 
or over-assistance); this volume depends mostly on the pressure support level and the 
respiratory system compliance [35, 36]. The presence of this “minimum tidal volume” 
erroneously suggests to clinicians that the patient is spontaneously breathing, while the 
patient only triggers the ventilator and relaxes his inspiratory muscles thereafter, implying 
ventilator over-assistance (Figure 3) [35]. Ventilator over-assistance results in excessive tidal 
volumes, very low diaphragm activity, and possibly risk of disuse atrophy [5, 37]. Excessive 
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inspiratory assist decreases patient effort to virtually zero [38] and leads to central apnea 
events during sleep as soon as the PaCO2 apneic threshold is reached. Apneas result in 
arousals and awakenings, making deep (restful) sleep difficult [39]. The initial slope of the 
Pmus-Vt relationship is unaffected in PSV, as a constant pressure is applied regardless of 
patient effort. As such, patients with a high respiratory drive can also be under-assisted, 
with a risk of diaphragm load-induced injury and patient self-inflicted lung injury [15, 16]. 
Additionally, perfect patient-ventilator synchrony is frequently not achieved in PSV [19, 40, 
41]. The risk of late cycling (i.e., mechanical insufflation finishing after the end of inspiratory 
effort; also known as prolonged insufflation or prolonged cycling) is high during PSV, as 
insufflation cycles-off to exhalation once the flow has reached a set percentage of the peak 
inspiratory flow: the higher the assist, the longer the time to reach the cycling-off criterion 
and the longer the mechanical inspiratory time, thereby increasing the mismatch with 
the patient’s neural inspiratory time [42, 43] (Figure 2b). Since excessive ventilator assist 
promotes dynamic hyperinflation and decreases patient effort, this places the patient at risk 
of ineffective efforts [6, 8] (Figure 2b). In addition, auto-triggering resulting in delivery of a 
full breath may happen during PSV but not under proportional modes. Electrical artifacts 
in the EAdi signal can trigger some pressure delivery during NAVA; however, this will always 
be very low (proportional to the artifact) [44].
In contrast, during NAVA and PAV+, the proportionality gain set by the clinician 
determines the slope of the Pmus-Vt curve [2, 35] (Figure 2a), meaning that more assist 
is delivered with increased patient’s ventilatory demands. As the curve starts at zero (i.e., 
no upward shift as in PSV), some activity of the respiratory muscles is required to maintain 
adequate ventilation and ventilator assist is terminated as soon as patient effort diminishes 
(Figure 2a,c). Therefore, proportional modes provide patient-ventilator synchrony over 
the full inspiratory cycle, preventing ventilator over-assistance and diaphragm disuse, and 
avoiding apnea events during sleep. These principles explain why NAVA and PAV+ are more 
























































Figure 2. (a) Schematic illustration of the relationship between patient effort (respiratory muscle 
pressure, Pmus) and tidal volume (Vt) in unassisted spontaneous breathing (dashed line), during 
pressure support ventilation (PSV) and for proportional modes such as proportional assist ventila-
tion with load-adjustable gain factors (PAV+) and neurally adjusted ventilatory assist (NAVA). (b) 
Patient-ventilator interaction during PSV. Increasing the level of assist increases Vt (blue line) and 
ventilator inspiratory time (Ti, green line), while patient effort (Pmus, grey dotted line) is downreg-
ulated. In addition, neural Ti (dark blue line) remains unaltered with increasing levels of assist which 
results in late cycling. (c) Patient-ventilator interaction during NAVA and PAV+. Ventilator assist is 
delivered proportional to the patient’s demand over the full inspiratory cycle (neural Ti = ventilator 
Ti; note that the dashed green and dark blue lines overlap). Increasing the inspiratory assist level 
(NAVA level or PAV+ gain) downregulates Pmus (grey dotted line). Because the patient’s brain con-
trols mainly the desired Vt, changing the level of assist often has only minimal effects on the Vt, as 
shown by the horizontal blue line on the Volume vs. Level of assist graph.
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Figure 3. Representative example of over-assistance during pressure support ventilation (PSV). The 
patient was ventilated with an inspiratory pressure set at 10 cmH2O above a positive end-expirato-
ry pressure of 8 cmH2O. A double-balloon nasogastric catheter was placed for measurements of 
esophageal pressure (Pes) and gastric pressure. Transdiaphragmatic pressure (Pdi) was calculated 
as gastric pressure minus Pes. As can be seen in the Pes waveform, the patient only triggers the 
ventilator (small drop in Pes) and relaxes inspiratory muscles thereafter, as demonstrated by the 




Respiratory muscle unloading and neuromuscular coupling
In patients recovering from acute respiratory failure, muscle unloading was comparable 
between PSV levels within the range of 7 to 25 cmH2O and NAVA levels ranging from 0.5 
to 2.5 cmH2O/μV [38]. NAVA, however, improved patient-ventilator interactions, preserving 
breathing variability and allowing better synchronization. Interestingly, NAVA led to a larger 
contribution of the diaphragm to inspiratory efforts [45], which could potentially improve 
gas exchange due to enhanced ventilation in basal lung regions [46]. Another study 
confirmed improved diaphragm function with NAVA compared to PSV after prolonged 
controlled mechanical ventilation [47], while differences between PSV and PAV+ were not as 
pronounced [48]. However, in response to increases in elastic loading, a greater respiratory 
muscle efficiency was found with PAV+ compared to PSV [49, 50].
Proportional modes for lung and diaphragm-protective ventilation
Proportional modes improve patient-ventilator synchrony, neuromuscular coupling and 
gas exchange, and restore breathing variability [19, 41, 50–53]. This improved patient-
ventilator interaction is a potential mechanism by which NAVA and PAV+ might provide lung 
and diaphragm-protective ventilation. Lung overdistention is prevented due to two known 
physiological mechanisms. First, the Hering-Breuer inflation-inhibition biological feedback 
mechanism downregulates respiratory drive (and thus EAdi amplitude and patient effort) 
at higher tidal volumes in order to avoid hyperinflation [27, 54, 55]. Second, with increasing 
lung volumes the diaphragm shortens and may become a less effective pressure generator, 
thereby decreasing effort [27, 56]. Indeed, Carteaux et al. [38] showed that most patients 
could self-regulate their tidal volumes in a protective range (between 6 and 8 ml/kg PBW) 
despite increasing NAVA levels within a certain “reasonable” range. Furthermore, it was 
recently shown that patients ventilated in PAV+ after acute respiratory distress syndrome 
were able to avoid lung overdistention, as indicated by a driving pressure kept below 15 
cmH2O [57]. Increasing support levels during PSV, by contrast, increases tidal volumes 
despite a downregulation of neural drive [45]. Proportional modes may, therefore, protect 
the patient from harmful tidal volumes and simultaneously prevent diaphragm disuse 
atrophy. It should be stressed, however, that excessive respiratory drive may overwhelm 
lung-protective reflexes, and hence, additional caution is required when using proportional 
modes in patients with high respiratory drive and extremely impaired respiratory mechanics.
Clinical comparisons of proportional modes and PSV
The use of proportional modes, especially PAV+, has been associated with a shorter weaning 
duration compared to PSV in small studies [19] and increased probability of remaining with 
assisted spontaneous ventilation [58]. It was reasoned that this was because of better patient-
ventilator interaction, reduced sedation requirements [12, 59] and improvement in sleep 
quality [60–62]. Because of these reasons, increased patient comfort during proportional 
modes is often assumed to be present but has rarely been measured [53, 63, 64]. Although 
reduced asynchronies during sleep were reported, the direct effects of proportional modes 
on sleep quality were small: improving sleep in two studies [60, 61] but not in all [62].
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Differences in weaning duration or ICU outcome were not demonstrated in a large 
randomized study (n=128) that compared NAVA with PSV in patients recovering from 
acute respiratory failure [18]. It is important to note, however, that EAdi monitoring was 
also available in the PSV group. In that study, NAVA reduced patient-ventilator asynchrony 
and the rate of post-extubation application of noninvasive ventilation, and feasibility and 
safety of NAVA over several days was successfully demonstrated. A recent study confirmed 
acceptable adherence to the assigned mode beyond 48 hours when comparing NAVA 
with PSV [21]. Furthermore, Liu et al. recently showed shorter weaning duration with NAVA 
compared to PSV in selected difficult-to-wean patients [20] .
SETTING INSPIRATORY ASSIST DURING NAVA
Different methods for NAVA titration starting from PSV or based on a thorough physiological 
assessment in NAVA mode exist and are summarized in Table 1. Before starting any titration, 
adequate EAdi catheter placement according to published recommendations [65] and 
the manufacturer’s positioning tool (using a calculated distance and ECG artifacts in the 
signal) and EAdi signal quality should be confirmed. If EAdi is abnormally low or absent 
despite correct catheter placement, ventilator over-assistance, excessive sedation, central 
apneas, severe diaphragm weakness, or pre-existing neuromuscular diseases should be 
considered as possible reasons for low EAdi. Direct phrenic nerve lesions could hamper 
NAVA application if no inspiratory EAdi can be measured, but this is quite rare.
NAVA “preview”
A grey curve (Figure 4) displayed on the monitor during PSV shows a “preview” of the 
estimated Paw that would exist if the patient was ventilated in NAVA mode with current 
proportionality setting. The shape of the Paw curve resembles the EAdi profile (i.e., 













Figure 4. Example of the neurally adjusted ventilatory assist (NAVA) preview during pressure support 
ventilation (inspiratory assist of 10 cmH2O above a positive end-expiratory pressure of 8 cmH2O). The 
grey curve shows a “preview” of the estimated airway pressure (Paw) that would exist if the patient 
was ventilated in NAVA mode. The shape of this Paw curve resembles the diaphragm electrical ac-
tivity (EAdi) curve (i.e., proportionality). The amount of assist depends on the EAdi amplitude and 
the selected NAVA level (0.8 cmH2O/μV for this example).
Airway pressure targets
The most frequently used method is setting the NAVA level such that inspiratory assist 
reaches the same peak Paw (Pawpeak) that is obtained in PSV. However, when applying 
this method, differences in the shape of the Paw curve explain why the pressure delivered 
(i.e., area under the Paw curve) is generally lower with NAVA than PSV. It is suggested to 
target NAVA levels to obtain similar mean Paw (Pawmean) values [45]. The main uncertainty 
regarding the relevance of this method is whether support was adequate (no over-assist 
or under-assist) in PSV.
Ventilation targets
Coisel et al. [66] set the NAVA level to obtain the same minute ventilation as determined 
by a prior 5-min application of PSV with tidal volumes of 6–8 ml/kg PBW and a respiratory 
rate of 20–30 breaths/min. Similar as for Paw targets, this method depends on the quality 
of the initial PSV titration. In addition, ventilation is not really “controlled” by the settings.
Assessment of physiological response to inspiratory assist
The above methods do not take advantage of the working principle of NAVA as a 
proportional mode. The following methods for NAVA titration are based on the fact that 
neural drive and patient effort, and not necessarily tidal volume, vary with the level of 
inspiratory assist.
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Two-phased response of Paw and tidal volumes
Starting from a condition of ventilator under-assist (i.e., minimal ventilator assist of 
approximately 3 cmH2O), Brander et al. [67] assessed changes in Paw and tidal volumes 
during a stepwise increase in NAVA level. A two-phased response was observed: the initial 
increase in NAVA level resulted in a steep increase in both Paw and tidal volumes (first 
response) and, at some point, further increasing the NAVA level resulted in less Paw increase 
and no change in tidal volume (second response). The optimal NAVA level was identified at 
the transition point, describing a change from an initial insufficient assist level to an assist 
level that meets the patient’s respiratory demand as indicated by a stable tidal volume. In 
the initial phase, the patient allows Paw and tidal volumes to increase, while in this second 
phase tidal volume reaches a plateau (EAdi downregulation) since ventilation meets the 
patient’s demands. The same group confirmed this response in resistively loaded rabbits 
[54]. Another study compared this method to an initial NAVA level set using the preview tool 
with matching NAVA Pawpeak to the Pawpeak measured during PSV; although not significant, 
a trend toward overestimation of the NAVA level when using the NAVA preview tool was 
reported [68]. It is not clear how often this procedure is feasible, since many patients do 
not demonstrate clearly these two phases [38].
Percentage of the maximum EAdi during a failed SBT
In difficult-to-wean patients, Rozé et al. [69] set the NAVA level to obtain EAdi amplitudes 
corresponding to ~60% of the EAdi peak (level chosen arbitrarily) that was measured 
during a failed spontaneous breathing trial under PSV (PS 7 cmH2O, no PEEP); this level 
was referred to as EAdimaxSBT. This procedure was repeated daily, allowing a progressive 
reduction of the NAVA level until extubation. Setting the NAVA level using EAdimaxSBT 
was reasoned to be a non-fatiguing and objective target more relevant than volumetric 
goals, but additional monitoring may be required in patients with excessive respiratory 
drive [70].
Neuroventilatory efficiency index (NVE)
In patients who had started weaning, Campoccia et al. [71] titrated NAVA to unloading 
targets. The ratio of unloading provided by the ventilator can be calculated as the tidal 
volume provided by the ventilator only, divided by the total tidal volume (Vttot, volume 
resulting from patient effort + ventilator assistance). The tidal volume provided by the 
ventilator can be estimated by the difference between the assisted tidal volume minus 
the non-assisted tidal volume generated by the patient. The latter can be obtained during 
one unassisted breath where the NAVA level is zeroed. The neuroventilatory efficiency 
(NVE) index can then be calculated (Figure 5a). The NVE describes the capacity of the 
respiratory muscles to convert EAdi to tidal volume (Vt/EAdipeak, in ml/µV). The percentage 
of unloading provided by the ventilator is calculated as: (1 – (NVE × EAdipeak/Vttot)) × 100%. 
Unloading targets of 40% and 60% were feasible to implement, and less unloading 
was associated with greater diaphragm activity and improved ventilation in the dorsal 




Patients with high respiratory drive
For most patients the NAVA level can be kept below 2.5 cmH2O/μV [38]. Setting inspiratory 
assist in patients with high respiratory drive can, however, be especially challenging. High 
NAVA levels should be prevented to limit excessive inspiratory assist. Excessive pressures 
during inspiration could be prevented by appropriate Paw alarm settings, and NAVA will 
cycle-off at 3 cmH2O below the set maximal Paw. Paradoxically, the combination of high 
NAVA levels and a pressure limit has been used in several studies to deliver a square pressure 
like in PSV [72–74]. High support is then delivered at the start of a breath in synchrony with 
the patient’s demands, while excessive Paw is prevented. Of note, this neurally triggered 
PSV mode is not yet available for clinical use, and using “alarm settings” to control the 
ventilator is potentially unsafe and cannot be recommended.
Potential EAdi-derived indices
Patient-ventilator breath contribution index
The inspiratory tidal volume (Vtinsp) during NAVA reflects the volume resulting from the 
patient’s effort plus the proportional ventilator assist. An “effort sharing” index can be 
derived by comparing assisted to unassisted breaths. This patient-ventilator breath 
contribution (PVBC) index is defined as the ratio of Vtinsp/EAdipeak of an unassisted breath 
(i.e., NVE, as described above) to that of a breath with ventilator assistance (Figure 5a) 
[73, 75]:
PVBC = (Vtinsp/EAdipeak)no-assist / (Vtinsp/EAdipeak)assist
PVBC values can range between 0 (Vtinsp fully provided by the ventilator) and 1 (Vtinsp 
completely generated by the patient) and have been validated against measurements of 
transpulmonary pressure [73, 75]. Reliability of PVBC improves when comparing unassisted 
and assisted breaths with similar respiratory drive (i.e., EAdi amplitude and slope) [76]. 
PVBC interpretation is complex. For instance, high PVBC values can be found in patients 
with low respiratory drive that are ready to be weaned (patient effort is low but sufficient 
to perform the majority of the work), but also in patients with excessive respiratory drive 
(the patient is under-assisted). Interpretation must take into account absolute ventilator 
assist and patient effort.
Estimates of breathing effort
The neuromechanical efficiency (NME) index quantifies the amount of pressure that the 
respiratory muscles can generate, normalized to EAdi (in cmH2O/μV) [26]. Calculating 
the NME index during brief end-expiratory occlusions (NMEoccl) can allow a noninvasive 
estimate: in the absence of airflow, changes in Paw equal changes in Pmus. NMEoccl can 
thus simply be calculated at the bedside as ∆Pawoccl/EAdioccl [26, 77] (Figure 5b). Taking an 
average of three out of five measurements with the lowest variability is recommended [77].
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NMEoccl could be used to estimate inspiratory muscle pressure during unoccluded tidal 
breathing, using the following equation: Pmus = EAdi × NMEoccl/1.5. The correction factor 
(/1.5) is required, because in the presence of an occlusion, the diaphragm generates more 
pressure for the same EAdi than with an open airway [26]. NME calculations over a brief 
airway occlusion of 0.2 seconds at inspiratory onset tightly reflect NMEoccl [78], allowing to 
estimate inspiratory effort. A change in NME could also indicate recruitment of accessory 
respiratory muscles since EAdi is insensitive to recruitment of accessory muscles.
When using PVBC and NME in clinical practice, it is important to confirm adequate 
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Figure 5. (a) Example of the calculations of the neuroventilatory efficiency (NVE) index and the 
patient-ventilator breath contribution (PVBC) index. An unassisted breath is obtained by reducing 
the neurally adjusted ventilatory assist level to zero for one breath, indicated by the absence of pro-
portional ventilator assist of the last breath. NVE is calculated as the ratio of the tidal volume (Vt) 
to peak diaphragm electrical activity (EAdi) of this unassisted breath. When dividing the NVE by the 
ratio of tidal volume and EAdi of the previous assisted breath, a PVBC index is obtained. Note that 
the airway pressure (Paw) waveform represents the Paw above positive end-expiratory pressure. (b) 
Example of the calculation of the neuromechanical efficiency (NME) index during an end-expiratory 
hold maneuver. During the occlusion (zero flow), the ratio of delta Paw and EAdi represents the NME.
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SETTING INSPIRATORY ASSIST DURING PAV+
Some approaches have been described to set the gain for PAV+ and are described in 
Table 1.
Airway pressure targets
Costa et al. [48] suggested to set PAV+ such that the same Pawmean as in the current PSV 
mode is obtained, and found that respiratory pattern, gas exchange, and inspiratory effort 
where comparable, while improving patient-ventilator interaction.
Inspiratory effort targets
Modifying the level of assistance during proportional modes mainly alters respiratory 
muscle unloading, as tidal volume remains relatively constant, insufflation time is kept close 
to the neural inspiratory time, and breathing variability and synchronization are preserved. 
Theoretically, the amount of respiratory muscle unloading would therefore be a relevant 
target to adjust the level of assistance in proportional modes in order to optimize patient-
ventilator interactions. Carteaux et al. [14] assessed the feasibility of setting PAV+ gain 
in order to target a predefined range of effort. They used the ability of PAV+ to deliver a 
pressure proportional to Pmus, where Pmus was recalculated based on estimates from 
Paw (derived from Equation 4):
Pmuspeak = (Pawpeak – PEEP) × ((100 – %assist) / %assist)
A grid built from this equation was available on the ventilator monitor, providing an 
estimated Pmuspeak for each combination of gain and delta Paw (i.e., Pawpeak – PEEP). 
Pmus between 5 and 10 cmH2O was defined as a good objective to target a respiratory 
muscle pressure-time product (PTPmus, i.e., area under the Pmus curve during inspiration) 
between 50 and 150 cmH2O∙s/min. The gain was initially set to 50%, and subsequently 
adjusted to obtain Pmuspeak values within the 5–10 cmH2O target range. This approach was 
demonstrated feasible in clinical practice in most patients. It should be noted, however, 
that measurements of effort as provided by the ventilator may underestimate the patient’s 
true work of breathing, particularly when intrinsic PEEP is high [79]. Target values may be 
difficult to achieve in patients with excessive respiratory drive and impaired respiratory 
mechanics as lung protective reflexes may be overridden [35, 57].
Monitoring of effort
During PAV+, the measured respiratory system resistance and elastance values provide 
information on respiratory mechanics and their changes over time or in response to different 
levels of inspiratory assist [10, 11]. Because compliance and tidal volume are provided, the 
driving pressure is easily monitored. Furthermore, with these parameters, the ventilator 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DIFFERENCES WITH AUTOMATED MODES
Automated ventilation modes such as adaptive support ventilation (ASV) and SmartCareTM 
continuously adapt certain ventilator settings to keep the patient’s respiratory variables 
within target ranges set by the clinician [4, 80]. Although NAVA, PAV+ and automated 
modes all integrate closed-loop principles, it is important to stress that automated modes 
do not deliver proportional assist, nor directly measure patient effort. In contrast, automated 
modes incorporate algorithms that attempt to target a desired outcome by automatically 
modifying ventilator settings according to changes in the patient’s condition [80]. This 
may reduce the clinician’s workload. Among them, ASV controls minute ventilation by 
finding the optimum combination of respiratory rate and tidal volume using estimates of 
the respiratory system time constant [81]. This is based on Otis [82] and Mead [83] models, 
which postulated that there is an optimum respiratory rate minimizing breathing effort. ASV 
is suitable for both passive and spontaneously breathing patients, but does not necessarily 
deliver lung-protective ventilation, which also depends on the initial parameters set by the 
clinician [84, 85]. Provided that it is properly programmed, ASV can provide safe ventilation 
in the general population; however, caution is required in acute lung injury patients with less 
compromised compliance as higher tidal volumes may occur [86]. One important difference 
between automated and proportional modes is the greater importance, with the former, of 
the way the clinician correctly adjusts the settings. Studies have shown that ASV reduces 
weaning duration most frequently in the post-operative period [87, 88]. The further evolved 
fully closed-loop ASV mode, IntelliVent-ASV, incorporates additional control for end-tidal 
CO2 and oxygen saturation and has shown to be feasible and able to deliver relatively 
protective ventilation in passive and spontaneously breathing patients with different lung 
conditions [81, 89]. The automated IntelliVent-ASV weaning protocol provides automatic 
gradual decreases in inspiratory assist levels while assessing readiness to wean criteria, 
and has been associated with reduced mechanical ventilation duration in different settings 
[87, 88, 90]. SmartCareTM, a PSV-based mode, was specifically designed to automatically 
facilitate and expedite the weaning process. It is mainly based on respiratory rate and 
also integrates values of tidal volume and end-tidal CO2 [91]. Based on certain patient 
characteristics and targets set by the clinician, automated weaning involves adaptations 
in the PSV level, followed by an automatic gradual reduction of the PSV level and weaning 
tests when the level of support is sufficiently low [91]. Compared to non-automated weaning 
strategies, reductions in weaning time with SmartCareTM were demonstrated in some 
studies; adequately powered randomized clinical studies are warranted [92, 93].
CONCLUSION
During PSV ventilator over-assist and poor patient-ventilator interaction are common and 
often unnoticed. Proportional ventilation modes improve the match between the patient 
and the ventilator and provide the potential for both lung and diaphragm-protective 
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ventilation. A key challenge is to titrate inspiratory assist levels at the bedside, as optimal 
targets of respiratory muscle effort may vary among patients and over the course of critical 
illness. During PAV+, titrating inspiratory assist to reach Pmus targets is feasible, and allows 
monitoring of breathing effort. In NAVA, it can be recommended as a first approach to set 
inspiratory assist levels through matching of Pawmean as obtained in PSV, which is a simple 
and feasible method to perform at the bedside, and readjust subsequently. EAdi-derived 
indices such as the NME and PVBC hold future promise, but require further studies on their 
use during the course of mechanical ventilation and in weaning trials. Automated modes 
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ABSTRACT
Respiratory muscle ultrasound is used to evaluate the anatomy and function of the 
respiratory muscle pump. It is a safe, repeatable, accurate, and noninvasive bedside 
technique that can be successfully applied in different settings, including the general 
intensive care and the emergency department. Mastery of this technique allows the 
intensivist to rapidly diagnose and assess respiratory muscle dysfunction in critically ill 
patients and in patients with unexplained dyspnea. Furthermore, it can be used to assess 
patient-ventilator interaction and weaning failure in critically ill patients. This paper provides 
an overview of the basic and advanced principles underlying respiratory muscle ultrasound, 
with an emphasis on the diaphragm. We review different ultrasound techniques useful for 
monitoring of the respiratory muscle pump and possible therapeutic consequences. Ideally, 
respiratory muscle ultrasound is used in conjunction with other components of critical care 
ultrasound to obtain a comprehensive evaluation of the critically ill patient. We propose 
the ABCDE ultrasound approach: a systematic ultrasound evaluation of the heart, lungs 
and respiratory muscle pump, in patients with weaning failure.
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INTRODUCTION
Ultrasound imaging has become increasingly popular for the diagnosis of deranged 
physiology and to guide treatment in critically ill patients. In particular, the sonographic 
evaluation of the heart and lungs is well established and widely implemented in the 
intensive care unit (ICU) [1, 2]. The use of ultrasound to evaluate the respiratory muscle 
pump function is relatively new. The relative infrequency with which respiratory muscle 
ultrasound is employed in clinical practice may be attributable to the complexity of this 
pump (especially the number of muscles involved), the difficulty in obtaining adequate 
ultrasound windows, and the common assumption that ultrasound evaluation of the 
respiratory muscles would not alter patient management in the ICU. The aim of this review 
is to provide an overview of the principles and current applications of respiratory muscle 
ultrasound and to discuss its limitations and to describe innovative ultrasound-based 
techniques. We propose a systematic ultrasound-based evaluation of the respiratory 
muscle pump, integrated with cardiac and lung ultrasound, in ICU patients.
ANATOMY OF THE RESPIRATORY MUSCLES
The main muscle of inspiration is the diaphragm, a thin dome-shaped muscle positioned 
between the chest and abdomen. Contraction of the zone of apposition (cylindroid part of 
the diaphragm attached to the thoracic outlet) results in caudal movement of the diaphragm 
dome, and increases intrathoracic volume. When the load imposed on the diaphragm 
increases, the accessory inspiratory muscles (parasternal, external intercostal, scalene, and 
sternocleidomastoid muscles) are recruited. With further loading, the expiratory muscles 
are activated to assist expiration [3]. The most prominent expiratory muscles include 
the transversus abdominis muscle, and the internal and external oblique muscles. The 
differential diagnosis of diaphragm weakness is extensive (Supplemental file, Table E1).
TECHNIQUES AND VIEWS
Diaphragm
Two ultrasound approaches to visualize the diaphragm should be performed: the mid-axillary 
intercostal approach at the zone of apposition, and the subcostal approach using the liver or 
spleen as an acoustic window. Tips and tricks of respiratory muscle ultrasound are summarized 
in Supplemental file E-Figure 1.
Intercostal approach: thickness and thickening fraction
The intercostal approach is performed with a 10–15 MHz linear array transducer positioned 
in a cranio-caudal direction and perpendicular to the skin in the zone of apposition between 




The diaphragm appears at a depth of two to four centimeters as a three-layered structure 
between the pleural and peritoneal membrane (Figure 1). Characteristically, a white 
linear structure is seen in the middle of the diaphragm [4, 5]. We recommend measuring 
diaphragm thickness perpendicular to its fiber direction between the pleural and peritoneal 
membrane, but not including the membranes (Figure 1). The lower limit for normal 
diaphragm thickness is around 1.5 mm in healthy subjects. Reference values are given in 
Table 1. Diaphragm thickness is affected by body composition and gender [6, 7].
The diaphragm thickens with active shortening and, therefore, thickening fraction (TF) 
reflects contractile activity [8, 9]. Thickening fraction of the diaphragm (TFdi) is calculated 
in B-mode or M-mode as the percentage inspiratory increase in diaphragm thickness 
relative to end-expiratory thickness during tidal breathing (TFdi) or maximal inspiratory 
effort (TFdi,max): TFdi = (end-inspiratory thickness − end-expiratory thickness) / end-
expiratory thickness × 100% (Figure 1). Inspiratory thickening of the diaphragm can be 
used to assess muscle function. Reference values are given in Table 1 and demonstrate 
a relatively wide range in healthy subjects [6, 9–11]. A reasonable relationship exists 
between TFdi and the pressure (or electrical activity) developed by the diaphragm during 
unassisted breathing [9, 12] and mechanical ventilation [13]. Few studies directly evaluated 
the correlation between TFdi and muscle pressure (Pmus) [14, 15] and, therefore, care 
should be taken when estimating Pmus from TFdi.
Subcostal approach: excursion
Diaphragmatic excursion is measured with a low frequency phased-array or curved-array 
(“abdominal”) probe (2–5 MHz) positioned just below the costal arch at the midclavicular 
line, with the patient in semi-seated position and by angling the ultrasound beam as 
much as possible cranially and perpendicular to the diaphragmatic dome (Figure 1). The 
diaphragm is identified as a bright line covering the liver and the spleen. Obtaining a clear 
image of the left hemidiaphragm can be difficult due to the poor acoustic window of 
the spleen. During inspiration, the diaphragm should move toward the probe (Figure 1). 
Excursion is quantified in M-mode, with the M-line placed perpendicular to the direction 
of motion (Figure 1); the sweep speed is best adjusted to around 10 mm/s to obtain a 
minimum of three respiratory cycles within one image. Diaphragm excursion should only 
be measured during unassisted breathing (i.e., T-piece trial or minimum tolerable CPAP 
level), since active contraction of the diaphragm cannot be distinguished from passive 
displacement due to ventilator inspiratory pressures [4, 12].
In a cooperative patient, a maximum inspiratory effort is performed to assess maximal 
excursion. Excursion of both hemidiaphragms is compared to identify unilateral weakness 
or paralysis (for reference values, see Table 1). The success rate for visualizing excursion 
is high during tidal breathing (>95%), whereas during maximal breathing visualization is 
more difficult, especially on the left side [17].
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If experiencing difficulties visualizing the diaphragm from the subcostal window, movement 
of the liver or spleen during tidal respiration can be used as an alternative. To this end, 
an intercostal window at the zone of apposition in B-mode or M-mode is advised, using 
a low frequency probe [18, 19]. As there is some inconsistency in agreement between 
diaphragmatic and subdiaphragmatic excursion [20, 21], it is advised to use this approach 
for a qualitative rather than a quantitative assessment of diaphragm motion.
Under normal conditions, expiration largely depends on the elastic recoil pressure of 
the respiratory system, although some diaphragm activity in early expiration has been 
demonstrated [22]. Nevertheless, diaphragm relaxation rate derived from excursion should 
not be used as a measure for diaphragm function [16].
Table 1. Reference values for diaphragm muscle ultrasound in ICU patients and general population.
Setting Parameter Patient position Normal values Abnormal values/
values related to 
outcome
Ref.

















































Men: 1.9 ± 0.4
























Men: 18 ± 3
Women: 16 ± 3
Men: 29 ± 6
Women: 26 ± 5
Men: 70 ± 11








Values are expressed in mm. Normal values are expressed as mean ± SD or median (range); For ICU patients, 
mean thickness values are reported from baseline measurements. TFdi: thickening fraction during tidal 
breathing (or during maximal breathing: TFdi,max), expressed in %; Position is reported as described in the 
original manuscript, although sitting and semi-recumbent (and potentially supine) may have overlap.
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Extra-diaphragmatic inspiratory muscles
Ultrasound assessment of accessory inspiratory muscles could add information regarding 
the patient’s inspiratory effort and patient-ventilator interaction. Parasternal intercostal 
muscle ultrasound is performed with a 10–15 MHz linear probe positioned in cranio-caudal 
direction at the second intercostal space (Figure 1). Thickness and inspiratory thickening 
fraction can be assessed. In healthy subjects, thickening of parasternal intercostal muscles 
is observed only during maximal efforts [23], and preliminary findings in ICU patients 
suggest the existence of a dose-response relationship between respiratory load and the 
parasternal intercostal muscle thickening fraction [24].
Although the topic of future studies, parasternal intercostal muscle ultrasound may be 
a useful tool in the evaluation of the capacity/load balance of the respiratory muscle pump 
in the ventilated patient. Reference values need to be determined.
Abdominal wall expiratory muscles
Using a 10–15 MHz linear probe positioned perpendicular to the abdominal wall, with the 
patient in supine position, the different expiratory muscles are relatively easily to visualize 
as hypoechogenic layers enclosed by fascial sheaths (Figure 1). The pressure applied to 
the probe should be kept to a minimum to prevent compression of the abdominal wall as 
this may alter the shape/thickness of the underlying muscles.
To visualize the rectus abdominis muscle, the transducer is positioned in a transverse 
orientation approximately 2–3 cm above the umbilicus and 2–3 cm lateral from the midline 
(Figure 1) [25]. Maximum muscle thickness is obtained by sliding the probe in a cranial-
caudal direction, while keeping the probe perpendicular to the skin. Next, the probe is 
moved laterally; the semilunar line is first identified as a thick echogenic fascia that blends 
lateral to the rectus abdominis muscle and medial to the oblique muscles. The external 
oblique, internal oblique and transversus abdominis muscles can be identified as three 
parallel layers (Figure 1), usually best visualized on the anterior axillary line, midway between 
the inferior border of the rib cage and the iliac crest [25–27]. Reference values are provided 
in the Supplemental file, Table E2 [25–28].
Thickening fraction of the expiratory abdominal muscles (TFabd) can be calculated as 
the magnitude of thickness increase during expiration (TFadb = (end-expiratory thickness − 
end-inspiratory thickness) / end-inspiratory thickness × 100%) and may reflect expiratory 
muscle effort. Preliminary data seem to demonstrate reasonable correlation between 
TFabd and expiratory force generation [29]. It should be noted that expiratory muscles 
have more degrees of freedom compared to the diaphragm; active contraction of one 
muscle layer may directly affect the shortening and position of the adjacent layer, which 
may make interpretation of TFabd more complex. Moreover, the relationship between 
shortening, thickening, and pressure generation is complex because of the geometry of 
the abdominal muscles during contraction (a “shrinking sphere” rather than a “shortening 
piston-in-a-cylinder” like the diaphragm). Future studies should confirm the relationship 




CLINICAL APPLICATIONS OF RESPIRATORY MUSCLE ULTRASOUND 
(TABLE 2)
Role of respiratory muscle ultrasound in acute respiratory failure
Respiratory muscle weakness as the major cause for acute respiratory failure is uncommon, 
but should be considered if more common causes have been excluded [30, 31]. The 
clinical presentation of diaphragm dysfunction depends on the cause, severity and rate of 
progression (see Supplemental file, Table E1) [32]. A characteristic physical sign of bilateral 
diaphragm dysfunction is the supine abdominal paradox: activity of accessory inspiratory 
muscles generates a negative inspiratory thoracic pressure (though the same pattern may 
be observed when respiratory loads are increased) [33]. As the diaphragm is paralyzed, 
this negative pressure is transferred to the abdomen, resulting in inward movement of the 
abdominal wall. The ultrasound corollary of this is cranial excursion of the diaphragm during 
inspiration, measured in M-mode. In addition, severe isolated diaphragm weakness results 
in an increased thickening fraction of the accessory respiratory muscles [24]. Therefore, 
respiratory muscle ultrasound is an excellent modality to diagnose (unilateral) diaphragm 
weakness or paralysis in patients with acute respiratory failure [34, 35].
Diaphragm weakness is diagnosed by an excursion of <10–15 mm during tidal breathing 
or a TFdi,max <20% (Table 1) [6, 7, 10]. In patients with unilateral diaphragm paralysis, 
thickness and TFdi of the paralyzed diaphragm were significantly less compared to the 
other hemidiaphragm (Table 1) [10]. A left–right ratio for thickness of <0.5 or >1.6 should 
be considered abnormal [19]. Notably, with unilateral diaphragmatic dysfunction the normal 
hemidiaphragm may show relatively large excursions, a compensatory mechanism to 
generate sufficient tidal volumes [36, 37]. For patients with bilateral paralysis, diaphragm 
thickness and TFdi are below reference values [10].
In patients with acute hypercapnic exacerbation of COPD (AE-COPD), diaphragm 
ultrasound may be used to predict success of noninvasive ventilation (NIV). Increased 
diaphragm excursion during NIV (>18 mm vs. <12 mm) was associated with NIV success 
and a decrease in PaCO2 after one hour [38, 39]. Air trapping has been found to be the 
major limiting factor in diaphragm excursion in COPD patients [40]; therefore, improved 
excursion is probably an indication of reduced pulmonary hyperinflation. In a cohort of 
patients with AE-COPD requiring ICU admission (n=41), TFdi <20% was associated with NIV 
failure (r = 0.51) [41], which was confirmed in a larger (n=75) follow-up study (risk ratio for 
NIV failure, 4.4) [42]. Diaphragm ultrasound may thus reduce the risk of delayed intubation 
in patients with severe AE-COPD requiring NIV; however, further validation is required.
Role of respiratory muscle ultrasound in diaphragm-protective mechanical ventilation
It has been postulated that both ventilator over-assist and ventilator under-assist, 
resulting in muscle atrophy and muscle injury, respectively, play an important role in critical 
illness-associated diaphragm weakness pathophysiology [13]. To limit these detrimental 
consequences, it seems reasonable to titrate ventilator support such that diaphragm effort 
is within physiological limits, the so-called diaphragm-protective mechanical ventilation 
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strategy [13, 43, 44]. The optimal level of diaphragm activity is currently unknown and 
may vary under different conditions (e.g., sepsis, weakness); however, a relatively low 
level of diaphragm activity, corresponding to esophageal pressure swings of 4–8 cmH2O 
appears safe [45]. The role of ultrasound in diaphragm-protective ventilation has not 
been specifically studied, but assessment of TFdi, as a proxy for effort, is a reasonable 
approach. Data from Goligher and colleagues demonstrate that a TFdi between 15% 
and 30% during the first days of mechanical ventilation is associated with stable muscle 
thickness [44] and the shortest duration of ventilation [13]. Accordingly, a low TFdi (<15%) 
in a patient on a partially-supported ventilatory mode raises the possibility of ventilator 
over-assist; therefore, decreasing assist, while monitoring other respiratory parameters 
(e.g., tidal volume, respiratory rate), is a reasonable approach. The upper limit for TFdi 
allowing diaphragm-protective ventilation is more controversial. Although a moderate 
and statistically significant correlation exists between TFdi and diaphragm effort (Pdi, 
PTP) [9, 14], the range of diaphragm effort at a certain TFdi is large. We suggest that in 
patients with TFdi >30–50%, ventilator support may be increased under the monitoring of 
other respiratory parameters to avoid hyperinflation. Given the relative imprecision of TFdi 
measurements, other techniques for monitoring respiratory effort should be considered.
Role of respiratory muscle ultrasound in weaning failure
An imbalance between load and capacity of the respiratory system is an important cause for 
SBT failure and extubation failure [46]. Therefore, respiratory muscle ultrasound could play 
an important role in the differential diagnosis of weaning failure. However, it is important to 
emphasize that a substantial proportion of patients can be successfully weaned from the 
ventilator despite having diaphragm dysfunction [47–49]. In addition, the clinical relevance 
of predicting SBT outcome with ultrasound is debatable; more relevant from a clinical 
perspective is the use of ultrasound to predict extubation success.
Diaphragm excursion
Kim et al. evaluated diaphragm excursion in a series of 89 patients on a T-tube, before the start 
of an SBT [50]. Diaphragm dysfunction, arbitrary defined as excursion <10 mm, was associated 
with weaning failure, but its predictive performance was poor (AUROC, 0.61). Using the same 
cutoff value, no association was found between diaphragm dysfunction and extubation failure 
[51]. Interestingly, when diaphragm excursion is measured after 30 minutes from initiation of a 
2-hour SBT, predictive performance of the 10 mm cutoff value seems to be significantly higher 
(AUROC, 0.88) [52]. Post-cardiac surgery patients with unilateral diaphragmatic paralysis 
could be extubated without delay, when the contralateral diaphragm excursion was >25 mm 
at maximal inspiratory effort [53]. In a meta-analysis of 10 studies evaluating diaphragm 
excursion to predict weaning failure and combining different definitions of weaning failure, the 
authors reported a sensitivity of 75% (95% CI, 65–85%) and specificity of 75% (95% CI, 60–
85%), with substantial heterogeneity [54]. As diaphragm excursion is strongly dependent of 
lung volume [37], the reported heterogeneity could be explained by patient position and the 
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Spadaro et al. [55] evaluated the diaphragmatic rapid shallow breathing index (D-RSBI: 
respiratory rate divided by diaphragm excursion) during a T-tube SBT and reported good 
performance as compared to the RSBI alone (D-RSBI AUROC 0.89 vs. RSBI AUROC 0.72, 
respectively, p = 0.006). Palkar et al. [56] evaluated the performance of the diaphragmatic 
excursion-time product (E-T index: the product of diaphragm excursion (cm) and inspiratory 
time (s)). A decrease in E-T index of <3.8% between assist-control ventilation and a pressure 
support ventilation SBT (support 5 cmH2O with PEEP 5 cmH2O) had a sensitivity of 79.2% 
and a specificity of 75% to predict extubation success.
Remarkably, in 191 patients having successfully passed an SBT, diaphragm excursion was 
not associated with extubation failure [57]. This suggests that once an SBT is successfully 
completed, extubation outcome is primarily determined by factors other than diaphragm 
function.
Diaphragm thickening fraction
When performed during an SBT, TFdi >30–36% has shown to predict extubation success 
[52, 54, 58]. Ferrari et al. evaluated in 46 patients ventilated through a tracheostomy tube, 
the role of TFdi,max of the right hemidiaphragm during an SBT, as a predictor of weaning 
outcome [59] and reported that a TFdi,max >36% was associated with a successful SBT 
(sensitivity, 0.82; specificity, 0.88; AUROC, 0.95). In another study, TFdi was calculated 
either during a T-tube trial or low levels of pressure support ventilation in patients (n=63) 
after a failed weaning attempt. A TFdi ≥30% had a sensitivity of 0.88 and specificity of 
0.71 (AUROC, 0.79) for extubation success [60]. In the above-mentioned meta-analysis 
assessing the predictive value of diaphragm excursions, TFdi/TFdi,max demonstrated an 
AUROC of 0.87 and diagnostic odds ratio of 21 (95% CI, 11–40) for prediction of weaning 
failure [54]. The diagnostic odds ratio is a measure of effectiveness of a diagnostic test 
and it is defined as the ratio of odds of a test being positive if the subject has the disease 
relative to the odds of the test being positive if the subject does not have the disease.
Overall, these results seem to suggest a role for diaphragm ultrasound in the differential 
diagnosis of patients experiencing difficult weaning, allowing bedside recognition of 
diaphragmatic weakness. However, the role of diaphragm ultrasound to predict SBT 
success and successful extubation requires further evaluation and currently cannot be 
recommended.
The ABCDE approach: a systematic ultrasound evaluation of patients with weaning 
failure
A weaning trial may be considered as a cardio-pulmonary stress test: it demands an 
increase in cardiac index, oxygen demand/consumption, and breathing effort. In most 
patients, post-extubation distress is the result of a combination of cardiac dysfunction, 
impaired gas exchange, and/or diaphragmatic dysfunction. Therefore, in patients with 
weaning failure we suggest the use of a structured and integrated approach that combines 
clinical parameters, laboratory parameters (e.g., pro-BNP) and the sonographic assessment 




approach, an intuitive aid designed to standardize the sonographic approach to weaning 
failure (Figure 2). A similar but less exhaustive approach has been suggested by Mayo et 
al. [62]. The use of ultrasound to evaluate the heart and lungs has been described in this 
Intensive Care Medicine critical care ultrasound series [1, 2].
Timing of ultrasound examination depends on the clinical question. For identification 
of patients at high risk of weaning failure, the examination is performed before the SBT. For 
prediction of weaning outcome or to diagnose the cause of weaning failure, the examination 
is best done after the start and/or end of an SBT [62].
Role of respiratory muscle ultrasound to assess patient-ventilator interaction
Patient-ventilator asynchrony can be defined as a mismatch between the neural inspiratory 
time and ventilator inspiratory time [63]. Patient-ventilator asynchrony is associated with 
worse outcome [64] and occurs in up to half of mechanically ventilated patients. Visual 
inspection of the airway flow and pressure signals may detect asynchrony, but was shown 
to be unreliable [65]. Both measurements of esophageal pressure and diaphragm electrical 
activity are used as state-of-the-art techniques to assess patient-ventilator interactions 
[66]. These two techniques are invasive, limiting their use in daily practice. Diaphragm 
ultrasound might be a reasonable alternative to detect most types of patient-ventilator 
asynchrony (Table 3), but further studies are needed to determine its exact role [4, 67].
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Table 3. Types of patient-ventilator asynchronies and their ultrasound correlate.
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LIMITATIONS OF RESPIRATORY MUSCLE ULTRASOUND
We briefly summarize current challenges of respiratory muscle ultrasound. This highlights 
the need for a systematic ultrasound approach to be implemented in clinical practice and 
research.
Reproducibility
The first and largest study regarding reliability of diaphragm thickness and TFdi 
measurements in mechanically ventilated patients (n=66) was conducted by Goligher et 
al. [68]. Measurements were performed after marking the probe location. Intra-observer 
and inter-observer reproducibility coefficients for end-expiratory diaphragm thickness were 
0.2 mm and 0.4 mm, respectively [68], meaning it is expected that the absolute difference 
between two measurements by the same observer does not differ by more than 0.2 mm 
on 95% of occasions (or 0.4 mm in case of two different observers). However, it should be 
kept in mind that 0.2 mm represents approximately 10% of total diaphragm thickness at 
end expiration. While in general diaphragm ultrasound seems to be a reliable technique 
to assess changes in diaphragm thickness over time, comparing individual patient results 
should be done with a degree of caution and only after adequate training, as small observer-
dependent variations (e.g., measurement location, probe angulation) will affect results.
Accuracy
Accurate muscle thickness measurement depends not only on operator skills but also on 
technical aspects related to ultrasound physics and patient characteristics. Unclarity of 
surrounding membranes and insufficient ultrasound beam angulation to the muscle axis may 
lead to measurement error. Furthermore, the spatial axial resolution (depth resolution; i.e., 0.5 
× spatial pulse length) of the probe plays a critical role. Given that the ultrasound pulse length is 
typically two cycles and that the ultrasound wavelength of a 10 MHz transducer is 0.15 mm (i.e., 
wavelength = speed of sound in soft tissue / frequency = 1540 m/s / 10 MHz = 0.15 mm), the 
corresponding depth resolution is 0.5 × (2 × 0.15) = 0.15 mm, which is in the same order as the 
intra-observer reproducibility and sufficient in order to visualize the diaphragm. Based on the 
ultrasound technique and equipment used, identification of the smallest detectable change 
that is permitted is fundamental to distinguish true changes in muscle thickness from artifacts.
RESEARCH: NOVEL TECHNIQUES AND FUTURE DEVELOPMENTS FOR
FUNCTIONAL IMAGING AND QUANTIFICATION OF TISSUE PROPERTIES
Tissue Doppler imaging
Tissue Doppler imaging (TDI) quantifies the velocity of moving structures [69]. This could 
be an interesting modality superimposed over the B-mode diaphragm excursion images for 
quantification of diaphragm kinetics (video in Supplemental file). Feasibility and reliability of 
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diaphragm TDI have been confirmed in neonates [70], and the role of TDI for assessment 
of diaphragm mobility and dysfunction in patients following cardiac surgery is under 
investigation (ClinicalTrials.gov: NCT03295344). Potential applications include assessment 
of regional diaphragm contractile function at rest and with loading, and measurement of 
diaphragm relaxation velocity. Diaphragm relaxation abnormalities have been described as 
a marker of impaired contractility in patients who failed weaning [71], but nowadays they 
can only be assessed with invasive esophageal or diaphragmatic pressure measurements 
(or possibly M-mode excursion decay).
Strain imaging
Strain imaging is based on the ability to track ultrasound speckles over time and an 
excellent feature to quantify motion and deformation of anatomical structures. This 
has a great benefit over TDI, as strain imaging is not affected by the angle between the 
ultrasound beam and the direction of tissue motion. Furthermore, it allows calculation 
of displacement, velocity, and deformation of tissue in two directions. It was recently 
demonstrated that strain and strain rate were highly correlated to transdiaphragmatic 
pressure in healthy subjects [72]. In addition, Goutman and colleagues applied speckle 
tracking for evaluating true diaphragm excursion in two directions, which is more accurate 
compared to measurements of motion along one M-mode line [73].
Shear wave elastography
Shear wave elastography is a technique that allows quantification of the elastic modulus of 
tissues (Supplemental file, E-Figure 2). Application of this technique on the diaphragm could 
be of clinical importance since changes in muscle stiffness may reflect alterations in muscle 
physiology (e.g., injury, fibrosis). Moreover, shear wave elastography is considered to be more 
accurate and reproducible than evaluation of echogenicity, which is highly dependent on 
ultrasound settings (e.g., gain, contrast, etc.). A recently published proof-of-concept work 
demonstrated that changes in diaphragm stiffness during inspiratory efforts as assessed 
with ultrasound shear wave elastography reflect changes in transdiaphragmatic pressure 
[74]. Therefore, it might offer a new noninvasive method for gauging diaphragm effort.
CONCLUSION
Respiratory muscle ultrasound is a widely available, highly feasible, noninvasive radiation-
free technique that can be easily applied at the bedside. It is, therefore, the imaging 
modality of choice for assessment of the respiratory muscles in ICU patients. Mastery of 
respiratory muscle ultrasound allows the intensivist to rapidly obtain information on global 
function of the respiratory muscle pump, in particular to diagnose diaphragm weakness 
or paralysis. In combination with cardiac and lung ultrasound, it can detect patients at risk 
for difficult weaning, predict weaning outcome and help diagnose the cause of weaning 
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SUPPLEMENTAL FILE
Table E1. Causes of Diaphragmatic Dysfunction according to the level of impairment (Ref. [1]).
Central nervous system
Brain lesions (e.g., stroke, Arnold-Chiari 
malformation, Multiple Sclerosis)
Spinal cord lesions (cervical)
Traumatic
Tumors
Anterior horn lesions (e.g., ALS, SMA, 
poliomyelitis)
Myopathies
Muscular dystrophies (e.g., Limb-Girdle, 
Duchenne)
Myotonic dystrophy
Metabolic (e.g., malnutrition, 
hypophosphatemia)
Endocrine (e.g., thyrotoxicosis, myxedema, 
Cushing)




Immunologic (e.g., Guillain-Barre syndrome)
Metabolic (e.g., porphyria)
Endocrine (e.g., diabetes mellitus)
Toxic (e.g., organophosphates)
Traumatic
Iatrogenic (e.g., surgery, radiation)
Paradiaphragmatic
Lung (e.g., large pleural effusion, COPD, 
fibrosis)
Abdomen (e.g., ascites, abdominal mass)












Abbreviations: ALS, amyotrophic lateral sclerosis; COPD, chronic obstructive pulmonary disease; 





Table E2. Reference values for expiratory abdominal muscle ultrasound in the general population (no 
data available for ICU patients).
Position/muscles Reference values thickness Ref.
Sitting, resting breathing












Rectus abdominis 11.0 ± 4.3 [2]
Supine, resting
External oblique Men: 6.7 ± 1.7 (R); 6.9 ± 1.6 (L)
Women: 5.9 ± 1.8 (R); 5.8 ± 1.6 (L)*
Men: 9.7 ± 2.3 (R); 9.6 ± 2.1 (L)
Women: 7.3 ± 2.0 (R); 7.4 ± 1.5 (L)
Men: 5.7 ± 1.2 (R); 5.4 ± 1.3 (L)
Women: 4.8 ± 1.1 (R); 4.8 ± 1.1 (L)
[4]
[5]
Internal oblique Men: 10.2 ± 2.7 (R); 10.4 ± 2.7 (L)
Women: 7.5 ± 1.8 (R); 7.3 ± 1.8 (L)*
Men: 11.8 ± 2.7 (R); 11.7 ± 2.8 (L)
Women: 8.5 ± 2.2 (R); 8.1 ± 2.3 (L)
Men: 8.9 ± 2.3 (R); 8.5 ± 2.0 (L)
Women: 6.1 ± 1.3 (R); 5.8 ± 1.2 (L)
[4]
[5]
Transversus abdominis Men: 5.4 ± 1.1 (R); 5.7 ± 1.1 (L)
Women: 3.9 ± 0.08 (R); 4.4 ± 0.08 (L)*
Men: 4.5 ± 1.3 (R); 5.1 ± 1.3 (L)
Women: 3.6 ± 0.09 (R); 3.7 ± 0.10 (L)
Men: 4.5 ± 0.09 (R); 3.8 ± 0.1 (L)
Women: 3.5 ± 0.08 (R); 3.3 ± 0.07 (L)
4.7 ± 1.1 (dominant side); 4.6 ± 0.9 (non-dominant side)
Men: 5.0 ± 0.9




Total thickness of lateral three 
layers
Men: 34.8 ± 5.9 (R); 35.3 ± 6.1 (L)
Women: 27.6 ± 4.4(R); 27.8 ± 4.0 (L)*
Men: 38.6 ± 6.4 (R); 38.8 ± 6.7 (L)
Women: 29.6 ± 4.6 (R); 29.4 ± 4.3 (L)
21.5 ± 5.9 (dominant side); 20.9 ± 5.5 (non-dominant side)
Men: 25.3 ± 3.9
Women: 16.6 ± 3.1
[4]
[6]
Rectus abdominis Men: 12.5 ± 2.2 (R); 12.4 ± 2.4 (L)
Women: 10.2 ± 1.6 (R); 10.2 ± 1.5 (L)
Men: 10.3 ± 1.8 (R); 10.4 ± 1.9 (L)
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Table E2. Continued.
Position/muscles Reference values thickness Ref.
Supine, contracted
Transversus abdominis 8.7 ± 2.1 (dominant side); 8.6 ± 2.2 (non-dominant side)
Men: 9.8 ± 2.0
Women: 7.4 ± 1.2
[6]
Total thickness of lateral three 
layers
26.5 ± 8.0 (dominant side); 26.0 ± 8.2 (non-dominant side)
Men: 31.7 ± 6.3
Women: 20.0 ± 3.8
[6]
Values are expressed in mm, and as mean ± SD. *Measurements performed immediately below the rib 
cage with the probe position in vertical alignment with the anterior superior iliac spine. Abbreviations: 
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TO PERFORM RESPIRATORY MUSCLE 










use same position for repeated measurements
TIMING
- Best during T-piece SBT
- Measurements at start and end of SBT 
- can be compared
PATIENT COOPERATION
If patient can follow instructions: 








- Perpendicular to the skin
- Mark probe location
VENTILATOR
Muscle thickness
- all settings, no NMBAs
- TFdi: SBT / low support
Diaphragm excursion
- no support 
- no PEEP
Diaphragm excursion








No assymetric diaphragm dysfunction?
   right hemidiaphragm can be used as proxy
   for whole diaphragm
1. Diaphragm excursion; 2. Diaphragm thickness and TFdi; 3. Rectus abdominis; 




















































E-Figure 2. Shear wave elastography of the diaphragm. (a) B-mode image of the diaphragm with 
shear wave elastography overlay as a measure of muscle stiffness. (b) M-mode image of the dia-
phragm. (c) M-mode image of the diaphragm with shear wave elastography overlay. (d) Esopha-
geal pressure (Pes), gastric pressure (Pga), diaphragmatic pressure (Pdi) and shear modulus of the 
diaphragm (SMdi) during tidal breathing. Note that changes in Pdi and changes in SMdi follow the 
same pattern.
229
Respiratory muscle ultrasonography: methodology, principles and applications in ICU and ED patients
Video




C ha p t e r 12
Tissue Doppler imaging of the diaphragm: a novel approach 






Am J Respir Crit Care Med. 2020 Dec 15;202(12):1741-1742

233
Tissue Doppler imaging of the diaphragm: a novel approach but too early for clinical implementation?
To the Editor:
Tissue Doppler Imaging (TDI) is a robust ultrasound technique used in cardiology to 
quantify myocardial motion velocity, but the validity and clinical applications of diaphragm 
TDI are yet uncertain. We read with great interest the work of Soilemezi and colleagues [1] 
on TDI to describe diaphragm motion properties of critically ill patients during ventilator 
weaning. The authors mention that diaphragm pulsed-wave (PW)-TDI is a straightforward 
method with a fast learning curve. Although we agree that these are essential features for 
any ultrasound method, we would like to address some important challenges that should 
be taken into account before implementing this technique in clinical practice.
First, PW-TDI results are very dependent on ultrasound settings and probe position. 
Doppler signals within a region of interest (“sample volume”, or “gate”) are converted into 
an average velocity signal. However, increasing the gain broadens the velocity spectrum 
and results in higher peak velocities [2, 3]. Furthermore, as TDI measures the motion 
vector that is parallel to the ultrasound beam, the insonation angle must be kept as low 
as possible and changes in angle will affect both pulse length and spectral width. Angle 
correction can be applied, but only for angles <60˚ because this correction is nonlinear. In 
addition, reverberation artifacts may occur, resulting in a clutter band along the baseline. 
This is presented in Figure E1B in the online supplement of Reference 1, where the concept 
of “smoothing” is introduced. Although smoothing improves visualization of the contour 
of the velocity signal, peaks are directly affected by the gain and too much smoothing 
results in signal loss. The authors mentioned that different filters and gains were set to 
obtain the best velocity images according the speed of the diaphragmatic motion and 
the subject under examination. It would be great if they could address how this method 
was standardized (i.e., quantify “best”), as PW-TDI results can be manipulated easily by 
adjusting settings on the ultrasound machine.
Furthermore, despite high reliability of results reported in healthy volunteers, it is not 
entirely clear if PW-TDI results represent what they are intended to. As the velocity-time 
integral (VTI) reflects diaphragm displacement, VTI should match M-mode displacement 
(less sensitive to measurement errors compared with PW-TDI) but large discrepancy was 
reported in patients (mean 1.27 vs. 0.78 cm for M-mode displacement vs. VTI, respectively; 
see Table 2 of Reference 1). Also, inspiratory and expiratory VTI should be similar over a large 
number of breaths, as end-expiratory diaphragm position should not change. Based on our 
own experience with PW-TDI, and in line with the presented examples [1], VTI inspiration 
is often larger than VTI expiration. Therefore, reporting a direct comparison of M-mode 
displacement vs. VTI, and VTI inspiration vs. VTI expiration would be valuable in order to 
address the validity of PW-TDI results. If there is a systematic underestimation of VTI (and 
thus also of velocity results), it should be explored whether differences can be minimized 
sufficiently by adapting ultrasound settings or by performing offline correction.
Noninvasive measures to quantify diaphragm mechanics are highly needed and 
correlations between transdiaphragmatic pressure (Pdi) and PW-TDI were evaluated. No 
relationship between VTI and the diaphragm pressure-time product (PTPdi) was found. 




defined as the area under the inspiratory PW-TDI curve, similarly to PTPdi being the area 
under the Pdi-time waveform. This lack of relationship is not surprising given the poor 
correlation between diaphragm displacement and breathing effort [4, 5]. A correlation was 
found between TDI-maximal relaxation rate (MRR) and Pdi-MRR. TDI-MRR was defined as 
the slope of the steepest part of the PW-TDI signal during expiration. From a physiological 
perspective, however, TDI-MRR represents diaphragm deceleration as the signal is already 
a derivative of displacement. Hence, peak relaxation velocity better reflects MRR and it 
would be of clinical interest to evaluate its relationship with Pdi-MRR.
Undoubtedly, diaphragm TDI is an exciting approach. However, standardization of the 
method and further understanding of the capabilities and limitations is important before 
using this technique for clinical decision-making.
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ABSTRACT
Mechanical ventilation may have adverse effects on both the lung and the diaphragm. 
Injury to the lung is mediated by excessive mechanical stress and strain, whereas the 
diaphragm develops atrophy as a consequence of low respiratory effort and injury in case 
of excessive effort. The lung and diaphragm-protective mechanical ventilation approach 
aims to protect both organs simultaneously whenever possible. This review summarizes 
practical strategies for achieving lung and diaphragm-protective targets at the bedside, 
focusing on inspiratory and expiratory ventilator settings, monitoring of inspiratory 
effort or respiratory drive, management of dyssynchrony, and sedation considerations. 
A number of potential future adjunctive strategies including extracorporeal CO2 removal, 
partial neuromuscular blockade, and neuromuscular stimulation are also discussed. While 
clinical trials to confirm the benefit of these approaches are awaited, clinicians should 
become familiar with assessing and managing patients’ respiratory effort, based on existing 
physiological principles. To protect the lung and the diaphragm, ventilation and sedation 
might be applied to avoid excessively weak or very strong respiratory efforts and patient-
ventilator dyssynchrony.
TAKE-HOME MESSAGE
This review explains the principles of lung and diaphragm-protective mechanical ventilation. 
The overall aim of this approach is to limit the adverse effects of mechanical ventilation 
on the lung and the diaphragm at the same time. This requires understanding of the 
pathophysiology of ventilator-induced lung injury, critical illness-associated diaphragm 
weakness and especially respiratory drive. We discuss clinical applicable techniques 
to monitor lung and diaphragm function, and how to use these techniques to optimize 
ventilator settings and sedation. Future techniques that allow to control respiratory drive 
are discussed.
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INTRODUCTION
Lung and diaphragm-protective mechanical ventilation is a novel approach that aims 
to limit the side effects of mechanical ventilation in critically ill patients. This approach 
integrates the principles of lung-protective ventilation with the new concept of diaphragm-
protective ventilation in an effort to simultaneously protect both organs. The approach 
centers on optimizing patient respiratory effort to avoid lung and diaphragm injury while 
maintaining acceptable respiratory homeostasis. Ultimately, the goal of the approach is to 
reduce the duration of mechanical ventilation, enhance survival, accelerate recovery, and 
prevent long-term disability in patients with acute respiratory failure.
PRINCIPLES AND RATIONALE
Principles of lung-protective ventilation
Lung-protective ventilation can best be understood in terms of limiting global and regional 
mechanical stress (pressure applied to the lung) and strain (deformation from resting 
shape) (Figure 1). Lung injury may occur from overdistension (volutrauma/barotrauma), 
repetitive tidal recruitment and collapse (atelectrauma), both resulting from heterogeneous 
insufflation of patchy alveolar flooding or collapsed alveoli [1]. Importantly, lung injury may 
occur irrespective of whether the ventilator (ventilator-induced lung injury, VILI), patient 
breathing effort (patient self-inflicted lung injury, P-SILI), or both together are generating 
the forces applied to the lung [2].
Bedside measures of stress are available (changes in transpulmonary pressure, driving 
pressure), but not for measuring the resulting strain, making it challenging to appropriately 
individualize mechanical ventilation settings to maximize lung protection. Furthermore, 
even if global stress can be measured quite precisely using transpulmonary pressure 
calculated from airway and esophageal pressure, the effect of gravity on the edematous 
lung makes the distribution of collapse and aeration very uneven between the dependent 
and nondependent lung regions; therefore, global indices do not reflect regional stress or 
strain. To minimize total stress and strain, dependent regions (usually prone to atelectasis) 
often require recruitment while nondependent regions (usually well ventilated) require 
relief of overdistension.
During invasive ventilation, tidal volume (Vt) is routinely scaled to predicted body weight 
(PBW), which correlates with lung volume in healthy subjects. This correlation is much 
less accurate in patients with the acute respiratory distress syndrome (ARDS) because of 
alveolar flooding and atelectasis, resulting in a “baby lung” much smaller than the predicted 
lung volume [3, 4]. Using the driving pressure to scale tidal volume to respiratory system 
compliance (Crs, Vt/Crs = airway driving pressure, ΔPaw) is particularly attractive because 
Crs is affected by the aerated lung size and could, therefore, better reflect the global strain 
(Vt/baby lung). Driving pressure correlates with ARDS outcomes among patients with the 




to be tested in a prospective trial. It should be acknowledged that static airway pressure 
is not a very reliable marker of lung stress (both at end-inspiration and end-expiration), 
because it reflects contributions from both the lung and chest wall (two pressures acting 
in series). Obese patients are an example where high intrathoracic pressure (and therefore 
higher plateau pressure) exist because of the weight imposed by the chest wall [6]. Lung 
stress is preferably measured as transpulmonary pressure (PL), which allows to quantify 
the contribution of the lung and chest wall to changes in airway pressure.
Principles of diaphragm-protective ventilation
The respiratory muscle pump drives alveolar ventilation and is composed of a number of 
skeletal muscles acting in a highly organized fashion. The diaphragm is the primary muscle 
of inspiration and the lateral abdominal wall muscles are the most prominent expiratory 
muscles [7]. Mechanical ventilation is employed to unload the respiratory muscle pump 
and to limit the consequences of high breathing effort (e.g., dyspnea sensation, respiratory 
failure, possible respiratory muscle injury). However, mechanical ventilation delivered as 
the predominant breathing source can also lead to diaphragm atrophy and injury with a 
substantial deleterious impact on patient outcome [8]. Clinical studies demonstrate that 
after 24 hours of mechanical ventilation, 64% of patients exhibit diaphragm weakness 
[9], and at the time of weaning, diaphragm weakness is present in up to 80% of patients 
with weaning difficulties [10]. While many factors contribute to diaphragm weakness in the 
critically ill [11], both excessive and insufficient respiratory muscle unloading rapidly result 
in deleterious changes in diaphragm structure and function [11]. Low respiratory muscle 
effort, due to ventilator over-assist or sedation, may result in muscle atrophy, while high 
effort has been associated with load-induced injury (Figure 1). In a landmark study, Levine 
et al. demonstrated the development of diaphragm disuse atrophy in brain-dead patients 
on controlled mechanical ventilation [12] and subsequent studies confirmed the presence 
of time-dependent fiber atrophy in the diaphragm of ventilated patients [13, 14]. In line 
with these findings, ultrasound studies demonstrated that low diaphragm effort during 
mechanical ventilation is associated with time-dependent development of atrophy [15] and 
that atrophy is associated with poor outcomes [8]. It may be hypothesized that patients 
are at risk of developing load-induced diaphragm injury, as suggested by the presence of 
fiber injury, sarcomere disruption, inflammation and contractile dysfunction in biopsies [13] 
and acute increases in diaphragm thickness on ultrasound [15] – this hypothesis requires 
further confirmation.
Taken together, these considerations suggest that the diaphragm might be protected by 
titrating ventilation and sedation to restore early diaphragm activity while avoiding excess 
respiratory effort. The various lines of physiological and clinical evidence suggesting that a 
respiratory effort level similar to that of resting quiet breathing is probably optimal for both 
lung and diaphragm protection were recently summarized elsewhere [16].
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To implement lung and diaphragm-protective mechanical ventilation, the variables that 
mediate injury, principally lung stress and respiratory effort, should be monitored. The 
available monitoring techniques, their advantages and disadvantages, and proposed 
specific targets are summarized in Table 1.
Airway driving pressure, ΔPaw (i.e., plateau pressure – total positive end-expiratory 
pressure (PEEPtot)), is a measure that aims to estimate global tidal lung stress [5]. ΔPaw can 
be measured either during controlled or assisted ventilation by manual or automated short 
end-inspiratory and end-expiratory occlusions [17–19]. Importantly, ΔPaw is determined by 
transpulmonary driving pressure (ΔPL) and driving pressure across the chest wall (ΔPcw); 
thus, changes in chest wall elastance affect ΔPaw without affecting lung stress [20]. 
Because pendelluft and regional variations in lung stress are “dynamic” phenomena that 
cannot be detected under static conditions, the risk of excess regional lung stress during 
assisted breathing may be more accurately estimated by the dynamic ΔPL (ΔPL,dyn, i.e., 
peak PL – end-expiratory PL) rather than by static measures like ΔPaw [21, 22]. Esophageal 
pressure (Pes) monitoring, as an estimate of pleural pressure, can provide information 
about both the predisposition to end-expiratory collapse and atelectasis (end-expiratory 
PL) and alveolar overdistension within the baby lung (elastance-derived plateau PL) [23].
Monitoring and controlling respiratory muscle effort are major challenges in 
implementing lung and diaphragm-protective mechanical ventilation. The gold standard 
to quantify global respiratory muscle effort is the esophageal pressure-time product (PTP), 
while the PTP of the transdiaphragmatic pressure (Pdi, i.e., difference between gastric 
pressure (Pga) and Pes) during inspiration provides a measure of diaphragmatic effort 
[24]. The amplitude of Pes or Pdi during tidal breathing provides a simple estimate of the 
pressure generated by all respiratory muscles (Pes) or the diaphragm (Pdi), whereas the 
expiratory increase in Pga reflects expiratory muscle activity. The diaphragm electrical 
activity (EAdi) is the most precise surrogate of respiratory drive and correlates with indices 
of effort [25] but with considerable variability between patients. Also, values for peak 
EAdi in young healthy subjects during tidal breathing may vary between 4 and 29 μV [26]. 
Nevertheless, changes in EAdi are useful to monitor changes in patient’s respiratory drive 
and effort, especially to identify patients at risk for ventilator over-assistance. Finally, Pes 
or EAdi can complement ventilator waveform analysis to facilitate the identification of 
patient-ventilator dyssynchronies.
Other less invasive techniques are available to monitor patient breathing efforts during 
mechanical ventilation at the bedside. The airway occlusion pressure (P0.1), the deflection 
in Paw during the first 0.1 seconds of an inspiratory effort against an occluded airway, is 
an estimate of the respiratory drive and can be used to detect both very low and high 
effort [27]. The maximum deflection of Paw during a whole breath occlusion (ΔPocc) has 
been recently shown to accurately detect excessive respiratory muscle pressure (Pmus) 
or ΔPL,dyn; this maneuver can also be used to assess different forms of patient-ventilator 
dyssynchrony [28, 29]. Ultrasound can be used to visualize and quantify the thickening of 
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the diaphragm during inspiration in the zone of apposition (thickening fraction, TFdi) [30]. 
TFdi provides an index of diaphragmatic contractility and correlates reasonably well with 
inspiratory effort (ΔPes) and EAdi [31].
In conclusion, although estimation of pleural pressure using an esophageal balloon 
catheter appears to be the preferred technique to quantify lung stress and respiratory 
effort, the technique is currently not widely implemented; moreover, the potential impact 
on patient outcome remains to be determined in clinical studies. We suggest routine 
monitoring of tidal volume, inspiratory plateau pressures, and airway driving pressure to limit 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Clinical strategies for implementing lung and diaphragm-protective ventilation
CLINICAL STRATEGIES TO FACILITATE LUNG AND DIAPHRAGM- 
PROTECTIVE VENTILATION
Several strategies can be used to facilitate lung and diaphragm protective ventilation, 
including modulation of ventilator inspiratory and expiratory assist, drugs that modify 
respiratory drive and/or effort, extracorporeal CO2 removal (ECCO2R) and electrical 
stimulation of the respiratory muscles, as shown in Figure 2. Here, we will briefly discuss 
these different strategies.
Inspiratory ventilator settings
A lung and diaphragm-protective ventilation approach aims to minimize lung stress and 
strain while limiting diaphragm atrophy and injury. To achieve these goals, inspiratory 
ventilator settings can be adjusted to 1) modulate the patient’s inspiratory effort, 2) 
minimize the dynamic lung stress, and 3) prevent or correct patient-ventilator dyssynchrony 
or any form of mismatch between needs and support.
Titrating the inspiratory ventilator settings to optimize respiratory effort requires a 
thorough understanding of the control of breathing under mechanical ventilation [32, 33], 
acknowledging that the control of breathing system responds to changes in ventilatory 
demands by modifying inspiratory effort (and thus tidal volume) to a greater extent than 
respiratory rate [34]. Therefore, the inspiratory ventilator settings will affect the inspiratory 
effort by modifying the delivered tidal volume, and thus, in spontaneously breathing 
patients, increasing pressure or volume assist will increase the delivered tidal volume 
and reduce the inspiratory effort (as respiratory drive depends mainly on the chemoreflex 
control of arterial pH). Excessive assist, resulting in a tidal volume that is higher than the 
patient’s demands, may almost abolish the patient’s the inspiratory effort, and as such 
promote diaphragmatic atrophy. However, increasing inspiratory support may not attenuate 
inspiratory effort in the presence of high respiratory drive due to stimuli other than arterial 
pH/PaCO2, such as pain, anxiety, or stimulation of peripheral lung receptors by lung edema 
or inflammation [32]. In such case, transpulmonary pressure (and hence dynamic lung 
stress) may progressively increase with increasing inspiratory support. Increasing FiO2 
to increase PaO2 and reduce the hypoxic stimulus to breathe may alleviate increased 
respiratory drive in some patients (hyperoxemia is not required to achieve this effect) [35].
In a volume-targeted mode, the patient’s effort will be modified mainly by the set tidal 
volume and the flow delivery profile (flow pattern and peak flow). In pressure-targeted 
modes, the delivered tidal volume, and thus the patient’s inspiratory effort, is influenced by 
the set inspiratory pressure, rise time and cycling-off criterion, and of course the mechanical 
properties of the respiratory system [36]. Irrespective of the mode of assist, the delivered 
tidal volume and respiratory effort will together determine global and regional lung stress, 

















































































































































































































































Clinical strategies for implementing lung and diaphragm-protective ventilation
Neurally adjusted ventilatory assist (NAVA) delivers inspiratory assist proportional to the 
electrical activity of the diaphragm [38]. Increasing inspiratory assist will reduce EAdi (and 
vice versa) over a wide range of respiratory demand, and consequently tidal volume remains 
relatively stable over a wide range of assist [39]. In theory, pulmonary reflex mechanisms 
prevent patients from spontaneously inspiring large tidal volumes and NAVA may therefore 
facilitate lung-protective ventilation. Also, diaphragm inactivity due to over-assistance is 
unlikely in NAVA, as low diaphragm activity will immediately reduce inspiratory assist. Future 
studies should confirm the role of NAVA in lung and diaphragm-protective ventilation, but 
recent randomized trials suggest clinical benefit of NAVA (reduced time on the ventilator) 
compared to pressure support mode [40, 41].
Expiratory ventilator settings
The expiratory ventilator setting (i.e., PEEP) has been traditionally adjusted to optimize 
oxygenation and/or lung mechanics [42, 43]. A higher PEEP ventilation strategy (of which 
there are several, generally resulting in 15 ± 4 cmH2O) is currently recommended over lower 
PEEP (approximately 9 ± 3 cmH2O) in moderate and severe ARDS [44]. In the presence 
of spontaneous breathing during mechanical ventilation, a higher PEEP strategy offers 
several additional potential advantages to facilitate lung and diaphragm-protective 
ventilation (Figure 1). First, in patients with significant lung recruitability, PEEP reduces the 
amount of atelectatic “solid-like” lung and, therefore, can achieve a more homogeneous 
distribution of the tidal pleural pressure swing (∆Ppl) over the whole lung surface following 
a diaphragmatic contraction. The even distribution of inspiratory dynamic stress can 
diminish injurious asymmetric inflation associated with spontaneous effort (i.e., pendelluft), 
reducing regional lung stress in dependent lung regions [45]. Second, by increasing end-
expiratory lung volume, forcing the diaphragm to operate at a shorter length and thereby 
impairing diaphragm neuromuscular coupling [46, 47], increased PEEP can attenuate the 
force generated by diaphragmatic contraction [48]. Indeed, several clinical studies provide 
indirect evidence to suggest that higher PEEP may render spontaneous effort less injurious 
in patients with acute respiratory failure before intubation [49], in patients with ARDS [45, 
50], and in pediatric patients with lung injury [51].
On the other hand, preliminary experimental evidence suggests that if the diaphragm is 
maintained at a shorter length during acute mechanical ventilation, the diaphragm muscle 
fibers could adapt to the reduced length by absorbing sarcomeres in series (i.e., longitudinal 
atrophy) [52]. This may result in fibers overstretching with the release of PEEP during a 
T-tube weaning trial or after extubation. The possibility of diaphragm weakness resulting 
from excess PEEP should therefore be borne in mind.
Resolving dyssynchrony
Patient-ventilator dyssynchronies may cause lung and/or diaphragm injury by increasing 
dynamic lung stress and/or injurious diaphragmatic contractions, respectively. 
Dyssynchronies may occur during inspiration (flow starvation, short cycles, prolonged 




or both during inspiration and expiration (reverse triggering and double triggering). We will 
briefly discuss dyssynchronies most relevant for lung and diaphragm-protective ventilation; 
for more extensive discussion of dyssynchronies we refer to other reviews [53].
Reverse triggering, a diaphragmatic contraction triggered by mechanical inflation, is 
common in fully sedated patients (in whom drive is abolished) [54]. Reverse triggering can 
induce breath stacking resulting in excessive tidal volumes and high dynamic lung stress 
[55], and it may create eccentric diaphragm loading conditions with resultant muscle injury 
[56]. When necessary to avoid breath stacking, reverse triggering can be abolished by 
neuromuscular blocking agents. Alternatively, the development of reverse triggering may 
indicate that sedation should be stopped to allow the patient to take control of ventilation.
In patients with relatively high respiratory drive and a low respiratory system time 
constant, the neural inspiration time may exceed the mechanical inflation (premature 
cycling). In such cases, the contraction of the inspiratory muscles continues during 
mechanical expiration and the diaphragm is forced to contract while lengthening (eccentric 
contraction). In volume-targeted modes, unmet high demands appear as “flow-starvation”, 
a downward curvature of the inspiratory Paw signal, and the patient may experience 
dyspnea and distress, which can be resolved by increasing inspiratory flow rate using a 
decelerating flow pattern. Strong inspiratory efforts may result in double triggering and 
breath stacking, and, therefore, delivery of high tidal volumes. A better match of mechanical 
and neural inspiratory time can be achieved by increasing ventilator inspiratory time and 
using a decelerating flow pattern in volume-assist control mode, by decreasing the cycling-
off criterion in pressure support mode, or using proportional modes of assist. Importantly, 
in patients with high respiratory drive, modification of inspiratory time may not suffice 
to resolve dyssynchrony. Increasing the level of assist to match the patient’s demands 
should be considered; however, if that results in an injurious high ventilation, other means 
to decrease the patient’s respiratory drive, such as sedation, may be required.
Another dyssynchrony occurring in patients with absent or low respiratory drive is auto-
triggering, i.e., the delivery of a ventilator-assisted breath in the absence of patient effort. 
Auto-triggering due to strong cardiac oscillations transmitted to the Paw or airflow signal 
is more likely to occur when the respiratory system time constant is low, such as in ARDS. 
Air leaks and moisture in the ventilator circuit are also common causes of auto-triggering.
Ineffective triggering (or ineffective efforts) develops when a patient’s effort fails to 
trigger a ventilator-delivered breath. Ineffective triggering is generally the consequence 
of weak inspiratory efforts, either from low respiratory drive due to sedation, metabolic 
alkalosis or excessive ventilatory assist, or because of diaphragm weakness. When the 
respiratory system time constant is high (i.e., obstructive lung disease), ventilator over-
assistance results in delayed cycling, dynamic hyperinflation, and increased intrinsic PEEP, 
predisposing to ineffective triggering. Decreasing the level of assist can therefore alleviate 
ineffective efforts [57]. Over-assistance in assisted ventilation can also induce apneas 
during sleep.
Interestingly, several studies have demonstrated that NAVA improves patient-ventilator 
interaction, especially reducing the risks of ineffective efforts and over-assist [39, 58]. 
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Whether the reduced duration of mechanical ventilation reported in some NAVA trials 
[40, 41] results from improved patient-ventilator interaction remains to be investigated.
Sedation strategies
Sedation can facilitate lung and diaphragm-protective ventilation by ameliorating, when 
present, excessive respiratory effort. Complete suppression of respiratory drive and effort 
with sedation can also contribute to diaphragm disuse atrophy. A judicious approach to 
sedation is key and monitoring of respiratory drive and effort may be helpful in selecting 
the sedation strategy that facilitates lung and diaphragm-protective ventilation. Before 
administering sedation to address excessive respiratory drive or ventilator dyssynchrony, 
ventilator settings should be adjusted and other factors increasing respiratory drive such 
as metabolic acidosis or pain should be addressed. Relying on sedation alone to enhance 
patient-ventilator interaction without addressing these issues can paradoxically exacerbate 
dyssynchrony, prolong mechanical ventilation, and exacerbate diaphragm dysfunction 
[59]. Recent clinical practice guidelines have recommended an “analgesia-first approach” 
to minimize the risk of excessive sedation as opioids during mechanical ventilation were 
associated with less dyssynchrony and depressed consciousness in comparison to sedative-
based approaches [60].
Nevertheless, when elevated respiratory drive cannot otherwise be resolved, sedatives 
can attenuate the ventilatory response to hypoxemia and hypercapnia and cortical input 
to the respiratory centers [33] (Table 2). Propofol and benzodiazepines are gamma-
aminobutyric acid (GABA) agonists known to cause respiratory depression, primarily 
by reducing the amplitude of respiratory effort [61–63]. Because benzodiazepines are 
associated with a high risk of delirium and prolonged mechanical ventilation [64], propofol 
is the preferred sedative of choice for controlling high respiratory drive. Because propofol 
or benzodiazepines reduce the amplitude of inspiratory effort, ineffective triggering may 
develop as sedation depth increases [61]. Inhalational sedation offers a potential alternative 
for controlling respiratory effort though clinical experience is limited to date [65]. To avoid 
excessive sedation, strategies aimed at active titration of sedatives or daily interruption of 
sedation should be employed and respiratory drive and effort should be monitored closely.
For patients without excessive breathing effort (Table 2), a multimodal analgesia 
approach that minimizes opiate use is recommended to avoid diaphragm inactivity. 
Dexmedetomidine is a selective alpha-2 agonist which, in contrast to propofol and 
benzodiazepines, provides sedation, anxiolysis, and analgesia without respiratory 
depression [66]. This property makes it an interesting drug of choice to preserve awareness 
and diaphragm contractility and at the same time limiting excess delirium risk in agitated 
patients without elevated respiratory drive.
Prone positioning
The prone position has been used for decades in early ARDS to improve oxygenation 
and over time an appreciation for the lung-protective benefit of prone positioning has 




forces generate more dependent atelectasis in the supine position compared to prone 
position. Therefore, ventilation-perfusion matching is improved in the prone position and, 
more importantly, the energy applied to the lung by mechanical ventilation is distributed 
among more (non-atelectatic) alveoli, reducing lung stress. This is the putative basis 
for the observed mortality benefit of prone positioning in patients with ARDS [68]. The 
mechanistic benefits of prone positioning may also apply under assisted ventilation with 
spontaneous breathing, because the lung recruitment accrued by prone positioning may 
attenuate “solid-like” lung behavior and reduce effort-dependent regional lung stress. 
Prone positioning improves oxygenation in spontaneously breathing patients with COVID-19 
pneumonia [69]; it is possible that prone positioning could also reduce the risk of patient 
self-inflicted lung injury [70]. Thus, prone positioning might facilitate safe spontaneous 
breathing and diaphragm-protective ventilation as well as lung protection.
Table 2. Effect of sedation on respiratory drive, effort and breathing pattern.






to hypercapnia and 
hypoxemia
Effect on diaphragm 
function and patient-
ventilator interaction
Benzodiazepines ↓ ⟷ or ↑
↓ at high 
doses
↓ Delay restoration of 
diaphragm activity
Propofol ↓ ⟷ or ↑
↓ at high 
doses
↓ May ↑ dyssynchrony 
(i.e., ineffective efforts 
because of lower 
respiratory effort)
Opioids ⟷ or ↑ ↓ ↓ May ↓ dyssynchrony (i.e., 
fewer ineffective efforts 
because of slower, 
deeper respiratory 
efforts)
Dexmedetomidine ⟷ ⟷ ⟷ ↓ dyssynchrony by 
decreasing agitation/
delirium
FUTURE APPROACHES TO LUNG AND RESPIRATORY MUSCLE- 
PROTECTIVE VENTILATION
Extracorporeal carbon dioxide removal
Eliminating CO2 is the primary purpose of alveolar ventilation. ECCO2R reduces the 
ventilatory demands, decreasing the respiratory effort, and thus may ameliorate dynamic 
lung stress. ECCO2R is feasible and effective in reducing tidal volume, driving pressure, and 
mechanical power in patients with ARDS [71]. In spontaneously breathing patients, ECCO2R 
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can dampen respiratory drive and effort [72], theoretically reducing the requirement for 
ventilatory support or sedation to control respiratory effort. Karagiannidis et al. showed 
that increasing sweep gas flow (thereby increasing CO2 elimination) in ARDS patients 
undergoing extracorporeal membrane oxygenation (ECMO) reduced respiratory drive, 
estimated by EAdi [73]. Mauri et al. [7] also showed that higher ECCO2R support reduced 
P0.1, respiratory muscle effort, and transpulmonary pressure in spontaneously breathing 
patients recovering from severe ARDS [74]. Pilot clinical studies have explored the extreme 
possibility of extubating severe ARDS patients early after intubation by means of ECCO2R: 
preliminary results were encouraging but they also recognized the need to identify the 
subgroup of patients with a high probability of success [75–77].
Despite the appeal and physiological rationale of this strategy, there are relevant 
limitations. First, in some patients, non-chemoreceptive stimuli (e.g., pain, agitation, 
discomfort, metabolic acidosis, lung mechanical stimuli) may predominate and 
high respiratory drive may persist despite ECCO2R [78]. Second, ECCO2R requires full 
anticoagulation and the risk of bleeding is not insubstantial [79]. Third, the application of 
ECCO2R may exacerbate hypoxemia by various mechanisms [80].
Partial neuromuscular blockade
Complete neuromuscular blockade may increase the risk for diaphragm disuse atrophy and 
increases sedation requirements. Low-dose neuromuscular blockers (“partial neuromuscular 
blockade”) is an interesting compromise between total paralysis and strenuous breathing 
efforts, particularly when respiratory effort does inadequately respond to titration of 
ventilatory support or sedation. The feasibility of partial neuromuscular blockade has 
been evaluated in a proof-of-concept study in patients with moderate ARDS and high 
respiratory drive on partially supported modes [81]. Titration of rocuronium decreased tidal 
volume from approximately 9 ml/kg to approximately 6 ml/kg while maintaining Pdi at 
approximately 5 cmH2O (within the physiological range for diaphragm activity in healthy 
subjects). These preliminary findings suggest that partial neuromuscular blockade could 
be a feasible approach to achieving lung and diaphragm-protective ventilation targets in 
patients with high respiratory effort. Importantly, partial neuromuscular blockade does 
not reduce respiratory drive, but only the mechanical consequences of high drive. This 
dissociation between central drive and respiratory muscle mechanical output may result 
in dyspnea [33]; adequate relief of dyspnea and distress must be ensured by judicious 
application of sedatives and opioids. Future clinical studies should confirm the safety and 
efficacy of prolonged partial neuromuscular blockade in ventilated patients.
Neuromuscular stimulation
Neuromuscular stimulation (“pacing”) uses electrical currents to generate muscle 
contraction in the absence of volitional efforts, making it an attractive intervention in 
incapacitated critically ill patients. There is growing interest in neuromuscular stimulation 
as a novel strategy to preserve or restore respiratory muscle activity and, in turn, to 




contractions, neuromuscular stimulation may improve lung aeration of dependent lung 
regions [82]. Pacing must be synchronized with the ventilator and potentially injurious 
inspiratory efforts must be avoided. There is as of yet no clinical evidence of benefit from 
diaphragm pacing in ICU patients. Direct stimulation of the phrenic nerves by surgically 
implanted electrodes has been employed to restore spontaneous ventilation in patients 
with high-level spinal cord injury and central hypoventilation syndrome [83]. The feasibility 
of direct pacing using temporary implanted electrodes for the prevention of diaphragm 
dysfunction is currently under investigation in cardiac surgery patients identified to be at 
risk for prolonged mechanical ventilation (ClinicalTrials.gov: NCT04309123). Preclinical 
work showed that this technique could reduce the development of diaphragm type II fiber 
atrophy [84, 85]. Recently, Reynolds et al. presented a first-in-human series of temporary 
transvenous phrenic nerve pacing in surgical patients and showed that this technology 
delivered safe and effective diaphragm contractions [86]. This strategy is currently being 
studied as potential intervention for improving diaphragm strength in difficult-to-wean 
patients (ClinicalTrials.gov: NCT03096639). The role of transvenous phrenic nerve pacing 
for the prevention of diaphragm disuse atrophy remains to be investigated.
Neuromuscular stimulation strategies targeting the expiratory muscles of ICU patients 
are less well studied. This is surprising, as stimulation of the expiratory abdominal wall 
muscles can be employed noninvasively via surface electrodes placed over the abdominal 
wall. Feasibility of a breath-synchronized expiratory muscle stimulation technique during 
the early phase of mechanical ventilation was recently demonstrated with promising results 
[87] and its efficacy is under investigation (ClinicalTrials.gov: NCT03453944).
SUMMARY AND FUTURE DIRECTIONS
Clinicians caring for mechanically ventilated patients are generally well aware of the risk 
of causing barotrauma, volutrauma, and atelectrauma. Given the mounting evidence 
of clinically important diaphragm atrophy and injury, consideration must also be given 
to protecting the diaphragm. Based on the foregoing discussion about ventilation and 
sedation, a basic algorithm and approach to lung and diaphragm-protective ventilation 
is presented in Figure 3. Clinical trials testing new ventilation algorithms and sedation 
strategies targeted at optimizing respiratory effort are required to confirm the benefit of the 
lung and diaphragm-protective approach outlined in this paper. The benefit of adjunctive 
strategies such as ECCO2R, partial neuromuscular blockade and phrenic nerve stimulation 
requires further evaluation, in particular to identify the subpopulations of patients most 
likely to benefit from these more costly and invasive interventions. For the present, we 
encourage clinicians to incorporate routine monitoring of respiratory drive and effort in 
their clinical practice and to adjust the ventilator to achieve a physiological level of effort 
where possible while carefully attending to the effect on lung stress.
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ABSTRACT
Positive end-expiratory pressure (PEEP) is routinely applied in mechanically ventilated 
patients to improve gas exchange and respiratory mechanics by increasing end-expiratory 
lung volume (EELV). In a recent experimental study in rats, we demonstrated that prolonged 
application of PEEP causes diaphragm remodeling, especially longitudinal muscle fiber 
atrophy. This is of potential clinical importance, as the acute withdrawal of PEEP during 
ventilator weaning decreases EELV and thereby stretches the adapted, longitudinally 
atrophied diaphragm fibers to excessive sarcomere lengths, having a detrimental effect on 
force generation. Whether this series of events occurs in the human diaphragm is unknown. 
In the current study, we investigated if short-term application of PEEP affects diaphragm 
geometry and function, which are prerequisites for the development of longitudinal atrophy. 
Nineteen healthy volunteers were noninvasively ventilated with PEEP levels of 2, 5, 10, 
and 15 cmH2O. Magnetic resonance imaging was performed to investigate PEEP-induced 
changes in diaphragm geometry. Subjects were instrumented with nasogastric catheters 
to measure diaphragm neuromechanical efficiency (i.e., diaphragm pressure normalized 
to its electrical activity) during tidal breathing with different PEEP levels. We found that 
increasing PEEP from 2 to 15 cmH2O resulted in a caudal diaphragm displacement (19 
[14–26] mm, p < 0.001), muscle shortening in the zones of apposition (20.6% anterior 
and 32.7% posterior, p < 0.001), increase in diaphragm thickness (36.4 [0.9–44.1] %, p 
< 0.001) and reduction in neuromechanical efficiency (48.0 [37.6–56.6] %, p < 0.001). 
These findings demonstrate that conditions required to develop longitudinal atrophy in 
the human diaphragm are present with the application of PEEP.
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INTRODUCTION
Diaphragm weakness is highly prevalent in critically ill patients and associated with 
adverse outcomes such as difficult ventilator weaning, prolonged intensive care unit 
(ICU) stay, higher risk of complications, and mortality [1–3]. Inappropriate inspiratory 
ventilator assist plays a prominent role in the development of diaphragm weakness [4], 
as over-assist is associated with diaphragm muscle fiber atrophy [5–7] and under-assist 
has been hypothesized to result in load-induced diaphragm injury [8–10]. In addition to 
inspiratory assist, expiratory assist (i.e., positive end-expiratory pressure (PEEP)) is applied 
to improve gas exchange and respiratory mechanics by increasing end-expiratory lung 
volume (EELV). Previous studies evaluated the effects of increased EELV on diaphragm 
geometry [12–14] and function [15, 16]. However, in those studies EELV was increased by 
active inspiration from functional residual capacity (FRC) up to total lung capacity (TLC), 
which might have different impact on diaphragm geometry and function as compared to a 
passive increase in EELV with the application of PEEP. Using two-dimensional ultrasound, 
we recently demonstrated that PEEP results in caudal movement of the diaphragm in 
ventilated ICU patients [17]. Moreover, our experimental study in rats demonstrates that 
prolonged application of PEEP induced shortening of the diaphragm muscle fibers and 
results in muscle fiber remodeling. This remodeling is mainly characterized by a reduced 
muscle length due to the loss of sarcomeres in series [17]. We termed this “longitudinal 
atrophy” [17], which is pathophysiologically different from the well-known cross-sectional 
atrophy that is characterized by a decreased muscle fiber thickness [5, 18–20]. Longitudinal 
atrophy is considered an adaptive response of muscles to restore their optimal length for 
force generation [21]. Whether PEEP-induced longitudinal fiber atrophy develops in the 
human diaphragm is unknown. This is of potential clinical importance during ventilator 
weaning: the acute release of PEEP upon patient-ventilator disconnection acutely 
decreases EELV and thereby stretches the adapted, longitudinally atrophied diaphragm 
fibers to excessive sarcomere lengths (for schematic, see Figure 1), having a detrimental 
effect on force generation.
Before investigating potential long-term diaphragm adaptations to PEEP in ICU 
patients, the acute short-term effects of PEEP on the in vivo human diaphragm should 
be assessed (i.e., the effects occurring at T1 in Figure 1), as acute changes in diaphragm 
geometry and function are a prerequisite for development of longitudinal atrophy. The 
current study tested the hypotheses that PEEP 1) causes changes in diaphragm geometry, 
especially shortening and thickening of the diaphragm muscle in the zone of apposition 
(ZoA), and 2) decreases in vivo contractile diaphragm function. We tested both hypotheses 








Figure 1. Schematic illustrating the hypothetical framework of the development of longitudinal 
atrophy in diaphragm fibers during mechanical ventilation with positive end-expiratory pressure 
(PEEP). Sarcomere absorption after long-term application of PEEP (T0 to T2) was demonstrated 
in previous experimental work [17]. The current study investigates the geometrical and functional 
effect of acute changes in PEEP on the human diaphragm, i.e., the effects occurring at T1. T0: 
Normal muscle resting length at end-expiration, without application of PEEP. For simplicity, only 
three sarcomeres were drawn. T1: The acute effect of PEEP on sarcomere length: application of PEEP 
results in a shorter muscle and more overlap of the thin (actin) and thick (myosin) filaments, i.e., a less 
optimal length for tension generation, which will acutely reduce diaphragm efficiency. T2: Long-term 
application of PEEP causes muscle remodeling: sarcomere absorption occurs to restore sarcomere 
length back to its original length for optimal tension generation. T3: The acute withdrawal of PEEP 
upon patient-ventilator disconnection acutely decreases end-expiratory lung volume and thereby 
stretches the adapted, longitudinally atrophied diaphragm fibers to excessive sarcomere lengths. 
At these lengths, overlap of the actin and myosin filaments within sarcomeres is suboptimal or even 
absent. This will substantially reduce the force generating capacity of the muscle fiber.
MATERIALS AND METHODS
Ethics approval
This proof-of-principle study was performed at the Amsterdam UMC, location VUmc. The 
protocol was approved by the institutional research ethics board (ethics ref. 2017.590) 
and conducted in accordance with the Declaration of Helsinki and its later amendments.
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Study participants
We recruited 19 healthy volunteers. Exclusion criteria were contraindications for magnetic 
resonance imaging (MRI) (e.g., electrical/metallic implants, claustrophobia) and for 
placement of nasogastric catheters (e.g., esophageal varices, recent (<2 weeks) nasal 
bleeding, use of anticoagulants). Written informed consent was obtained.
Study design
The protocol was divided into two parts: we investigated PEEP-induced effects on 1) 
diaphragm geometry using MRI, and 2) diaphragm contractile function using 
transdiaphragmatic pressure and electromyography measurements.
Part 1: static MRI
Magnetic resonance (MR) imaging was performed with a 1.5 Tesla MR scanner (MAGNETOM 
Avanto, Siemens Medical Solutions, Erlangen, Germany) using a 6-channel phased-
array coil. NIV was applied using a face mask (Nivairo RT046 NIV Mask, Fisher & Paykel 
Healthcare, Auckland, New Zealand) and an MRI-compatible ventilator (Servo-I, Getinge, 
Solna, Sweden). An oil-filled flexible tube was positioned around the subject’s costal margin 
to act as localization marker during the MRI, which was an estimator for the insertion 
of the diaphragm muscle into the thoracic wall [13]. Subjects were in supine position 
throughout the scanning protocol and were randomized to a PEEP level of 5, 10, or 15 
cmH2O (PEEPrandom); PEEPrandom was used only in step 1 and 2 of the experimental protocol 
(see below).
At baseline, PEEP was 2 cmH2O (a PEEP level <2 cmH2O cannot be applied in NIV mode 
with the Servo-I ventilator for safety reasons), and throughout the experimental protocol 
the following settings were applied: pressure support level of 0 cmH2O, fraction of inspired 
oxygen of 0.21, inspiratory rise time of 0.1 seconds, and inspiratory cycle-off of 30%.
Experimental protocol
The experimental protocol started after the subject was familiarized to NIV at 5 cmH2O 
PEEP for 5 minutes. The protocol was designed to obtain static MR images in different 
planes and PEEP levels of 2, 5, 10, and 15 cmH2O were applied to determine PEEP-induced 
changes in position, shape, length and thickness of the diaphragm; for MRI settings, see 
Table 1. All MRI measurements were performed during an end-expiratory breath hold of up 
to 30 seconds (i.e., for the duration of the image acquisition), to ensure that the observed 
effects were caused by passive lung volume increases solely and not by any inspiratory 
effort. The scanning protocol consisted of the following steps:
1. Full coverage imaging at baseline PEEP and PEEPrandom: the entire thorax was 
scanned in the sagittal and coronal orientations to obtain full coverage stacks. 
Images were used to plan the orientations used in step 2 and 3.
2. Static imaging at baseline PEEP and PEEPrandom: sagittal images were acquired 




coronal full coverage stack) and coronal mid images were obtained through the top 
of both diaphragm domes (COR-mid, as planned on the sagittal full coverage stack).
3. High spatial resolution imaging at all PEEP levels: images were obtained in the 
SAG-R plane, allowing a detailed assessment of diaphragm geometry, including 
the detection of muscle to tendon transition, and diaphragm thickness. The left 
sagittal plane was not scanned as any tissue movement (i.e., heart motion) during 
the acquisition period would affect image quality.
Image analysis
The following parameters were determined using XERO viewer (Agfa HealthCare GmbH, 
Bonn, Germany) and ImageJ (version 1.51; National Institutes of Health, USA).
High spatial resolution SAG-R images (see also Figure 2a and Figure 5ab):
1. Diaphragm displacement: at the top of the dome (identified visually) and at 50% 
anterior and 50% posterior (i.e., the point on the dome halfway between its top 
and the inner anterior and posterior border of the thoracic wall, respectively), a 
straight line was drawn to the upper edge of the image field of view, which was fixed 
during all measurements. Diaphragm displacement was measured as the change 
in position relative to its baseline position.
2. Diaphragm shape (posterior angle and K-dome): at the 50% posterior position 
on the diaphragm dome, a straight line was drawn through this point, in parallel to 
the diaphragm curvature. The posterior angle (alpha) was calculated between this 
line and the height axis. The larger the alpha, the steeper the posterior diaphragm 
orientation. The K-dome was determined as the length of the diaphragm dome 
divided by the diaphragm diameter (i.e., distance between the anterior and posterior 
diaphragm insertion into the thoracic wall) [13].
3. Anterior-posterior thoracic diameter: the maximal diameter as measured from the 
inner anterior border to the inner posterior border of the thoracic wall.
4. Diaphragm length: dome length was measured as the curved length from the 
anterior to the posterior diaphragm insertion into the thoracic wall. The distance 
from these insertion points to the localization marker was defined as the anterior 
and posterior zone of apposition length, respectively.
5. Tendon length: for those subjects in which the central tendon to muscle transition 
could be visualized for the anterior and posterior diaphragm, tendon length was 
measured as the distance between these transition points.
6. Diaphragm thickness: as muscle, liver and soft tissue have different gray values 
on MRI, diaphragm thickness could be measured using an averaged gray intensity 
profile plot of a line drawn from the soft tissue (white pixels) to the liver (light gray 
pixels). Diaphragm (dark gray pixels) thickness was estimated as the distance 
between the transition in gray values.
7. Lung cross-sectional area (CSA): defined as the area within the outline of the inner 
thoracic wall and the diaphragm dome.
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COR-mid images:
8. Left-right thoracic diameter: maximal diameter from the inner left border to the 
inner right border of the thoracic wall.
SAG-R full coverage stack:
9. Intrathoracic volume: the lung CSA of twenty consecutive images of the right 
hemithorax was measured and multiplied by the slice thickness (8 mm) [22]; 
values were summed to estimate right intrathoracic volume. These estimates allow 
assessment of volume differences related to PEEP, as well as to estimate whether 
changes in lung CSA as measured in the single SAG-R high resolution image are 
representative for changes in the total right intrathoracic volume.
Reliability of MRI parameters
Measurements for the main analysis were performed by one observer. Image analysis from 
a randomly chosen subject (66 measurements) was repeated by this observer for an intra-
rater reliability test. A second observer repeated the measurements from three random 
subjects (182 measurements) for assessment of inter-rater reliability.
Table 1. Magnetic resonance imaging settings for full coverage imaging in the sagittal right (SAG-R) 
and coronal mid (COR-mid) plane, and for high-resolution imaging in the SAG-R plane in healthy 
subjects.
Static full coverage imaging High resolution imaging SAG-R
Pulse sequence Steady-state free precession T1-weighted turbo spin echo
Number of slices 35 to 45 1
Field of view1 400 x 400 mm (COR-mid)
280 x 340 mm (SAG-R)
280 × 340 mm
Slice thickness 8 mm 5 mm
Acquisition matrix (col x row) 168 × 256 (COR-mid)
108 × 256 (SAG-R)
250 × 384
Repetition time 285 ms 606 ms
Echo time 1.14 ms 25 ms
Turbo factor Not applicable 12
Flip angle 80 degrees 180 degrees
Bandwidth 1149 Hz/pixel 303 Hz/pixel
Parallel imaging Grappa, acceleration factor 2 Not applicable
1This was the average field of view.
Part 2: Physiological measurements
Experimental protocol
Subjects were in supine position while NIV was applied with the same ICU ventilator and the 




experimental protocol started after the subject was familiarized to NIV at 5 cmH2O PEEP 
for 5 minutes. PEEP levels of 2 (baseline), 5, 10, and 15 cmH2O were applied in stepwise 
increments for 15 minutes each. In between these steps, PEEP was reduced to baseline 
for 5 minutes. A PEEP level of 5 cmH2O was applied twice to evaluate if measurements 
at the beginning and at the end of the protocol were consistent. Throughout the 
experiment, we recorded continuous data on ventilation, respiratory effort and diaphragm 
electromyography (EMGdi) for offline time-series analysis. At each PEEP level, magnetic 
stimulation of the phrenic nerves was performed to measure diaphragm twitch strength 
(see below).
Nasogastric catheters, EMG electrodes, flow and airway pressure
Gastric pressure (Pga) and esophageal pressure (Pes) were obtained with a nasogastric 
catheter equipped with two air-filled balloons (Nutrivent, Sidam group, Mirandola, Italy). 
Transdiaphragmatic pressure (Pdi) was calculated as Pga – Pes. Correct catheter position 
and inflation of the balloons was confirmed using the end-expiratory occlusion test [23] 
and by observing cardiac oscillations and esophageal spasms in the Pes signal, whereas 
these artifacts were not visible in Pga tracings. EMGdi was obtained with a nasogastric 
catheter (EAdi catheter, Getinge, Solna, Sweden) with nine stainless steel wire electrode 
rings. Prior to the experiment, the catheter was connected to the ventilator equipped with 
EAdi positioning software to confirm correct catheter placement [24]. Once positioned, the 
catheter was connected to a dedicated measurement setup (see below) to allow acquisition 
of the raw signals of all eight sequential electrode pairs. Electromyographic activity of the 
abdominal wall muscles (rectus abdominis muscle (EMGRA) and external oblique muscle 
(EMGEO)) was obtained with Ag/AgCl surface electrodes that were positioned as described 
previously [25, 26] and with position confirmed after volitional activation of the abdominal 
wall muscles. Flow and airway pressure (Paw) were measured with a pneumotachograph 
(Adult Flow Sensor, Hamilton Medical, Bonaduz, Switzerland) placed in line with the 
ventilator tubing, in between the face mask and the Y-piece. All recordings were acquired 
synchronously at 2 kHz, using a dedicated measurement setup (MP160, BIOPAC Systems, 
Inc., Goleta, California, USA).
Magnetic stimulation
Supramaximal bilateral anterolateral stimulation of the phrenic nerves was performed 
during short end-expiratory occlusions to measure twitch Pdi (Pdi,tw). Two figure-of-eight 
coils were powered by a Magstim stimulator (MagStim 200, Magstim Co. Withland, Dyfed, 
UK). At each applied PEEP level, three Pdi,tw measurements were performed. Before the 
experimental protocol, a ramp of stimulations (70–80–90–100% of maximal power 
output) was performed during NIV with baseline PEEP to determine the power output for 
supramaximal stimulations (usually at 90% or 100%). A period of at least 30 seconds in 
between repeated stimulations was implemented to prevent twitch potentiation [27, 28], 
and pressure tracings were rejected if the baseline Pes or Pdi was distorted, or when the 
twitch was imposed on a spontaneous breathing effort.
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Data analysis
Offline breath-by-breath analysis was performed in a software routine developed for 
MATLAB R2018b (Mathworks, Natick, USA). EMGdi signal processing was performed 
according to the method of Sinderby et al. [29–31], and as described previously [32]. 
Removal of artifacts was done prior to calculation of respiratory timing, mechanics and 
breathing effort. Prolonged periods with substantial noise (e.g., esophageal spasms) 
were removed, as well as single breaths with potential artifacts and outliers based on 
physiological criteria defined prior to the analysis (e.g., breaths <0.5 seconds, substantial 
drift in baseline pressures, breaths with Pes increases during active inspiration).
At each PEEP level, the mean of two Pdi,tw measurements with the lowest variation 
was calculated, provided that this variation was <20%. Mechanical inspiratory time (Ti), 
expiratory time (Te), total breathing cycle (Ttot), respiratory rate, and expiratory tidal volume 
(Vt) were derived from the flow recordings. Dynamic transpulmonary pressure during tidal 
breathing (PL,dyn) was calculated as Paw – Pes. The inspiratory increase in PL,dyn (ΔPL,dyn, 
i.e., peak PL – end-expiratory PL) was calculated as a measure of lung driving pressure. Pes 
amplitude during inspiration (∆Pes,insp) was calculated as the difference between the start 
of Pes decrease and its nadir. ∆Pdi was calculated as the increase in Pdi during inspiration. 
The inspiratory diaphragm pressure-time product (PTPdi) was defined as the time integral 
of the inspiratory Pdi, reported per minute. The expiratory Pga increase (∆Pga,exp) was
calculated as the Pga difference between the end of inspiration (based on the flow zero-
crossing) and the start of decrease in Pes (i.e., start of next inspiration) [32] to reflect
expiratory muscle activity: ∆Pga,exp >2 cmH2O was arbitrarily considered as expiratory
muscle recruitment and ∆Pes,insp was corrected for ∆Pga,exp of the preceding breath
[33–35]. The inspiratory amplitude of diaphragm electrical activity (ΔEAdi), an estimation 
of neural respiratory drive, was calculated as the peak root mean square of the inspiratory 
EMGdi. The ratio of ∆Pdi and ΔEAdi reflects diaphragm neuromechanical efficiency (NME) 
[36, 37]. As the number of breaths at each PEEP level varied among subjects, only variables 
corresponding to the last ten adequate breaths at each PEEP level were included in the
statistical analysis.
Statistical analysis
Subjects and investigators were not blinded to the PEEP levels when applied and unblinded 
analysis was performed. Values are reported as mean ± standard deviation, or median 
[interquartile range] when appropriate. Statistical analysis was performed with SPSS 
Statistics version 24.0 (IBM Corp., USA) and GraphPad Prism version 7.0 (GraphPad 
Software, Inc., USA). For all analyses, p < 0.05 was considered significant; reported p values 
represent the overall effect of PEEP, unless otherwise stated. Assumption of normality was 
tested using the Shapiro-Wilk test, histograms and Q-Q plots.
Changes in MRI parameters with increasing PEEP levels were analyzed using a one-
way repeated measures ANOVA or its nonparametric equivalent the Friedman test; in the 
presence of a PEEP-effect with p < 0.05, pairwise comparison was performed using Tukey 




and inter-rater reliability of MRI parameters was assessed with a one-way random and a 
two-way random intraclass correlation model, respectively, with measures of consistency. 
Intraclass correlation coefficients (ICC) are reported as single measures ICC with 95% 
confidence interval (CI) (lower bound–upper bound). We calculated the required sample 
size assuming an ICC between two raters of ≥0.70 with a 95% CI width ≤0.155, and an 
intra-rater ICC of 0.70 with a 95% CI width ≤0.265. Under these assumptions, at least 
170 measurements were required for the evaluation of inter-rater reliability, and 60 
measurements were required to evaluate intra-rater reliability.
For physiological parameters, a linear mixed model design was used with a fixed 
effect of PEEP level and random intercept per subject (i.e., change in parameter ~ PEEP 
+ (1|subject)). A log transformation was applied for those parameters in which the mixed
model residuals did not fit a normal distribution. In the presence of a PEEP-effect with
p < 0.05, pairwise comparison was performed after Bonferroni adjustment. Values are
described as estimated means with 95% CI (lower bound–upper bound).
Since no data are available on the effect of PEEP on the position and function of the 
human diaphragm, a valid a priori sample size calculation could not be performed. The 
number of subjects (n=19) was considered an adequate sample size of the study based 
on previous respiratory physiological studies conducted in healthy volunteers [38–40].
RESULTS
Study population
Nineteen subjects (male/female, 9/10; age, 28 ± 5.5 years; bodyweight, 70 ± 8.7 kg; BMI, 
22 ± 2.3 kg/m2) completed the study protocol without adverse events. Three subjects 
were excluded from the physiological analysis due to inadequate data quality (esophageal 
spasms (n=1) or low signal-to-noise ratio (n=2)). Additionally, EMGdi-derived parameters 
could not be obtained in 3 other subjects due to inadequate EAdi signal acquisition 
(technical problems with the EMGdi transducers (n=1) or low signal-to-noise ratio (n=2)). 
MRI parameters for diaphragm length could not be obtained in 2 subjects due to insufficient 
visualization of the localization marker. Diaphragm shape and diaphragm thickness could 
not be measured in 2 subjects due to insufficient image quality. MRI measurement of 
central tendon length was feasible in 8 subjects.
The repeatability of MRI measurements was excellent; ICC values were 0.988 (0.981–
0.993) and 0.991 (0.988–0.993) for intra-rater and inter-rater reliability, respectively.
Diaphragm position, shape and chest wall configuration
Application of PEEP resulted in a caudal displacement of the diaphragm, with a median 
caudal displacement of the dome of 19 [14–26] mm when increasing PEEP from 2 to 15 
cmH2O (p < 0.001, Figure 2b). In addition, left-right thoracic diameter was not affected 
(mean (95% CI), 247 (242–252) mm vs. 244 (235–252) mm, respectively; p = 0.363), while 
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the anterior-posterior thoracic diameter significantly increased (142 [131–158] mm vs. 150 
[138–161] mm, respectively; p < 0.0001) when comparing PEEP 2 vs. 15 cmH2O.
Lung CSA significantly increased (185 [158–217] cm2 to 228 [205–253] cm2, respectively, 
p < 0.0001) when increasing PEEP from 2 to 15 cmH2O. This reflected an increase of 25.3 
[12.2–31.1] %, which was representative for the increase in right intrathoracic volume 
(r2 = 0.95, p < 0.0001).
The shape of the diaphragm was not affected by the increase in PEEP from 2 to 
15 cmH2O (posterior angle, 25.0 [21.5–31.6] vs. 26.8 [22.1–31.5] degrees, respectively 
(p = 0.2369), and K-dome, 1.29 [1.24–1.32] vs. 1.26 [1.21–1.34], respectively (p = 0.1132), 
see Figure 3ab).
Diaphragm length and thickness
Increasing PEEP from 2 to 15 cmH2O resulted in shortening of the ZoA (p < 0.0001); the 
posterior ZoA shortening was more pronounced than the anterior ZoA shortening (median 
shortening of 32.7 [20.8–46.7] % vs. 20.6 [18.1–32.6] %, respectively, p = 0.0255) (Figure 
4a). While the length of the dome did not change (p = 0.9941, Figure 4b), total diaphragm 
length (i.e., dome plus posterior and anterior ZoA) significantly decreased (p < 0.0001, 
Figure 4c). Measurements of central tendon length (n=8, Figure 5ab) demonstrated that 
tendon length was not affected by PEEP (p = 0.3125, Figure 5c). Figure 5d shows that 
diaphragm thickness increased with 36.4 [0.9–44.1] % (p = 0.0010) when PEEP increased 





















































































































































































































































































































































































































































































































































































































































































































































































Figure 3. Effect of PEEP on diaphragm shape: (a) posterior angle and (b) K-dome. Data are pre-





























































































































Figure 4. Effect of PEEP on diaphragm length in the zone of apposition (ZoA) anterior (solid) and 
posterior (squares) (a), the length of the diaphragm dome (b), and total diaphragm length (c). Data 



























































Figure 5. (a) Example of the visualization of the muscular part of the diaphragm in the sagittal right 
plane. The blue line denotes the tendon part. The light green arrows point to the muscular parts. 
(b) Example of the measurement of the diaphragm thickness at a PEEP level of 2 cmH2O (sagittal 
right plane), using gray value mapping. Left: a line was drawn from the soft tissue (white) to the 
liver (light gray) with the diaphragm (dark gray) in between. Right: the corresponding averaged 
gray intensity profile plot. The high gray values indicate the white pixels (soft tissue), the lower gray 
values the dark gray pixels (diaphragm) and the intermediate gray values the light gray pixels (liver). 
Diaphragm thickness was estimated as the distance between the transition in gray values, as shown 
by the yellow line in the intensity plot. (c) Tendon length at a PEEP level of 2 cmH2O and 15 cmH2O 
for those subjects in which the tendon could be measured at the two PEEP levels. (d) End-expiratory 
diaphragm thickness at different PEEP levels.
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Ventilation, respiratory timing, and lung mechanics
Variables of ventilation, respiratory timing and lung mechanics are listed in Table 2 and did 
not change with increasing PEEP levels.
Diaphragm effort and contractile efficiency
During tidal breathing with increasing PEEP levels, ΔEAdi significantly increased whereas 
∆Pdi and PTPdi decreased (Table 2), resulting in a significantly reduced diaphragm NME 
(i.e., ∆Pdi/ΔEAdi) (Figure 6a). The release of PEEP immediately restored diaphragm 
efficiency as NME at both PEEP 5 cmH2O levels was not significantly different (mean 
difference, 0.03 cmH2O/µV, p = 0.597).
Bilateral magnetic phrenic nerve stimulation resulted in reproducible twitch pressures 
in 15 subjects. Pdi,tw decreased with increasing PEEP levels (Table 2). Upon reviewing 
EMG recordings of the abdominal wall muscles, 5 subjects showed activation of their 
abdominal wall muscles during expiration prior to and during the magnetic twitch at one 
or more PEEP levels. This was reasoned to influence the effect of the twitch response, and 
a subdivision was made between subjects with and without activation of their abdominal 
wall muscles prior to or during the Pdi,tw measurement: the effect of PEEP on Pdi,tw was 
more pronounced in the latter subgroup (n=10) (Table 2 and Figure 6b).
Expiratory muscle recruitment during tidal breathing was observed in 3 subjects 


































Figure 6. PEEP-induced changes in diaphragm neuromechanical efficiency (NME) (a) and twitch 
transdiaphragmatic pressure (Pdi,tw) (b). Regarding Pdi,tw, a subdivision was made for those sub-
jects that did (squares, p = 0.458) and did not show activation of their abdominal wall muscles just 
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DISCUSSION
In the current study, we investigated the acute effects of PEEP on both geometry and 
contractile function of the human diaphragm. The major findings can be summarized 
as follows: first, application of PEEP resulted in caudal displacement of the diaphragm 
and a slight increase in anterior-posterior thoracic diameter. Second, PEEP shortened 
the diaphragm in the ZoA with a concomitant increase in diaphragm thickness. Third, 
PEEP decreased the contractile efficiency of the diaphragm. This sequence of events is a 
prerequisite for muscle remodeling associated with longitudinal fiber atrophy that has been 
described experimentally with prolonged application of PEEP [17]. Hence, this study is an 
important step in the understanding of the role of PEEP in the development of diaphragm 
weakness in ICU patients (Figure 1).
Effect of PEEP on diaphragm and chest wall geometry
The impact of anesthesia or positive pressure ventilation on chest wall geometry is complex 
but important from a scientific and clinical perspective [41]. Warner et al. [42] demonstrated 
that halothane anesthesia decreased end-expiratory cross-sectional area of the rib cage (and 
FRC) in healthy subjects (n=6). In all subjects, the most dependent (dorsal, posterior) parts of 
the diaphragm moved cephalad, but in 5 out of 6 subjects the most nondependent (ventral, 
anterior) part of the diaphragm moved caudally under anesthesia without PEEP. However, 
Reber et al. [43] demonstrated that mechanical ventilation and deep sedation in elective 
neuro/eye surgery patients resulted in a cephalad movement of the whole diaphragm at 
end-expiration, although effects were more pronounced in the dependent region. In contrast 
to Warner et al. [42] no part of the diaphragm was displaced caudally, due to sedation, 
and changes in end-expiratory cross-sectional area of the rib cage were variable [43]. 
The explanations for these apparent contradictory findings are unknown, but may include 
sedation depth (level of unconsciousness), computed tomography imaging techniques 
applied, and subject characteristics. The importance of these findings is that changes in 
geometry of the diaphragm and chest wall due to sedation appear difficult to predict, and 
that the changes in position of the diaphragm are different along the anterior-posterior axis. 
Our study provides new and detailed insights on the impact of PEEP on diaphragm and chest 
wall geometry. We demonstrated that the PEEP-induced increase in EELV resulted in caudal 
diaphragm displacement and increased anterior-posterior thoracic diameter, with the first 
more pronounced. Thus, the diaphragm exhibits a “widening piston”-like behavior (i.e., the 
diaphragm acts as a piston, in which the “container” widens in the anterior-posterior direction 
as the piston descends). This concept was first described by Petroll et al. [44] and has important 
implications for diaphragm function. Gauthier and coworkers [13] investigated in non-
ventilated healthy subjects changes in EELV (induced by active inspiration and subsequent 
relaxation at different lung volumes) on diaphragm shape. Using MRI, a caudal diaphragm 
displacement was demonstrated when lung volume was increased actively from residual 
volume (RV) to TLC. However, changes in diaphragm geometry induced by active inspiration 




ventilation with PEEP. Therefore, the study by Gauthier [13] cannot be used to predict the 
effect of PEEP on the diaphragm. Furthermore, MRI techniques used in that study were less 
advanced as they are today and studying the effects of PEEP on diaphragm thickness and 
muscular length (distinguished from tendon length) was not feasible at that time. In a recent 
study [17], we reported that the release of PEEP results in cranial movement of the diaphragm 
in invasively ventilated ICU patients. However, for imaging two-dimensional ultrasound was 
used, providing a limited view of the diaphragm. The MRI protocol used in the current study 
provides novel and detailed insights into diaphragm geometrical changes due to PEEP.
Gauthier et al. [13] reported that the K-dome (dome shape) was progressively decreased 
(from 1.31 to 1.15) with increasing lung volumes (from RV to TLC), indicating flattening 
of the diaphragm dome. While our K-dome values at baseline PEEP were in line with 
those reported by Gauthier et al. at RV [13], we did not find a reduction in K-dome with 
increasing PEEP. Gauthier et al. [13] demonstrated that flattening of the diaphragm dome 
mainly occurred at very high lung volumes (up to TLC) and such volumes were not reached 
within the range of PEEP levels that were applied in our study. In addition, flattening of the 
diaphragm dome in Gauthier’s study [13] might result from active inspiration.
Effect of increased PEEP on diaphragm length and thickness
PEEP-induced caudal movement of the diaphragm was associated with diaphragm 
muscle shortening and increased thickness in the ZoA. The first is in line with previous 
work demonstrating significant reduction in diaphragm length (204 ± 16 mm vs. 91 ± 13 
mm at FRC vs. TLC) when increasing lung volume by active inspiration [13]. Furthermore, 
rabbit studies demonstrated that PEEP acutely reduces in vivo end-expiratory costal 
diaphragm length [45]. By using high-resolution MRI techniques, we demonstrated that 
diaphragm shortening only occurred in the muscular parts (anterior and posterior ZoA), and 
that the length of the central tendon did not change. Shortening of the muscular part in 
the ZoA is the prerequisite for development of longitudinal atrophy (Figure 1, effect at T1). 
Interestingly, PEEP application resulted in a more pronounced shortening of the posterior 
ZoA compared to anteriorly (32.7% and 20.5%, respectively) when increasing PEEP from 
2 to 15 cmH2O. These findings are in line with Gauthier et al. [13] and likely indicate a 
posterior tilt of the diaphragm along the transversal axis. Furthermore, we demonstrated 
that with PEEP-induced passive diaphragm shortening the muscle thickens, consistent 
with previous experimental studies in dogs [14]. Diaphragm thickening due to PEEP was 
previously demonstrated in healthy subjects [46]. However, in that study, only one PEEP 
level (10 cmH2O) was evaluated and changes in diaphragm thickness were assessed by 
ultrasound. Since ultrasound has a limited field of view, it may provide a less detailed 
assessment of the effects of PEEP as compared to our high-resolution static MRI.
Effect of increased PEEP on diaphragm contractile efficiency
We demonstrated a PEEP-induced decrease in diaphragm contractile efficiency, both 
during magnetic phrenic nerve stimulation (Pdi,tw) and spontaneous breathing (NME). 
This is in line with Beck et al. [47] showing decreased maximum Pdi with actively increasing 
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lung volume from FRC to TLC. In addition, Similowski et al. [16] reported reduced Pdi,tw 
after actively increasing lung volume from FRC to TLC in healthy volunteers and COPD 
patients. Interestingly, at comparable lung volumes, COPD patients showed higher Pdi,tw 
and inspiratory action of the diaphragm, as compared to healthy controls. This could 
indicate that functional alterations in diaphragm muscle structure, including longitudinal 
atrophy, are present in hyperinflated COPD patients in order to restore sarcomere length 
and tension generating capacity [48, 49].
The PEEP-induced decrease in NME found in our study indicates that for the same 
pressure development (Pdi), a higher neural effort (EAdi) is required. This impaired NME 
could be explained by the fact that muscle fiber length has a major effect on muscle 
force generation [50, 51]. When considering the diaphragm as a curved membrane with 
specific tension, Laplace’s law would indicate a lower Pdi with widening of the thoracic 
cage and flattening of the diaphragm at high lung volumes [11, 52]. Indeed, Grassino et 
al. [15] described that the neuromechanical coupling of the diaphragm depends mainly 
on chest wall deformation in response to active increases in lung volume. Gauthier et 
al. [13] described that decreased diaphragm pressure with increasing lung volume could 
be entirely explained by decreases in muscle fiber length, which was earlier described in 
instrumented dogs [53]. Moreover, with PEEP a change in the direction of the force vector 
of the diaphragm may occur and fibers that were initially part of the ZoA become part of the 
diaphragm dome. This changes the force vector from a vertical vector to a more horizontal 
vector and could further reduce diaphragm contractility.
Interestingly, a small subset of subjects recruited their expiratory abdominal wall muscles 
in response to PEEP. Recruitment of the expiratory muscles under mechanical ventilation 
is well known and may limit the increase in EELV [54] through a physiological feedback 
mechanism involving proprioceptive influences and vagal pathways [55, 56]. Recruitment of 
the expiratory muscles generates an increase in abdominal pressure moving the diaphragm 
to a more cranial position at end-expiration, thereby counteracting the effect of PEEP. It is 
unknown why only a subset of subjects recruited their expiratory muscles. Notably, in two 
subjects, PEEP resulted in a cranial displacement of the diaphragm shown by MRI (Figure 
2b), which was reasoned to be the result of abdominal wall muscle activation.
Strengths and limitations
We applied novel high-resolution MRI techniques and sophisticated functional 
measurements to assess PEEP-induced changes in diaphragm geometry and function. 
These techniques have not been applied earlier to evaluate the effects of PEEP on the 
diaphragm and chest wall, and provide novel insights.
Some limitations should be acknowledged. First, this physiological study was conducted 
in healthy subjects and the results should be extrapolated to ICU patients with caution. 
In general, ICU patients have lower lung compliance and thereby probably show less 
increase in EELV and caudal diaphragm displacement for the same PEEP level. However, 
it should be noted that in a previous pilot study in ICU patients using ultrasound, it was 




of ±10 mm [17], corresponding to our findings in healthy subjects. We suggest that in ICU 
patients the PEEP-induced changes should be related to increases in EELV rather than 
to the absolute PEEP level. In the current study, we did not directly measure EELV, but 
estimated lung volume based on the lung CSA obtained from 20 consecutive sagittal MR 
images, multiplied by the image slice thickness. This method has been used previously 
for measurements of thoracic volume [22]. State-of-the-art techniques such as nitrogen 
washout or gas dilution techniques to measure EELV are not reliable during NIV with 
increasing air leaks at higher levels of PEEP [57]. Third, MRI results are mainly based on 
images acquired in the SAG-R plane through the top of the diaphragm dome, which was 
considered the optimal image plane to assess the effects of PEEP under static conditions 
and with high resolution (e.g., not affected by the heart and its motion). However, this 
limits the assessment of PEEP-induced rotational movements of the dome and changes 
in muscle fiber direction, which requires three-dimensional modelling techniques, as used 
in previous studies [58, 59]. Fourth, length measurements of the ZoA with MRI depend on 
the assumption that the flexible oil-filled tube marker reflects the location of the insertion 
of muscle fibers into the rib cage. This is debatable [13], but probably has limited effects on 
the interpretation of the data, and better techniques are not available. Fifth, for technical 
reasons we excluded some subjects from the analysis of EMGdi parameters at one or 
more PEEP levels. Obtaining reliable EMGdi signals can be challenging at the acquisition 
and post-processing level, especially in the presence of multiple nasogastric catheters in 
healthy volunteers, cardiac and movement artifacts, and changes in diaphragm position 
relative to the catheter electrodes. As the EMGdi signal was constructed during offline 
post-processing, we could not account for all factors influencing signal quality at the time 
of recordings. Although a linear mixed model design was used to account for missing data, 
EMGdi-based parameters (ΔEAdi and NME) should be interpreted with some degree of 
caution. In addition, we did not perform maximal inspiratory or expiratory maneuvers 
during NIV with PEEP, precluding the assessment of maximal respiratory muscle strength. 
Finally, MRI and functional measurements were not performed at the same time, as MRI 
compatible equipment for diaphragm functional measurements is not available.
CONCLUSION
In conclusion, the PEEP-induced increase in EELV in healthy subjects led to a caudal 
diaphragm displacement and widening of the thorax, resulting in diaphragm shortening 
and thickening in the ZoA, and reduced contractile efficiency. This sequence of events 
is a prerequisite for development of diaphragm longitudinal atrophy, since prolonged 
application of PEEP has been associated with remodeling of the diaphragm muscle fibers. 
If similar effects occur in ICU patients, the acute release of PEEP upon ventilator weaning 
could overstretch the longitudinally atrophied fibers to excessive sarcomere lengths 
which could severely impact function. This may provide a new mechanism for diaphragm 
weakness-related ventilator weaning failure in ICU patients.
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ABSTRACT
Background
In patients intubated for mechanical ventilation, prolonged diaphragm inactivity could 
lead to weakness and poor outcome. Time to resume a minimal diaphragm activity may 
be related to sedation practice and patient severity.
Methods
Prospective observational study in critically ill patients. Diaphragm electrical activity 
(EAdi) was continuously recorded after intubation looking for resumption of a minimal 
level of diaphragm activity (beginning of the first 24-hour period with median EAdi >7µV, 
a threshold based on literature and correlations with diaphragm thickening fraction). 
Recordings were collected until full spontaneous breathing, extubation, death, or 120 hours. 
A 1-hour waveform recording was collected daily to identify reverse triggering.
Results
Seventy-five patients were enrolled and 69 analyzed (mean age ± standard deviation, 
63 ± 16 years). Reasons for ventilation were respiratory (55%), hemodynamic (19%) and 
neurologic (20%). Eight catheter disconnections occurred. The median time for resumption 
of EAdi was 22 hours (interquartile range, 0–50 hours); 35/69 (51%) of patients resumed 
activity within 24 hours while 4 patients had no recovery after 5 days. Late recovery 
was associated with use of sedative agents, cumulative doses of propofol and fentanyl, 
controlled ventilation, and age (older patients receiving less sedation). Severity of illness, 
oxygenation, renal and hepatic function, and reason for intubation were not associated with 
EAdi resumption. At least 20% of patients initiated EAdi with reverse triggering.
Conclusion
Low levels of diaphragm electrical activity are common in the early course of mechanical 
ventilation: 50% of patients do not recover diaphragmatic activity within one day. Sedatives 
are the main factors accounting for this delay independently from lung or general severity.
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INTRODUCTION
In critically ill adults, diaphragm weakness is exceedingly common and has been described 
in more than 60% of patients [1]. There is mounting evidence that it may be associated with 
poor outcomes in mechanically ventilated patients, including difficult weaning, prolonged 
intensive care unit (ICU) stay, a higher risk of complications, and an increased mortality rate 
[2–5]. The most well-established form of mechanical ventilation related diaphragm injury 
(also known as myotrauma) is disuse atrophy, resulting from excessive ventilatory support, 
deep sedation and/or paralysis, and has been referred to as over-assistance myotrauma 
[6, 7]. Daily examination of the diaphragm with ultrasound in critically ill ventilated patients 
has shown a progressive reduction of the thickness of the diaphragm occurring in the 
first three days in approximately 40% of patients [2, 3]. Studies in specific populations 
such as brain-dead organ donors have demonstrated muscle fiber atrophy and contractile 
dysfunction occurring within a few hours or days of controlled mechanical ventilation [8]. 
Diaphragm biopsies from ICU patients also demonstrated a reduction in active and passive 
diaphragm myofibrillar force and reduced cross-sectional area of slow-twitch and fast-
twitch fibers as compared with control values [9–11]. Importantly, maintaining diaphragm 
activity under mechanical ventilation has been shown to be protective [12, 13]. Changes in 
diaphragm thickness were correlated with the amount of inactivity and are associated with 
complications of mechanical ventilation and a poor outcome [12, 13].
While the detrimental effects of diaphragm inactivity are widely recognized, no data yet 
exists regarding the duration of diaphragm inactivity after intubation in critically ill patients, and 
the factors associated with a delay in the resumption of minimal or normal diaphragm activity 
have not been explored. Such a delay may be primarily related to the severity of illness, the 
lung severity or the oxygenation defect, impacting the sedation delivered. Therefore, before 
considering implementing new strategies to mitigate the risks of diaphragm dysfunction 
in critically ill patients, the effects of current practices should be better understood. In this 
study, we aimed to assess the duration of absent or excessively low diaphragm activity 
after intubation by continuously measuring the electrical activity of the diaphragm 
(EAdi) soon after intubation in critically ill patients, and also assessed the relationship 
between EAdi and diaphragm activity on ultrasound. We hypothesized that resumption 
of diaphragm activity was influenced by disease severity and sedation management.
MATERIALS AND METHODS
Full methods can be found in the Supplemental file 1.
Study design
This prospective observational cohort study in acutely ill mechanically ventilated adult 
patients was approved by the Ethics Committee of St. Michael’s Hospital (REB #15-073) 





To be enrolled, adult patients intubated in the ICU (or emergency department) were 
expected to have a duration of mechanical ventilation >48 hours (to exclude routine post-
operative monitoring) and an oro- or nasogastric feeding tube equipped with electrodes 
at the level of the diaphragm (EAdi catheter, Getinge, Solna, Sweden), placed within 30 
minutes after intubation (June 2015 to August 2017). Patients were excluded if there 
was anticipated removal of the catheter within 48 hours of ICU admission for endoscopic 
interventions or the need for magnetic resonance imaging (due to metal electrodes). Daily 
sedation interruption or minimization, and spontaneous breathing trials were performed 
as per the University of Toronto academic ICU policy [14].
Experimental procedure
The EAdi catheter was positioned as described [15], using distance and with position 
confirmed based on the electrocardiogram tracings (the QRS amplitude decreases from top 
to bottom tracings and the P wave disappears on the bottom tracing). Once inserted, the 
nasogastric tube was connected to a Servo-I ventilator (Getinge, Solna, Sweden) equipped 
with a NAVA module (for EAdi recording). EAdi was then continuously recorded with trends 
captured every minute (value of the peak EAdi). Study recordings continued until EAdi 
was continuously above a threshold of 5–7 μV in a 24-hour period, assessed visually (see 
Outcome measures for details), extubation, death, or 120 hours (5 days) of mechanical 
ventilation without achieving the primary outcome.
After ethics committee approval of an amendment to add in daily diaphragm ultrasound 
in consecutive patients, daily ultrasound measurements were performed over a few 
minutes to assess the relationship between EAdi and diaphragm thickening fraction 
(TFdi). Thickness of the diaphragm at end-expiration (Tdi,ee) and end-inspiration (Tdi,ei) 
was measured in M-mode as the distance between the parietal pleural and peritoneal 
membrane, and TFdi was calculated as TFdi = (Tdi,ei − Tdi,ee) / Tdi,ee × 100%. A mean 
value of three breaths was taken and the average EAdi peak value corresponding to those 
breaths was recorded.
Outcome measures and data collection
The primary outcome of interest was the time from intubation to resumption of EAdi >7 μV 
for the next 24 hours (see Supplemental file 1 for details and Supplemental file 2, E-Figure 
1). We decided to look for a sustained diaphragm activity, defined as a median activity 
during a continuous 24-hour period. The threshold of 7 μV corresponded to a minimal 
TFdi of 15%, which has been previously associated with a minimally acceptable inspiratory 
effort [2, 3], as per the correlation between EAdi and diaphragm activity on ultrasound in 
our subset of patients (see Results section and Supplemental file 3, E-Figure 2).
As we stopped recording EAdi after 120 hours, the maximum onset time is 96 hours 
from EAdi recording start. For patients with 120 hours of EAdi recording and no diaphragm 
activity detected during this period, we assumed that the primary outcome occurred at a 
minimal time of 120 hours. Secondary endpoints included the time to EAdi resumption using 
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a threshold of 5 μV for a 24-hour time window as a sensitivity analysis (see Supplemental 
file 1), and a 12-hour time window, both for the 7 μV and 5 μV threshold.
A 1-hour recording of ventilator and EAdi waveforms was also collected daily at a 
fixed time of the day to record and store EAdi-time, flow-time and pressure-time curves. 
The recording occurring within the 24-hour period of EAdi resumption was reviewed and 
analyzed visually for the presence of spontaneous breathing efforts and reverse triggering 
dyssynchrony [16]. Based on visual analysis, reverse triggering was defined by the presence 
of ventilator-initiated breaths (i.e., passive insufflation in controlled mechanical ventilation) 
followed by a patient spontaneous effort; i.e., indicating that the patient was triggered by 
the ventilator and not the reverse, usually with a repetitive pattern.
Statistical methods
Sample size
About 40% of patients have a decrease in diaphragm thickness due to disuse within the 
first three days of mechanical ventilation [2]. Accordingly, having 70 patients would allow 
us to analyze approximately 30 patients with delayed or no resumption within the study 
period, and therefore obtain relatively precise estimates of the time to EAdi resumption and 
identifying late recovery of diaphragm activity. We added 5 subjects in case of dropout or 
technical problems related to EAdi recording.
Analysis
Baseline characteristics were summarized as mean ± standard deviation, median 
[interquartile range], or as number and percentage. We performed two sets of analyses 
(see Supplemental file 1 for details):
1. Time to EAdi resumption: survival analysis was performed to estimate the time to
EAdi resumption, applying the Kaplan-Meier method accounting for any censoring 
that occurred before the fifth day of EAdi recording. As per this approach, the
median time to EAdi resumption was calculated as the time point where 50% of
participants experienced the event of interest. In addition, the mean (standard error) 
time to EAdi resumption was estimated as the area under the Kaplan-Meier survival 
function curve. Note that the standard error was used as a measure of precision of
this estimated mean.
In a univariate model, we analyzed main baseline and clinical characteristics
associated with the time to EAdi resumption. Because the modality of ventilation
(assisted or controlled) could change during the observation time, we used it as
time-dependent covariate in the Cox model. The use and cumulative daily dose of 
continuous sedative infusions during the full study period were modelled as time-
dependent covariates.
2. Early vs. late EAdi resumption: in a multivariable analysis, we compared early (<24




baseline, until EAdi resumption in the early group or in the first 24 hours for the late 
group. Differences between groups were assessed with the unpaired t-test or Mann-
Whitney U test, according to the distribution. Categorical variables were compared with 
the use of the chi-square test or Fisher’s exact test, according to expected frequencies 
for each discrete variable. Logistic regression models were applied to investigate the 
relationship between main baseline and clinical characteristics and the probability to 
have a late resumption of EAdi, as well as the predictors for the use of sedative agents 
during the first 24 hours (or until EAdi resumption if it occurred before 24 hours).
EAdi and TFdi: the relationship between EAdi and TFdi was analyzed by a general linear 
regression model. Then, we classified data according to a TFdi value above or below 15% 
(i.e., minimal diaphragm contractile activity [3]); differences in EAdi between these groups 
were assessed with a Mann-Whitney U test.
All analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC, USA), R 
software version 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria) and SPSS 




Seventy-five patients were enrolled and 69 patients were kept in the analysis (Figure 1). The 
characteristics at baseline are detailed in Table 1 and Supplemental file 1, Table E1. Most 
patients (58/69 (84%)) were critically ill medical patients and the reason for intubation 
was respiratory (38/69 (55%)), hemodynamic (13/69 (19%)) and neurologic (14/69 
(20%)) failure. Fifty-three (77%) patients received a bolus of neuromuscular blockade 
to facilitate endotracheal intubation. Following intubation and EAdi catheter placement, 
the initial mode of ventilation in 62/69 (90%) of patients was volume control or pressure 
assist-control ventilation and a spontaneous mode was used in 7/69 (10%) of patients as 
determined by the clinical team. In the first 24 hours of EAdi recording, 63/69 (91%) patients 
received continuous sedative infusions and 4/69 (6%) patients received additional boluses 
or a continuous infusion of neuromuscular blockade. Among all patients’ characteristics, 
including gender, severity of illness scores, oxygenation, reason for intubation, and kidney 
and liver function, the only factor associated with receiving a continuous sedative infusion 
in the first 24 hours was younger age (odds ratio for age, 0.933; 95% confidence interval 
(CI) 0.896–0.971, p = 0.0007) (Supplemental file 1, Table E2). The overall ICU and hospital 
mortality were 25% and 37%, respectively. In the study period of 120 hours, 90% of the
cohort had continuous monitoring of EAdi, while for 8 patients, unintended EAdi catheter
disconnection happened prematurely (in 2 patients for palliation and in 6 patients for
catheter removal at time of clinical procedures such as magnetic resonance imaging)
(Figure 1 and Table 1).
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Enrolled patients
(n=75)
Recording from NAVA card not available
(n=2)






Inadequate EAdi signal (n=1)
>13h from intubation to first available EAdi 
signal (n=2)
EAdi catheter removed for clinical procedure 
by 24h from connection and before 
EAdi resumption (n=1)









Figure 1. Flowchart of the study population. *Catheter disconnection occured after 24 hours; pa-




Table 1. Characteristics of study population (n=69).
Characteristic
Male, n (%) 41 (59.42)
Age (years), mean ± SD 63.33 ± 16.58
Body mass index (kg/m2), mean ± SD 28.68 ± 9.31
APACHE II (score)
Mean ± SD 24.62 ± 8.28
Median [IQR] 24.50 [19.00–30.00]
Reason for ICU admission, n (%)
Elective surgery 1 (1.45)
Emergency surgery 5 (7.25)
Trauma 5 (7.25)
Medical 58 (84.06)




Airway protection 4 (5.80)
Intubation time, n (%)
Day (6 AM–9 PM) 57 (82.61)
Night (9 PM–6 AM) 12 (17.39)
Arterial blood gasa
FiO2, median [IQR] 0.50 [0.50–0.70]
PaO2 (mmHg), mean ± SD 121.84 ± 48.86
PaCO2 (mmHg), mean ± SD 44.16 ± 10.89
HCO3
- (mmol/L), mean ± SD 23.58 ± 6.24
PaO2/FiO2 (mmHg), mean ± SD 226.36 ± 104.82
Baseline creatinine (µmol/L), median [IQR] 106.00 [71.00–176.00]
Baseline acute kidney injury stage, n (%)b




Baseline bilirubin (µmol/L), median [IQR]c 10.00 [7.00–17.00]
Ventilator settings at EAdi catheter connection
Volume control or pressure assist-control ventilation, n (%) 62 (89.86)
PEEP (cmH2O), mean ± SD
All patients 8.05 ± 2.96
Patients on controlled mode (n=62) 8.08 ± 3.08
Patients on assisted mode (n=7) 7.83 ± 1.72
Mean airway pressure (cmH2O), mean ± SD
All patients 12.50 ± 3.93
Patients on controlled mode (n=62) 12.73 ± 4.01
Patients on assisted mode (n=7) 10.54 ± 2.53
Time with available EAdi recording (hours), median [IQR] 69.20 [45.05–96.20]
Tracheostomy during ICU stay, n (%)d 7 (10.14)
Mortality, n (%)
At ICU discharge 17 (24.64)
At hospital dischargec 25 (36.76)
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Table 1. Continued.
Characteristic
Resumption of EAdi during study periode
Subjects with complete recordings, n (%) 61 (88.41)
Time to resumption, n (%)
<24 hours 35 (57.38)
24–48 hours 11 (18.03)
48–72 hours 6 (9.84)
72–96 hours 5 (8.20)
>96 hours (no resumption) 4 (6.56)
Estimated time (hours) to resumptionf
Median [IQR] 22.02 [0.00–50.28]
Mean ± SE 35.20 ± 4.93
Average EAdi amplitude (µV) during resumption, mean ± SD 8.60 ± 7.07
Use of sedative during the first 24 hours, n (%)g 63 (91.30)
Propofol, n (%) 49 (77.78)
Cumulative dose (mg/kg), median [IQR] 18.99 [9.60–32.86]
Midazolam, n (%) 46 (73.02)
Cumulative dose (mg/kg), median [IQR] 0.07 [0.03–0.59]
Fentanyl, n (%) 51 (80.95)
Cumulative dose (µg/kg), median [IQR] 4.40 [1.40–15.91]
Neuromuscular blocking agent use, n (%)h
No 16 (23.19)
Yes 53 (76.81)
Yes, for intubation 49 (71.01)
Yes, additional bolus or continuous infusion 4 (5.80)
Sedation analgesia score (during the first 6 hours of EAdi recording), median [IQR]i 1.75 [1.00–2.50]
Abbreviations: APACHE, Acute Physiologic Assessment and Chronic Health Evaluation; EAdi, electrical 
activity of the diaphragm; FiO2, fraction of inspired oxygen; HCO3
-, bicarbonate; ICU, intensive care unit; 
IQR, interquartile range; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen; 
PEEP, positive end-expiratory pressure; SD, standard deviation; SE, standard error.
a 63 patients had arterial blood gas measured at baseline.
b Acute kidney injury staging was determined using KDIGO Clinical Practice Guideline for Acute Kidney 
Injury.
c For 1 patient, data was missing.
d Tracheostomy performed after 120 hours from first available EAdi.
e Percentage was calculated on 61 patients with complete EAdi recordings.
f Estimated time was assessed on whole study population (69 patients) with the Kaplan-Meier 
approach. Time to resumption was calculated from the first available EAdi using a threshold of 7 μV.
g 6 patients did not receive continuous sedative infusions in the first 24 hours. Note that patients may 
have received sedation after resumption of EAdi, see Supplemental file 1, Table E1.
h Standard doses for neuromuscular blocking agents were used; intubation doses for rocuronium were 
0.6–1.2 mg/kg, succinylcholine 1–2 mg/kg and cisatracurium 0.15–0.2 mg/kg. Continuous infusions 
of rocuronium or cisatracurium were titrated to clinical effect and were dosed as for 0.2–0.7 mg/kg/
hour and 0.06–0.18 mg/kg/hour, respectively, as per hospital policy.




Time to EAdi resumption
The estimated median time for resumption of a minimal EAdi as defined per the primary 
endpoint was 22.02 [0.00–50.28] hours and the estimated mean time was 35 hours 
(standard error, 5 hours) for the study population (Table 1, Figure 2). In total, 35/69 (51%) 
of patients had resumption of activity within 24 hours, whereas 4/69 (6%) of patients had 
no EAdi resumption after 5 days (Table 1). Supplemental file 2, E-Figure 1 shows an example 
of a recording of a patient with 4 days of total time of EAdi recording and who recovered 
EAdi approximately 48 hours after intubation. The mean EAdi during the first 24 hours of 
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Figure 2. Probability of electrical activity of the diaphragm (EAdi) resumption during the study 
period (n=69). Following intubation, the estimated mean time for resumption of a minimal EAdi 
was 35 hours (standard error, 5 hours) and the estimated median [IQR] time was 22 [0–50] hours. 
Note: probabilities were estimated with the Kaplan-Meier approach and patients with catheter dis-
connection were censored at the time of EAdi catheter disconnection.
Predictors of EAdi resumption
The infusion of at least one continuous sedative agent during the first 24 hours (or until 
EAdi resumption if time to resumption was <24 hours) after intubation was associated 
with a significantly longer time to EAdi resumption (i.e., lower chance of resumption) with 
a hazard ratio of 0.18 (95% CI 0.10–0.32, p < 0.0001), and a time-dependent effect of 
dosing for propofol and fentanyl (p = 0.0029 and p = 0.0125, respectively). Older age was 
significantly associated with time to EAdi resumption (hazard ratio for age, 1.03; 95% CI 
1.01–1.05, p = 0.0022). Time to EAdi resumption was not associated with the PaO2/FiO2 
ratio at baseline, mean airway pressure, reason for intubation, time of intubation (day/
night) or severity of illness scores in any analysis.
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Figure 3a shows the probability of EAdi resumption during the study period in patients 
stratified according to the use of sedatives during the first 24 hours (or until EAdi resumption 
if time to resumption was <24 hours). In the multivariable analysis, only the use of sedatives 
was associated with time to EAdi resumption, while the use of paralytic or sedation scores 
were not (Table 2). Although the mode of ventilation was not significantly associated with 
the time to EAdi resumption during the study period in the univariate logistic model (hazard 
ratio, 1.79; 95% CI 0.98–3.26, p = 0.0587), Figure 3b shows that the probability of EAdi 
resumption was higher in patients on assisted modes of ventilation at the time of EAdi 
catheter connection compared to patients on controlled modes of ventilation (p = 0.0259 
and p = 0.0191 for the log-rank and Wilcoxon test, respectively). Figure 4 shows the 
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Figure 3. Probability of electrical activity of the diaphragm (EAdi) resumption during the study 
period, stratified according to (a) the use of sedatives (yes/no), and (b) the mode of ventilation at 
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Figure 4. Probability of electrical activity of the diaphragm (EAdi) resumption during the study 
period, stratified according to sedative drug: (a) propofol, (b) midazolam, and (c) fentanyl.
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Table 2. Relationship between baseline parameters and EAdi resumption during the study period.
Hazard ratio (95% CI) p value n=
Univariate logistic models
Age (year) 1.03 (1.01–1.05) 0.0022 69
Sex (ref. Female) 0.97 (0.58–1.63) 0.9179 69
APACHE II (score) 1.02 (0.98–1.06) 0.2900 68
Body mass index (kg/m2) 1.02 (0.99–1.05) 0.1771 67
Mode of ventilation (ref. Assisted) 1.79 (0.98–3.26) 0.0587 69
PaO2/FiO2 (mmHg) 1.00 (1.00–1.00) 0.3537 63
Creatinine (µmol/L) 1.00 (1.00–1.00) 0.2590 69
Baseline acute kidney injury stage (ref. No acute kidney injury) 69
1 1.76 (0.96–3.20) 0.0665
2 0.87 (0.26–2.89) 0.8155
3 1.64 (0.75–3.62) 0.2178
Baseline bilirubin (µmol/L) 1.00 (0.99–1.01) 0.8071 68
Cause of intubation (ref. Neurologic) 65*
Pulmonary 1.14 (0.60–2.18) 0.6904
Hemodynamic 0.93 (0.40–2.13) 0.8578
Sedation analgesia score during the first 6 hours (score) 1.19 (0.88–1.60) 0.2639 54
Use of sedative (ref. No) 0.18 (0.10–0.32) <0.0001 69
Use of sedative (ref. No), time-dependent 0.09 (0.04–0.21) <0.0001 69
Use of propofol (ref. No) 0.34 (0.19–0.60) 0.0002 69
Use of propofol (ref. No), time-dependent 0.32 (0.18–0.57) 0.0001 69
Dose of propofol (1 mg/kg) 0.98 (0.96–1.00) 0.0334 69
Dose of propofol (1 mg/kg), time-dependent 0.98 (0.96–0.99) 0.0029 69
Use of midazolam (ref. No) 0.29 (0.16–0.52) <0.0001 69
Use of midazolam (ref. No), time-dependent 0.29 (0.15–0.55) 0.0002 69
Dose of midazolam (0.01 mg/kg) 1.00 (0.99–1.00) 0.1018 69
Dose of midazolam (0.01 mg/kg), time-dependent 0.96 (0.91–1.00) 0.0603 69
Use of fentanyl (ref. No) 0.36 (0.21–0.62) 0.0002 69
Use of fentanyl (ref. No), time-dependent 0.36 (0.20–0.64) 0.0004 69
Dose of fentanyl (1 µg/kg) 0.99 (0.97–1.00) 0.1540 69
Dose of fentanyl (1 µg/kg), time-dependent 0.98 (0.96–0.99) 0.0125 69
Use of neuromuscular blocking agent (ref. No) 0.78 (0.43–1.43) 0.4262 69
Multivariable logistic model with time-dependent variables
Model 1 69
Use of sedative (ref. No), time-dependent 0.09 (0.04–0.21) <0.0001
Model 2 69
Use of midazolam (ref. No), time-dependent
Without propofol 0.49 (0.22–1.10) 0.0799
With propofol 0.11 (0.05–0.26) <0.0001
Multivariable logistic model without time-dependent variables
Model 1 69
Use of sedative (ref. No) 0.18 (0.10–0.32) <0.0001
Model 2 69
Use of midazolam (ref. No) 0.31 (0.17–0.57) 0.0001
Use of propofol (ref. No) 0.38 (0.21–0.67) 0.0009
* 4 patients with other causes of intubation were excluded. For other reasons why some analyses did not 
include 69 patients, see Table 1. Abbreviations: APACHE, Acute Physiologic Assessment and Chronic Health 




Early vs. late EAdi resumption
When patients with early EAdi resumption (<24 hours) were compared to patients with late 
EAdi resumption (≥24 hours), no statistical relationship was found for sex, APACHE II score, 
body mass index, renal or hepatic function, reason for intubation, positive end-expiratory 
pressure, mean airway pressure (as a surrogate of the intensity of ventilation) or arterial 
blood gas parameters at baseline. Patients with early EAdi resumption were older (68.6 
± 15.9 vs. 57.9 ± 15.7 years for early vs. late EAdi resumption, p = 0.0043). Details on the 
study population stratified by early (<24 hours, 51% of patients) vs. late (≥24 hours, 49% 
of patients) EAdi resumption are reported in Supplemental file 1, Table E1. Continuous 
sedation after intubation and increased doses of propofol and fentanyl were the only factors 
associated with a late resumption (Table 3).
Table 3. Relationship between baseline parameters and the probability to have a late resumption of 
diaphragm electrical activity (after 24 hours) during the study period.
Odds ratio (95% CI) p value n=
Univariate logistic models
Age (year) 0.958 (0.928–0.990) 0.0101 69
Sex (ref. Female) 0.748 (0.286–1.962) 0.5557 69
APACHE II (score) 0.975 (0.919–1.034) 0.3949 68
Body mass index (kg/m2) 0.987 (0.936–1.040) 0.6146 67
Mode of ventilation (ref. Assisted) 6.824 (0.776–60.040) 0.0835 69
PaO2/FiO2 (mmHg) 1.002 (0.997–1.007) 0.3904 63
Creatinine (µmol/L) 1.002 (0.998–1.005) 0.4109 69
Baseline acute kidney injury stage (ref. No acute kidney injury) 69
1 0.439 (0.142–1.356) 0.1526
2 2.824 (0.266–30.021) 0.3894
3 2.196 (0.483–9.991) 0.3088
Baseline bilirubin (µmol/L) 1.005 (0.988–1.022) 0.5666 68
Cause of intubation (ref. Neurologic) 65*
Pulmonary 0.324 (0.086–1.217) 0.4076
Hemodynamic 0.250 (0.050–1.251) 0.2145
Sedation analgesia score during the first 6 hours (score) 0.732 (0.408–1.313) 0.2950 54
Use of sedative (ref. No) 25.833 (6.411–104.094) <0.0001 69
Use of propofol (ref. No) 6.944 (2.412–19.994) 0.0003 69
Dose of propofol (1 mg/kg) 1.090 (1.031–1.151) 0.0022 69
Use of midazolam (ref. No) 17.231 (4.375–67.860) <0.0001 69
Dose of midazolam (0.01 mg/kg) 1.026 (0.998–1.055) 0.0666 69
Use of fentanyl (ref. No) 8.100 (2.750–23.855) 0.0001 69
Dose of fentanyl (1 µg/kg) 1.073 (1.003–1.148) 0.0394 69
Multivariable logistic model
Use of neuromuscular blocking agent (ref. No) 2.658 (0.811–8.713) 0.1067 69
* 4 patients with other causes of intubation were excluded. For other reasons why some analyses did 
not include 69 patients, see Table 1. Abbreviations: APACHE, Acute Physiologic Assessment and Chronic 
Health Evaluation; CI, confidence interval; FiO2, fraction of inspired oxygen; PaO2, partial pressure of 
oxygen.
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Relationship between EAdi and TFdi
The correlation between EAdi and TFdi was performed in 21 patients with adequate 
ultrasound measurements available. We excluded one patient with major chronic lung 
distension and a flat diaphragm, making the reliability of thickening fraction measurements 
questionable. The correlation is shown in Supplemental file 3, E-Figure 2a and could be 
described as TFdi (%) = 6.18 + 1.25 × EAdi (r2 = 0.623, p < 0.001). A minimal TFdi of 15% as 
previously defined would thus correspond to an EAdi amplitude of >7 μV. The median EAdi 
amplitude during the ultrasound recording was 2.06 [0.53–6.50] μV and 14.75 [7.20–29.0] 
μV for those patients with TFdi below and above 15%, respectively (Supplemental file 3, 
E-Figure 2b, p = 0.001 for differences between groups).
Different definitions for EAdi resumption
Using a threshold of 7 μV and 12-hour period, the estimated time for resumption of a 
minimal EAdi was a median of 18.40 [0.00–53.88] hours. Using a threshold of 5 μV, the 
time for resumption of EAdi for a 24-hour and 12-hour period were 22.02 [0.00–50.77] 
hours and 18.38 [0.00–53.88] hours, respectively (Supplemental file 1, Table E3).
Presence of reverse triggering at time of resumption of EAdi
In 55 patients with a 1-hour recording available within the first 24 hours of EAdi resumption, 
ventilator and EAdi waveforms were analyzed: 47 patients showed spontaneous efforts 
triggering the ventilator, 6 patients had evidence of reverse triggering with no spontaneous 
effort triggering the ventilator, and 2 patients had a mixture of reverse triggering and 
spontaneous efforts over this hour. For patients who were already triggering the ventilator 
during this 1-hour recording, we reviewed tracings from the preceding day when they were 
on a controlled mode of ventilation; 3 additional patients showed reverse triggering (total of 
11/55 (20%) patients). Considering only the 29 patients under controlled ventilation either 
the day before or the day of EAdi resumption, reverse triggering was present in 38% of cases.
DISCUSSION
In this short-term observational physiological study, we evaluated the temporal pattern 
of EAdi resumption in critically ill adult patients requiring endotracheal intubation. The 
prevalence of excessively low diaphragm activity in the first hours after intubation was 
high and the median time to EAdi resumption was 22 hours. Younger patients and those 
on higher doses of sedative infusions in the first 24 hours of mechanical ventilation 
experienced delayed resumption of EAdi. Delayed EAdi resumption was not associated 
with the reason for intubation, the severity of illness, renal or hepatic dysfunction, the level 
of intensity of ventilation, or oxygenation defect. Around the time of EAdi resumption, at 
least 20% of patients exhibited reverse triggering and this was the case for almost 40% 





Our results show that an absent or abnormally low diaphragm activity is present in almost 
half of the patients (49%) for more than 24 hours after intubation. Decreases in diaphragm 
strength and fiber cross-sectional area that have been demonstrated in both animal and 
human studies [2, 17–19] might thus be a consequence of frequently suppressed activity 
early during invasive mechanical ventilation.
When clinically stable, transitioning a patient to spontaneous breathing using assisted 
modes of ventilation with reduced or interrupted sedation might preserve diaphragm 
activity and prevent the development of disuse atrophy. This approach, however, must be 
weighed against the need for lung protection [7], especially in the presence of excessive 
respiratory drive. We confirmed that a transition to assisted modes of ventilation, however, 
does not imply direct resumption of normal EAdi levels. In fact, the relatively low EAdi values 
in our patients might be the result of ventilator over-assistance, which is common and often 
unnoticed in modes such as pressure support ventilation [2, 20, 21]. This underscores the 
potential importance of monitoring respiratory effort during mechanical ventilation in order 
to target diaphragm activity within a safe physiological range [3, 7].
Our analysis shows that the presence of a continuous sedative infusion after intubation is 
the main risk factor for delayed EAdi resumption, while severity of illness, including intensity 
of ventilation and oxygenation, renal and hepatic function, reason for intubation and other 
clinical factors were not statistically associated. Our findings support a previous single 
center randomized controlled trial of a “no sedation” approach in mechanically ventilated 
patients who had significantly reduced time on the ventilator [22, 23]. Our findings confirm 
that the prescription of continuous sedation has a major impact on the resumption of 
diaphragm activity and this seems independent from a patient’s illness severity. Although 
the effect of sedation was expected, the lack of relationship with severity suggests that 
the administration of sedation may not be dictated by the needs of the patient but more 
by predetermined behavior, habits and/or protocols. Also, these findings suggest that the 
administration of sedation may be amenable to improvement. Somewhat unexpectedly, we 
found that older patients had an earlier resumption of EAdi compared to younger ones. This 
finding is explained by the fact that older patients also received significantly less propofol, 
suggesting that clinicians limit continuous sedation in older patients given the potential for 
exacerbating delirium or risk of deep sedation. This also confirms indirectly that sedation 
might be administered based on clinicians’ decisions. Although our study did not capture 
in more granular details the characteristics of the patient at the time of early ventilation, 
this result suggests that sedation administration for maintaining respiratory muscle activity 
could be better controlled.
A median EAdi threshold of 7 μV for 24 hours was chosen to represent a resumption of 
clinically relevant EAdi. In our initial protocol we were interested in the first time EAdi values 
were >5 μV, but there was significant variability in the EAdi signals and a “one time” value 
of 5 μV for a few minutes was often very transient (see Supplemental file 4, E-Figure 3), 
with a high risk of noise [24]. This voltage threshold value was chosen arbitrarily as half of 
the minimal 10 μV value observed in different studies, and it was reasoned that this would 
represent a conservative value for resumption of minimal EAdi. Healthy subjects have EAdi 
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values during normal spontaneous breathing close to 17 μV and above 10 μV in 92% of 
subjects [25]. We found a significant correlation between EAdi and TFdi, which demonstrated 
that a minimal TFdi of 15% as previously defined [2, 3] would correspond to an EAdi amplitude 
>7 μV. This physiological rationale justified using a threshold of 7 μV, while performing a 
sensitivity analysis using a threshold of 5 μV, with essentially identical results, as well as 
analyses performed at an onset time of 12 hours and 24 hours, again with very similar results.
The presence of patient-ventilator dyssynchrony may be driven by complex interactions 
between sedatives and opioids [26]. We were particularly interested in reverse triggering [16], 
which was frequently observed at the time minimal EAdi was detected during controlled 
mechanical ventilation. The physiological mechanism and clinical consequences of this specific 
dyssynchrony are subject of ongoing research. Reverse triggering can lead to breath stacking, 
and might be associated with lung and diaphragm injury. In contrast, reverse triggering may 
also be a protective reflex to prevent diaphragm atrophy and further investigation is required 
to better understand its consequences. Although our analysis was limited by having only a 
1-hour recording at a fixed time of the day, therefore underestimating the true incidence, 
we observed that reverse triggering may be a frequent way for diaphragm activity to restart. 
This is further supported by previous research which demonstrated an increased amount 
of dyssynchrony with higher as compared to lower doses of propofol for sedation [27].
To improve ventilatory management of the critically ill patient, our data suggest 
that monitoring of respiratory drive and inspiratory effort could be helpful [28, 29]. Low 
respiratory drive and effort as a result of ventilator over-assistance and/or excessive 
sedation may lead to diaphragm atrophy and dysfunction, while strong inspiratory efforts 
might lead to load-induced diaphragm injury [3, 6, 28]. Clinicians frequently give sedation 
to treat or even prevent obvious patient-ventilator dyssynchrony, but this is probably at the 
expense of excessive sedation. EAdi amplitudes vary between individuals and safe upper 
limits for diaphragm activity are currently unknown. A diaphragm-protective ventilation 
strategy might employ EAdi monitoring or other techniques to identify patients at risk 
for ventilator over-assistance myotrauma, for assessing changes in respiratory drive, and 
to adjust ventilator settings accordingly [25]. EAdi is not a direct measure of breathing 
effort but studies have shown reasonable correlation with functional parameters such as 
muscular pressure [30]. Here, we demonstrate a reasonably strong correlation between 
EAdi and diaphragm thickening measured by ultrasound in critically ill mechanically 
ventilated patients. A tidal variation in TFdi of 15–30% was associated with shorter duration 
of mechanical ventilation in a large cohort of critically ill patients [3]. Accordingly, TFdi 
below 15% might put the patient at risk for development of disuse atrophy [3, 31]. The 
current study shows that patients with TFdi values below 15% indeed had abnormally low 
EAdi amplitudes, which was significantly different from patients with normal TFdi; this 
strengthens the rationale for titrating ventilator assistance to reach a minimal TFdi of 15%.
Limitations
This study had a limited number of enrolled subjects and was conducted in a single ICU. 




and practice variation could influence the time and magnitude of EAdi resumption. 
However, sedation practices and therefore EAdi resumption were not associated with 
patient severity of illness or oxygenation deficit, suggesting that this practice may be 
modified. Pain, agitation, delirium and sleep are complex pathophysiological processes 
in critically ill patients [32]. Clinically, each of these components should be addressed 
separately and assuming that all intravenous agents act uniformly on EAdi recovery is an 
oversimplification. As analgesics, opioids seem to have vastly different effects on respiratory 
function and muscle activity compared to other agents, manifested in reductions in 
ventilator dyssynchrony and less suppressed EAdi activity compared to non-opioid based 
strategies [26, 27]. Conversely, propofol based sedation, even in healthy volunteers, has 
a profound impact on diaphragm activity [33]. While we attempted to separately analyze 
individual agents, they were used most often in combination. Future research in this area 
should attempt to study the individual effects of sedative agents more precisely.
Secondly, we enrolled 75 patients in a 2-year time frame, which is much less than 
the number of acutely intubated patients in our ICU. This was explained in part by the 
logistical difficulty to conduct such a study in which recordings had to start almost at time 
of intubation. Our findings have reasonable external validity as the baseline characteristics 
of our cohort were representative of a general medical ICU patient population; however, 
the actual number of surgical patients was low limiting our ability to draw associations 
in that cohort. Third, we felt that we used a reasonable threshold to detect minimal EAdi 
activity, as confirmed with our ultrasound data, but did not measure directly the effort of 
the patient. Although it would have been less sensitive, this could also be assessed with 
transdiaphragmatic pressure measurements, but would have added to the complexity 
and time-sensitive nature of the measurements. Moreover, we focused only on diaphragm 
activity in this study, while the time to recovery of activity of other inspiratory muscles may 
be interesting to characterize. Finally, there were episodes of intermittent EAdi catheter 
dislodgement, which required adjustment of catheter positioning and in 7 patients the 
inability to measure recordings for the complete duration of the study. These catheter 
disconnections occurred after 24 hours and the patients were kept in the early vs. late EAdi 
resumption comparison.
CONCLUSION
Following endotracheal intubation, critically ill adults experience suppression of diaphragm 
activity and the time to resumption of a reasonably minimal EAdi takes almost one day. 
Continuous infusions of sedatives and the use of controlled modes of mechanical ventilation 
contribute to delayed recovery while severity of illness scores did not. Our results suggest 
that sedation practices in particular contribute to prolonged disuse of the respiratory 
muscles with a risk of diaphragm atrophy independent of patient severity of illness. Better 
monitoring of respiratory drive and integration of breathing effort to sedation practice 
algorithms may be of benefit.
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SUPPLEMENTAL FILES
Supplemental file 1: Extended methods and tables
EXTENDED METHODS
Study design
This prospective observational cohort study in acutely ill mechanically ventilated adult 
patients was approved by the Ethics Committee of St. Michael’s Hospital (REB #15-073) 
and registered on ClinicalTrials.gov (NCT02434016). Patients were included by waiver of 
consent since the use of feeding tubes allowing EAdi monitoring was standard in the ICU.
Patients
To be enrolled, adult patients intubated in the ICU (or emergency department) were 
expected to have a duration of mechanical ventilation >48 hours (to exclude patients 
admitted to the ICU for routine post-operative monitoring) and an oro- or nasogastric 
feeding tube equipped with electrodes at the level of the diaphragm (EAdi catheter, 
Getinge, Solna, Sweden), placed within 30 minutes after intubation between June 2015 
and August 2017. Patients were excluded if there was anticipated removal of the catheter 
within 48 hours of ICU admission for endoscopic interventions or a presumed need for 
magnetic resonance imaging (due to metal electrodes). Patients were also excluded if 
there was a history of phrenic nerve lesions, high risk for intracranial hypertension, proven 
intracranial hypertension (as discontinuation of sedation would be potentially dangerous 
in this group), or those who were already intubated for at least 12 hours. Patients were 
managed as per the attending physician and the clinical team. When appropriate, daily 
sedation interruption or minimization, and spontaneous breathing trials were performed 
as per the University of Toronto academic ICU policy [1].
Experimental procedure
The EAdi catheter was positioned as previously described [2], using distance and with 
position confirmed based on the electrocardiogram tracings (the QRS amplitude decreases 
from top to bottom tracings and the P wave disappears on the bottom tracing). Once 
inserted, the nasogastric tube was connected to a Servo-I ventilator (Getinge, Solna, 
Sweden) equipped with a NAVA module (for EAdi recording). EAdi was then continuously 
recorded with trends captured every minute (value of the peak EAdi). Study recordings 
continued until EAdi was continuously above a threshold of 5–7 μV in a 24-hour period, 
assessed visually (see Outcome measures for details), extubation, death, or 120 hours (5 
days) of mechanical ventilation without achieving the primary outcome.
After ethics committee approval of an amendment to add in daily diaphragm ultrasound 
in consecutive patients, ultrasound measurements were performed over a few minutes 
to assess the relationship between EAdi and diaphragm thickening fraction (TFdi). 




zone of apposition using a high frequency (10–15 MHz) linear array transducer (FUJIFILM, 
Sonosite) as previously described [3]. Thickness of the diaphragm at end-expiration (Tdi,ee) 
and end-inspiration (Tdi,ei) was measured in M-mode as the distance between the parietal 
pleural and peritoneal membrane and TFdi was calculated as TFdi = (Tdi,ei – Tdi,ee) / 
Tdi,ee × 100%. A mean value of three breaths was taken and the average EAdi peak value 
corresponding to those breaths was recorded.
Outcome measures and data collection
The primary outcome of interest was the time from intubation to resumption of EAdi. In our 
initial protocol, we wanted to look at the first time EAdi was above 5 µV even for a very brief 
period. There was no consensus in the literature to agree on what is a normal EAdi. This 
initial EAdi threshold was based on data in healthy subjects showing that normal values are 
usually above 10 µV [4], the average values of data in published studies in adults showing 
values of approximately 10 µV [5], and a systematic review in pediatric patients showing 
that the average EAdi values in patients under NAVA were approximately 10 µV [6]. We 
reasoned that choosing a low level would be conservative for describing abnormally low 
diaphragm activity, and sensitive to detect an early start of moderate electrical activity. 
Before performing the final analysis, we decided to make two changes in our statistical 
plan: first, after examining the waveforms of 25% of the patients, we realized that brief 
and frequent fluctuations in activity made such a brief endpoint uninterpretable. We 
then decided to look for a more clinically relevant endpoint, and to look for a sustained 
activity, defined as a median activity during a continuous 24-hour period: the time of 
resumption was therefore the (first) time at which the median EAdi was >5 µV during the 
next continuous 24 hours (see Supplemental file 2, E-Figure 1). Second, we looked at the 
correlation between EAdi and diaphragm activity on ultrasound in our subset of patients: 
we found that a TFdi of 15% corresponded approximately to an EAdi amplitude of 7 µV (see 
Supplemental file 3, E-Figure 2). We therefore decided to change our primary endpoint to 
the first time at which the median EAdi was >7 µV for the next 24 hours, and to keep our 
initial threshold of 5 µV as a sensitivity analysis.
As we stopped recording EAdi after 120 hours, the maximum onset time is 96 hours 
from EAdi recording start. For patients with 120 hours of EAdi recording and no diaphragm 
activity detected during this period, we assumed that the primary outcome occurred at 
a minimal time of 120 hours. Secondary endpoints included the time to EAdi resumption 
using only a 12-hour time window, both for the 7 µV and 5 µV threshold.
Members of the study team were on call to enroll patients and to conduct study 
measurements. The medical record was used to collect patient demographics, severity 
of illness scores, renal and hepatic function, and clinical outcomes. Renal function was 
described as creatinine levels on admission and acute kidney injury stage at 24 hours based 
on KDIGO guidelines [7]. Hepatic function was evaluated by serum total bilirubin values 
at 24 hours. The paper chart, nursing flow sheets and respiratory therapist records were 
used to collect the time of intubation and doses of continuous infusions of sedative agents. 
The depth of sedation was measured by the Riker scale [8] and ventilatory management 
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strategies including arterial blood gases and ventilator settings were also recorded. Mean 
airway pressure was used as a marker of the intensity of ventilation and could be compared 
across both assisted and controlled modes of ventilation. In addition to the continuous 
trend recordings of EAdi (giving values every minute), a 1-hour recording of ventilator and 
EAdi waveforms was also collected daily at a fixed time of the day: the Servo-I ventilator 
was connected through a RS232 cable to a laptop equipped with dedicated software 
(Servo-tracker software version 4.2, Getinge, Solna, Sweden) to record and store EAdi-
time, flow-time and pressure-time curves. This 1-hour recording occurring within the 24-
hour period of EAdi resumption was reviewed and analyzed visually for the presence of 
spontaneous breathing efforts and reverse triggering dyssynchrony [9]. Based on visual 
analysis, reverse triggering was defined by the presence of ventilator-initiated breaths (i.e., 
passive insufflation in controlled mechanical ventilation) followed by a patient spontaneous 
effort, i.e., indicating that the patient was triggered by the ventilator and not the reverse, 
usually with a repetitive pattern.
Statistical methods
Sample size
Estimates of time from catheter positioning to EAdi resumption were not available in the 
scientific literature and the main aim of this exploratory study was to provide detailed 
clinical information on this parameter for future trials. A minimum convenient sample size 
of at least 25–30 patients was required for adequate exploration of our objective. Previous 
data using diaphragm ultrasound showed that about 40% of patients have a decrease in 
diaphragm thickness due to disuse within the first three days of mechanical ventilation [3]. 
Accordingly, having 70 patients would allow us to analyze approximately 30 patients with 
delayed or no resumption within the study period; therefore, it would allow us to obtain 
relatively precise estimates of the time to EAdi resumption and to identify late recovery 
of diaphragm activity. We added 5 subjects to the final sample size in case of dropout or 
technical problems related to EAdi recording.
Analysis
Baseline characteristics were summarized as means ± standard deviations, medians 
[interquartile ranges (IQR)], or as numbers and percentages. We performed two sets of analyses:
1. Time to EAdi resumption: in a univariate model, we analyzed factors associated with 
the time to EAdi resumption based on our primary endpoint and included time-
dependent variables (if necessary). Survival analysis was performed to estimate 
the time to EAdi resumption, applying the Kaplan-Meier method accounting for 
any censoring that occurred before the fifth day of EAdi recording. In detail, the 
mean time was calculated as the area under the estimated survival curve, variability 
was assessed with Greenwood’s standard error formula and the median time was 




as the time when 50% of the subjects had EAdi resumption). The Kaplan-Meier 
method was also used to show and compare (log-rank and Wilcoxon test) the 
probability of having EAdi resumption during the study period (120 hours), in 
the study population stratified by the main baseline and clinical characteristics. 
To assess the association between each characteristic and the probability to 
have EAdi resumption during the study period, we performed Cox proportional-
hazards models and results were reported as hazard ratio with 95% confidence 
interval (CI). A stepwise approach was applied to detect the set of independent 
variables significantly associated to the outcome. This approach combines 
forward and backward selection methods (with a significance level of 0.05 both 
for entry and retention) in an iterative procedure to select predictors in the final 
multivariable model. The validity of the proportional hazards assumption in the Cox 
regression models was assessed with the test proposed by Harrel and Lee based 
on Schoenfeld residuals and Kolmogorov-type supremum test for continuous 
covariates [10, 11]. Martingale residuals of null Cox regression models were used 
to check the assumption of linearity in the relationship between the log hazard and 
continuous covariates. Because the modality of ventilation (assisted or controlled) 
could change during the observation time, we used it as time-dependent covariate 
in the Cox model. The use and cumulative daily dose of continuous sedative 
infusions during the full study period were modelled as time-dependent covariates.
2. Early vs. late EAdi resumption: in a multivariable analysis, we compared early (<24 
hours) versus late (≥24 hours) resumption of EAdi accounting for variables present 
at baseline, until EAdi resumption in the early group or in the first 24 hours for 
the late group. Differences between groups in baseline and clinical characteristics 
were assessed with the unpaired t-test or Mann-Whitney U test, according to the 
distribution of each continuous variable. Categorical variables were compared 
with the use of the chi-square test or Fisher’s exact test, according to expected 
frequencies for each discrete variable. Moreover, logistic regression models 
were applied to investigate the relationship between main baseline and clinical 
characteristics and the probability to have a late resumption of EAdi, as well as 
the predictors for the use of sedative agents during the first 24 hours (or until EAdi 
resumption if it occurred before 24 hours). The Box-Tidweel procedure was applied 
to test the assumption of a linear relationship between continuous independent 
variables and the logit transformation of the dependent variable. Also, in this case, 
we applied a stepwise approach in order to determine which specific independent 
variables made meaningful contributions to the overall prediction. Results were 
reported as odds ratio with 95% CI.
For the Cox model examining the relationship between baseline parameters 
and EAdi resumption during the study period, we used the following variables in 
the univariate model: age (year), sex, APACHE II (score), body mass index (kg/m2), 
mode of ventilation (ref. assisted), PaO2/FiO2 ratio (mmHg), baseline creatinine 
(µmol/L), baseline acute kidney injury stage, baseline bilirubin (µmol/L), cause 
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of intubation, sedation analgesia score during the first 6 hours (score), use of 
neuromuscular blocking agents, use of sedatives, and the use and doses of 
propofol, midazolam and fentanyl, both as time-dependent variables and non-
time-dependent variables. For the multivariable model we included the presence 
of sedative infusions used in combination as both time-dependent and non-time-
dependent variables.
For the Cox model examining the relationship between baseline parameters and 
the probability of EAdi resumption after 24 hours we used the following variables: 
age (year), sex, APACHE II (score), body mass index (kg/m2), mode of ventilation 
(ref. assisted), PaO2/FiO2 ratio (mmHg), baseline creatinine (µmol/L), baseline 
acute kidney injury stage, baseline bilirubin (µmol/L), cause of intubation, sedation 
analgesia score during the first 6 hours (score), use of neuromuscular blocking 
agents, use of sedatives, use and doses of propofol, midazolam and fentanyl.
Predictors used in the multivariable models (logistic or Cox) were detected 
through the stepwise regression approach that combines forward and backward 
selection methods in an iterative procedure (significance level of 0.05 both for 
entry and retention). The validity of the proportional hazards assumption in the Cox 
regression models was assessed with the test proposed by Harrel and Lee based 
on Schoenfeld residuals. Concerning logistic models, we observed 35 events (EAdi 
resumption) and according to the minimal “10 events per variable” rule in medical 
literature, if anything, we were able to evaluate three independent predictors in a 
same logistic model.
EAdi and TFdi: the relationship between EAdi and TFdi was analyzed by a general linear 
regression model. For patients with measurements available during both controlled and 
assisted modes of ventilation, both measurements were included in the model. When 
patients had multiple measurements per ventilation modality available, average EAdi and 
TFdi values were included to account for differences in repeated measurements between 
patients. Recordings obtained during reverse triggering were excluded from the analysis. 
Then, we classified data according to a TFdi value above or below 15% (i.e., TFdi associated 
with minimal diaphragm contractile activity [12]); differences in EAdi amplitude between 
these groups were assessed with a Mann-Whitney U test. A two-sided p < 0.05 was 
considered to indicate statistical significance.
All analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC, USA), R 
software version 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria) and SPSS 





Table E1. Characteristics of the study population (n=69), stratified according to the time to resumption 
of diaphragm electrical activity (EAdi). Early resumption = resumption of EAdi <24 hours; late 
resumption = resumption of EAdi after 24 hours, no recorded resumption of EAdi during the study 
period, or catheter disconnection after 24 hours.
Characteristic Early resumption Late resumption p value
n (%) 35 (50.72) 34 (49.28) -
Male, n (%) 22 (62.86) 19 (55.88) 0.5553
Age (years), mean ± SD 68.57 ± 15.89 57.94 ± 15.73 0.0043
Body mass index (kg/m2), mean ± SD 29.24 ± 9.27 28.10 ± 9.45 0.5556
APACHE II (score)
Mean ± SD 25.47 ± 9.28 23.76 ± 7.18 0.3996
Median [IQR] 24.50 [18.00–31.00] 24.50 [19.00–29.00]
Reason for ICU admission, n (%) 0.3761
Elective surgery 0 (0.00) 1 (2.94)
Emergency surgery 3 (8.57) 2 (5.88)
Trauma 1 (2.86) 4 (11.76)
Medical 31 (88.57) 27 (79.41)
Reason for intubation, n (%) 0.3057
Pulmonary 21 (60.00) 17 (50.00)
Hemodynamic 8 (22.86) 5 (14.71)
Neurologic 4 (11.43) 10 (29.41)
Other (airway protection) 2 (5.71) 2 (5.88)
Intubation time, n (%) 0.9559
Day (6 AM–9 PM) 29 (82.86) 28 (82.35)
Night (9 PM–6 AM) 6 (17.14) 6 (17.65)
Arterial blood gasa
FiO2, median [IQR] 0.50 [0.40–0.70] 0.50 [0.50–0.75] 0.2185
PaO2 (mmHg), mean ± SD 110.57 ± 30.25 132.09 ± 59.74 0.2154
PaCO2 (mmHg), mean ± SD  41.70 ± 8.45  46.39 ± 12.41 0.2024
HCO3
- (mmol/L), mean ± SD  24.34 ± 6.55  22.91 ± 5.98 0.3394
PaO2/FiO2 (mmHg), mean ± SD 214.49 ± 78.46 237.14 ± 124.33 0.3866
Baseline creatinine (µmol/L), median [IQR] 99.00 [72.00–158.00] 106.50 [70.00–200.00] 0.9761
Baseline acute kidney injury stageb 0.1423
No acute kidney injury 16 (45.71) 17 (50.00)
1 15 (42.86) 7 (20.59)
2 1 (2.86) 3 (8.82)
3 3 (8.57) 7 (20.59)
Baseline bilirubin (µmol/L), median [IQR]c 11.00 [6.00–17.00] 10.00 [7.00–17.00] 0.8104
Ventilator settings at EAdi catheter connection
Controlled mode, n (%) 29 (82.86) 33 (97.06) 0.1060
PEEP (cmH2O), mean ± SD
All patients 7.82 ± 2.51 8.29 ± 3.39 0.5891
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Table E1. Continued.
Characteristic Early resumption Late resumption p value
Patients on controlled mode (n=62) 7.82 ± 2.65 8.31 ± 3.44 0.7509
Patients on assisted mode (n=7) 7.84 ± 1.89 7.77 ± . -
Mean airway pressure (cmH2O), mean ± SD
All patients 12.09 ± 3.17 12.93 ± 4.60 0.6058
Patients on controlled mode (n=62) 12.38 ± 3.21 13.03 ± 4.63 0.7832
Patients on assisted mode (n=7) 10.68 ± 2.75 9.70 ± . -
Time with available EAdi recording (hours), 
median [IQR]
46.20 [27.10–67.22] 95.80 [74.58–118.50] <0.0001
Tracheostomy during ICU stay, n (%)d 4 (11.43) 3 (8.82) 1.0000
Mortality, n (%)
At ICU discharge 8 (22.86) 9 (26.47) 0.7277
At hospital dischargec 13 (38.24) 12 (35.29) 0.8014
Resumption of EAdi during study period
Subjects with complete recordings, n (%) 35 (100.00) 26 (76.47) 0.0022
Time to resumption, n (%)
<24 hours 35 (100.00) - -
24–48 hours - 11 (42.31) -
48–72 hours - 6 (23.08) -
72–96 hours - 5 (19.23) -
>96 hours (no resumption) - 4 (15.38) -
Estimated time (hours) to resumptione
Median [IQR] 0.00 [0.00–7.45] 53.28 [43.85–84.67]
Mean ± SE 3.81 ± 1.06 66.99 ± 6.13 <0.0001
Average EAdi amplitude (µV) during 
resumption, mean ± SD
10.81 ± 8.43 6.74 ± 3.42 0.0018
Use of sedative during the first 24 hours, n (%)f 32 (91.43) 31 (91.18) 1.0000
Propofol, n (%) 24 (75.00) 25 (80.65) 0.5900
Cumulative dose (mg/kg), median [IQR] 16.67 [6.53–28.70] 20.95 [10.82–36.30] 0.1645
Midazolam, n (%) 25 (78.13) 21 (67.74) 0.3533
Cumulative dose (mg/kg), median [IQR] 0.07 [0.03–0.25] 0.10 [0.05–1.33] 0.2294
Fentanyl, n (%) 27 (84.38) 24 (77.42) 0.4821
Cumulative dose (µg/kg), median [IQR] 3.19 [1.22–10.70] 9.64 [2.04–17.51] 0.1545
Use of sedatives prior to EAdi resumption (early 
group) or within the first 24 hours (late group), 
n (%)
10 (28.57) 31 (91.18) <0.0001
Propofol, n (%) 10 (100.00) 25 (80.65) 0.3072
Cumulative dose (mg/kg), median [IQR] 8.41 [5.71–21.97] 20.95 [10.82–36.30] 0.0466
Midazolam, n (%) 3 (30.00) 21 (67.74) 0.0632
Cumulative dose (mg/kg), median [IQR] 0.04 [0.03–0.98] 0.10 [0.05–1.33] 0.4069
Fentanyl, n (%) 8 (80.00) 24 (77.42) 1.0000





Characteristic Early resumption Late resumption p value
NMBA use, n (%)g 0.0368
No 11 (31.43) 5 (14.71)
Yes 24 (68.57) 29 (85.29)
Yes, for intubation 24 (68.57) 25 (73.53)
Yes, additional bolus or continuous infusion 0 (0.00) 4 (11.76)
Sedation analgesia score (during the first 6 hours 
of EAdi recording), median [IQR]h
2.00 [1.00–3.00] 1.50 [1.00–2.25] 0.2707
Abbreviations: APACHE, Acute Physiologic Assessment and Chronic Health Evaluation; EAdi, electrical 
activity of the diaphragm; FiO2, fraction of inspired oxygen; HCO3
-, bicarbonate; ICU, intensive care 
unit; IQR, interquartile range; NMBA, neuromuscular blocking agents; PaCO2, partial pressure of 
carbon dioxide; PaO2, partial pressure of oxygen; PEEP, positive end-expiratory pressure; SD, standard 
deviation; SE, standard error.
a 63 patients had arterial blood gas measured at baseline.
b Acute kidney injury staging was determined using KDIGO Clinical Practice Guideline for Acute Kidney 
Injury.
c For 1 patient, data was missing.
d Tracheostomy performed after 120 hours from first available EAdi.
e Estimated time was assessed on the whole study population (69 patients) with the Kaplan-Meier 
approach. Time to resumption was calculated from the first available EAdi using a threshold of 7 µV.
f 6 patients did not receive continuous sedative infusions in the first 24 hours.
g Standard doses for neuromuscular blocking agents were used; intubation doses for rocuronium were 
0.6–1.2 mg/kg, succinylcholine 1–2 mg/kg and cisatracurium 0.15–0.2 mg/kg. Continuous infusions 
of rocuronium or cisatracurium were titrated to clinical effect and were dosed as for 0.2–0.7 mg/kg/
hour and 0.06–0.18 mg/kg/hour, respectively, as per hospital policy.
h Sedation analgesia score was recorded in 54 patients in the first 6 hours.
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Table E2. Relationship between baseline parameters and the probability to be sedated during the first 
24 hours (or until EAdi resumption).
Odds ratio (95% CI) p value n=
Univariate logistic models
Age (year) 0.933 (0.896–0.971) 0.0007 69
Sex (ref. Female) 0.710 (0.264–1.908) 0.4971 69
APACHE II (score) 0.965 (0.908–1.024) 0.2413 68
Body mass index (kg/m2) 0.983 (0.933–1.036) 0.5247 67
Mode of ventilation (ref. Assisted) 4.239 (0.760–23.645) 0.0996 69
PaO2/FiO2 (mmHg) 1.000 (0.996–1.005) 0.8606 63
Creatinine (µmol/L) 1.001 (0.997–1.004) 0.6882 69
Baseline acute kidney injury stage (ref. No acute kidney injury) 69
1 0.346 (0.113–1.057) 0.0625
2 1.500 (0.139–16.144) 0.7380
3 1.167 (0.252–5.409) 0.8439
Baseline bilirubin (µmol/L) 1.004 (0.986–1.022) 0.6760 68
Reason for intubation (ref. Neurologic) 65*
Pulmonary 0.494 (0.131–1.857) 0.7445
Hemodynamic 0.343 (0.070–1.684) 0.2700
Multivariable logistic model
Age 0.933 (0.896–0.971) 0.0007 69
* 4 patients with other causes of intubation were excluded. Abbreviations: APACHE, Acute Physiologic 
Assessment and Chronic Health Evaluation; CI, confidence interval; FiO2, fraction of inspired oxygen; 
PaO2, partial pressure of oxygen.
Table E3. Estimated time to resumption of diaphragm electrical activity (EAdi) for secondary time and 
voltage thresholds as a sensitivity analysis.
Voltage and time threshold Time to EAdi resumption (hours), median [IQR]
5 µV, 12 hours 18.38 [0.00−53.88]
5 µV, 24 hours 22.02 [0.00−50.77]
7 µV, 12 hours 18.40 [0.00−53.90]
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E-Figure 1. Example of diaphragm electrical activity (EAdi) amplitude recording for a representa-
tive patient. Note the high variability in signal strength in the early time course for this patient. This 
patient had a total time of EAdi recording of about 96 hours and diaphragm activity occurred after 
48 hours and 51 minutes from EAdi catheter connection; the first 24-hour period with a median EAdi 




























E-Figure 2. (a) Linear correlation between diaphragm thickening fraction (TFdi) and diaphragm 
electrical activity (EAdi). (b) Stratification based on TFdi above or below 15% (minimal diaphragm 
activity on ultrasound). Median [interquartile range] EAdi amplitude during the ultrasound recording 
was 2.06 [0.53–6.50] μV and 14.75 [7.20–29.0] µV for those patients with TFdi below and above 




























































E-Figure 3. Example of a diaphragm electrical activity (EAdi) recording for a representative patient; 
EAdi amplitudes are captured every minute. Note the high variability in signal strength.
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Role of a successful spontaneous breathing trial in ventilator 
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ABSTRACT
Background
Spontaneous breathing trials (SBTs) have been shown to improve outcomes in critically ill 
patients. However, in patients with brain injury, indications for intubation and mechanical 
ventilation are different from those of non-neurological patients, and the role of an SBT in 
patients with brain injury is less established. The aim of the present study was to compare 
key respiratory variables acquired during a successful SBT between patients with successful 
ventilator liberation versus failed ventilator liberation.
Methods
In this prospective study, patients with brain injury (≥18 years of age) who completed a 
30-minute SBT were enrolled. Airway pressure, flow, esophageal pressure, and diaphragm 
electrical activity (EAdi) were recorded before (baseline) and during the SBT. Respiratory 
rate, tidal volume, delta global inspiratory muscle pressure (ΔPmus), ΔEAdi, and the 
neuromechanical efficiency (ΔPmus/ΔEAdi) of the diaphragm were calculated breath by 
breath and compared between the liberation success and failure groups. Failed liberation 
was defined as the need for invasive ventilator assistance within 48 hours after the SBT.
Results
In total, 46 patients (51.9 ± 13.2 years, 67.4% male) completed the SBT. Seventeen (37%) 
patients failed ventilator liberation within 48 hours. Another 11 patients required invasive 
ventilation within 7 days after completing the SBT. There were no differences in baseline 
characteristics between the success and failure groups. In-depth analysis showed similar 
changes in patterns and values of respiratory physiological parameters between the groups.
Conclusions
In patients with brain injury, ventilator liberation failure was common after a successful SBT. 
In-depth physiological analysis during the SBT did not provide data to predict successful 
liberation in these patients.
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INTRODUCTION
In critically ill patients with brain injury, mechanical ventilation aims to minimize secondary 
brain injury (e.g., due to ischemia and edema) by securing oxygenation and preventing 
hypercapnic acidosis [1–5]. However, the time-dependent nature of ventilator-related 
complications requires timely ventilator liberation [6–10]. Protocolized weaning, including 
the use of a spontaneous breathing trial (SBT), improves outcomes and is recommended 
in international guidelines [11–15].
Indications for endotracheal intubation and mechanical ventilation in patients with 
brain injury are largely different from those of critically ill patients without brain injury 
(further referred to as general critically ill patients) [8, 16–18]. The predictive value of a 
successful SBT for ventilator liberation in patients with brain injury is largely unknown. 
Recent studies have demonstrated higher extubation failure rates after a successful SBT 
in patients with brain injury compared with general critically ill patients [19–23]. After a 
successful SBT, extubation failure rates between 31% and 46% have been reported in 
patients with brain injury. In contrast, 10–14% of general critically ill patients completing 
an SBT failed ventilator liberation [24–27]. Reasons for the high failure rates in patients 
with brain injury may be related to upper airway function or neurological status [19, 21, 23]. 
Therefore, guidelines specifically recommend assessment for airway protection ability, 
including suctioning frequency, cough strength, and mental status [11, 28]. However, the 
role of impaired respiratory reserve has not been systematically evaluated in this population. 
This is important, as ventilator reconnection is frequent in tracheostomized patients with 
brain injury, indicating that factors other than upper airway protection may be involved [29]. 
Therefore, the aim of the current study was to investigate patients with brain injury and to 
determine if the respiratory physiological parameters during a successful SBT are different 
between patients with successful ventilator liberation versus failed ventilator liberation.
We present the following article in accordance with the STROBE reporting checklist 
(available at http://dx.doi.org/10.21037/atm-20-6407).
METHODS
Study design and patients
The present prospective study was conducted in the neurocritical intensive care unit (ICU) 
of the Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Patients with 
brain injury (≥18 years old), who were mechanically ventilated for >48 hours, were screened 
daily between 9 AM and 10 AM (from Monday to Friday) (see Supplemental file, Appendix 1). 
The readiness criteria for an SBT were as follows: 1) intracranial pressure <20 mmHg, or no 
clinical evidence of elevated intracranial pressure; 2) adequate oxygenation (PaO2/FiO2 >200 
mmHg or pulse oximetry >95% with FiO2 ≤0.5) and low level of ventilator support (positive 
end-expiratory pressure (PEEP) ≤5 cmH2O, and pressure support level ≤8 cmH2O); 3) 




and 160 mmHg); and 4) no sedatives or intermittent dosing of sedatives. Patients were 
excluded if they were moribund or brain dead, had spinal cord injury or any contraindications 
for esophageal pressure catheter placement, or were tracheostomized before or within 48 
hours after the SBT (as it affects weaning strategies).
The study was conducted in accordance with the Declaration of Helsinki (as revised 
in 2013), and was approved by the institutional ethics board of Beijing Tiantan Hospital 
(No. KY2016-018-02). Informed consent was obtained from all patients or their legal 
representatives.
Study protocol
Patients were ventilated with a Servo-I ventilator (Getinge, Solna, Sweden). A nasogastric 
catheter for diaphragmatic electrical activity (EAdi) (Getinge, Solna, Sweden) monitoring 
was inserted to replace the standard nasogastric feeding tube, and esophageal pressure 
(Pes) monitoring (SensorMedics, Yorba Linda, CA, USA) was conducted. Details for 
the catheter placement have been described previously [30–35]. Baseline data were 
collected just before the SBT in pressure support ventilation (PSV) mode (inspiratory 
support: 8 cmH2O; PEEP: 5 cmH2O). Subsequently, patients underwent a 30-minute SBT 
at continuous positive airway pressure (CPAP) of 5 cmH2O, with no inspiratory pressure 
support and without changing FiO2. At 1, 5, 10, 20, and 30 minutes after the start of the 
SBT, an end-expiratory occlusion maneuver was applied on the ventilator for at least 3 
consecutive breathing efforts to determine diaphragm neuromechanical efficiency. Criteria 
for terminating the SBT are listed in the Supplemental file, Table S1 [6].
After completing the SBT, patients were disconnected from the ventilator, either 
breathing through a T-tube circuit with humidified oxygen or extubated as decided by 
the clinical team using a screening checklist (see Supplemental file, Table S2) [36, 37]. 
Reconnection to the ventilator support was solely decided by the clinical team, who were 
unaware of the physiological data obtained for study purposes (especially data derived 
from EAdi and Pes). Reasons for resuming mechanical ventilation and/or reintubation 
were recorded. As per the clinical protocol, reintubation and/or reconnection to the 
ventilator was performed in patients meeting at least one of the following criteria: 1) 
decreased mental status compared with pre-SBT level of consciousness; 2) peripheral 
oxygen saturation <90% despite FiO2 >0.5; and 3) increased respiratory effort, such as 
tachypnea, accessory respiratory muscle recruitment, or thoracic-abdominal paradox [36]. 
Failed ventilator liberation was defined as the need for invasive ventilator support within 48 
hours after the SBT, independent of the presence of an artificial airway (tracheostomy or 
endotracheal tube). The Glasgow Coma Scale (GCS) score was recorded before ventilator 
disconnection to assess neurological status. The verbal score was counted as 1 for patients 
with an artificial airway [38]. Arterial blood samples and hemodynamic parameters (i.e., 
noninvasive blood pressure and heart rate) were collected before and at the end of the SBT. 
Patients were followed up until they were reconnected to mechanical ventilation, extubated, 
tracheostomized, discharged from the hospital, or 28 days after the first successful SBT, 
whichever came first.
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Data acquisition during the SBT
Flow was measured with a heated Fleisch pneumotachograph (Vitalograph, Lenexa, KS, USA) 
placed between the Y-piece of the ventilator circuit and the endotracheal tube. Two differential 
pressure transducers (KT 100D-2; KleisTEK di Cosimo Micelli, Monopoli, Italy; range: ±100 
cmH2O) were used to measure the airway opening pressure (Pao) and the Pes. The transducers 
were connected proximal to the endotracheal tube (Pao) and to the esophageal catheter (Pes), 
respectively. Flow and pressures signals were recorded by an ICU-Lab pressure box (ICU Lab, 
KleisTEK Engineering, Bari, Italy), with a sample frequency of 100 Hz. The pressure transducers 
were calibrated with a water column and the pneumotachograph with a 1-Liter calibration 
syringe (SN: 554–2266; Hans Rudolph, Shawnee, KS, USA) prior to each measurement [30]. 
The EAdi catheter was connected to the Servo-I ventilator. EAdi signals were recorded at a 
sample frequency of 100 Hz using dedicated software (Servo-tracker version 4.1, Getinge, 
Solna, Sweden). All recordings were saved and synchronized for offline analysis in a software 
developed for the ICU-Lab monitoring system (DigimaClic-1, ICU-Lab System, KleisTEK, Italy).
Data analysis
As per the study design, only patients completing the SBT were included for further analysis. 
Data were analyzed on a breath-by-breath basis at 6 time points as follows: at baseline 
(PSV prior to the SBT), and at 1, 5, 10, 20, and 30 minutes after start of the SBT. These 
time points were arbitrarily selected, as used previously [39, 40]. For each time point, 5 
consecutive breaths without artifacts (e.g., esophageal contractions) were selected.
Inspiratory time, expiratory time, respiratory rate (RR), minute ventilation, and duty cycle 
were derived from the flow signal. Tidal volume (Vt) was computed as the time integral 
of inspiratory flow. Intrinsic PEEP was calculated as the decrease in Pes until the start of 
inspiratory flow [41]. The chest wall recoil pressure (Pcw) was calculated as the product 
of tidal volume and the predicted elastance of the chest wall (4% of vital capacity). The 
effort of the inspiratory muscles was quantified by calculating the global inspiratory muscle 
pressure (Pmus) and the inspiratory esophageal pressure-time product (PTPes,insp). 
Delta Pmus (ΔPmus) was calculated as the peak difference between Pcw and Pes during 
inspiration. PTPes,insp was calculated as the time integral of the difference between Pes 
and Pcw (see Supplemental file, Figure S1) [42].
Neural respiratory drive was measured as the inspiratory increase in EAdi from basal 
activity (ΔEAdi). The static neuromechanical efficiency (NMEoccl) of the diaphragm was 
computed as ΔPao/ΔEAdi during an end-expiratory occlusion maneuver [31]. The NMEoccl 
was calculated from the first occluded breathing effort. In the presence of artifacts in the 
EAdi waveform, the second or third breathing effort of the same series was selected (see 
Supplemental file, Figure S2). This was acceptable, as we have demonstrated that NMEoccl 
remains stable during a 20-second occlusion. The dynamic neuromechanical efficiency of 
the diaphragm (NME,dyn) was defined as ΔPmus/ΔEAdi measured during tidal breathing 
(see Supplemental file, Figure S3). As the respiratory centers are located in the brainstem, 
we performed the chi-square test to determine if responses were different between patients 





Data were analyzed with IBM SPSS Statistics version 22.0 (IBM Corp., Armonk, NY, USA) and 
GraphPad Prism version 7.0 (GraphPad Software, Inc., San Diego, CA, USA). Assumption 
of normality was tested using the Shapiro-Wilk normality test. Differences in patient 
characteristics between the two groups were analyzed using the t-test, Mann-Whitney U 
test, or chi-square test, as appropriate.
To analyze the effects of time and group (failure and success) on each respiratory 
parameter, a linear mixed model design was used with fixed effects of time, group, group by 
time interaction, and a random effect of patient. For nonparametric respiratory parameters, 
an appropriate mathematical transformation was applied. Post hoc pairwise comparisons 
of estimated means over time and between groups at each time point were performed 
after applying Bonferroni correction [34]. Sensitivity analyses were performed in a subgroup 
analysis by defining the failed ventilator liberation as the need for invasive ventilator support 
within 7 days after the SBT.
For all tests, a 2-tailed p < 0.05 was considered to be statistically significant. Values 
were given as mean ± standard deviation, or median [interquartile range] for continuous 
variables, and as number and percentage for categorical variables. Because of the 
exploratory nature of this study, convenience sampling was used [39, 40].
RESULTS
During the 12-month study period, 251 patients were screened, and 46 were included for 
analysis (Figure 1). Reasons for exclusion included mechanical ventilation <48 hours (n=82) 
and early tracheostomy (n=59). Patient characteristics at baseline are reported in Table 
1. Seventeen (37%) patients failed ventilator liberation within 48 hours after a successful 
SBT. Of these patients, 4 were reintubated and 13 were reconnected to the ventilator before 
extubation. Reasons for failing ventilator liberation within 48 hours were post-extubation 
upper airway obstruction (n=4), neurological deterioration (n=8), and respiratory-related 
issues (n=5). Clinical characteristics of patients failing ventilator liberation within 48 hours 
were not different from patients with successful liberation (Table 1). The proportion of patients 
that remained liberated from mechanical ventilation decreased rapidly within 7 days after the 
first SBT and remained stable thereafter (Figure 2). In total, 28 patients were reconnected 
to the ventilator within 7 days after the first SBT. The median time until reconnection was 
1.4 [0.4–3.0] days. Further patient details are presented in the Supplemental file, Table S3.
Breathing pattern during the SBT in successful and failed liberation
Immediately after the transition from PSV to the SBT, Vt decreased and RR increased in 
both groups, but remained stable during the rest of the SBT (Table 2). Minute ventilation 
decreased in the successful liberation group only (9.0 [7.7–10.4] to 7.8 [6.1–10.0] L/min, p < 
0.05). There was no difference in respiratory pattern between the groups. Other respiratory 
physiological parameters are shown in the Supplemental file, Table S4.
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Patients that passed the SBT and enrolled
(n=46)
Extubated immediately after the SBT (n=9)
Remained intubated >48h after the SBT (n=20)
Extubated >48h after the SBT (n=7)
Tracheostomized >48h after the SBT (n=2)
Reconnected to MV >48h after the STB 





Not the 1st episode of MV or SBT (n=24)
Moribund or brain dead (n=16)
Spinal cord injury (n=12) 
Contraindications for esophageal 
catheter placement (n=8)
Patients screened for eligibility
(n=251)
Patients that performed the 30-min SBT
(n=50)
Succesful liberation (n=29)




Indications for resumed MV:
Upper airway obstruction after extubation (n=4)
Neurological deterioration (n=8)
Severe pneumonia (n=3)
Suspected respiratory muscle weakness (n=1)
Pulmonary edema (n=1)
Figure 1. Flowchart of patients enrolled in the study. Abbreviations: MV, mechanical ventilation; 























48h 72h 7 days 28 days
25
Number of subjects left
46 29 25 17 3
0 48h 72h 7 days 28 days
Figure 2. Proportion of patients liberated from mechanical ventilation after a successful sponta-
neous breathing trial (SBT). Number of patients left at the time of observation is shown below the 
x-axis. Patients were followed up until they were reconnected to the ventilation, extubated, tracheos-






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Respiratory muscle effort during the SBT in successful and failed liberation
As shown in Figure 3, parameters of inspiratory muscle effort including ∆Pmus, PTPes,insp, 
and ∆EAdi increased after the transition from PSV to the SBT in both groups, but remained 
stable during the SBT. There were no significant differences between groups.
NMEoccl, a measure for neuromechanical efficiency of the diaphragm, did not change 
after the transition from PSV to the SBT and remained stable during the SBT. No difference 
was found in NMEoccl between the two groups (Figure 4).
A subgroup analysis was performed to compare respiratory physiological parameters 
between patients that were successfully liberated from mechanical ventilation and patients 
failing ventilator liberation within 7 days. This, however, did not change the results compared 
with failure within 48 hours after the successful SBT (see Supplemental file, Table S5). 
Subgroup analysis was also performed in patients remaining intubated within 48 hours. 
First, the rate of liberation failure was comparable to that of patients who were extubated 
(39.4% vs. 30.8%, p = 0.74). Second, the respiratory physiological variables showed no 
difference between patients who failed and those who were successfully liberated from 
the ventilator within 48 hours (see Supplemental file, Table S6).
Arterial blood gas variables and hemodynamic variables
Arterial blood gas and hemodynamic variables are shown in Table 3. The arterial HCO3
- at 
the start of the SBT was significantly higher in the successful liberation group compared 
with the failed liberation group (28.4 ± 2.0 vs. 26.1 ± 2.7 mmol/L, p = 0.001). There were 
no differences between groups in hemodynamic variables at baseline or during the SBT.
Clinical outcomes
Clinical outcomes are shown in Table 4. There were no significant differences between the 
failed liberation and successful liberation groups with regard to discharge status, ICU length 
of stay, and hospital length of stay. At the time of hospital discharge, 40 (87.0%) patients 
were liberated from the ventilator in a median of 3.4 [0–6.2] days after the first successful 
SBT. In these patients, the median number of SBTs before final ventilator liberation was 2 
[1–5]. Two patients died before ventilator liberation and 4 patients were transferred to a 
local hospital for end-of-life care.
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Figure 3. Respiratory muscle effort quantified as (a) delta inspiratory muscle pressure (ΔPmus), (b) 
inspiratory esophageal pressure-time product (PTPes,insp), and (c) diaphragm electrical activity 
amplitude (ΔEAdi) during pressure support ventilation (baseline, gray area) prior to the spontaneous 
breathing trial (SBT) and during the course of the SBT for the successful (green dots) and failed (blue 
boxes) ventilator liberation groups. In 9 patients, Pes-derived parameters could not be analyzed due 
to the low quality of the signals (1 patient in the failure group and 8 patients in the success group). 
Data are presented as median with interquartile range. **p < 0.001, difference between the first 
minute of the SBT and baseline. No significant differences between the two groups were observed 








































Figure 4. Changes in diaphragm neuromechanical efficiency (NMEoccl) during pressure support 
ventilation (baseline, gray area) and during the course of the spontaneous breathing trial (SBT) in 
the successful (green dots) and failed (blue boxes) ventilator liberation groups. Data are presented 
as median with interquartile range. No significant differences were observed at any time point within 
and between the two groups.
Table 3. Arterial blood gas variables and hemodynamic variables at the start and at the end of the 
spontaneous breathing trial for the successful (S) and failed (F) ventilator liberation groups.
Parameters Group SBT start SBT end
p value
Main effects Interaction
Time Group Time × Group
pH S 7.49 ± 0.03 7.49 ± 0.03 0.351 0.13 0.06
F 7.47 ± 0.04 7.48 ± 0.04
PaO2 (mmHg) S 103.5 ± 25.4 98.6 ± 30.9 0.499 0.528 0.799
F 97.3 ± 28.5 96.0 ± 34.4
PaCO2 (mmHg) S 36.7 ± 5.0 37.2 ± 5.2 0.552 0.233 0.269
F 35.6 ± 6.7 34.5 ± 5.9
HCO3
- (mmol/L) S 28.4 ± 2.0* 28.5 ± 2.3* 0.373 0.004 0.441
F 26.1 ± 2.7 26.9 ± 2.6
PaO2/FiO2 (mmHg) S 258.7 ± 63.5 246.5 ± 77.3 0.499 0.528 0.799
F 243.2 ± 71.2 240.0 ± 86.0
MAP (mmHg) S 98.2 ± 12.0 99.1 ± 13.0 0.775 0.973 0.489
F 98.8 ± 7.2 98.4 ± 8.8
HR (min-1) S 89.0 ± 20.6 94.3 ± 15.5 0.659 0.776 0.095
F 94.5 ± 12.6 91.4 ± 13.1
Data are presented as mean ± standard deviation. Comparison between the successful (S) and failed 
(F) ventilator liberation groups: *p < 0.05. No significant differences were observed within each group 
before and after the SBT. Abbreviations: FiO2, fraction of inspired oxygen; HCO3
-, bicarbonate; HR, heart 
rate; MAP, mean arterial pressure; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of 
oxygen; SBT, spontaneous breathing trial.
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Table 4. Clinical outcomes in the successful and failed ventilator liberation groups.







Received tracheostomy 11 (21.7) 4 (13.8) 7 (41.2) 0.07
Length of stay in ICU (days) 13.5 [11.0–20.0] 14.0 [11.0–18.5] 13.0 [10.5–20.5] 0.793
Length of stay in hospital (days) 34.0 [23.8–54.0] 30.0 [22.0–50.5] 44.0 [28–57.5] 0.175
Successful ventilator liberation 
at time of discharge
40 (87.0) 26 (89.7) 14.0 (82.4) 0.389
Died on mechanical ventilation 2 (4.3) 1 (3.4) 1 (5.9) 0.608
Data are presented as median [interquartile range] or n (%). Four patients (2 in each group) were 
transferred to the local hospital in their hometown for end-of-life care. Abbreviation: ICU, intensive 
care unit.
DISCUSSION
In the current study, we demonstrated that, in patients with brain injury completing a 30-
minute SBT, 37% required invasive ventilator support within 48 hours and 61% within 7 
days. In-depth analysis of respiratory muscle effort and breathing patterns during the SBT 
did not provide any predictive information for ventilator liberation failure. Therefore, the 
clinical usefulness of a successful SBT in this patient category is debatable.
Successful SBT and failed ventilator liberation
Our study demonstrated that, in patients with brain injury, ventilator liberation failure 
within 48 hours after a successful SBT was more common (37%) compared with general 
critically ill patients [24–27, 44]. In general critically ill patients, Subira et al. reported 12% of 
extubation failure within 48 hours after a successful SBT [24], and Burns et al. reported that 
the reintubation rate was 13% in younger patients (age <65 years) and 10.8% in patients 
aged ≥65 years [25]. The differences in ventilator reconnection may be related to underlying 
illness [45]. Reasons for resuming ventilator support may be different between general 
critically ill patients and patients with brain injury. In general critically ill patients, reasons 
for resuming ventilator support are mainly related to cardiorespiratory function [24, 25, 46, 
47]. In our study, 4 of 17 (24%) patients were reconnected to the ventilator because of upper 
airway obstruction, and 8 of 17 (47%) patients for neurological reasons. These data are in 
line with previous studies on patients with brain injury [21, 48]. Karanjia et al. retrospectively 
investigated the cause of reintubation in 99 patients with brain injury reintubated within 72 
hours after a successful SBT [48]. They found that the primary cause for reintubation was 
respiratory distress associated with decreased mental status, without signs of aspiration 
or pneumonia. Given that most patients with brain injury are intubated and mechanically 
ventilated for neurological reasons, these results are not surprising. Accordingly, in patients 
with brain injury, the predictive value of a successful SBT for ventilator liberation appears 




patients with brain injury. Neurological dysfunction may not affect the ability to breathe 
(tested with an SBT), but may affect ventilator liberation success.
We explored if more advanced respiratory physiological parameters collected during the 
SBT were helpful in predicting ventilator liberation outcome. Similar respiratory parameters 
have been systematically measured during a 30-minute SBT in general critically ill patients 
[39, 40]. In these studies, variables of breathing pattern (RR, Vt, minute ventilation, and 
RR/Vt), EAdi and its derived parameters (neuromechanical and neuroventilatory efficiency) 
were reliable and early predictors for ventilator liberation outcome. In contrast, we did not 
find differences in physiological parameters related to breathing pattern or respiratory 
muscle effort between liberation success and failure patients with brain injury in our study. 
Interestingly, the values of the respiratory parameters assessed in our study were similar 
to the values earlier reported in successfully liberated general critically ill patients [39, 
40]. Immediate changes occurred after the transition from PSV to the SBT, but remained 
relatively stable during the course of the SBT. This indicates that limited cardiorespiratory 
physiological reserve was not the main reason of ventilator liberation failure. Although the 
cardiorespiratory reserve and neuro-respiratory drive can be assessed during an SBT, it is 
unlikely that neurological deterioration affects the course of an SBT. Therefore, the clinical 
usefulness of a successful SBT in patients with brain injury can be challenged or even 
considered misleading. In patients with brain injury, both neurological and non-neurological 
features should be evaluated before the decision of ventilator liberation. Therefore, 
other valid tools to assess underlying neurological conditions need to be developed and 
prospectively evaluated to predict the success of ventilator liberation.
Neurological status is one of the major concerns before the decision of ventilator 
liberation is made for patients with brain injury. Investigators have used the GCS to 
decide on extubation in these patients [49, 50]. However, the role of the consciousness 
level on extubation outcome remains controversial [20, 38, 51, 52]. Whether a low level 
of consciousness affects the breathing pattern in brain-injured patients is unclear. In our 
study, the GCS at the time of ventilator disconnection was similar for liberation success and 
failure patients. Moreover, half of the patients with a GCS <8 were successfully liberated 
from the ventilator. Accordingly, the level of consciousness appears not a main predictor for 
ventilator liberation outcome in these patients. Studies have demonstrated that together 
with visual pursuit, adequate swallowing function may improve ventilator liberation outcome 
[50], although no recommendations on this topic are available in recent guidelines [28]. 
Therefore, further studies are required to investigate more specific parameters, rather than 
the level of consciousness, to assess neurological status during the SBT.
High rate of liberation failure
Compared with other studies in patients with brain injury, the liberation failure rate in our 
patients appeared rather high [20, 21, 50, 53]. This may be related to the anatomical site 
of the injury. In our study, 54% (25/46) of the patients had infratentorial lesions and 10 of 
these patients had lesions that involved the brainstem. Infratentorial lesions include lesions 
located in the cerebellum and/or brainstem, which puts patients at high risk of respiratory 
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compromise by involving primary neural respiratory centers, lower cranial nerve nuclei, and 
reticular activating pathways [43, 54].
In addition, the type of SBT used may affect extubation outcome. An SBT with low 
inspiratory support reduces patient respiratory effort. However, this technique may 
overestimate the patient’s ability to breathe without assistance. Conversely, an SBT with 
a T-piece provides no inspiratory (and expiratory) support, which more accurately reflects 
the physiological condition after extubation [55]. However, the sudden drop in PEEP may 
induce cardiac dysfunction [56, 57]. It has been suggested that an inspiratory pressure 
support SBT improves extubation outcomes compared with a T-piece SBT [24, 58]. In our 
study we did not apply inspiratory support, but CPAP only. We chose this strategy as it 
better reflects breathing effort after extubation [55, 57].
Strengths and limitations
The present study has several strengths, including the in-depth analysis of breathing 
pattern and respiratory muscle effort during an SBT. This has not been evaluated in earlier 
studies in patients with brain injury. In addition, half of the patients had an infratentorial 
lesion, 10 of which had brainstem involvement. This provided an opportunity to explore the 
impact of the anatomical location on liberation outcome, especially brainstem injury. Our 
study suggests that, for patients completing an SBT, the anatomic location of the lesion is 
not associated with the rate of liberation failure.
However, several limitations should be acknowledged. First, this was a single-center 
study, possibly challenging the generalizability of the data. Nevertheless, the study 
was performed in the largest neurological ICU in China, admitting the full spectrum of 
patients with brain injury. Second, we did not perform a formal sample size analysis. This 
is reasonable given the explorative nature of the study, and the current sample size was 
comparable to earlier studies [39, 40]. The results of the current study are helpful for sample 
size calculation in future studies with this specific patient population. Third, although all 
patients completing the SBT were disconnected from the ventilator, not all patients were 
extubated directly after the SBT. Therefore, the difference between ventilator liberation and 
extubation should be acknowledged. However, our study showed that the liberation failure 
rate in patients who were not extubated was comparable to patients who were immediately 
extubated. Moreover, respiratory physiological parameters were not different between the 
liberation success and failure groups in these subgroups of patients. Breathing without 
ventilator assistance through an endotracheal tube after a successful SBT is common in 
our ICU, especially in patients with anatomical injury at the brainstem level. This strategy 
allows for the recovery of upper airway protective reflexes before the decision of early 






A successful SBT does not predict ventilator liberation in patients with brain injury, indicating 
that factors other than respiratory dysfunction are involved in this specific population. Given 
the high rate of ventilator liberation failure in patients with brain injury, further studies 
focusing on non-respiratory parameters to predict liberation success are warranted.
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Appendix 1: Definition of the brain-injured patients screened
Potential candidates for this study were brain-injured patients, including:
• Traumatic brain injury (including contusion, brain hemorrhages, shearing lesions, 
and subdural and epidural hematomas)
• Stroke
• Global cerebral ischemia (e.g., after cardiac arrest)
• Infections of the brain
• Brain tumor (including post-neurosurgical status)
Table S1. Protocolized criteria for a failed spontaneous breathing trial.
Tachypnea: respiratory rate >35 breaths/min for ≥5 minutes
Hypoxemia: saturation as per a pulse oximeter <90% despite increasing FiO2 to 0.5 for ≥30 
seconds
Heart rate: >140 beats/min or a 20% change from baseline for ≥1 minute
Hypertension or hypotension: systolic blood pressure >180 or <90 mmHg for ≥1 minute
Agitation, diaphoresis, or anxiety confirmed as a change from baseline and present for >5 minutes
Table S2. Screening checklist used to determine the patient’s suitability for extubation.
Question Answer
1. Awake and alert with cerebral function adequate for patient co-operation or 
equivalent pre-SBT state of consciousness?
Yes □ No □
2. Hemodynamic stability (lack of vasopressor support and mean arterial pressure 
within 10–15% of baseline)?
Yes □ No □
3. Adequate recovery of muscle strength? Yes □ No □
4. Normal tidal volumes, normocapnia (end-tidal carbon dioxide 30–45 mmHg), 
minimum pulse oximetry saturation >95% with FiO2 0.5?
Yes □ No □
5. Intact gag reflex and swallow function (presence of clearly audible cough during 
suctioning)?
Yes □ No □
The answer to all questions must be “yes” in order for extubation to be approved.
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Figure S1. Calculation illustration of the global pressure generated by the inspiratory muscles 
(ΔPmus), the inspiratory esophageal pressure-time product (PTPes,insp), and the electrical ac-
tivity of diaphragm (EAdi). The recoil pressure of the chest wall (Pcw, black line superimposed to 
the esophageal pressure (Pes) tracing) is calculated from the predicted elastance of the chest wall 
(4% of vital capacity) and the tidal volume. The inspiratory increase in Pcw starts from the onset 
of the decrease in Pes, as indicated by the vertical dashed red line. The following vertical dashed 
black lines indicate the start and end of the flow-based inspiration and expiration of one breathing 
cycle. The ΔPmus is the difference between the Pes nadir and the Pcw at that same time point (see 
arrow). The intrinsic positive end-expiratory pressure (PEEPi) is the difference in Pes between the 
onset of the decrease in Pes and the start of the inspiratory flow. The PTPes,insp is calculated as 
the area between the Pcw and Pes tracings during inspiration (light green area). The amplitude of 















Figure S2. Calculation illustration of the neuromechanical efficiency index during an end-expiratory 
occlusion maneuver (NMEoccl). From top to bottom: airway opening pressure (Pao), esophageal pres-
sure (Pes), flow, and electrical activity of diaphragm (EAdi) tracings. The end-expiratory occlusion 
(EEO) includes three breathing efforts. The calculation is performed with the first breath; both the 
Pes and Pao could be used to calculate the NMEoccl. Amplitudes of inspiratory Pes (ΔPesEEO) and EAdi 
(ΔEAdiEEO) during the EEO are calculated in the same way as described in Figure S1. The NMEoccl is 
calculated as ΔPaoEEO divided by ΔEAdiEEO.
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Figure S3. Calculation illustration of the dynamic neuromechanical efficiency (NME,dyn) index 
and neuroventilatory efficiency (NVE) index during tidal breathing. Tidal volume is calculated as 
the integral of the flow signal during inspiration. ΔEAdi and ΔPmus are calculated as described in 
Figure S1. The NME,dyn is calculated as ΔPmus divided by ΔEAdi. The NVE index is calculated as 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Early and delayed extubation after the first spontaneous breathing trial (SBT)
Within 48 hours after the first SBT, 13 (28.3%) subjects were extubated, and 33 (71.7%) 
subjects continued to breathe through a T-tube circuit with humidified oxygen. The rate 
of failed ventilator liberation in extubated subjects and subjects without extubation were 
not different (4/13 (30.8%) vs. 13/33 (39.4%), respectively, p = 0.74).
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ABSTRACT
Background
During the COVID-19 pandemic, a need for innovative, inexpensive, and simple ventilator 
devices for mass use has emerged. The Oxylator (CPR Medical Devices, Markham, Ontario, 
Canada) is an FDA-approved, fist-size, portable ventilation device developed for out-of-
hospital emergency ventilation. It has not been tested in conditions of severe lung injury 
or with added PEEP. We aimed to assess the performance and reliability of the device 
in simulated and experimental conditions of severe lung injury, and to derive monitoring 
methods to allow the delivery of safe, individualized ventilation during situations of surge.
Methods
We bench-tested the functioning of the device with an added PEEP valve extensively, 
mimicking adult patients with various respiratory mechanics during controlled ventilation, 
spontaneous breathing, and prolonged unstable conditions where mechanics or breathing 
effort was changed at every breath. The device was further tested on a porcine model (4 
animals) after inducing lung injury, and these results were compared with conventional 
ventilation modes.
Results
The device was stable and predictable, delivering a constant flow (30 L/min) and cycling 
automatically at the inspiratory pressure set (minimum of 20 cmH2O) above auto-PEEP. 
Changes in respiratory mechanics manifested as changes in respiratory timing, allowing 
prediction of tidal volumes from breathing frequency. Simulating lung injury resulted in 
relatively low tidal volumes (330 ml with compliance of 20 ml/cmH2O). In the porcine 
model, arterial oxygenation, CO2, and pH were comparable to conventional modes of 
ventilation.
Conclusions
The Oxylator is a simple device that delivered stable ventilation with tidal volumes within 
a clinically acceptable range in bench and porcine lung models with low compliance. 
External monitoring of respiratory timing is advisable, allowing tidal volume estimation 
and recognition of changes in respiratory mechanics. The device can be an efficient, low-
cost, and practical rescue solution for providing ventilatory support as a temporary bridge, 
but it requires a caregiver at the bedside.
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QUICK LOOK
Current knowledge
During the COVID-19 pandemic, a need for innovative, inexpensive, and simple 
ventilator devices for mass use has emerged. The Oxylator is an FDA-approved, 
fist-size, portable ventilation device developed for out-of-hospital emergency 
ventilation. However, it has never been tested in conditions of severe lung injury or 
with an added PEEP valve.
What this paper contributes to our knowledge
In bench and porcine lung injury models, the Oxylator delivered stable ventilation 
with tidal volumes within a clinically acceptable range in lungs with low compliance. 
External monitoring of respiratory timing is advisable to allow bedside estimation 
of tidal volume and recognition of changes in respiratory mechanics. The device 
can be an efficient, low-cost, and practical rescue solution for providing ventilatory 
support as a temporary bridge, but its use requires a caregiver to always be present.
INTRODUCTION
The coronavirus (COVID-19) pandemic has highlighted challenges with access to, and 
possible critical shortages of medical equipment in settings with overwhelming needs 
[1–3]. Unexpected surges of patients with life-threatening respiratory illnesses motivated 
some centers to consider splitting ventilators between patients [4, 5], ventilating patients 
outside of the intensive care unit (ICU), and using ventilators not designed for ICUs. These 
approaches have major limitations, and the capabilities and potential complications of 
these unconventional methods are poorly understood. Substantial government funding 
has led to scaled-up production of ventilators, and a number of initiatives to design and 
build new, “simple” ventilators suitable for mass production in emergencies [6]. Effective, 
inexpensive, and simple to use mechanical ventilators are needed to ventilate COVID-19 
patients at the onset of respiratory failure, in emergency rooms, outside of ICU settings, or 
during ICU stay and the prolonged recovery period [1–3, 7, 8]. Such equipment may also be 
needed in future regional epidemic episodes or in under-resourced settings.
The Oxylator (CPR Medical Devices, Markham, Ontario, Canada), which has the Conformitè 
Europëenne mark and is FDA approved, is a fist-size, ultra-light, portable ventilation device 
developed for out-of-hospital use during resuscitation from cardiac arrest and emergency 




cycled breaths. It can be used with a positive end-expiratory pressure (PEEP) valve placed 
in series and requires minimal adjustments (adjustable set pressure above PEEP). Limitations 
include a complete lack of monitoring displays, and settings restricted to the pressure limit. 
Although the device is used in different countries during pre-hospital emergencies, it is 
unclear whether its use could be extended to situations of severe lung injury, especially given 
its lack of monitoring. It has never been tested in conditions of severe lung injury such as 
seen in COVID-19-related acute respiratory distress syndrome (ARDS), nor in an ICU setting. 
Provided that the ventilation delivered can be predicted, it could be a useful device in critical 
situations as a bridge treatment until an ICU ventilator is available, or in resource-deprived 
settings where mechanical ventilators are unavailable or impractical. We aimed to assess 
the ventilation delivered and its predictability in terms of volume and rate based on pressure 
settings and respiratory mechanics, especially in simulated and experimental conditions of 
severe lung injury; and to derive bedside monitoring methods to allow the delivery of safe, 
individualized ventilation in situations of surge, such as during the COVID-19 pandemic.
METHODS
We studied 6 individual Oxylator devices (4 EMX models and 2 HD models; weight, 0.25 
kg), in a bench simulation and an animal model of lung injury. Experiments were primarily 
conducted with the EMX model, which is most commonly used worldwide. The bench 
study was performed at St. Michael’s Hospital, Toronto, Canada. Animal experiments were 
performed at The Hospital for Sick Children, Toronto, Canada.
Working principle
The device (Figure 1a) can be connected to a tracheal tube, face mask, or supraglottic 
airway. Connected to a standard compressed (50 psig) air/oxygen tank or wall unit, the 
device delivers a constant flow of 30 L/min and is entirely mechanical, therefore requiring 
no electricity. A breath is triggered when the airway pressure (Paw) at end expiration 
drops below a fixed low pressure, and no longer opposes the weight of a valve that is 
then magnetically pulled into the inspiration position. Inspiration continues until a user-
adjustable pressure above PEEP is reached, which can be set between 20–45 cmH2O on 
the EMX model and between 15–30 cmH2O on the HD model. Inspiration then abruptly 
ceases, and expiration occurs passively (secondary to lung elastic recoil) until Paw declines 
to 2–4 cmH2O (auto-PEEP generated by the device), which triggers the next breath. There 
is no capability for manual adjustment of respiratory rate (RR), inspiratory time (Ti) or tidal 
volume (Vt) by the clinician. We reasoned that these parameters would be determined 
primarily by the patient’s respiratory system compliance (Crs) and airway resistance, a 
characteristic that could be exploited for monitoring purposes. In addition to this automatic 
mode, breaths can be delivered manually by intermittently depressing the oxygen release 
button on the device. The device itself has no monitoring available; however, it does provide 
audible feedback (i.e., cycling).
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Figure 1. (a) The device (Oxylator model: EMX, 0.25 kg) and resulting airway flow and pressure 
(Paw) waveforms when no PEEP valve is attached. Connected to compressed gas (50 psig), the 
device delivers a constant flow of 30 L/min, without use of electricity. Inspiration, triggered by a 
nadir in airway pressure (Paw), continues until a user-adjustable peak Paw is achieved (between 
20–45 cmH2O). Expiration occurs passively (secondary to lung elastic recoil) until Paw declines 
to 2–4 cmH2O (auto-PEEP generated by default), which triggers the next breath. Respiratory rate, 
inspiratory time and tidal volume are not pre-set, and are determined primarily by the patient’s 
respiratory system compliance and airway resistance. The device itself has no monitoring available. 







The device was tested with a spring-loaded PEEP valve (AMBU A/S, Denmark) (Figure 
1b) on a two-chamber Michigan test lung (Michigan Instruments, Grand Rapids, USA) to 
simulate various situations of severe lung injury; the device was also tested on an Active 
Servo Lung 5000 (ASL 5000; IngMar Medical, Pittsburgh, USA) to simulate unstable 
situations and active assisted breathing. Because of the intrinsic expiratory resistance 
offered by the AMBU PEEP valve, we also performed experiments with a simple and less 
resistive PEEP generated by an underwater column [11].
The Michigan test lung was used to simulate ARDS with various respiratory mechanics 
during controlled ventilation. The dial pressure of the device was set at 20 cmH2O for the 
EMX model and at 15 cmH2O for the HD model (minimum pressure possible). Crs was varied 
between 15–70 ml/cmH2O and airway resistance was varied between 10–30 cmH2O/L/s to 
mimic lung injury and obstructive conditions. PEEP levels were set at 0, 10, and 20 cmH2O. 
This resulted in over 80 combinations of Crs, resistance, and PEEP levels that were tested; 
at least 8–10 breaths per combination were recorded.
To test the reliability of the device, we simulated the following clinical problems of 
abrupt onset: 1) lung volume reduction due to complete airway obstruction: starting from 
a Crs of 50 ml/cmH2O and a resistance of 5 cmH2O/L/s, one lung was clamped, followed 
by clamping of both lungs; 2) leak conditions were simulated by placing a connector with 
two small holes (2 mm diameter) at the airway opening of the test lung, such that small 
leaks and large leaks were generated by opening one or both holes, respectively; and 3) 
pneumothorax: starting with normal Crs and resistance values, compliance of the affected 
lung was drastically reduced to simulate lung collapse. In addition, a heat and moisture 
exchanger (HME) filter was placed in-line for some measurements. To record Paw and 
airway flow waveforms, a pneumotachograph was placed at the airway opening of the test 
lung and was connected to a dedicated measurement setup (FluxMed GrT, MBMED, Buenos 
Aires, Argentina). Data were acquired at 256 Hz. For some experiments, the pressure inside 
the test lung (i.e., reflecting alveolar pressure) was recorded. The relationships between Vt, 
RR, Ti and Crs were analyzed by linear or nonlinear curve fitting, where appropriate (see 
Statistical analysis).
The ASL 5000 was used first to evaluate the device during assisted ventilation. With 
combinations of a Crs of 30 and 50 ml/cmH2O, resistance of 10 and 20 cmH2O/L/s, and a 
PEEP of 0 and 10 cmH2O, spontaneous breathing was simulated as an inspiratory patient 
effort (i.e., muscular pressure; Pmus) of 5, 15, and 25 cmH2O to mimic low, moderate, 
and high breathing effort, respectively, with spontaneous RR varying between 25 and 35 
breaths/min and values of mechanics simulating what has been described for COVID-19 
[12–14]. Second, we tested the stability of the ventilation during prolonged periods (>4 
hours) of unstable respiratory mechanics to simulate an unstable patient. Mechanics 
(similar ranges of Crs and resistance values as used for the Michigan test lung experiments) 
and/or breathing effort (Pmus varying between 3–13 cmH2O) were randomly changed at 
every breath. Waveforms were acquired on the ASL 5000 at a sampling frequency of 512 
Hz and stored for offline analyses.
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Animal model
All experimental procedures were in compliance with the guidelines of the Canadian 
Committee for Animal Care and were conducted after approval by the Animal Care 
Committee of the Research Institute in The Hospital for Sick Children. Anesthetized pigs 
(4 animals, 35–40 kg) were ventilated with an EMX model with dial pressure set at 20 or 
25 cmH2O, using an in-line HME filter and an AMBU PEEP valve. FiO2 was controlled with 
an external gas blender. The device was tested under three conditions for a 40-kg animal: 
normal lungs (Crs, 26–35 ml/cmH2O), mild lung injury (Crs, 15–19 ml/cmH2O), and severe 
lung injury (Crs, 9–11 ml/cmH2O). Lung injury was induced by a two-hit method: lung lavage 
followed by high-stretch ventilation [15]. Lung lavage was performed using warmed saline 
0.9%, in aliquots of 30 ml/kg until PaO2 was <100 mmHg for 10 minutes. Pigs were then 
subjected to high-stretch ventilation and Crs was measured every 15 minutes. High-stretch 
ventilation was stopped upon reaching the desired target for a drop in compliance or in 
PaO2/FiO2 ratio. Mild and severe lung injury were defined according to the Berlin definition 
of ARDS [16].
For the first 3 pigs, respiratory mechanics and gas exchange (sampled from the right 
carotid artery) measured during ventilation with the device were compared with conventional 
ventilation modes (pressure control and volume control ventilation) under conditions of 
normal lungs and after inducing lung injury (2 animals for mild injury, 1 animal for severe 
injury). Two animals underwent conventional ventilation before changing the ventilator 
to the device, and one animal underwent ventilation with the device before conventional 
ventilation (Engström Carestation, GE, Boston, USA). The total experiment duration was 
between 5–7 hours. Because there are no standards for ventilation modes in pigs, we used 
pressure control and volume control ventilation modes with settings derived from previous 
experiments of lung injury in the laboratory to deliver lung-protective ventilation [15]. 
PEEP and driving pressure delivered by the device (i.e., peak Paw – PEEP) were matched 
whenever possible (Table 1). A fourth pig was studied to assess the relationships between 
Vt, RR, Ti and Crs under conditions of normal lungs and after mild and severe lung injury. 
At each condition, additional changes in Crs were induced by performing stepwise lung 
recruitment maneuvers followed by both incremental and decremental PEEP conditions 
(from 0 to 25 cmH2O and back to 0 cmH2O, in steps of 5 cmH2O per 10–20 seconds). During 
all measurements, a pneumotachograph was placed at the endotracheal tube and Paw 
and airway flow waveforms were acquired at 1 KHz in LabChart (ADInstruments, Sydney, 
Australia) and stored for offline analysis. In 2 pigs, an electrical impedance tomography 
(EIT) device (PulmoVista 500, Drager, Lubeck, Germany) was attached via a 16-electrode 
belt for additional recording of lung impedance and ventilation distribution.
Data analysis and statistics
Pressure and flow recordings were analyzed using software developed for MATLAB 2019b 
(Mathworks, Natick, MA, USA). From the flow tracings, peak inspiratory flow, RR, Ti, 
expiratory time (Te), Ti to Te ratio (I:E ratio) and Vt (i.e., integral of inspiratory flow) were 




waveforms. To assess the possibility of predicting Vt based on respiratory timing, the 
relationships between Vt, RR, Ti, set pressure and Crs were studied using linear or nonlinear 
(e.g., power function) regression models, where appropriate.
Stability of the device during prolonged periods of unstable respiratory mechanics 
was inspected visually as well as quantified as the percentage of breaths for which Paw 
tracings remained within expected limits. To be considered stable, the device had to meet 
the following criteria: 1) for a device set pressure of 20 cmH2O, driving pressure had to be 
at least 15 cmH2O (anticipating some resistive pressure to be subtracted); and 2) for a 
set PEEP of X cmH2O, the resulting total PEEP had to be between X – 1 and X + 5 cmH2O 
(considering additional auto-PEEP of the device).
For the animal experiments (i.e., the first 3 pigs), respiratory mechanics and blood gas 
results for mechanical ventilation with the device and conventional modes, at different 
severities of induced lung injury, are presented as their mean with 95% confidence interval 
(CI) (lower limit–upper limit). Modes were compared by computing the distribution (95% 
CI) for the difference of the means (at the 0.05 significance level). Data from the fourth 
pig were used to assess how predictable the device output (i.e., the possibility to estimate 
Vt) was; the bench-derived model fit for predicting Vt using RR was applied to the pig 
data and the percentage of breaths that fell within the 95% CI was calculated. From the 
EIT recordings, end-inspiratory lung impedance (EILI), end-expiratory lung impedance 
(EELI) and delta Z (i.e., changes in impedance during the respiratory cycle) were recorded 
at each PEEP level; as the device’s driving pressure is constant, changes in delta Z reflect 




The device output varied as a function of the set pressure, the auto-PEEP generated by 
the device (2 to 4 cmH2O), and the respiratory mechanics. The flow was found to be quite 
constant at 28.7 ± 1.7 L/min across all conditions. A set pressure of 20 cmH2O produced a 
driving pressure of 15–17 cmH2O depending on the resistance and after subtracting resistive 
pressure and auto-PEEP of the device. Adding an HME filter reduced driving pressure by 
approximately 1 cmH2O, due to a small increase in resistance.
Because the flow is constant and the cycling is based on a pre-set pressure, the pressure 
limit is reached after a Ti depending on compliance. Ti and Vt vary together and depend 
on the set pressure and the compliance. Figure 2 shows the linear relationship between Ti 
and Vt using the EMX model with a set pressure of 20 cmH2O. The delivered Vt was very 
close to expected based on the constant flow of 28.7 ± 1.7 L/min and the observed Ti; 
therefore, it was highly predictable. There was some variability in I:E ratio depending on 
the respiratory mechanics, ranging from 1:1 to 1:1.7. Therefore, the relationship between RR 
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(assessed over a range of 5–35 breaths/min) and Vt followed a power function, and Vt 
could be reasonably well estimated: Vt (ml) = 10,530 × RR
-0.979, r2 = 0.95 (p < 0.001). During 
simulated severe ARDS with a set Crs of 20 ml/cmH2O, the EMX model at a set pressure 
of 20 cmH2O resulted in a RR of 30 breaths/min (range, 25–35 breaths/min) and Vt of 
330 ml (range, 300–360 ml) (range due to variation in simulated resistance). With a Crs 
>50 ml/cmH2O, the delivered Vt was larger (>800 ml) and RR lower (<14 breaths/min). As 
Vt and RR change reciprocally with changes in respiratory mechanics, minute ventilation 
remained fairly constant across all conditions at 10.4 ± 0.3 L/min. For the HD model with a 
set pressure of 15 cmH2O, the driving pressure was 11–14 cmH2O. Accordingly, Vt was within 
a clinically acceptable range (<420 ml) for Crs <30 ml/cmH2O. With knowledge of the 



















Figure 2. Linear relationship between inspiratory time and tidal volume delivered with the device 
in a bench simulation with varied compliance and resistance (r2 = 0.997, p < 0.001). Dashed lines 
represent the 95% confidence interval. Delivered tidal volume based on inspiratory time was very 
close to expected based on the constant flow of 28.7 ± 1.7 L/min and the inspiratory time.
Spontaneous breathing
Figure 3 illustrates that spontaneous ventilation was possible: inspiration was almost always 
triggered when breathing effort resulted in a Paw drop below total PEEP. Due to the fixed 
flow rate, the pressure curve displayed a downward curvature suggesting relative flow 
starvation, which was, as expected, more pronounced with increasing inspiratory breathing 
effort. Wasted efforts were only seen in simulated conditions of low inspiratory breathing 















Figure 3. Airway pressure (Paw) waveforms for simulated active assisted breathing with the device 
under conditions with a compliance of 30 ml/cmH2O and resistance of 20 cmH2O/L/s. A PEEP of 12 
cmH2O was applied with the AMBU PEEP valve, resulting in a total PEEP of 15 cmH2O. Patient effort 
was simulated as a muscle pressure (Pmus) of (a) 5 cmH2O (low effort), (b) 15 cmH2O (moderate 
effort) and (c) 25 cmH2O (high effort). Note that flow starvation is present with increases in Pmus, 
as evidenced by the downward curvature of the Paw.
Simulated acute problems
Simulated acute clinical problems were immediately noticed by abrupt audible changes in 
RR (e.g., inspiratory and expiratory cycling is easily audible); simulation of acute obstruction 
(e.g., mucus plugging and atelectasis) resulted in a direct increase in RR as a result of a 
compliance drop. In addition, the audible feedback from the device (ultra-rapid cycling 
manifests as vibrations at high RR) indicated a sudden obstructed airway. Similarly, 
simulation of pneumothorax resulted in increased RR due to decreases in compliance. 
Simulation of leaks resulted in prolonged Ti, or audible lack of cycling with significant leaks.
Unstable conditions
Flow, pressure, and cycling were stable for a total of 8 hours of study with different EMX 
models. A recording of at least 1 hour was performed for each device. For a total of 11,295 
simulated breaths in which Crs, resistance and Pmus were randomly varied at every breath, 
Paw tracings (i.e., total PEEP and driving pressure values) were considered within expected 
limits for 99.6% of breaths. The output of the studied HD model was less stable; during a 
1-hour unstable respiratory mechanics simulation with low Crs (15–30 ml/cmH2O), normal 
resistance (5–15 cmH2O/L/s), and a PEEP of 10 cmH2O (using the spring-loaded PEEP 
valve), 61.7% of breaths (611/991 breaths) had Paw values within expected range. Visual 
inspection of the waveforms revealed that this was related to premature triggering (i.e., 
triggering at pressures >4 cmH2O above set PEEP) with rapid, small breaths.
Occasionally with the EMX model but more frequently with the HD model, premature 
triggering was observed when using the spring-loaded PEEP valve. It was never observed with 
the underwater column PEEP, nor when device was used without PEEP valve, which suggest 
that premature triggering was related to the way the spring-loaded PEEP valve worked 
and its interaction with the device. We could not identify specific respiratory mechanics 
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settings related to the occurrence of this malfunction. Temporarily adjusting the PEEP (any 
change) or set pressure (by increasing it) on the device always quickly resolved the issue.
Animal model
Device output
Four EMX models were studied in animals with lung injury; for any given condition, all 4 
devices showed similar ventilation output in terms of flow and pressure waveforms. In pigs, 
the I:E ratio was generally close to 1:1. As a result, the expiratory flow never reached a zero-
flow condition before the start of a next inspiration. Figure 4 shows the Paw output of the 
device and pressure control ventilation with Crs equal to 20 ml/cmH2O and a PEEP of 10 
cmH2O, and the comparison with device output during the bench simulation with similar 
respiratory mechanics and set pressure. Under matched mean Paw conditions between 
pressure control ventilation and the device, the total pressure delivered per breath (i.e., area 
under the curve) was fairly similar despite differences in Paw profile.
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Figure 4. Airway pressure (Paw) output of the device when tested on the bench (a) in pigs (b) and 
pressure control ventilation (PCV) in pigs (c) during a condition of Crs of 20 ml/cmH2O and a PEEP 
of 10 cmH2O. Note that in pigs, the I:E ratio is close to 1:1. Mean Paw during PCV was matched with 
the device, resulting in a fairly similar total pressure delivered per breath (i.e., area under the curves 
are relatively similar for ventilation with the device and PCV in pigs).
Gas exchange
Oxygenation, PaCO2 and pH values obtained with the device and conventional modes of 
ventilation are shown in Table 1 and resulted in comparable values with differences within 
acceptable clinical ranges among conditions and ventilator modes. For comparable PEEP 
and mean Paw, the EMX device achieved good Vt (normal lungs, 430–513 ml; injured lungs, 
250–344 ml), minute ventilation (normal lungs, 11.2–12.5 L/min; injured lungs, 10.3–11.8 L/
min), PaO2 (normal lungs, 142–236 mmHg; injured lungs, 147–209 mmHg), PaCO2 (normal 
lungs, 37–43 mmHg; injured lungs, 52–89 mmHg), and PaO2/FiO2 ratio (normal lungs, 
496–511; injured lungs, 252–412); values represent 95% CI (lower limit–upper limit) of the 
mean and results for mild and severe lung injury were combined. At times, these values 




Predicting tidal volumes from respiratory timing
In 1 pig, a total of 9 recruitment and derecruitment PEEP trials were analyzed during 
ventilation with 4 different EMX devices under 3 conditions: normal lungs, induced mild 
lung injury, and induced severe lung injury. Data from the resulting 1,072 breaths with a wide 
range of Crs (range, 5.4–46.3 ml/cmH2O) were used to evaluate the relationship between 
Ti, RR and Vt. Similar to the bench, predicting Vt using observed Ti and RR was possible. 
The equation for calculating Vt from Ti was Vt (ml) = 487.5 × Ti – 16.5, r
2 = 0.99 (p < 0.001), 
and the equation for calculating Vt from RR was Vt (ml) = 11,010 × RR
-0.989, r2 = 0.94 (p < 
0.001). We then assessed the accuracy of the bench-derived formula for calculating Vt 
based on RR compared to in vivo measured values. As shown in Figure 5, 84% of the breaths 
fell within the 95% CI limits of the bench formula; on average, the measured Vt was 2.0 ± 
34.5 ml higher than the predicted Vt.
















Figure 5. Respiratory rate (RR) and tidal volume (Vt) data from a pig obtained in conditions of normal 
lungs, and after inducing mild and severe lung injury. Additional changes in respiratory mechanics 
were obtained by performing PEEP recruitment maneuvers. The predictivity of the bench-derived 
formula for calculating Vt based on RR was tested by applying this formula to the pig data. As a 
result, 84% of the breaths (dots) fell within the 95% CI limits of the bench formula; on average, the 
measured Vt was 2.0 ± 34.5 ml higher than the predicted Vt.
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A decremental PEEP trial resulted in a U-shaped response curve for RR, reflecting inverse 
compliance changes (Figure 6a). Starting from a high PEEP, compliance increased and RR 
decreased until a nadir of RR was reached; a further reduction in PEEP resulted in increased 
RR due to the lower compliance induced by alveolar collapse. Therefore, the lowest RR 
corresponded to the highest Crs. Simultaneously recorded EIT data showed an inverse 
U-shaped pattern in delta Z (Figure 6b); because the driving pressure was constant, the 
highest delta Z corresponded to the highest Crs, which coincided with the lowest RR. Using 
the hysteresis behavior method, we confirmed that this PEEP level corresponded to the 
highest compliance (i.e., highest slope of the pressure-impedance curve) (Figure 6c). At 
the same PEEP level, the ventilation distribution was uniform between ventral and dorsal 
regions (Figure 6d).
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Figure 6. After lung injury, decremental PEEP steps were conducted while using an Oxylator EMX 
device. (a) Airway pressure (Paw) and respiratory rate (RR). As the applied PEEP was decreased from 
25 to 0 cmH2O, the measured PEEP decreased from 30 to 3 cmH2O. RR follows a U-shaped response 
curve with decreasing PEEP. (b) Data from a different pig while performing a decremental PEEP trial. 
In addition to the U-shaped response seen in RR, a reverse pattern is seen with delta Z measured 
on electrical impedance tomography (EIT). Since the driving pressure is constant, the highest delta 
Z corresponds to best lung compliance, which in turn corresponds to the lowest RR. (c) Same pig 
as in (b). Lung impedance numbers at inspiration and expiration during the decremental PEEP 
steps along with corresponding EIT images. Best compliance is in the middle steeper portion of the 
curve and correspond to the best PEEP in (b) which is at 14 cmH2O. (d) Ventilation distribution for 
the dorsal and ventral lung regions, showing a uniform distribution at this best PEEP level. At lower 
PEEP levels there is a discrepancy in ventilation distribution between ventral and dorsal lung regions, 
due to alveolar collapse occurring in the dorsal fields. The uniform ventilation distribution at higher 
PEEP levels (>14 cmH2O) is the result of hyperinflation as shown in (b) and (c). Abbreviations: PEEP, 
positive end-expiratory pressure; EELI, end-expiratory lung impedance; EILI, end-inspiratory lung 





In the era of the COVID-19 pandemic and in preparation for the next pandemic, we need 
simple, efficient, and safe ventilation devices to meet the unprecedented ventilator 
demands of patients, and to cope with extraordinary logistical challenges. Our evaluation 
of the Oxylator yielded 4 notable results. First, for severe lung injury (low compliance), the 
device offers simplicity, electricity independence, and portability, and it delivers a Vt within 
a clinically acceptable range at a relatively high RR. In normal lungs, Vt will be larger [18]. 
This makes the device especially suitable for respiratory systems with low compliance and 
short time constants. Second, the inability to adjust ventilator parameters other than the 
dial pressure makes controlling ventilation challenging; however, due to the predictable 
output and with monitoring of respiratory timing (via an external monitoring device or 
audible feedback), the user can calculate Crs and Vt very precisely from Ti and with 
reasonable accuracy from the RR (given variations in I:E ratio). Monitoring of respiratory 
timing is advisable because it could also help in recognizing acute clinical problems at the 
bedside. Third, the response curve in RR during a decremental PEEP trial confirms the 
dependence of RR on Crs and could help the clinician to adjust the PEEP level. Fourth, 
gas exchange in an animal model of lung injury was similar to conventional ventilation 
from a standard mechanical ventilator, using currently recommended pressure or volume-
prioritized ventilation settings.
Device performance
The ongoing pandemic has put a burden on critical care resources, especially mechanical 
ventilators. While modern ICU ventilators are sophisticated and reliable, and provide 
extensive patient monitoring, they are expensive, making stockpiling of these ventilators 
cost-prohibitive. ICU ventilators are complex requiring extensive training for safe use and 
maintenance, and require sources of electrical power, air, and oxygen pressure. They are not 
portable, and they require extensive quality control (especially if produced in non-standard 
conditions) and a reliable supply of disposables [7, 19]. Ultra-simple and user-friendly, 
durable, portable, and low-cost ventilation solutions are therefore potentially important 
[1–3, 7]. The Oxylator could meet these requirements. It is currently used worldwide in 
prehospital settings during rescue situations such as after cardiac arrest or severe trauma [9, 
10, 18]. However, the device could be recommended for use in acutely ill patients with lung 
injury if safe, effective, and individualized ventilation can be achieved to deliver protective 
ventilation. Over a wide range of respiratory mechanics conditions, we demonstrated stable 
device output, successful delivery of PEEP and protective Vt in mild to severe lung injury but, 
paradoxically, less in conditions of normal compliance, at least using the lowest pressure of 
the EMX model. Furthermore, its short-term use resulted in ventilation and gas exchange 
comparable to conventional ventilation modes. This suggests that the device could be a 
relatively safe and efficient solution for short-term rescue ventilation.
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Respiratory rate as minimal monitoring
In contrast to conventional ventilation modes, the pressure cycling mechanism makes the 
Vt delivered by the Oxylator directly dependent on the patient’s respiratory mechanics. 
Because the device lacks monitoring displays, challenges arise and monitoring would be 
necessary to avoid excessive or insufficient Vt. Our results indicate that bedside estimation 
of Vt is possible based on respiratory timing. Changes in RR could predict Vt using a bench-
derived formula that was validated in an animal model over a large range of respiratory 
mechanics conditions, showing clinically acceptable variability in predicted Vt. This formula 
could be incorporated in an online calculator. In addition, monitoring RR allows recognition 
of changes in respiratory mechanics due to abrupt clinical problems (e.g., acute obstruction, 
leaks) or disease progression. Furthermore, we suggest a method for setting PEEP at the 
bedside based on the RR response to changes in compliance during a decremental PEEP 
trial. Indeed, the PEEP level based on this response corresponded to the PEEP related 
to the best EIT-derived compliance, as confirmed with lung impedance EIT data at this 
pressure level and uniform ventilation distribution. Although RR could be monitored via 
audible feedback of the device, this requires a caregiver to be present to listen carefully to 
the device’s cycling. External devices such as a pulse oximeter, end-tidal CO2 monitor, or 
portable gas flow analyzer placed in series with the device would therefore be recommended.
Limitations and future work
Some limitations regarding the use of the device should be addressed. First, without an 
external blender, the gas is pure oxygen, which limits the duration of use. However, an air/
oxygen blender could be added to control FiO2 delivery, although this may affect portability 
of the device and increase costs. Second, the minimum driving pressure of the EMX model 
limits its use in lungs with normal compliance. In these patients, excessive Vt can be 
prevented when using the device in manual mode; however, this method requires a clinician 
to operate the device. Although lower driving pressures can be achieved with the HD model, 
fewer devices of this model are available worldwide compared to the EMX model (>20,000 
devices have been sold). It should also be noted that, according to its intended use as an 
automatic resuscitator, the device should not be used unattended. Third, the use of a 
spring-loaded PEEP valve occasionally resulted in device malfunction, which manifested 
as premature triggering with high RR. This problem never occurred with a non-resistive 
underwater PEEP generation. When this problem occurred, it was always easily solved 
quickly by temporarily changing the PEEP level or the set pressure of the device; recognizing 
this problem requires monitoring of RR. Last, spontaneous breathing is possible when 
using the device with added PEEP; however, due to the fixed flow rate, this may become 
uncomfortable if high respiratory efforts are allowed. Use without a PEEP valve (e.g., during 
noninvasive application when connected to a face mask) allows ambient air to be inhaled 
when the patient effort is high, but this should be used with caution and when PEEP is not 
necessary. Addressing these technical limitations in a next-generation model would enhance 
future clinical implementation. In addition, before widespread use of the device, its reliability 





In bench and porcine models of severe lung injury, the Oxylator is an ultra-simple device 
delivering stable ventilation with Vt within a clinically acceptable range in low compliance 
lungs. External monitoring of respiratory timing is advisable and allows estimation of 
the delivered Vt, could guide setting PEEP and helps with recognizing sudden changes 
in respiratory mechanics due to clinical problems or disease progression. In resource-
constrained settings such as those seen during the coronavirus pandemic or in environments 
with limited equipment, the Oxylator can be an efficient, low-cost practical rescue solution 
for providing ventilatory support as a temporary bridge until an ICU ventilator becomes 
available.
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ABSTRACT
Introduction
This narrative review summarizes current knowledge on the physiology and pathophysiology 
of expiratory muscle function in ICU patients, as shared by academic professionals from 
multidisciplinary, multinational backgrounds, who include clinicians, clinical physiologists 
and basic physiologists.
Results
The expiratory muscles, which include the abdominal wall muscles and some of the rib cage 
muscles, are an important component of the respiratory muscle pump and are recruited in 
the presence of high respiratory load or low inspiratory muscle capacity. Recruitment of the 
expiratory muscles may have beneficial effects, including reduction in end-expiratory lung 
volume, reduction in transpulmonary pressure and increased inspiratory muscle capacity. 
However, severe weakness of the expiratory muscles may develop in ICU patients and is 
associated with worse outcomes, including difficult ventilator weaning and impaired airway 
clearance. Several techniques are available to assess expiratory muscle function in the 
critically ill patient, including gastric pressure and ultrasound.
Conclusion
The expiratory muscles are the “neglected component” of the respiratory muscle pump. 
Expiratory muscles are frequently recruited in critically ill ventilated patients, but a 
fundamental understanding of expiratory muscle function is still lacking in these patients.
TAKE-HOME MESSAGE
The expiratory muscles are the “neglected component” of the respiratory muscle pump. This 
narrative review summarizes the physiology and pathophysiology of expiratory muscles in 
critically ill ventilated patients. Techniques to monitor expiratory muscle function in these 
patients are also discussed.
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INTRODUCTION
The respiratory muscle pump drives alveolar ventilation and is therefore of vital importance. 
The diaphragm, rib cage muscles and abdominal wall muscles are the most important 
components of the respiratory muscle pump [1]. Recruitment of each muscle depends on 
the (relative) load imposed on the respiratory system, lung volume, and the phase of the 
respiratory cycle. An acute imbalance between respiratory muscle load and capacity will 
result in respiratory failure and, ultimately, the need for mechanical ventilation. Many studies 
and reviews have focused on diaphragm structure and function in patients with acute 
respiratory failure, including critically ill patients [2–11]. However, the role of the expiratory 
muscles in the physiology of breathing in acute respiratory failure is largely neglected in 
the literature. This is surprising, given the important role of these muscles in respiration, 
especially in patients with impending respiratory failure.
The aim of the current paper is to discuss the role of the expiratory muscles in respiration, 
in particular in critically ill patients in whom respiratory muscle weakness develops rapidly, 
and may thus have a large clinical impact. We will also describe techniques used to evaluate 
expiratory muscle function in intensive care unit (ICU) patients. We will not focus in detail 
on the role of the expiratory muscles in coughing or maintaining body position.
PHYSIOLOGY OF EXPIRATORY MUSCLE RECRUITMENT
The expiratory muscles include those of the abdominal wall (transversus abdominis muscle, 
internal oblique muscle, external oblique muscle, and rectus abdominis muscle) and some 
of the rib cage ones (e.g., the internal intercostal muscles and the triangularis sterni muscle) 
[1, 12–16] (Figure 1). During tidal breathing, the expiratory muscles are largely inactive, 
although the transversus abdominis muscle may occasionally show some activity during 
quiet breathing [16]. Also, in the upright position, the abdominal wall muscles exhibit tonic 
activity to counteract the gravitational forces acting on the abdominal contents and thus 
to maintain the diaphragm at optimal length for pressure generation [17–19].
Figure 2 shows the physiology of expiratory muscle recruitment. Activation of the 
expiratory muscles during breathing occurs when the (relative) load imposed on the 
inspiratory muscles increases. High absolute respiratory loading may occur under different 
conditions, such as exercise, low respiratory system compliance, and intrinsic positive end-
expiratory pressure (PEEPi). Low inspiratory muscle capacity (high relative load on the 
inspiratory muscles) is common in ICU patients due to ICU-acquired respiratory muscle 
weakness [20]. In the presence of an imbalance between inspiratory muscle load and 
capacity, the abdominal wall muscles are recruited during expiration in a fixed hierarchy [21–
24]: initially the transversus abdominis muscle, followed by the internal oblique muscle and 
the external oblique muscle, and finally the rectus abdominis muscle [16, 17, 25]. Activation 
of the abdominal wall muscles increases abdominal pressure in the expiratory phase. As 




pressure is transmitted to the pleural space, consequently reducing the expiratory 
transpulmonary pressure, which helps to deflate the lung (less pulmonary hyperinflation/
lung strain). Furthermore, increased abdominal pressure enhances inspiratory muscle 
capacity via at least two mechanisms. First, increased abdominal pressure moves the 
diaphragm at end expiration to a more cranial position, which results in a more optimal 
length for tension generation [26, 27]. Second, when the end-expiratory lung volume falls 
below functional residual capacity (FRC), elastic energy is stored in the respiratory system. 
This stored energy facilitates the next inspiration (i.e., allows a more rapid and greater 
development of negative pleural pressure) [28, 29]. In fact, during strenuous inspiratory 
loading, up to 28% of tidal volume is generated below FRC, which can be attributed to 
expiratory muscle contraction [21].
It should be recognized that isolated contraction of the abdominal expiratory muscles 
causing an increase in abdominal pressure and pleural pressure would result in chest wall 
distortion, in particular expansion of the lower rib cage. This would likely increase the elastic 
inspiratory work of breathing and flatten the diaphragm. To limit distortion of the lower 
rib cage during active expiration, the internal intercostal muscles are recruited to stabilize 







posterior view anterior view 
Anterior rib cage
Figure 1. The expiratory muscles of the respiratory muscle pump. The respiratory muscle pump is a 
complex organ that involves a large number of muscles that contribute to inspiration or expiration. 
This figure schematically demonstrates the expiratory muscles. With the exception of the diaphragm, 
other inspiratory muscles are not shown.
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• inspiratory muscle weakness
      e.g., critical illness, phrenic nerve
       lesions, neurological disorders
   
Increased EELV
• obstructive lung disease / PEEPi
• expiratory flow limitation
• PEEPe
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Lung strain EELV Inspiratory musclecapacity
Figure 2. Physiology of expiratory muscle recruitment. Schematic illustration of the causes and 
consequences of expiratory muscle recruitment under physiological (healthy) conditions. All the 
consequences of expiratory muscle recruitment occur during expiration, except for the increased 
inspiratory muscle capacity (which occurs during the subsequent inspiration). See main text for ex-
planation. Abbreviations: EELV, end-expiratory lung volume; PEEPi, intrinsic positive end-expiratory 
pressure; PEEPe, external positive end-expiratory pressure.
In addition to an imbalance between inspiratory muscle load and capacity, an increased 
end-expiratory lung volume, as in application of positive end-expiratory pressure (PEEP), 
may also recruit the abdominal wall muscles (Figures 2 and 3) [30]. For example, in patients 
with normal respiratory system compliance (i.e., 80 ml/cmH2O), application of 10 cmH2O of 
PEEP would, theoretically, increase end-expiratory lung volume by 800 ml (in the absence of 
airway closure). However, a physiological feedback mechanism involving vagal pathways or 
proprioceptive influences limits the increase in end-expiratory lung volume by activation of the 
abdominal wall muscles during expiration, and thus protects against high lung strain [31, 32].
Another fundamental role of the expiratory muscles is to develop effective cough 
pressure to facilitate airway clearance [33]. Contraction of the expiratory muscles against 
a closed airway may increase the intrathoracic pressure to as high as 300 mmHg within 
0.2 seconds. Once the glottis is open, a very high expiratory flow (up to 720 L/min) can 
be generated [33, 34]. Expiratory muscle weakness reduces cough strength and peak flow 






















































































































































































































































































































































































































































































































































































































































































Expiratory muscle dysfunction in critically ill patients: towards improved understanding
UNDESIRABLE EFFECTS OF EXPIRATORY MUSCLE RECRUITMENT
Recruitment of the expiratory muscles during expiration may have undesirable effects in 
critically ill patients (Figure 4 and Table 1). First, in patients with the acute respiratory distress 
syndrome (ARDS) or atelectasis, increased pleural pressure during expiration resulting 
from expiratory muscle recruitment may result in negative transpulmonary pressure during 
expiration, leading to cyclic alveolar collapse or airway closure and thereby facilitating 
small airway and alveolar injury [37–40]. Consistent with this reasoning, a recent study 
in ARDS patients demonstrated a higher expiratory transpulmonary pressure in patients 
receiving neuromuscular blockers compared with control patients (1.4 ± 2.7 cmH2O versus 
-1.8 ± 3.5 cmH2O, respectively, p = 0.02) [41]. Interestingly, neuromuscular blockers also 
abolish expiratory activity of the diaphragm (if present) [42], which is expected to decrease 
expiratory transpulmonary pressure. However, the pressure generated by the diaphragm 
in the expiratory phase is relatively low compared with that generated by the expiratory 
muscles. Therefore, the effects of neuromuscular blockers on expiratory transpulmonary 
pressure largely depend on the relaxation of the expiratory muscles.
Second, expiratory flow limitation is a condition in which expiratory flow cannot be 
increased, despite an increase in expiratory driving pressure (pressure difference between 
the alveoli and mouth during expiration) [43]. Typically, this occurs in patients with 
emphysema, but it may also occur during tidal breathing in patients with expiratory muscle 
activity. The exact mechanism is unclear, but it has been proposed that dynamic airway 
compression plays an important role [44] (Figure 5). Elevated pleural pressure during active 
expiration decreases the airway transluminal pressure, which subsequently may compress 
the collapsible part of the airway. Total airway collapse is prevented as increased pleural 
pressure is also transmitted to the alveoli/airways (for an extensive discussion see also 
[43]). Expiratory airway compression may result in elevated end-expiratory lung volume 
and PEEPi [43], especially in patients with chronic obstructive pulmonary diseases (COPD) 
and in patients failing ventilator weaning [24, 45].
Table 1. Clinical impact of expiratory muscle dysfunction.
Clinical event Expiratory muscles-related mechanisms
Weaning failure, extubation failure Increased respiratory energy consumption, ineffective cough, 
inability to improve diaphragm efficiency
Atelectasis, pneumonia Ineffective cough
Small airway and alveolar injury Negative expiratory transpulmonary pressure resulting in alveolar 
collapse and/or airway closure













in EFL in ARDS
Tidal recruitment:
atelectasis/VILI
Figure 4. Pathophysiology of expiratory muscle recruitment. Schematic illustration of the patho-
physiological consequences of expiratory muscle recruitment in critically ill patients. The depicted 
relationships are mostly hypothetical due to the low number of studies on expiratory muscle function 
in ICU patients. The elevated pleural pressure caused by expiratory muscle recruitment might lead to 
dynamic airway collapse, especially in patients who already have expiratory flow limitation (EFL). This 
leads to an equal or increased end-expiratory lung volume (EELV). On the other hand, elevated pleural 
pressure might lead to negative expiratory transpulmonary pressures, especially in diseases with an in-
creased lung elastance such as in the acute respiratory distress syndrome (ARDS). In turn, this leads to 
atelectasis and tidal recruitment, potentially causing or worsening ventilator-induced lung injury (VILI).
Third, in patients weaning from mechanical ventilation, expiratory muscle recruitment is 
expected when an imbalance exists between the respiratory load and inspiratory muscle 
capacity. Indeed, activation of the expiratory muscles has been demonstrated during 
ventilator weaning, especially in patients failing a weaning trial [22–24]. We recently found 
that expiratory muscle effort progressively increased throughout the trial in such patients 
[24]. The neuromuscular efficiency of the diaphragm was lower in weaning failure patients 
compared with weaning success patients, which challenges the concept that expiratory 
muscle activation improves diaphragm contractile efficiency [24], although this requires 
further evaluation. Nevertheless, recruitment of the expiratory muscles during a weaning 
trial appears to be a strong marker of weaning failure.
Technically, expiratory muscle activity interferes with the assessment of PEEPi. PEEPi 
can be measured using different techniques. In patients with expiratory muscle activity, an 
end-expiratory occlusion will be highly influenced and exaggerated by the contraction of the 
expiratory muscles [46]. Similarly, the relaxation of the expiratory muscles at the beginning 
of the effort explains part of the initial drop in esophageal pressure, which is not entirely 
explained by so-called dynamic PEEPi. Either the drop in gastric pressure (Pga) at the 
beginning of the inspiratory effort or the rise in Pga during expiration must be subtracted 
from the esophageal pressure drop in order to measure a reliable PEEPi [47].
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Figure 5. Schematic and simplified illustration of the role of expiratory muscle recruitment in the 
development of expiratory flow limitation (EFL). (a-c) With activation of the expiratory muscles, the 
abdominal pressure increases, also increasing pleural pressure during expiration. This decreases the 
transluminal pressure resulting in partial airway collapse and therefore EFL. With higher expiratory 
muscle pressure, the flow-limiting site, or choking point, moves towards the alveoli. Note that grav-
itational forces are not considered in this illustration. Abbreviations: Pab, abdominal pressure; Palv, 
alveolar pressure; Pao, airway opening pressure; Ppl, pleural pressure.
EXPIRATORY MUSCLE STRENGTH IN CRITICALLY ILL PATIENTS
Several studies have demonstrated the development of expiratory muscle weakness in 
critically ill patients [48– 62, 64]. Most studies used the maximum expiratory pressure 
(MEP) as a marker of expiratory muscle strength [48–57]. Despite the heterogeneity of 
the studies in terms of populations and measurement techniques, the MEP was lower than 
the reference values [63] in all studies that obtained MEP at the time of ventilator weaning 
[48–55, 64]. Patients failing extubation exhibit a lower MEP (mean decrease varying from 
9 to 31 cmH2O) compared with extubation success patients [48–55, 64]. This indicates that 




muscle weakness affects weaning and extubation outcome is largely unknown. Potential 
explanations include inadequate secretion clearance and insufficient cough capacity 
resulting in atelectasis, reduced contractile efficiency of the diaphragm, or inadequate 
reduction of PEEPi.
Remarkably, no studies have investigated the association between diaphragm weakness 
and expiratory muscle weakness.
RISK FACTORS FOR EXPIRATORY MUSCLE WEAKNESS IN CRITICALLY 
ILL PATIENTS
Risk factors for the development of ICU-acquired weakness of the peripheral muscles and 
the diaphragm have been discussed recently [2, 4, 57, 65]. Whether these risk factors also 
have an impact on the expiratory muscles is largely unknown. We briefly discuss risk factors 
that may contribute to the development of expiratory muscle weakness.
Sepsis
Sepsis and systematic inflammation have been linked to the development of muscle 
weakness, including weakness of the expiratory muscles [2, 61, 65]. Sepsis induces a severe 
and persistent increase in protein catabolism, resulting in muscle wasting and muscle 
weakness [59, 60]. Compared with non-septic surgical patients, the rectus abdominis 
muscle from surgical patients with sepsis showed significantly lower in vitro contractility 
[59]. In addition, the reduced MEP (≤30 cmH2O) found at the time patients regained normal 
consciousness showed an independent association with septic shock [57].
Mechanical ventilation
Mechanical ventilation plays an important role in the development of diaphragmatic 
dysfunction in critically ill patients [2, 9, 10, 66]. Potential mechanisms include disuse atrophy 
due to ventilator over-assist, or load-induced injury as a result of ventilator under-assist. 
The impact of mechanical ventilation on the expiratory muscles has not been systematically 
investigated. However, as mentioned earlier, ventilator settings including PEEP and the level 
of inspiratory assist may have an impact on the activity of the expiratory muscles (Figure 
3) [46, 67], although the ultimate impact of mechanical ventilation on expiratory muscle 
strength is largely unknown and should be further investigated.
Other risk factors
Co-morbidities, such as COPD and myopathies, or complications such as intra-abdominal 
hypertension, may put patients at increased risk of ICU-associated expiratory muscle 
weakness [68, 69]. Drugs such as sedatives, neuromuscular blockers and corticosteroids 
have been shown to affect peripheral muscle function and diaphragm muscle function in 
ICU patients [2, 65, 70]. The effects of these drugs on expiratory muscle function have not 
been systematically studied.
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STRATEGIES TO MAINTAIN OR IMPROVE EXPIRATORY MUSCLE 
STRENGTH
Strategies that aim to improve diaphragm function [71, 72] may also benefit the expiratory 
muscles, although clinical studies are lacking. The feasibility of neuromuscular electrical 
stimulation to reduce expiratory muscle atrophy in ICU patients is under investigation 
(ClinicalTrials.gov: NCT03453944).
QUANTIFICATION OF EXPIRATORY MUSCLE EFFORT IN CRITICALLY 
ILL PATIENTS
While visual inspection of the trunk and palpation of the abdominal wall may reveal 
activation of the expiratory muscles, they do not allow quantification of effort. In this 
section, we summarize the main clinical techniques that can be used to quantify expiratory 
muscle effort in ICU patients.
Gastric pressure
Activation of the abdominal wall muscles increases abdominal pressure. Changes in Pga 
during expiration reflect changes in abdominal pressure and can thus be used to quantify 
expiratory muscle effort [22, 24, 39, 63, 73]. Pga is measured using an air-filled balloon 
catheter inserted into the stomach. Bladder pressure has also been proposed as a means 
of quantifying intra-abdominal pressure [74, 75], and showed an acceptable correlation 
with Pga in the supine position (bias, 0.5 mmHg; precision, 3.7 mmHg (limits of agreement, 
-6.8 to 7.5 mmHg)) [74]. To quantify the effort of expiratory muscles, Pga amplitude and 
the pressure-time product (PTP) of Pga during expiration can be calculated (Figure 3).
Amplitude of gastric pressure
Both the rise in Pga over the course of expiration [46] and the drop in Pga at the onset 
of the next inspiration [76] have been used to quantify the activity of the expiratory 
muscles. However, only the expiratory increase in Pga showed a good correlation with the 
electromyographic amplitude of the transverse abdominis muscle (correlation coefficient 
ranging from 0.70 to 0.95) [77].
Pressure-time product
The PTP of the expiratory muscles has been quantified using the area enclosed by the 
esophageal pressure curve and the static chest wall recoil pressure curve during expiration 
[78]. The PTP accounts for the energy expenditure during both the isometric and dynamic 
phases of expiration (independent of volume displacement). However, expiratory 
esophageal pressure only represents the pressure generated by the abdominal wall 
muscles when the diaphragm is completely relaxed [39, 79]. As diaphragm activity has been 




quantified using the expiratory esophageal PTP alone. Therefore, it is recommended to use 
the expiratory Pga in order to calculate the PTP of the expiratory muscles [80–83]. The 
gastric PTP (PTPga,exp) can be obtained from the area under the expiratory Pga curve, in 
which the baseline is defined as the resting end-expiratory Pga from the preceding breath 
[24, 80, 81] (Figure 3).
Work of breathing
Traditionally, the Campbell diagram is used to quantify the inspiratory work of breathing 
[84], but it allows estimation of the expiratory work as well. The area of the esophageal 
pressure-volume loop at the right side of the chest wall relaxation curve represents 
expiratory muscle effort [85, 86]. By definition, work is performed only when there is volume 
displacement (work = pressure × volume). However, as explained above, during dynamic 
airway collapse, part of the pressure generated by the expiratory muscles does not result in 
lung volume displacement, and therefore the Campbell diagram underestimates the total 
effort of the expiratory muscles [44, 87]. Under these circumstances, the PTP may better 
reflect expiratory muscle effort.
Volitional tests of expiratory muscle strength
The MEP is the most widely used measure of expiratory muscle strength [63]. Standard 
procedures for non-intubated subjects have been established [63]. For intubated patients, 
the MEP can be measured using a unidirectional valve that allows inspiration but prevents 
expiration [48, 51, 88]. Some investigators coached subjects to perform an expiratory effort 
against an occluded airway for 25 to 30 seconds, and then recorded the most positive 
pressure developed [48, 51, 88]. Calculating the ratio of maximum inspiratory pressure to 
MEP is a simple way to assess the relative impairment of the inspiratory muscles versus the 
expiratory muscles [89]. As MEP measurement requires a voluntary patient effort, this might 
not be feasible in a proportion of ICU patients. As an alternative to MEP, cough pressure 
can be assessed to quantify expiratory muscle strength [33, 63, 73].
Cough test
The cough test is a relatively easy to perform, complementary test for the diagnosis of 
expiratory muscle weakness. Both cough pressure measured via air-filled balloons in the 
stomach or esophagus, and cough peak expiratory flow measured at the opening of an 
endotracheal tube or using the ventilator flow sensor [90], are feasible in ICU patients. In 
patients unable to cooperate, a cough may be induced either by instilling physiological 
saline [35] or by advancing a suctioning catheter through the patient’s tube [36].
Abdominal wall muscle ultrasound
Ultrasound has become a popular tool for quantifying changes in the thickness and activity 
of the diaphragm in ICU patients [3, 91, 92], but few studies have used this technique to 
evaluate the expiratory muscles. Abdominal ultrasound allows direct visualization of the 
three layers of the abdominal wall muscles and the rectus abdominis muscle [93–96] (Figure 
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6). In our experience, the abdominal wall muscles are easy to visualize using ultrasound, 
and measurements of thickness are feasible in almost all patients. In healthy subjects, 
the thickness of individual abdominal wall muscles follows a certain pattern: transversus 
abdominis < external oblique < internal oblique < rectus abdominis [96]. The thickness 
of the transversus abdominis muscle measured with ultrasound is strongly correlated 
with the pressure developed during an expiratory maneuver (assessed by the change in 
Pga) [94]. In addition, the transversus abdominis muscle thickness increase is significantly 
correlated with the muscle’s electrical activity [93]. However, all these studies were 
performed in healthy subjects, and further studies are needed to determine the reliability 
and validity of ultrasound assessment of expiratory muscle thickness and function in ICU 
patients.
Other diagnostic tests
Electrical and magnetic stimulation of the abdominal wall muscles are other methods used 
to quantify the strength of these muscles [25, 79, 81]. As these techniques are cumbersome 
and uncomfortable, they are rarely used either in clinical practice or for research purposes.
Electromyography of the expiratory muscles has been used in research settings to 
study the timing of expiratory muscle recruitment during respiration [17, 77], but has not 















Figure 6. Ultrasound image of the abdominal muscles. (a) Ultrasound image of the rectus abdominis 
muscle (RA) (top), obtained with the probe placed 2–3 cm above the umbilicus and 2–3 cm from the 
midline (bottom). (b) Ultrasound image of the external oblique muscle (EO), internal oblique muscle 
(IO) and transversus abdominis muscle (TRA) (top), obtained with the probe placed midway between 
the costal margin and the iliac crest, along the anterior axillary line (bottom).
CONCLUSIONS
The expiratory muscles are the “neglected component” of the respiratory muscle pump. 
Rather as the heart does not comprise only a left ventricle, but also a right one, the 
respiratory muscle pump is much more than just the diaphragm. In this paper, we have 
summarized the physiology and pathophysiology of the expiratory muscles, with a special 
focus on critically ill patients. Expiratory muscles are frequently recruited in critically ill 
ventilated patients, but a fundamental understanding of expiratory muscle function is still 
lacking in these patients. Gastric pressure monitoring provides multiple bedside parameters 
for analysis of expiratory muscle effort, but their clinical implications need to be established.
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ABSTRACT
Background
For every day a person is dependent on mechanical ventilation, respiratory and cardiac 
complications increase, quality of life decreases and costs increase by >$1500 USD. 
Interventions that improve respiratory muscle function during mechanical ventilation 
can reduce ventilation duration. The aim of this pilot study was to assess the feasibility 
of employing an abdominal functional electrical stimulation (abdominal FES) training 
program with critically ill mechanically ventilated patients. We also investigated the effect of 
abdominal FES on respiratory muscle atrophy, mechanical ventilation duration and intensive 
care unit (ICU) length of stay.
Methods
Twenty critically ill mechanically ventilated participants were recruited over a 6-month 
period from one metropolitan teaching hospital. They were randomly assigned to receive 
active or sham (control) abdominal FES for 30 minutes, twice per day, 5 days per week, 
until ICU discharge. Feasibility was assessed through participant compliance to stimulation 
sessions. Abdominal and diaphragm muscle thickness were measured using ultrasound 3 
times in the first week, and weekly thereafter by a blinded assessor. Respiratory function 
was recorded when the participant could first breathe independently and at ICU discharge, 
with ventilation duration and ICU length of stay also recorded at ICU discharge by a blinded 
assessor.
Results
Fourteen of 20 participants survived to ICU discharge (8 intervention and 6 control 
participants). One control participant was transferred before extubation, while one withdrew 
consent and one was withdrawn for staff safety after extubation. Median compliance to 
stimulation sessions was 92.1% (interquartile range (IQR), 5.77%) in the intervention 
group, and 97.2% (IQR, 7.40%) in the control group (p = 0.384). While this pilot study 
is not adequately powered to make an accurate statistical conclusion, there appeared to 
be no between-group thickness changes of the rectus abdominis (p = 0.099 at day 3), 
diaphragm (p = 0.652 at day 3) or combined lateral abdominal muscles (p = 0.074 at day 
3). However, ICU length of stay (p = 0.011) and ventilation duration (p = 0.039) appeared 
to be shorter in the intervention compared to the control group.
Conclusions
Our compliance rates demonstrate the feasibility of using abdominal FES with critically 
ill mechanically ventilated patients. While abdominal FES did not lead to differences in 
abdominal muscle or diaphragm thickness, it may be an effective method to reduce 
ventilation duration and ICU length of stay in this patient group. A fully powered study into 
this effect is warranted.
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BACKGROUND
Approximately 33% of critically ill patients treated in intensive care units (ICUs) require 
mechanical ventilation to support respiration, some for a few hours, and others for months 
[1]. During this time, disuse atrophy of the major respiratory muscles, namely the diaphragm, 
abdominal and intercostal muscles, may occur [2]. This reduces respiratory function and 
leads to a range of complications including difficulty weaning from mechanical ventilation 
[3], increased mortality, respiratory and cardiac complications, readmissions to hospital and 
ICU [2–6], and decreased quality of life [7, 8]. While a life-saving intervention, the need for 
mechanical ventilation is also associated with additional health care costs [9]. Interventions 
that reduce respiratory muscle atrophy or increase respiratory muscle strength are likely to 
reduce mechanical ventilation duration, with a direct impact on morbidity and mortality, 
quality of life and costs to the health care provider.
Functional electrical stimulation (FES) is the application of a train of electrical pulses 
to a motor nerve, causing the associated muscle to contract. Transcutaneous FES of the 
abdominal muscles, termed abdominal FES, can improve respiratory function [10–13] and 
assist ventilator weaning in spinal cord injury [12, 14]. Unlike inspiratory muscle training, 
which has been shown to improve weaning outcomes for difficult-to-wean patients [15, 
16], abdominal FES does not require patient participation or cooperation [16]. A pilot study 
of 25 ventilated critically ill participants showed that FES of the rectus abdominis and 
pectoral muscles maintained respiratory muscle thickness to a greater degree than sham 
stimulation and shortened ICU length of stay [17]. This is despite the rectus abdominis 
muscle making minimal contribution to expiratory pressures [18, 19], and that stimulation 
was not applied in synchrony with respiration (increasing the risk of patient-ventilator 
asynchrony and increasing the load of breathing). FES of muscles in the upper legs of 
ventilated critically ill patients has also been shown to reduce ventilation duration [20]. 
Although widely advocated as an effective technique to maintain muscle mass and reduce 
critical illness polyneuromyopathy for critically ill patients [21, 22], it does not directly target 
the respiratory muscles. As the abdominal muscles play an active role in cough generation 
and respiration during respiratory distress [23] and we have previously shown that abdominal 
FES is an effective way to improve cough function [13], abdominal FES may provide a more 
direct, practical and efficacious way to reduce mechanical ventilation duration in critical 
illness. This hypothesis is further supported by the fact that respiratory muscle strength, 
as measured by maximum expiratory pressure (MEP) and cough peak flow (CPF), has been 
shown to be an independent predictor of delayed extubation, weaning success, morbidity 
and mortality [24, 25]. The primary aim of this pilot study was to assess the feasibility of 
employing an abdominal FES training program with critically ill mechanically ventilated 
patients. Secondary objectives were to investigate the effect of abdominal FES on muscle 
atrophy, mechanical ventilation duration and ICU length of stay. The data collected from 
this study will be used to assess feasibility and estimate sample size for a fully powered 







A double-blinded, randomized, sham-controlled pilot study was conducted in the 12-bed 
ICU of a metropolitan teaching hospital. The study was approved by the local research 
ethics board.
The aim of this pilot study was to assess the feasibility of employing an abdominal FES 
training program with critically ill mechanically ventilated patients. Secondary objectives 
were to investigate whether abdominal FES affects abdominal muscle and diaphragm 
thickness, respiratory function, ventilation duration, ICU length of stay and mortality in this 
population. Dall’Acqua et al. [17] found a medium effect (effect size, 0.75) from abdominal 
FES on abdominal muscle thickness. Our study improves on this method by stimulating the 
posterolateral abdominal wall as opposed to the rectus abdominis muscle, and applying 
stimulation in synchrony with respiration. Assuming our intervention will also have a medium 
effect size on abdominal muscle thickness, the optimal sample size for this pilot study is 
10 participants per arm [26].
Participants
All consecutive admissions (n=273) between 1 November 2017 and 12 April 2018 were 
screened against the eligibility criteria (Figure 1). Patients were eligible if they were ≥18 
years of age and dependent on mechanical ventilation due to critical illness. Patients were 
excluded if they were expected to be ventilated for <24 hours or already ventilated for >72 
hours, were pregnant, had non-pharmacological paralysis (e.g., spinal cord injury), had 
physical obstacles that prevent abdominal FES (e.g., abdominal trauma, pacemaker), had 
a diagnosed terminal illness, had no response to abdominal FES (e.g., lower motor neuron 
impairment or obese) or had abdominal surgery within 4 weeks prior to potential inclusion. 
Similar criteria were used in a previous trial of the effectiveness of FES of the quadriceps to 
reduce critical illness polyneuromyopathy in critically ill mechanically ventilated patients [22].
Stimulation
Twenty participants were randomized to receive active (intervention) or sham (control) 
abdominal FES (Table 1). Participants received the first session of their allocated 
intervention approximately 48 hours post initiation of mechanical ventilation (enabling 
washout of neuromuscular blocking agents). The setup for both groups was identical, 
with the only difference being the stimulation parameters. Stimulation was applied for 30 
minutes, twice per day, 5 days per week (including first 5 days consecutively), until discharge 
from the ICU, via surface electrodes (5 cm × 10 cm rectangular, UF2040, Axelgaard, USA). 
Electrodes were placed posteriorlaterally over the abdominal wall designed to activate the 
transversus abdominis and internal and external oblique muscles as previously described 
[18]. Stimulation was applied during exhalation using a commercially available abdominal 
FES device (Empi Continuum, Empi Inc., USA) with automatic synchronisation with the 
participant’s breathing achieved using an investigational device (VentFree VF03-K, 
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Liberate Medical LLC, USA; note, not approved for therapeutic use) connected between the 
Y-piece of the mechanical ventilator and the endotracheal tube. The active group received 
abdominal FES at an intensity that caused a strong visible muscle contraction (median 
intensity, 60 mA [range, 50–65 mA]), with a frequency of 30 Hz and a pulse width of 350 
μs. The stimulation current in the control group was set at 10 mA (possible sensation but no 
muscle contraction), with a frequency of 10 Hz and a pulse width of 350 μs. Similar training 
protocols have been used in other studies performed by the research team [11, 12, 14].
To achieve blinding, the researcher administering abdominal FES drew each participant’s 
bedside curtain while preparing the device. This person did not perform any outcome 
measurements. The machine was covered with a towel or sheet, and the participant’s 
abdomen was covered with a bed sheet so that participants, family members and caregivers 
could not see the machine or whether stimulation resulted in muscle contractions. Outcome 
assessors were never in the room when stimulation was delivered. Although participants 
were not informed of their randomization allocation, they could notice the contractions 
caused by abdominal FES (compared to the control) and therefore could become aware 
of the allocation. Participants were instructed not to discuss their perception of allocation 
with outcome assessors, other participants, or clinical staff.
Data collection
Ultrasound was performed at the end of exhalation (without stimulation) to measure the 
thickness of the rectus abdominis, internal and external oblique and transversus abdominis 
muscles, and diaphragm before the first abdominal FES session, twice more in the first week 
of participation, and then weekly until ICU discharge. All measurements were taken from 
muscles on the right-hand side of the participant by the same assessor at all assessment 
sessions. To measure the rectus abdominis, the probe was firstly placed on the midline 
of the abdomen, 2 cm above the umbilicus to identify the linea alba. The probe was then 
moved laterally until the right rectus abdominis muscle became visible, with the probe then 
moved in the cranial and caudal directions until the maximum thickness of the muscle was 
identified. From the position of the rectus abdominis, the probe was moved to the right 
until the lateral abdominal muscles became visible, and moved laterally until the upper 
and lower limits of each muscle were parallel to each other. This was approximately at the 
anterior axillary line. Minimal pressure to the skin was applied during these measurements 
to limit muscle deformation. For the diaphragm, the probe was placed parallel to the 
anterior axillary line in the intercostal space between the 9th and 10th rib and moved in the 
cranial and caudal directions until the pleural line was identified. From this point, the probe 
was moved approximately 1 or 2 intercostal spaces lower to identify the costal diaphragm 





Assessed for primary outcome: 
feasibility (n=10)
Assessed for secondary outcomes: 
muscle thickness, ventilation duration, 
ICU length of stay (n=10)
Assessed for secondary outcome: 
respiratory muscle function (n=5)
Assessed for primary outcome: 
feasibility (n=10)
Assessed for secondary outcomes: 
muscle thickness, ventilation duration, 
ICU length of stay (n=10)
Assessed for secondary outcome: 
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Lost to follow-up before extubation (n=5)
Death (n=4)
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 Lost to follow-up before ICU discharge (n=2)
Withdrew consent (n=1)
Sta safety (n=1)
Lost to follow-up before extubation (n=2)
Death (n=2)
Allocated to control (n=10)
Received allocated intervention (n=10)






Extubated before consent (n=10)
No consent (n=7)
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No response to abdominal FES (n=2)
Death prior to consent (n=2)
Pacemaker (n=1)
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Assessed for eligibility 
(n=67)
Excluded (n=206)
No mechanical ventilation (n=138)
Ventilated <24h (n=60)
Ventilated >72h (n=8)
Allocated to intervention (n=10)






Figure 1. Consort flow diagram of patients admitted to the intensive care unit (ICU) and the ran-
domization process.
409
Abdominal FES to assist ventilator weaning in critical illness
Respiratory function was measured via forced vital capacity (FVC), forced expiratory volume 
in 1 second (FEV1), peak expiratory flow (PEF), maximum inspiratory pressure (MIP) and 
maximum expiratory pressure (MEP), as soon as possible after the participant was able 
to breathe independently. FVC, FEV1 and PEF were measured with a handheld spirometer 
(One Flow FVC Memo, Clement Clarke International, UK) by asking the participant to exhale 
as fully and as forcefully as possible (verbal encouragement provided) from total lung 
capacity. MIP and MEP were measured using a hand-held pressure meter (MicroRPM, Vyaire 
Medical, USA), with participants inhaling and exhaling as fully and as forcefully as possible 
(verbal encouragement provided) against an occluded airway from residual volume and 
total lung capacity, respectively. The size of the filter approved for use with our mouth 
pressure device was not compatible with the tracheostomies being used at the study site. As 
such, MIP and MEP were not recorded from patients with tracheostomies. All measurements 
were recorded with the participant supine. When possible, each measurement was repeated 
until three reproducible results within 5% were registered, and the greatest value was used 
for analysis [28].
Ventilation duration (defined as the total number of days from the onset of ventilation 
until the first successful extubation of more than 48 hours during ICU stay [22]) and ICU 
length of stay (the number of days from ICU admission to ICU discharge) were obtained 
via chart review by a blinded assessor at ICU discharge, while mortality was obtained from 
the participant’s medical record by the same blinded assessor 6 weeks post ICU discharge. 
Participants without a tracheostomy were extubated by progressively reducing ventilator 
support. Here, ventilator rate, pressure support, and positive end-expiratory pressure 
(PEEP) were decreased while respiratory rate, respiratory effort, tidal volume and blood 
gases were monitored. When support reached low levels, typically PEEP and pressure 
support of 8 and 7 cmH2O, respectively, participants were extubated based on clinical 
judgement. Participants with a tracheostomy were weaned from ventilatory support via a 
similar scheme with progressive ventilator-free breathing.
Analysis
Categorical data are summarized in terms of the number of participants with data at the 
relevant time point (n) and as a percentage of all participants. Continuous data are expressed 
as median [interquartile range (IQR)], or mean ± standard deviation unless otherwise 
stated. Compliance is the number of sessions completed as a percentage of all sessions 
that should have been completed between randomization and completion or withdrawal 
and is considered a continuous variable. In cases where participants underwent a double 
session (i.e., one 60-minute session instead of two 30-minute sessions), this was regarded 
as compliant and taken as two completed sessions for analysis purposes. A Mann-Whitney 
U test was used to compare compliance between groups. The combined thickness of the 
internal and external oblique and transversus abdominis muscles (i.e., from the upper fascia 
of the external oblique to the lower fascia of the transversus abdominis) was also analyzed 
to increase accuracy, with this measurement referred to here as the combined lateral 




each assessment session was used for analysis. Blinded researchers in another country also 
checked the marked images to verify correct muscle identification and marker placement. In 
cases of disagreement, where the fascia was not clear in saved images, or the correct muscle 
group was not obvious, the data were excluded (18.2% (n=14), 27.3% (n=21), and 22.1% 
(n=17) of sessions were excluded for the rectus abdominis, combined lateral abdominal 
muscles, and diaphragm, respectively). Change from baseline of rectus abdominis, 
combined lateral abdominal, internal and external oblique and transversus abdominis 
muscles, and diaphragm thickness were treated as continuous variables and analyzed 
using a linear mixed effects model with fixed factors of baseline thickness, treatment, 
assessment session and treatment by assessment session interaction, and a random 
effect of participant (change from baseline thickness ~ baseline thickness + treatment + 
assessment session + (treatment × assessment session) + (1|patient)) [29]. These mixed 
models compare the thickness of the muscles over time. Due to the small sample size, 
and the risk of a normality test being underpowered, we followed the statistical methods 
in Dall’Acqua et al. [17], where the distribution of muscle thickness was assumed normal.
There are no respiratory function measures for the participants who died during the 
study. The Mann-Whitney U test, as a distribution-free non-parametric test, was used to 
analyze respiratory function data. Ventilation duration and ICU length of stay were analyzed 
using Gray’s test in the survival analysis [30], with the competing risks of death or withdrawal 
of treatment (e.g., ventilator support) with the intention of subsequent death. Gray’s test 
compares cause-specific cumulative incidence curves. In the case where less than 50% 
of participants achieved the outcome, due to either competing events or censoring, the 
median time to the outcome was not estimable. The sample size required for a larger study 
was also calculated based on survival test and cause-specific hazard approach accounting 
for competing events. All analyses were performed using SPSS (Version 22, IBM Corp, NY, 
USA).
RESULTS
Study population and compliance
Twelve males and eight females, with a median age of 56.5 years in the active group and 
61.0 years in the control group, were recruited for this study (Table 1). Fourteen patients 
survived to ICU discharge (8 active, 6 control). One control participant was transferred 
to another hospital before extubation. After extubation, one further control participant 
withdrew consent and one was withdrawn due to violent behavior. The median time on 
mechanical ventilation before starting the intervention was 1.5 days (IQR, 1 day). The 
median time on the study for participants who died was 11.5 days (IQR, 13.25 days). Median 
compliance for the training sessions was 92.1% (IQR, 5.77%) in the active group and 97.2% 
(IQR, 7.40%) in the control group (p = 0.384), with active participants having a median 
exposure to the intervention of 366 minutes (IQR, 293.8 minutes) and control participants 
555 minutes (IQR, 492.5 minutes) (Table 1).
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Table 1. Participant information.
Active (n=10) Control (n=10)
Age (years), median [IQR]
Gender (male/female)
56.6 [18.50] 61.0 [17.25] 
7/3 5/5
Severity of illness at ICU admission, APACHE III (score), median [IQR] 81.5 [37.75] 82.0 [14.00]























Mode of ventilation, n (%)
Synchronized intermittent-mandatory ventilation
Adaptive pressure ventilation
PEEP (cmH2O), median [IQR]









Exposure to intervention (minutes), median [IQR] 366 [293.8] 555 [492.5]
All ventilator settings refer to first day of study. APACHE III score was calculated in the first 24 hours of 
ICU admission as described by Knaus et al. [27]. Abbreviations: APACHE, Acute Physiologic Assessment 
and Chronic Health Evaluation; FiO2, fraction of inspired oxygen; IQR, interquartile range; PEEP, positive 
end-expiratory pressure.
Adverse events
There were eight non-serious adverse events in the active group and fourteen in the control 
group, and two serious adverse events (death) in the active group and eight in the control 
group (4 deaths, 3 cardiac events, 1 reintubation) (Table 2). Only one participant, who was a 
control, suffered multiple serious adverse events (2 cardiac events and death). For adverse 
events, two active participants experienced three events (2 hospital-acquired infections and 
pneumonia; 2 hospital-acquired infections and tracheostomy), and one had one adverse 
event and a serious adverse event (blocked pressure drain and death). In the control 
group, one participant experienced four adverse events (2 hospital-acquired infections, 
pneumonia and tracheostomy), two had three adverse events and a serious adverse event 
(high respiratory rate, hospital-acquired infection, diarrhea and serious cardiac event; 2 
hospital-acquired infections, laparotomy and reintubation) and one experienced an adverse 
event and serious adverse event (poor wound healing and death). All other adverse or 
serious adverse events were experienced by individual participants. An independent safety 





Table 2. Adverse events stratified by group.
Active Control
Serious adverse events, n (%)
Death
Serious cardiac events










Non-serious adverse events, n (%)
Hospital-acquired infection
Tracheostomy





































Serious adverse events and non-serious adverse events are reported separately. All data are reported 
as absolute number of events, as well as the proportion of all serious adverse or non-serious adverse 
events per group. While some participants experienced multiple adverse events (see Results 
section, Adverse events), none of the adverse events reported here were deemed to be related to the 
intervention.
Muscle atrophy
There was no difference in the longitudinal changes from baseline in the thickness of 
rectus abdominis, diaphragm and combined lateral abdominal muscles between groups 
at any assessment session (Table 3). Further analyses were also conducted on each 
individual muscle within the combined lateral abdominal muscles, where there did appear 
to be a change in the thickness of the transversus abdominis at day 3 (0.85 vs. -0.12 mm, 
p = 0.032). It should be noted that the results for assessment sessions beyond day 5 were 
not stable or not estimable due to the small or no sample sizes.
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Table 3. Group comparison of change from baseline in thicknesses of rectus abdominis, diaphragm, 
combined lateral abdominal muscles and each individual muscle by assessment session.
Assessment 
session
Active Control Active vs. control p value







0.33 ± 0.909 (6)
-0.03 ± 0.871 (5)




-0.10 ± 0.451 (9) 
0.29 ± 0.759 (6)
0.35 ± 0.453 (4)
1.22 ± 1.167 (2)
1.37 ± 0.813 (2)




















-0.17 ± 0.274 (7)
-0.11 ± 0.404 (7)




-0.18 ± 0.207 (6)
-0.18 ± 0.225 (4)























2.51 ± 2.535 (4) 





-0.01 ± 2.113 (9)
0.28 ± 2.186 (7)
-0.88 ± 2.902 (5)
0.22 ± 3.005 (2)
4.12 ± 4.419 (2)
3.75 (1)
3.05 (-0.35, 6.44) 


















0.52 ± 0.685 (4)





-0.05 ± 1.153 (9)
-0.35 ± 0.881 (7)
-0.49 ± 0.248 (5)
0.35 ± 0.071 (2)





















0.79 ± 1.718 (4)





0.13 ± 0.936 (9)
0.58 ± 1.694 (7)
-0.05 ± 2.385 (5)
0.50 ± 1.838 (2)




















Active Control Active vs. control p value







0.85 ± 1.065 (4)





-0.12 ± 0.849 (9)
0.10 ± 0.532 (7)
-0.11 ± 0.318 (5)
-0.18 ± 0.742 (2)














Data are summarized as mean ± SD (number of subjects). Active vs. control was analyzed using a least 
square mean difference based on a mixed effects model for repeated measures and is summarized as 
least square mean difference with 95% confidence interval (upper limit, lower limit). P values are based 
on a mixed effects model for repeated measures. Abbreviation: NE, not estimable.
Respiratory function
Respiratory function was assessed at a median of 6 days (IQR, 3 days) from randomization 
for the active group, and 15 days (IQR, 15 days) from randomization for the control group 
(p = 0.084). In the active group, one participant was unable to perform all respiratory 
function measures due to delirium and one was unable to adequately perform MIP and 
MEP measurements due to tracheostomy. In the control group, one participant was unable 
to perform all respiratory measures due to transfer to another hospital and one was unable 
to perform MIP and MEP due to tracheostomy. There was no difference in FVC (p = 0.371), 
FEV1 (p = 0.371), MIP (p = 0.762) or PEF (p = 0.061) between groups (Table 4).
Clinical outcomes
Ventilation duration (median 6.5 vs. 34 days, Gray’s test p = 0.039) and ICU length of stay 
(median 11 vs. not estimable days, Gray’s test p = 0.011) were shorter in the active compared 
to the control group (Figure 2). Of the thirteen participants liberated from mechanical 
ventilation, nine (69.2%; 6 active, 3 control) were liberated by reducing ventilator support. 
The four remaining participants (2 active, 2 control) were extubated via progressive 
ventilator-free breathing. The median time from initiation of progressive ventilator-free 
breathing to extubation was 9.5 days (IQR, 7.75 days).
There was no difference in mortality between groups (p = 0.629).
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Table 4. Respiratory function.
Active (median [IQR] (n)) Control (median [IQR] (n)) p value
MIP (cmH2O) 29.0 [26.75] (n=6) 32.5 [9.50] (n=4) 0.762
MEP (cmH2O) 35.5 [12.75] (n=6) 26.0 [4.00] (n=4) 0.283
PEF (L/min) 127.5 [62.5] (n=7) 50.0 [55.0] (n=5) 0.061
FVC (L) 1.3 [0.58] (n=7) 0.9 [0.90] (n=5) 0.371
FEV1 (L) 0.9 [0.48] (n=7) 0.6 [0.70] (n=5) 0.371
Respiratory function was analyzed as soon as possible after the participant was able to breathe 
independently. There are no respiratory function measures for the six participants who died during 
the study. See the section Analysis for further information relating to who participated in respiratory 
function measurements. Analysis was performed using the Mann-Whitney U test. All data are shown 
as median [interquartile range (IQR)] (number of participants providing data (n)). Abbreviations: FEV1, 
forced exhaled volume in 1 second; FVC, forced vital capacity; MEP, maximum expiratory pressure; MIP, 


























































Figure 2. Cumulative incidence curves for mechanical ventilation duration (a) and intensive care 
unit (ICU) length of stay (b). Fourteen participants survived to ICU discharge (8 active, 6 control). 
One control participant was transferred to another hospital before extubation and as such was 
censored from both the ventilation duration and ICU length of stay analysis. After extubation, one 
control participant withdrew consent and one was withdrawn due to threatening behavior, both 
were censored from the ICU length of stay analysis. Competing events were death or withdrawal of 





The aim of this pilot study was to assess the feasibility of employing an abdominal FES 
training program with critically ill mechanically ventilated patients. We also investigated 
the effect of abdominal FES on respiratory muscle atrophy, mechanical ventilation 
duration and ICU length of stay. Our compliance to the stimulation sessions of >90% 
in both groups demonstrates the feasibility of applying this intervention in the critically 
ill mechanically ventilated population. While this pilot study is not adequately powered 
to make an accurate statistical conclusion, we did not find a longitudinal difference in 
respiratory muscle thickness between groups. However, ICU length of stay and duration of 
mechanical ventilation were shorter in the active abdominal FES group than in the control 
group. This provides justification for a fully powered study to determine whether abdominal 
FES can reduce mechanical ventilation duration in critical illness. Such a study would require 
254 participants (based on a cause-specific hazard approach accounting for competing 
events, assuming 60% of intervention and 45% of control participants being liberated 
from the ventilator by day 9; log-rank test (2-sided), α = 0.05 (2-sided), β = 0.1, mortality 
on day 9 of 20%, and 10% loss to follow-up).
Routsi et al. [22] demonstrated that participants who received FES of the quadriceps 
had a ventilation duration of 7 days compared to 10 days for controls (p = 0.07). Abu-
Khaber et al. [20] found the same technique reduced ventilation duration from 12 to 9 days 
in a similar group of patients (p = 0.048). However, while advocated clinically as a way to 
reduce ventilation duration [21, 22], this technique does not directly target the respiratory 
muscles. Here, we found abdominal FES appeared to reduce ventilation duration and ICU 
length of stay. In agreement, Dall’Acqua et al. [17] found that FES of the rectus abdominis 
and intercostal muscles reduced ICU length of stay (p = 0.045). In contrast, Routsi et al. 
[22] found that FES of the quadriceps did not change ICU length of stay (p = 0.11). With 
each ICU bed day in Australian public hospitals estimated at $A6141 (compared to $A2351 
for a general ward bed) [31], a reduction in ICU length of stay would result in a significant 
cost saving for local health care providers. As such, abdominal FES may offer a useful 
clinical addition or alternative to FES of the quadriceps and is worthy of further exploration.
Our finding that there appeared to be no longitudinal change in the thickness of 
the rectus abdominis muscles in either the intervention or control group is in contrast 
to Dall’Acqua et al. [17], who found no change in rectus abdominis thickness in patients 
who received FES of the rectus abdominis and intercostal muscles, but a significant 
16.3% decrease in the control group. This, coupled with the fact that we did not observe a 
difference in diaphragm thickness between the groups, may indicate that the mechanisms 
of abdominal FES to reduce ventilation duration are not solely based on muscle thickness. 
Furthermore, MIP and MEP are good indicators of respiratory muscle strength [32]. While 
these outcomes and those of lung function were not different between the two groups, a 
previous systematic review has shown that abdominal FES can improve respiratory function 
in spinal cord injury [13]. Further study of the effect of abdominal FES on respiratory function 
in this population is warranted.
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Our average recruitment rate of four participants per month was higher than expected and 
shows the feasibility of a larger study, particularly if it were multi-institutional. However, 
12.6% of all interventions in this study were double sessions (stimulation applied for 1 
consecutive hour, as opposed to two 30-minute sessions), largely due to staffing issues 
and difficulty accessing participants (e.g., they were away for a procedure). This suggests 
that one training session per day may be more practical for a follow-up study. The mortality 
rate in this study (30%) was slightly lower than that in a larger study by Routsi et al. [22] 
(35%) that employed the same inclusion and exclusion criteria, but is in line with large 
epidemiological studies of ICU patients [33].
Limitations
While ultrasound has been shown to be a reliable measure of diaphragm thickness in the 
ICU [34], ultrasound measurements of the abdominal muscles and diaphragm recorded 
here had large intra- and inter-participant variability. This may have been due, at least in 
part, to a number of these critically ill patients having fluid overload, large amounts of 
edema and high intra-abdominal pressures, or a combination of all three. This could have 
led to changes in muscle architecture unrelated to atrophy or abdominal FES. However, 
it should be noted that fluid imbalance alone has been shown not to affect diaphragm 
thickness [34, 35]. Difficulty with the ultrasound measurements led to a number of sessions 
having to be excluded from the analysis. As a result, more robust methods are needed to 
measure respiratory muscle thickness in a large clinical trial.
The majority of the analysis in this pilot study was affected by post-randomization 
events and effects, particularly death. This was only accounted for in the analysis of 
ventilation duration and ICU length of stay, which employed Gray’s test with death and 
withdrawal of treatment treated as competing events or censoring. As such, there may be 
some bias in the other outcome measures due to the larger number of control participants 
not completing the study. Analysis of a larger study will need to account for these post-
randomization events in all outcome measures.
CONCLUSION
This pilot study demonstrates the feasibility of employing an abdominal FES training 
program with critically ill mechanically ventilated patients. While there were no longitudinal 
changes in respiratory muscle thickness between groups, participants who received 
abdominal FES had a shorter mechanical ventilation duration and ICU length of stay. A 
fully powered study into this effect is now warranted, with a positive outcome likely to lead 
to the rapid clinical translation of this technique. This should lead to reduced morbidity and 
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ABSTRACT
Background
Expiratory muscle weakness leads to difficult ventilator weaning. Maintaining their activity 
with functional electrical stimulation (FES) may improve outcome. We studied the feasibility 
of breath-synchronized expiratory muscle FES in a mixed ICU (“Holland study”) and pooled 
data with our previous work (“Australian study”) to estimate potential clinical effects in a 
larger group.
Methods
Holland: Patients with contractile response to FES received active or sham expiratory 
muscle FES (30 minutes, twice daily, 5 days/week until weaned). Main endpoints were 
feasibility (e.g., patient recruitment, treatment compliance, stimulation intensity) and 
safety. Pooled: Data on respiratory muscle thickness and ventilation duration from the 
Holland and Australian studies were combined (n=40) in order to estimate potential effect 
size. Plasma cytokines (day 0, 3) were analyzed to study the effects of FES on systemic 
inflammation.
Results
Holland: A total of 272 sessions were performed (active/sham: 169/103) in 20 patients 
(n=active/sham: 10/10) with a total treatment compliance rate of 91.1%. No FES-related 
serious adverse events were reported. Pooled: On day 3, there was a between-group 
difference (n=active/sham: 7/12) in total abdominal expiratory muscle thickness favoring 
the active group (treatment difference (95% confidence interval), 2.25 (0.34, 4.16) mm, 
p = 0.02) but not on day 5. Plasma cytokine levels indicated that early FES did not induce 
systemic inflammation. Using a survival analysis approach for the total population, median 
ventilation duration and ICU length of stay were 10 vs. 52 (p = 0.07), and 12 vs. 54 (p = 0.03) 
days for the active vs. sham group. Median [interquartile range] ventilation duration of 
patients that were successfully extubated was 8.5 [5.6–12.2] vs. 10.5 [5.3–25.6] days 
(p = 0.60) for the active (n=16) vs. sham (n=10) group, and median ICU length of stay was 
10.5 [8.0–14.5] vs. 14.0 [9.0–19.5] days (p = 0.36) for those active (n=16) vs. sham (n=8) 
patients that were extubated and discharged alive from the ICU. During ICU stay, 3/20 
patients died in the active group, vs. 8/20 in the sham group (p = 0.16).
Conclusion
Expiratory muscle FES is feasible in selected ICU patients and might be a promising 
technique within a respiratory muscle-protective ventilation strategy. The next step is to 
study the effects on weaning and ventilator liberation outcome.
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BACKGROUND
The respiratory muscle pump drives alveolar ventilation. The diaphragm is the most 
prominent inspiratory muscle, while the abdominal wall muscles play an important role 
in active expiration [1, 2]. Respiratory muscle weakness is highly prevalent in critically ill 
intensive care unit (ICU) patients and associated with difficult ventilator weaning, prolonged 
ICU stay, and mortality [3–10]. Mechanical ventilation is a critical contributor as excessive 
ventilator assist may result in diaphragm disuse atrophy [3, 4, 11]. Indeed, maintaining 
diaphragm activity during mechanical ventilation may preserve diaphragm function [4]. 
Moreover, in a preclinical study, electrical stimulation of the phrenic nerves was shown to 
attenuate diaphragm atrophy resulting from controlled mechanical ventilation [12].
In contrast, the impact of mechanical ventilation on the expiratory muscles is less 
well studied and interventions targeting these muscles are lacking. This is surprising, 
as the expiratory muscles are vital for airway clearance, prevention of atelectasis, and 
enhancement of minute ventilation in conditions of low inspiratory muscle capacity and/
or high respiratory load [1]. Development of expiratory muscle weakness during ICU stay 
has been associated with extubation failure and (re)hospitalization due to respiratory 
complications [9, 10, 13, 14]. Maintaining their activity under mechanical ventilation is 
therefore likely to improve outcome.
Functional electrical stimulation (FES) of limb muscles has been studied extensively as a 
strategy to limit disuse atrophy and to improve muscle function during prolonged immobilization 
[15, 16]. FES uses electrical currents to generate artificial skeletal muscle contraction without 
patient cooperation, making it an attractive intervention in uncooperative mechanically 
ventilated patients. Recently, we published results of a pilot study employing noninvasive breath-
synchronized FES of the expiratory abdominal wall muscles, further referred to as “expiratory 
muscle FES”, in twenty ICU patients (“Australian study”) [17] and showed that this intervention 
has potential benefits. However, the active group of this single-center study consisted mainly 
of neurocritically ill patients (70%) and results need to be confirmed in a more diverse ICU 
population. The aim of the current study (“Holland study”) was to assess feasibility of performing 
expiratory muscle FES in a mixed ICU population. Additionally, data from both studies were 
pooled to estimate potential clinical effects in a larger, more heterogeneous patient group.
METHODS
See Supplemental file for additional details.
Holland study
Participants and study design
Twenty patients were randomized in this prospective sham-controlled feasibility study 




Amsterdam UMC, location VUmc; Canisius Wilhelmina Ziekenhuis). Patients were enrolled as 
early as possible but within 72 hours after intubation. Exclusion criteria were an anticipated 
stay on the ventilator <72 hours at the time of study enrolment, congenital myopathies or 
neuropathies, and contraindications for expiratory muscle FES (cardiac pacemaker, refractory 
epilepsy, recent (<4 weeks) abdominal surgery, body mass index >35 kg/m2, and pregnancy). 
Written informed consent was obtained from the patient’s substitute decision-maker. Only 
patients with an adequate contractile response to expiratory muscle FES using stimulation 
settings similar as for the active group (see below and Supplemental file) were randomized.
Expiratory muscle FES
Expiratory muscle FES was applied for 30 minutes, twice daily, for 5 days per week (first 5 
days consecutively), until patients were weaned from mechanical ventilation, but no longer 
than six weeks. Local protocols for mechanical ventilation and weaning were followed.
Stimulation was applied during exhalation using an investigational device (VentFree 
model VK03-K, Liberate Medical LLC, USA) (see Supplemental file, E-Figure 1, and [17]) 
via surface electrodes on the abdominal wall, and stimulation intensity was titrated in 
order to activate the external oblique, internal oblique and transversus abdominis muscles 
(see Supplemental file, E-Figure 2). The patient’s tolerance of expiratory muscle FES was 
continuously monitored by means of clinical judgment; sessions were discontinued in the 
presence of stop criteria (see Supplemental file). In the active group (n=10), settings were 
as follows: frequency 30 Hz, pulse width 352 µs, and a current amplitude (intensity) set to 
cause strong muscle contraction, with a maximum intensity initially set at 60 mA (tolerated 
intensity in healthy volunteers [18]). After the first four patients were enrolled in the study, 
the protocol was amended to allow a maximum intensity of 100 mA (maximum device 
output). Strong muscle contraction was verified (visible and palpable) every ten minutes 
throughout each FES session, and if necessary, stimulation intensity was increased. In 
the sham group (n=10), the following settings were applied and would allow a patient to 
have a sensation of stimulation without muscle contraction (as verified clinically and with 
ultrasound): frequency 10 Hz, pulse width 352 µs, intensity 10 mA.
Data collection
During each stimulation session, ventilator parameters and vital signs were collected. 
Ultrasound measurements were performed (see Supplemental file and [19]) to study 
changes in respiratory muscle thickness (external oblique, internal oblique and transversus 
abdominis (their combined thickness is further referred to as total abdominal expiratory 
muscle thickness), rectus abdominis thickness, and diaphragm thickness). The researcher 
administering expiratory muscle FES did not perform ultrasound recordings, and outcome 
assessors were not in the patient room when stimulation was delivered. Blood samples 
for the analysis of plasma cytokine levels were collected at baseline and on day 3 (see 
Supplemental file). Ventilation duration was collected as the number of days from mechanical 
ventilation onset until the first successful extubation (i.e., no need for ventilator support 
(no noninvasive ventilation and no high flow nasal therapy) for 48 hours after extubation).
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Outcomes
The primary outcome was the feasibility of performing expiratory muscle FES in terms 
of patient recruitment, contractile response and treatment compliance, and safety. As 
an additional safety endpoint, plasma cytokine levels were studied to evaluate if early 
application of FES was associated with enhanced systemic pro-inflammatory response. 
This was evaluated for the full analysis set (per-protocol analysis). Ultrasound and clinical 
data of the Holland study were evaluated in a pooled analysis.
Pooled analysis
Data from the Holland and Australian studies could be combined (n=40) as FES protocols 
were similar until extubation. Pooled endpoints were respiratory muscle thickness, plasma 
cytokine levels, ventilation duration, ICU length of stay, and ICU mortality. Ultrasound data were 
combined for patients with a treatment compliance of ≥75% treatment days from the intent-
to-treat set and until day 5 after enrollment, as ultrasound protocols were similar until this 
point. Other pooled endpoints were analyzed for the full analysis set (per-protocol analysis).
Statistics
Data are presented as medians [interquartile range (IQR)], mean ± standard deviation, or 
percentages. Statistical analyses were performed using two-sided hypothesis tests at the 
5% significance level.
Holland study
As this is a feasibility study and no data were available on the effects of expiratory muscle 
FES on expiratory muscle thickness or function when designing the study, we planned to 
enroll a convenience sample of 10 subjects per group, 20 in total. Compliance to expiratory 
muscle FES sessions was calculated as the percentage of all sessions that should have 
been completed between randomization and study completion or withdrawal, and was 
considered a continuous variable. Stimulation intensities and safety endpoints (adverse 
events) are presented using descriptive statistics. Changes in plasma cytokine levels were 
assessed using a two-way analysis of variance (ANOVA) with factors of group (active, sham) 
and time (measurements at baseline and on day 3). Further details are presented in the 
Supplemental file.
Pooled analysis
Survival analysis was performed to estimate the median ventilation duration and ICU 
length of stay, applying the cumulative incidence competing risks method. Competing 
risks were death or withdrawal of treatment (e.g., ventilator support) with the intention 
of subsequent death. Participants who were alive but who did not experience the event 
of interest were right censored at the last available study day. Gray’s test was used for 
comparison of cumulative incidence functions and the median duration was defined as 
the timepoint where 50% of participants experienced the event of interest. In addition, we 




that experienced the event of interest during the study period. Differences between these 
groups were assessed with the Mann-Whitney U test, according to the distribution. Changes 
from baseline of total abdominal expiratory muscle thickness were analyzed with a linear 
mixed effects model with fixed factors of baseline thickness, group, assessment session, 
and group by assessment session interaction, and a random effect of participant. For 




Figure 1 presents the CONSORT flow diagram. Five patients did not show a contractile 
response to expiratory muscle FES (n=2 at 60 mA and n=3 at 100 mA) and were withdrawn 
before randomization. No potential explanatory factors hampering contractile response 
could be identified in these patients (i.e., no recent neuromuscular blockers, no relevant 
medical history, and body mass index, sedation, and fluid status were not different from 
other patients). Baseline characteristics of the randomized patients (n=active/sham: 10/10) 
are presented in Table 1.
Feasibility
Table 2 presents expiratory muscle FES session compliance and adverse events. Non-
serious adverse events categorized as “possibly” or “definitely” related to the intervention 
were reported in sixteen sessions (n=active/sham sessions: 13/3; percentage of total 
sessions per group active/sham: 7.7%/2.9%) in a total of five active patients and in one 
sham patient. In the active group, these events included discomfort (n=3 sessions, in 2 
patients) and brief, spontaneous reversible episodes of hypertension and/or tachycardia 
(n=10 sessions, in 4 patients) and were reasons for an early stop of the current expiratory 
muscle FES session (Table 2). Device-related adverse events reported in the sham group 
included hypertension and tachycardia (n=3, in one patient). No FES-related serious adverse 
events were reported, as judged by a physician and confirmed by the local ethics board.
For the total population, the threshold intensity for strong muscle contraction was 70 
[54–73] mA and the maximum tolerated intensity was 100 [60–100] mA, as assessed 
prior to randomization. Muscle contraction was confirmed during all active sessions. 
The average stimulation intensity remained stable over the study period (change of -0.9 
[-2.1–0.0] %). The patient’s average session-to-session change in stimulation intensity 
(either an increase or decrease as compared to the previous session) was 4.8 [3.0–7.1] %. 
Supplemental file, E-Figure 3 shows that with higher Richmond Agitation-Sedation Scale, 
the applied stimulation intensity was lower compared to the patient’s average intensity 
(p = 0.02). Most active sessions were performed during pressure support ventilation (PSV) 
(percentage of sessions during PSV, 96.4 [59.6–100] %).
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Analyzed for primary and secondary
outcomes (n=10)
Lost to follow-up before ICU discharge (n=2)
Death (n=1)
Transfer to other hospital (n=1)
Lost to follow-up before ICU discharge (n=6)
Death (n=5)






(Expected) extubation <72h (n=202)
Abdominal surgery <4 weeks (n=120)
Poor prognosis/stop treatment (n=74)
No informed consent possible <72h (n=58)
Invasive mechanical ventilation >72h (n=43)
Pacemaker (n=38)




Age <18 years (n=2)
Other reasons:
Medical reasons (n=48) 
Prone position for few days (n=17)
Participation in other trial (n=17)
Other (n=39)
Declined to participate (n=16)
Assessed for eligibility1 
(n=731)
Informed consent & assessment 







 No contractile response to expiratory muscle 
FES with max. 60 mA (n=2) or 100 mA (n=3)
 Positive contractile response to expiratory 
muscle FES with max. 100 mA, but withdrawn 
for medical reasons (n=1) or death (n=1) 
 Withdrawn prior to FES eligibility test:
extubation (n=2), medical reasons (n=2),
poor ultrasound quality of muscles (n=1)
Analyzed for primary and secondary
outcomes (n=10)
ANALYSIS
Figure 1. CONSORT flow diagram. Study flow diagram of patients admitted to the intensive care 
unit (ICU) and the randomization process between 1 January 2017 and January 2019. 1Screening of 
all admitted ICU patients under invasive mechanical ventilation, on days when the study team was 
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Inflammatory markers
Figure 2a presents the plasma cytokine levels at baseline and on day 3 (n=active/sham: 
9/9). There was a between-group difference in the change in pro-inflammatory marker 
TNF-α (p = 0.03), with a trend toward a decrease in TNF-α levels for the active group vs. 
no change in the sham group. Mean differences compared to baseline were -0.15 ± 0.20 
pg/ml (p = 0.05) vs. 0.02 ± 0.06 pg/ml (p = 0.32), respectively.
Pooled analysis
See Table 1 for characteristics of the pooled study population (n=active/sham: 20/20).
Ultrasound
Due to technical issues, ultrasound data of four Holland study patients from one site 
was incomplete (2 active and 2 sham patients). Missing data for the Australian study are 
addressed in [17]. In patients with adequate baseline measurements available and who 
completed ≥75% of stimulation sessions from the intend-to-treat set, total abdominal 
expiratory muscle thickness at baseline was 11.7 [10.6–20.6] vs. -12.4 [10.5–15.5] mm for the 
active (n=9) vs. sham (n=17) group, respectively. There was a between-group difference in 
the change in total abdominal expiratory muscle thickness on day 3; mean (95% confidence 
interval (CI)) changes from baseline on day 3 were 1.76 (0.21, 3.30) vs. -0.50 (-1.56, 0.57) 
mm for the active (n=7) and sham (n=12) group, respectively, with a treatment difference 
(95% CI) of 2.25 (0.34, 4.16) mm (p = 0.02) (Figure 3). No between-group difference in 
total abdominal expiratory muscle thickness was found on day 5. Ultrasound results for 
all individual respiratory muscles are presented in the Supplemental file, Tables E1-E6; no 
changes between groups or over days were found.
Inflammatory markers
Figure 2b presents the results for plasma cytokine levels at baseline and on day 3 (n=active/
sham: 19/17); no differences between groups or over days were found.
Clinical outcomes
Figure 4 shows results for extubation success and ICU length of stay. Using the cumulative 
incidence competing risks method for the total study population, median ventilation 
duration and ICU length of stay were 10 vs. 52 days (p = 0.07), and 12 vs. 54 days (p = 0.03) 
for the active vs. sham group, respectively. For patients that were successfully extubated 
during ICU stay, the median ventilation duration was 8.5 [5.6–12.2] vs. 10.5 [5.3–25.6] days 
(p = 0.60) for the active (n=16) vs. sham (n=10) group, respectively. Median ICU length of 
stay was 10.5 [8.0–14.5] vs. 14.0 [9.0–19.5] days (p = 0.36) for those active (n=16) vs. sham 
(n=8) patients that were extubated and discharged alive from the ICU. During the ICU stay, 



















































































































































































































































































































































































































































































































































































Figure 3. Pooled results for total abdominal expiratory muscle thickness changes over the first 5 
days after randomization. On day 3, changes from baseline were different between groups as per 


































































p = 0.03 
competing event
censored
Figure 4. Pooled results on clinical endpoints. (a) Pooled results on extubation success. (b) Pooled 
results on ICU length of stay. P values are based on Gray’s test. Cumulative event rates were esti-
mated based on competing risk analysis, with the competing risks of death or withdrawal of ICU 
treatment (e.g., ventilator support) with the intention of subsequent death.
DISCUSSION
The current feasibility study demonstrates that breath-synchronized expiratory muscle 
FES is feasible, safe and effective in eliciting expiratory muscle activity during mechanical 
ventilation in ICU patients. This supports the findings of the Australian study [17], but in a 
more heterogeneous ICU population. The pooled analysis of the Australian and Holland 
studies also provides important insights for the design of future studies to evaluate whether 




Rationale for expiratory muscle FES
Recent studies suggest that maintaining diaphragm activity during mechanical ventilation 
minimizes diaphragm disuse atrophy and may improve clinical outcome [4, 20]. The 
current study was designed to investigate the feasibility and efficacy of eliciting expiratory 
muscle activity in the early stages of mechanical ventilation, based on the assumption 
that mechanical ventilation is associated with expiratory muscle disuse atrophy. While 
this assumption has not been extensively studied, it is known that controlled mechanical 
ventilation may (partly) silence respiratory centers in the brainstem, resulting in disuse of 
the inspiratory and expiratory muscles [21]. In addition, data on rectus abdominis biopsies 
show that critically ill patients exhibit smaller myofiber cross-sectional area compared with 
controls [22]. The effects of critical illness and mechanical ventilation on the change in 
expiratory muscle thickness, however, are yet unknown but may be of clinical relevance as 
increasing evidence demonstrates expiratory muscle weakness at the time of ventilator 
weaning [1, 9, 10, 13, 23], likely as a consequence of muscle disuse. Potential explanations for 
how expiratory muscle weakness affect weaning or extubation outcome include inadequate 
secretion clearance and insufficient cough capacity, resulting in respiratory complications 
such as pneumonia and atelectasis. Also, the expiratory muscles support inspiration in the 
presence of diaphragm dysfunction [1]; weakness may thus result in reduced ventilatory 
capacity. In line with our earlier results [17], we report more successful extubations for the 
pooled active group; however, this needs confirmation in an appropriately powered study.
Feasibility, contractile response and safety
We demonstrate that expiratory muscle FES as applied twice daily in the Holland study with 
a maximum intensity of 100 mA is feasible and safe in selected critically ill patients and 
allows high therapy compliance after an adequate contractile response to FES was verified. 
No FES-related serious harm or complications were reported, and only few sessions were 
stopped early after meeting safety criteria.
Over the last decade, inconclusive evidence for the clinical benefits of FES in ICU patients 
was published [15, 24], mainly targeting limb muscles. One reason for these inconsistent 
results may be the lack of reporting of treatment compliance and contractile response 
to stimulation [25]. The effectiveness of FES in activating muscles at an adequate level 
depends on patient characteristics; factors such as sepsis, edema, and vasopressors may 
play a role [26, 27]. No potential explanatory factors hampering contractile response were 
found in our patients that did not pass the expiratory muscle FES eligibility test (n=2 for 
maximum intensity of 60 mA (no data available on whether these patients would respond 
at higher intensities), n=3 for maximum intensity of 100 mA). Besides changes in Richmond 
Agitation-Sedation Scale, no clinical or ventilator parameters were associated with changes 
in applied stimulation intensity for the active group. The latter could be explained by the 
fact that stimulation intensity remained relatively stable, while ICU patients show more 
day-to-day variation in clinical signs.
Interestingly, our high success rate of contractile activation is not in line with Grunow 
et al. [25], studying contractile response to FES (verified visually or on palpation) in eight 
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limb muscle groups and reporting that only 64.4% of applied stimulations led to an 
adequate response on the day of ICU admission; this number declined to 25% after one 
week. Although the expiratory muscles were not targeted in their study, their maximum 
stimulation intensity was 70 mA, i.e., our median threshold intensity. While a strong muscle 
contraction depends on many factors (e.g., pulse duration, skin/electrode interface, 
electrode size, and location to motor point), it is plausible that increasing intensity would 
provide higher contractile response rates in their study. In addition, we used ultrasound 
to verify the initial response, which we consider a more objective measure compared to 
palpation, especially in patients with high body mass index or edema. Last, we did not 
experience decreases in contractile response throughout the study, likely due to the higher 
intensities used and pre-randomization stimulation titration.
Plasma cytokine levels were measured to evaluate if early application of FES was 
associated with enhanced systemic inflammatory response. Starting expiratory muscle 
FES as early as possible is important, as respiratory muscle atrophy largely develops within 
the first four days of mechanical ventilation [20, 29]. However, it is important to assess if 
patients tolerate the increased physical demands and if early FES causes an inflammatory 
state. We did not find associations with systemic inflammatory response, but with the large 
variability in pro-inflammatory state of ICU patients, no clear implications can be generated 
about potential protective effects. This is in line with recent work [30] on limb muscle FES 
in ICU patients and with data in healthy subjects demonstrating that the effects of FES 
are similar to those of mild exercise [31], i.e., inhibiting pro-inflammatory cytokines [32]. 
Furthermore, Hickmann et al. [33] showed that early exercise during the onset of septic 
shock did not enhance inflammation and preserved muscle mass. Similar mechanisms 
may explain potential protective effects of FES on muscle loss, but this requires repeated 
measurements of cytokines during the full period of a FES protocol, which was not the 
focus of our study and would be of interest to address in future research.
There are yet no clinical applications of FES targeting the respiratory muscles of ICU 
patients under mechanical ventilation. Transvenous phrenic nerve pacing is currently 
being studied as potential intervention for improving diaphragm strength in difficult-to-
wean patients (ClinicalTrials.gov: NCT03096639). However, this technique is invasive, 
increasing risks associated with subclavian vein cannulation and blood stream infections. 
In contrast, we focused on employing breath-synchronized expiratory muscle FES in the 
early phase of critical illness, aiming to prevent (or attenuate) the development of muscle 
disuse in selected patients with an anticipated expected prolonged duration of mechanical 
ventilation. We reason that this could be a novel noninvasive application within a respiratory 
muscle-protective ventilation strategy.
Potential effects on clinical endpoints
For the pooled data, we observed a between-group difference in total abdominal expiratory 
muscle thickness changes on day 3, favoring the active group. Although effects were small, 
our observations are in line with Dall’Acqua et al. [28], showing that FES of the rectus 




therefore not specifically targeted in our study) of ICU patients resulted in muscle mass 
preservation in the active group, while thickness decreased in the sham group. However, 
we found no between-group differences on day 5, likely resulting from insufficient sample 
size and observer variability (see Strengths and Limitations section below).
In the pooled analysis of clinical outcomes using the cumulative incidence competing 
risks method, we report between-group differences in median ventilation duration and ICU 
length of stay. As the incidence rate of the event of interest was influenced by competing 
events (particularly death in the sham group) and the estimates might not be stable given 
the small sample size, we also calculated the median ventilation duration and ICU length 
of stay for those patients that experienced the event of interest. No between-group 
differences were found for these subgroups. A next step would be to test the treatment 
effect of expiratory muscle FES in a study powered on clinical endpoints. Assuming a 
median effect size with 60% of patients successfully extubated on day 9 for the intervention 
group, vs. 45% of patients in the sham group, a next study would require 254 participants 
(hazard approach; log-rank test (2-sided), α = 0.05 (2-sided), β = 0.1, mortality on day 9 
of 20%, and 10% loss to follow-up).
Strengths and limitations
Strengths are that we enrolled a heterogeneous group of patients from different centers 
and performed a relatively high number (n=272) of FES sessions. Also, contractile response 
was verified prior to randomization, resulting in high treatment compliance and to ensure 
that neuromuscular status was comparable between groups. Last, a pooled analysis was 
performed, including evaluation of cytokines, to assess potential benefits in a larger cohort.
This study has some limitations. First, it was designed with the assumption that 
ultrasound could provide sufficient insights into the effects of expiratory muscle FES on 
muscle mass preservation. Despite using a standardized protocol [19], obtaining reliable 
ultrasound measurements in ICU patients can be challenging. Changes in expiratory muscle 
thickness can reflect actual changes in muscle thickness (i.e., atrophy or hypertrophy), 
but could also be affected by observer variability and patient characteristics. For example, 
motion of abdominal contents with respiration could passively stretch the abdominal 
expiratory muscles. Also, abdominal expiratory muscles have more degrees of freedom to 
move compared to the diaphragm; active contraction of one muscle layer could directly 
influence the position of the adjacent layer. For this reason, we evaluated changes in total 
abdominal expiratory muscle thickness and used a linear mixed model to account for 
individual changes, but the study was not powered sufficiently to draw any conclusions 
on these results. In contrast, ultrasound is valuable for verifying contractile response 
to stimulation (see Supplemental file, E-Figure 4). Second, sample size was small and 
patients were enrolled relatively late after intubation. This resulted in a highly selected 
study population prone to prolonged mechanical ventilation. Because of this reason, the 
absence of protocolized ventilator and weaning strategies, and post-randomization events 
(particularly death in the sham group), results on clinical outcomes should be interpreted 
with caution and generalizability of the findings is limited. Third, this study lacks a robust 
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outcome parameter to assess physiological effects of expiratory muscle FES, including 
dose-response relationships. The dosage of 30-minute stimulation sessions twice daily 
was chosen based on a few practical and physiological considerations. First, while the 
rate of expiratory muscle atrophy is yet unknown, diaphragm atrophy rapidly occurs after 
the start of mechanical ventilation [20, 29]. Hence, we wanted to limit the delay between 
stimulation sessions to a maximum duration of 24 hours, which is only possible to guarantee 
by including more than one stimulation session per day. Second, it is known that the force 
evoked from a muscle by electrical stimulation could decline rapidly over time because 
of repetitive activation of the same motor units. We therefore reasoned that limiting the 
stimulation session duration to 30 minutes would help to ensure a strong muscle contraction 
throughout the session. Other considerations included availability of study personnel and 
possible interference with clinical protocols/activities. Nevertheless, a next study should 
consider different FES protocols in order to find the optimal session frequency and duration 
for improving clinical outcomes. Moreover, although it would be interesting to assess muscle 
changes on a cellular or functional level and in response to different expiratory muscle FES 
protocols, such measurements would require repeated muscle biopsies or assessment of 
gastric twitch pressures in response to stimulation of the expiratory muscle nerve roots, 
respectively. We did not perform these invasive and technically challenging techniques 
in our study, but focused on the feasibility and efficacy of employing expiratory muscle 
FES in the early phase of ICU stay. Addressing such physiological endpoints would be of 
interest in order to better understand the potential effects of expiratory muscle FES on 
maintaining muscle function.
CONCLUSION
Breath-synchronized expiratory muscle FES is a feasible and generally safe intervention to 
elicit expiratory muscle activity during the early stages of mechanical ventilation in selected 
ICU patients. This could be a novel intervention within a respiratory muscle-protective 
ventilation strategy. The effects of expiratory muscle FES on weaning and ventilator 
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The investigational product used in this study was the VentFree prototype (VF03-
K), an electrotherapy device developed by Liberate Medical LLC, USA. VentFree is an 
electrotherapy device that:
1. monitors the user’s voluntary breathing activity using an airflow sensor (placed in 
line with the expiratory limb of the ventilator), and
2. applies FES to the expiratory muscles over two stimulation channels, during the 
expiratory phase of breathing.
The VF03-K prototype consisted of a stimulation trigger system developed by Liberate 
Medical, a CE-marked variable orifice pneumotachograph (Model 3100, Braebon Medical), 
CE-marked transcutaneous stimulation electrodes (Ultrastim, Axelgaard Manufacturing), 
and an FDA-cleared neuromuscular electrical stimulator (Continuum, Empi). An overview 
of the prototype is shown in E-Figure 1.
The pneumotachograph was fitted in line with the expiratory limb of the subject’s 
mechanical ventilator. Stimulation was automatically applied during exhalation, based 
on the measured flow. As per the manufacturer’s instructions, the pneumotachograph 
component was for single patient use. In addition, two hydrophobic filters were placed 
between the pneumotachograph pressure ports and the tubing that connects the 
pneumotachograph to the stimulation trigger. Flow resistance was approximately 1.0 mbar 
per 60 lpm.
Placement of electrodes
A new set of electrodes was used for each subject enrolled in the study. To optimize 
electrical conduction, the skin was shaved (if needed) and rinsed with soap and water 
before applying the electrodes on dry skin. Electrodes were positioned at the postolateral 
side of the abdominal wall, such that the transversus abdominis (TRA), internal oblique 
(IO), and external oblique (EO) muscles could be stimulated. The rectus abdominis (RA) 
muscle was not directly stimulated since this muscle mainly provides stability to the 
abdominal wall and is less involved in forced exhalation as compared to the TRA, IO, and 
EO muscles. In general, the positioning of the anodes was directed form the midline, 2 
cm below and parallel to the costal margin, angled obliquely toward the anterior superior 
iliac spine. The position of the cathodes was directed from the midaxillary line at the level 
of the 8th thoracic vertebral body, angled directly toward the posterior superior iliac spine 
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(see Supplemental file, E-Figure 2a). The electrodes were positioned symmetrically on 
both sides of the abdomen. This configuration has been used in a study of Lim et al. [1] 
and McCaughey and colleagues [2], where the use of FES of expiratory muscles to assist 
respiration was investigated. Small adaptations of the electrode configuration were possible 
based on individual anatomical differences. In addition, if it was not possible to turn the 
patient, an alternative electrode position was used (see Supplemental file, E-Figure 2b).
The position of the electrodes was re-marked daily with a semi-permanent marker to 
maintain the same location of stimulation for each session. Proper electrode adherence to 
the skin was assessed prior to each stimulation session and electrodes were removed and 
replaced if needed (e.g., if the adhesive gel became dry or if the electrodes did not properly 
stick to the skin). At minimum, the electrodes were replaced every 5 stimulation sessions 
in order to minimize the risk of skin burns caused by electrical stimulation.







E-Figure 1. Picture of the VentFree prototype device, model VF03-K (labeled as Triggering Device). 
This device is connected to the airflow sensor that was placed in line with the ventilator tubing. The 
red connection cable connects the triggering device to the stimulator (a commercially available Empi 
Continuum stimulator was used for this study). When expiratory flow is detected by the triggering 
device, it automatically triggers the stimulator to apply FES to the expiratory muscles via surface 
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T8 on mid axillary line. T8 is at the 
same level as the xiphoid process




at least 1 cm 
between electrodes
E-Figure 2. (a) Primary position for electrode placement. “A” electrodes were placed starting at 
the anterior superior illiac spine and moving up toward the xiphoid process. “B” electrodes were 
positioned starting at the level of the 8th thoracic vertebra (T8) on the mid axillary line and extending 
down toward the posterior superior iliac spine. (b) Alternative electrode position that was used when 
it was not possible to place the electrodes in the primary position (e.g., when it was not possible to 
turn the patient). The top half of the top electrode overlapped slightly with the bottom of the rib 
cage. The bottom electrode was placed between the bottom of the top electrode and the top of 
the hip bone.
Confirmation of eligibility to expiratory muscle FES
Prior to randomization, a first expiratory muscle FES test was performed to confirm 
eligibility for the intervention. Trains of biphasic rectangular stimuli (frequency of 30 Hz, 
pulse width of 352 µs; same as the FES settings used for the active group) with incremental 
intensities (starting at 10 mA, in steps of 5 mA) were applied to determine the threshold 
current for tetanic muscle contraction and the maximum tolerated intensity. The maximum 
intensity was initially set to 60 mA; upon study enrolment this was increased to 100 mA (see 
main manuscript, Methods section). Stimulation increments were made based on clinical 
judgment of comfort (based on judgment of the nurse and/or present physician, or a 
Richmond Agitation-Sedation Scale (RASS) score ≥2). If FES resulted in patient discomfort, 
stimulation intensity was not further increased. If the threshold intensity for contraction 
was not reached at this point, the subject was withdrawn from the study. Patients were 
also withdrawn from the study if stimulations with maximum intensity did not result in 
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any visible contraction of the expiratory muscles. Subjects were replaced until 20 patients 
were successfully randomized and received at least one 30-minute stimulation session.
Contraction of the expiratory muscles in response to FES was verified with ultrasound. 
A linear ultrasound probe was placed on the abdominal wall parallel to the stimulation 
electrodes in order to visualize the EO, IO and TRA muscles. The response to stimulation 
was evaluated for both the left-sided and right-sided expiratory muscles. An example of a 
visible contraction in response to stimulation is presented in the Supplemental file, E-Figure 
4 below.
Stop criteria for expiratory muscle FES
Sessions were stopped early in the presence of at least one of the following changes in vital 
signs: heart rate <40 beats/min or >130 beats/min, mean arterial pressure <60 mmHg 
or >110 mmHg, respiratory rate >40 breaths/min, SpO2 <90%, behavior pain scale >4, or 
patient request to stop.
Randomization and blinding
Patients were randomized to receive active (intervention) of sham (control) expiratory 
muscle FES, using an online randomization tool, with a 1:1 allocation ratio using blocks of 
four patients. Randomization was performed by the researcher administering expiratory 
muscle FES. Patients, caregivers and outcome assessors were blinded to the treatment 
allocation. The researcher administering expiratory muscle FES did not perform ultrasound 




Muscle thickness of the expiratory muscles and diaphragm was determined on B-mode 
ultrasound images, obtained with a linear high-frequency (>7.5 MHz) transducer. 
Ultrasound was performed at baseline (before the first FES session), in between FES 
sessions at every Monday, Wednesday and Friday, within 24 hours after extubation, and 
at ICU discharge. Although both sides were electrically activated, only right-sided muscles 
were evaluated with ultrasound, assuming anatomical symmetry with left-sided muscles. A 
standardized ultrasound protocol was used [3]. For all measurements, the probe was placed 
perpendicular to the skin. To visualize the RA muscle, the transducer was positioned in a 
transverse orientation approximately 2–3 cm above the umbilicus, 2–3 cm lateral from the 
midline. Maximum thickness of the RA muscle was subsequently obtained by displacing 
the probe in cranial-caudal directions. When moving further laterally, the EO, IO and TRA 
muscles were identified as three parallel hypoechogenic layers, enclosed by clear bright 
lines representing muscle fascia sheaths. This was approximately at the anterior axillary 
line, midway between the inferior border of the rib cage and the iliac crest. Minimal pressure 




the zone of apposition, with the probe placed on the anterior axillary line, between the 8th 
and 11th rib.
For all measurements, a video of at least three breath cycles was captured and stored for 
offline analysis. From the ultrasound videos, thickness of the RA, EO, IO, and TRA muscles 
was measured as the distance between the inner edges of the superior and inferior fascia 
sheets, perpendicular to the muscle direction. Total lateral expiratory muscle thickness 
was measured as the distance between the upper EO fascia and lower TRA fascia (see 
Supplemental file, E-Figure 4 below). Diaphragm thickness was obtained as the distance 
between the diaphragmatic pleura and peritoneum (for reference to these methods, 
see [3]). For each muscle, the average thickness value of three consecutive breaths was 
calculated for both the end-inspiratory and end-expiratory phase of breathing. For the 
expiratory muscles, data on end-inspiratory muscle thickness (resting position) were used 
to assess changes in thickness over time. For assessment of diaphragm thickness changes 
over time, data on end-expiratory thickness were used.
Cytokines
At baseline and on the third treatment day (within 72 hours after the first FES session), 
peripheral blood samples were drawn into EDTA tubes and centrifuged immediately (for 10 
minutes at 21 degrees of Celsius and with 1800G). The plasma was frozen in aliquot tubes 
and stored at -80 degrees of Celsius until pooled analysis (see below).
Data analysis and statistics
Statistical analysis followed similar methods as described in our previous work [4]. 
Categorical data are summarized in terms of the number of participants with data at 
the relevant time point (n) and as a percentage of all participants. Continuous data are 
expressed as median [interquartile range (IQR)], or as mean ± standard deviation, unless 
otherwise specified. Statistical analyses were performed using two-sided hypothesis tests 
at the overall 5% significance level. SAS (SAS software, version 9.3) and SPSS (SPSS IBM 
Statistics, version 26) were used to perform all summaries and analyses. Results were 
visualized using GraphPad Prism (Prism, version 8.2.1).
As this is a feasibility study and no data were available on the effects of expiratory 
muscle FES on expiratory muscle thickness when designing the study, we planned to enroll 
a convenience sample of 10 subjects per group, 20 in total.
Feasibility
Compliance to the expiratory muscle FES session was calculated as the percentage of all 
sessions that should have been completed between randomization and completion or 
withdrawal and was considered a continuous variable.
For the active group, changes in applied stimulation intensity over the study period 
were calculated per subject as the percentage change in intensity between baseline and 
the subject’s last expiratory muscle FES session. Session-to-session changes in stimulation 
intensity were calculated as the geometric mean of the ratio of change, in which the ratio 
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of change between two consecutive sessions was assessed relative to the lowest intensity 
that was applied. Thus, a 5% change in intensity between session X and the previous 
session X – 1 could mean that at session X, the stimulation intensity was either 5% higher 
or lower compared to session X – 1. Associations between the Richmond Agitation-Sedation 
Scale (RASS) score and applied stimulation intensity (Supplemental file, E-Figure 3) were 
analyzed with a mixed model design, using a random effect of participant and fixed effect 
of RASS.
Cytokines
Changes in plasma cytokine levels were assessed using a two-way ANOVA with factors of 
group (active, sham) and time (measurements at baseline and on the third treatment day). 
Measured cytokines included tumor necrosis factor (TNF)-α, interleukin (IL)-1 receptor 
antagonist, IL-1β, IL-6, IL-8 and IL-10. Subjects with a missing blood sample at one of the 
time points were excluded from the analysis. For those patients with a plasma cytokine 
level below the limit of detection, the value corresponding to this limit of detection was 
used for further analyses. A log transformation was applied as data did not fit a normal 
distribution. In the presence of an interaction effect with p < 0.05, within-group differences 
were evaluated with a paired t-test.
Pooled analysis
Cytokines
After the last subject was enrolled, the frozen blood samples of the Australian study were 
shipped on dry ice to the Netherlands, such that cytokine levels were analyzed in one batch, 




Change from baseline of the total expiratory muscles, internal oblique, external oblique, 
transversus abdominis, rectus abdominis, and diaphragm thickness were treated as 
continuous variables and analyzed using a linear mixed effects model with fixed factors 
of baseline thickness, treatment, assessment session, and treatment by assessment 
session interaction, and a random effect of participant (change from baseline thickness ~ 
baseline thickness + treatment + assessment session + (treatment × assessment session) 
+ (1|patient)). These mixed models compare the thickness of the muscles over time. Due 
to the small sample size, and the risk of a normality test being underpowered, we followed 






Ventilation duration and ICU length of stay were analyzed using Gray’s test in the survival 
analysis, with the competing risks of death or withdrawal of treatment (e.g., ventilator 
support) with the intention of subsequent death. Gray’s test compares cause-specific 
cumulative incidence curves. Median ventilation duration (days) was defined as the 
timepoint when 50% of the participants experienced the event of interest. In the case 
where less than 50% of participants achieved the outcome, due to either competing 
events or censoring, the median time to the outcome was not estimable. In addition, we 
calculated the median [IQR] ventilation duration and ICU length of stay for those patients 
that experienced the event of interest during the study period. Differences between these 
groups were assessed with the Mann-Whitney U test, according to the distribution.
Cytokines
Analysis of plasma cytokine levels followed the same approach as described for the Holland 
study.
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E-Figure 3. Relative stimulation intensity categorized by Richmond Agitation-Sedation Scale (RASS) 
score. 100% corresponds to the patient’s average intensity that was applied during the study period. 
Data are presented as mixed model estimated means with 95% confidence interval (p = 0.02 for 







Baseline thickness total expiratory muscles Increase in expiratory muscle thickness with FES
E-Figure 4. Example of a representative patient that responded to expiratory muscle FES. Stimu-
lation intensity for this example was 50 mA, resulting in a FES-induced increase in total expiratory 
muscle thickness from 10.1 mm to 11.3 mm. Abbreviations: EO, external oblique muscle; IO, internal 
oblique muscle; TRA, transversus abdominis muscle. Total expiratory muscle thickness was mea-




Table E1. Pooled analysis: Mean change in end-inspiratory total expiratory muscle thickness (in mm) 





P value for treatment by assessment session interaction: 0.9625
Day 3 change from baseline (n) 12 6
 Mean (95% CI) -0.39 (-1.58, 0.79) 1.56 (-0.71, 3.83)
 LS mean (95% CI) -0.50 (-1.56, 0.57) 1.76 (0.21, 3.30)
 Treatment difference (95% CI) 2.25 (0.34, 4.16)
 P value 0.0234
Day 5 change from baseline (n) 11 6
 Mean (95% CI) -0.35 (-1.52, 0.82) 0.14 (-1.34, 1.62)
 LS mean (95% CI) -0.51 (-1.63, 0.60) 0.34 (-1.21, 1.89)
 Treatment difference (95% CI) 0.85 (-1.09, 2.80)
 P value 0.3690
All statistics except for Mean (95% CI) are resulted from a linear mixed model, with the fixed factors 
of baseline thickness, treatment, visit and treatment by visit interaction, and a random effect of 
participant. Sham vs. active treatment difference was analyzed using a least square mean difference. 
Abbreviations: CI, confidence interval; LS, least square.
Table E2. Pooled analysis: Mean change in end-inspiratory external oblique muscle thickness (in mm) 





P value for treatment by assessment session interaction: 0.5955
Day 3 change from baseline (n) 12 6
 Mean (95% CI) 0.09 (-0.40, 0.59) 0.32 (-0.44, 1.08)
 LS mean (95% CI) -0.01 (-0.43, 0.41) 0.58 (-0.04, 1.20)
 Treatment difference (95% CI) 0.59 (-0.18, 1.36)
 P value 0.1235
Day 5 change from baseline (n) 11 6
 Mean (95% CI) -0.25 (-0.79, 0.28) 0.19 (-0.55, 0.94)
 LS mean (95% CI) -0.37 (-0.81, 0.08) 0.46 (-0.16, 1.08)
 Treatment difference (95% CI) 0.82 (0.04, 1.60)
 P value 0.0407
All statistics except for Mean (95% CI) are resulted from a linear mixed model, with the fixed factors 
of baseline thickness, treatment, visit and treatment by visit interaction, and a random effect of 
participant. Sham vs. active treatment difference was analyzed using a least square mean difference. 
Abbreviations: CI, confidence interval; LS, least square.
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Table E3. Pooled analysis: Mean change in end-inspiratory internal oblique muscle thickness (in mm) 





P value for treatment by assessment session interaction: 0.3840
Day 3 change from baseline (n) 12 6
 Mean (95% CI) 0.01 (-0.64, 0.65) 0.37 (-1.07, 1.82)
 LS mean (95% CI) -0.06 (-0.83, 0.71) 0.50 (-0.63, 1.62)
 Treatment difference (95% CI) 0.56 (-0.83, 1.94)
 P value 0.4074
Day 5 change from baseline (n) 11 6
 Mean (95% CI) 0.16 (-0.78, 1.11) -0.40 (-1.57, 0.77)
 LS mean (95% CI) 0.03 (-0.77, 0.84) -0.28 (-1.40, 0.85)
 Treatment difference (95% CI) -0.31 (-1.72, 1.09)
 P value 0.6459
All statistics except for Mean (95% CI) are resulted from a linear mixed model, with the fixed factors 
of baseline thickness, treatment, visit and treatment by visit interaction, and a random effect of 
participant. Sham vs. active treatment difference was analyzed using a least square mean difference. 
Abbreviations: CI, confidence interval; LS, least square.
Table E4. Pooled analysis: Mean change in end-inspiratory transversus abdominis muscle thickness 





P value for treatment by assessment session interaction: 0.8495
Day 3 change from baseline (n) 12 6
 Mean (95% CI) -0.24 (-0.67, 0.20) 0.37 (-0.16, 0.89)
 LS mean (95% CI) -0.27 (-0.67, 0.14) 0.36 (-0.23, 0.94)
 Treatment difference (95% CI) 0.62 (-0.09, 1.33)
 P value 0.0828
Day 5 change from baseline (n) 11 6
 Mean (95% CI) -0.23 (-0.69, 0.24) 0.18 (-0.72, 1.07)
 LS mean (95% CI) -0.27 (-0.69, 0.15) 0.17 (-0.42, 0.75)
 Treatment difference (95% CI) 0.44 (-0.29, 1.16)
 P value 0.2240
All statistics except for Mean (95% CI) are resulted from a linear mixed model, with the fixed factors 
of baseline thickness, treatment, visit and treatment by visit interaction, and a random effect of 
participant. Sham vs. active treatment difference was analyzed using a least square mean difference. 




Table E5. Pooled analysis: Mean change in end-inspiratory rectus abdominis muscle thickness (in mm) 





P value for treatment by assessment session interaction: 0.5412
Day 3 change from baseline (n) 12 8
 Mean (95% CI) -0.27 (-0.69, 0.15) 0.05 (-0.61, 0.71)
 LS mean (95% CI) -0.21 (-0.67, 0.26) 0.04 (-0.54, 0.63)
 Treatment difference (95% CI) 0.25 (-0.51, 1.01)
 P value 0.4960
Day 5 change from baseline (n) 10 6
 Mean (95% CI) -0.01 (-0.72, 0.70) 0.01 (-0.80, 0.82)
 LS mean (95% CI) 0.02 (-0.49, 0.53) -0.08 (-0.74, 0.58)
 Treatment difference (95% CI) -0.10 (-0.95, 0.75)
 P value 0.8084
All statistics except for Mean (95% CI) are resulted from a linear mixed model, with the fixed factors 
of baseline thickness, treatment, visit and treatment by visit interaction, and a random effect of 
participant. Sham vs. active treatment difference was analyzed using a least square mean difference. 
Abbreviations: CI, confidence interval; LS, least square.






P value for treatment by assessment session interaction: 0.9933
Day 3 change from baseline (n) 7 9
 Mean (95% CI) -0.17 (-0.35, 0.01) -0.15 (-0.34, 0.04)
 LS mean (95% CI) -0.20 (-0.39, 0.00) -0.16 (-0.33, 0.02)
 Treatment difference (95% CI) 0.04 (-0.23, 0.31)
 P value 0.7515
Day 5 change from baseline (n) 6 8
 Mean (95% CI) -0.13 (-0.35, 0.09) -0.04 (-0.39, 0.30)
 LS mean (95% CI) -0.09 (-0.30, 0.13) -0.03 (-0.21, 0.16)
 Treatment difference (95% CI) 0.06 (-0.22, 0.34)
 P value 0.6619
All statistics except for Mean (95% CI) are resulted from a linear mixed model, with the fixed factors 
of baseline thickness, treatment, visit and treatment by visit interaction, and a random effect of 
participant. Sham vs. active treatment difference was analyzed using a least square mean difference. 
Abbreviations: CI, confidence interval; LS, least square.
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Synthesis

C ha p t e r 2 1
General discussion and future directions
Annemijn H. Jonkman
SCOPE OF THE THESIS
Inadequate delivery of ventilatory assist and unphysiological respiratory drive may severely 
worsen respiratory muscle function in mechanically ventilated critically ill patients. 
Diaphragm weakness in these patients is exceedingly common (>60% of patients [1]) 
and associated with poor clinical outcomes, including difficult ventilator liberation, 
increased risks of intensive care unit (ICU) and hospital readmission, and mortality [1–3]. 
The underlying mechanisms of diaphragm dysfunction were extensively discussed in the 
preamble of this thesis (chapters 2, 3) and in chapter 13. Pathways primarily include the 
development of diaphragm disuse atrophy due to muscle inactivity or low respiratory drive 
(strong clinical evidence), and diaphragm injury as a result of excessive breathing effort due 
to insufficient ventilator assist or excessive respiratory drive (moderate evidence, mostly 
from experimental work). Excessive breathing effort may also worsen lung injury through 
pathways that include high lung stress and strain, pendelluft, increased lung perfusion, 
and patient-ventilator dyssynchrony [4, 5]. Relatively little attention has been paid to the 
effects of critical illness and mechanical ventilation on the expiratory muscles; however, 
dysfunction of these muscles has been linked to inadequate central airway clearance and 
extubation failure [6–9].
The motivation for performing the work presented in this thesis was the hypothesis that 
maintaining physiological levels of respiratory muscle activity under mechanical ventilation 
could prevent or attenuate the development respiratory muscle weakness, and hence, 
improve patient outcomes. This strategy, integrated with lung-protective ventilation, was 
recently proposed by international experts from different professional societies, and is 
referred to as a combined lung and diaphragm-protective ventilation approach (chapter 
13 and [10]). Today, an important barrier for implementing and evaluating such an approach 
is the lack of feasible, reliable and well-understood modalities to assess breathing effort 
at the bedside, as well as strategies for assisting and restoring respiratory muscle function 
during mechanical ventilation. Furthermore, monitoring breathing effort is crucial to identify 
potential relationships between patient management and detrimental respiratory (muscle) 
function that can be targeted to improve clinical outcomes.
In this thesis we identified and improved monitoring modalities for the diaphragm (Part 1), 
we investigated the impact of mechanical ventilation on the respiratory pump, especially 
the diaphragm (Part 2), and we evaluated a novel strategy for maintaining expiratory 
muscle activity under mechanical ventilation (Part 3). Key findings and future lines of 
research are discussed in this chapter.
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PART 1 – TOWARDS IMPROVED RELIABILITY AND CLINICAL UTILITY OF 
DIAPHRAGM MONITORING MODALITIES
In chapter 4, we discussed a wide spectrum of basic and advanced modalities that are 
available for assessing inspiratory effort (diaphragm activity) under mechanical ventilation 
and their clinical implications. Gold standard parameters for inspiratory effort are based 
on manometry using either a catheter with esophageal balloon (for assessment of total 
inspiratory effort) or both esophageal and gastric balloons (to derive transdiaphragmatic 
pressure (Pdi)). The case report in chapter 8 demonstrates how manometry could aid in 
recognizing and preventing patient-ventilator dyssynchrony, specifically reverse triggering. 
Reverse triggering seems common in fully sedated patients with abolished respiratory drive 
[11–15] and we found that it is often present around the time of resumption of diaphragm 
activity after intubation (chapter 15). It can induce breath stacking leading to excessive 
tidal volumes and high lung stress [14, 16], but the physiological determinants and effects 
require further study. While chapter 8 shows how breathing effort monitoring helps to 
identify diaphragm activity that could be injurious to the lungs and diaphragm, we also 
demonstrate the need for specific equipment and expertise for the acquisition and analysis 
of the waveforms. As a result, such measurements are rarely employed in clinical practice. 
Indeed, a recent cohort study in 50 countries reported that esophageal pressure (Pes) 
monitoring was conducted in only 0.8% of ICU patients with severe respiratory disease [17], 
despite the recognized potential benefits of measuring Pes (chapters 4 and 13). Hence, 
there is an increasing interest in the development and application of simple, cheap, and 
less invasive alternatives to manometry.
EAdi holds future promise for titration of ventilator assist, but reliability of EAdi- 
derived indices is yet compromised due to inadequate signal filtering
In Part 1, we primarily focused on the role and reliability of diaphragm electrical activity 
(EAdi) monitoring. EAdi is measured via a nasogastric catheter equipped with electrodes 
at the level of the diaphragm [18, 19], and is considered more reliable and practical than 
surface electromyography. It is a relatively simple and minimally invasive technique that 
can be applied in the vast majority of patients (chapter 15) when using dedicated software, 
now only available with a specific ventilator (Servo-I/U, Getinge, Solna, Sweden). The 
difficulty with EAdi, however, is that no reference values are known (we propose a range 
in chapters 4 and 13), and that amplitudes vary widely among patients depending on 
anatomical variation. Normalization of EAdi to maximum EAdi has been proposed [20], 
but obtaining maximal volitional inspiratory efforts in mechanically ventilated patients is 
often not feasible. Alternatively, EAdi permits the assessment of the pressure-generating 
capacity of the diaphragm (i.e., neuromechanical efficiency (NME) index [21]) and of the 
patient’s ability to generate inspiratory volume relative to the ventilator effort (patient-
ventilator breath contribution (PVBC) index [22, 23]). From a diagnostic and physiological 
point of view, both the NME and PVBC are promising indices to guide titration of ventilator 




should focus on their use during the course of mechanical ventilation and in weaning 
trials. However, in chapters 5 and 6, we demonstrated low clinical reliability of the NME 
as measured noninvasively as per the ratio of airway pressure (Paw) to EAdi during an 
end-expiratory occlusion (NMEoccl = Pawoccl/EAdioccl) (chapter 5) and of the PVBC (chapter 
6) when repeated measurements were performed within a short time interval and under 
similar circumstances. Non-physiological EAdi waveforms played an important role, and 
improved signal processing within the ventilator software could enhance reliability and 
clinical implementation of the NME and PVBC indices. As a practical approach that can 
be easily implemented at the bedside, we recommend for both indices to use an average 
of three out of five repeated measurements with the lowest variability.
In chapter 7a, we demonstrated the clinical implications of suboptimal EAdi 
signal filtering. EAdi is the ventilator-processed envelope signal of the raw diaphragm 
electromyogram (EMGdi) as measured by the eight electrode pairs. However, inadequate 
removal of cardiac activity-related artifacts that interfere with the EMGdi limits 
interpretation of patient-ventilator interaction. Specifically, we found that it could hamper 
the detection of neural inspiratory time and results in a misclassification of the number of 
ineffective efforts when very sensitive criteria are used. This may result in ventilator settings 
poorly adapted to the patient’s physiology. Unfortunately, we could not quantify waveform 
characteristics of these cardiac activity-related artifacts, nor predict their occurrence based 
on patient’s characteristics – mainly because of the uncertainty of how the ventilator 
software processes the signal. This work highlights the need for improved EAdi filtering 
methods. It also initiated discussion in the field with regard to which EAdi threshold should 
be used for automatic detection of ineffective efforts in large datasets: the authors from the 
BetterCare® software [24] carefully reanalyzed the performance of their algorithm [25], and 
concluded that increasing the EAdi threshold from 1 µV to 2.3 µV improved the sensitivity of 
their software for detecting true ineffective efforts while maintaining adequate specificity. 
We agreed with them that this threshold would be an appropriate practical solution until 
a more reliable EAdi signal is available (chapter 7b).
Signal processing solutions could improve the use of EAdi in clinical decision-making 
and research
We took several steps to improve the implementation of EAdi-derived indices. First, with 
regard to the PVBC index, we developed a robust algorithm for automatic matching of 
assisted and unassisted breaths with similar respiratory drive (i.e., similar EAdi amplitude 
and slope). This prevented the use of non-physiological EAdi waveforms in the calculation of 
the PVBC and greatly improved its reliability (chapter 6). Implementation of this algorithm 
into the ventilator software could enable continuous and automated estimates of relative 
patient efforts during assisted breathing, and constructive discussions have taken place 
with research engineers on this matter. Second, in chapter 9 we combined our knowledge 
on physiology and signal processing to develop an improved method for removal of cardiac 
electrical artifacts (i.e., electrocardiogram (ECG)) from the EMGdi signal. Our Estimated 
ECG Subtraction (EES) technique consists of three steps: 1) identification of the timing of 
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the cardiac artifact without an ECG reference channel, 2) estimation of the normalized 
ECG, considering the EMGdi as noise, and 3) subtraction of the denormalized ECG estimate 
from the EMGdi recordings. Using EMGdi recordings from ICU patients with various levels 
of diaphragm activity and ECG contamination [26], we demonstrated that applying this 
technique resulted in a clean raw EMGdi signal, which yielded better performance as 
compared to a commonly used wavelet-based filtering method. Implementation of this 
technique could improve processing of the EMGdi for diaphragm activity monitoring and 
control. A next step would be the translation into a (near) real-time application. Then, we 
can quantify whether assessment of patient-ventilator interaction or calculation of neural 
inspiratory time improves when comparing a simultaneously recorded EAdi signal with the 
envelope signal of the EMGdi as processed with our EES technique.
Diaphragm monitoring requires a profound understanding of respiratory physiology 
and technology: an argument for reliability and accuracy studies before clinical im-
plementation
While both the NME and PVBC studies were quite simple to conduct at the bedside (repeated 
end-expiratory occlusions and zero-assist breaths, respectively), they were much more 
complex in terms of data analysis and interpretation (chapter 5 and 6). Performing extensive 
EAdi signal analysis greatly enhanced our knowledge on the potential value of the EAdi and 
how to successfully identify, address and overcome existing limitations. We also made clear 
that proper use of diaphragm monitoring modalities requires a profound understanding of 
respiratory physiology and technological capabilities and limitations. This is of course not 
just limited to EAdi monitoring, as we have illustrated with the example of tissue Doppler 
imaging as a potential novel ultrasound modality for assessing diaphragm contractile 
function (chapter 12). It basically holds true for any monitoring modality in clinical practice: 
There is always the excitement of employing new techniques, but if we do not properly 
understand if what we measure reflects the patient’s true physiology (and if not: can we 
quantify the level of uncertainty?), potentially wrong decisions can be made.
Furthermore, I think that if there is a great mismatch between the simplicity of performing 
a bedside measurement and the complexity of subsequent processing and interpretation, 
a new monitoring tool will likely fail clinical implementation. Nevertheless, complexity 
and uncertainty of diaphragm monitoring techniques should definitely not withhold 
researchers and clinicians to use them in selected patients: it should stimulate the field to 
learn about working principles, to identify and overcome limitations, and to familiarize with 
data interpretation in the complex context of the critically ill. Then, recommendations for 
standardized clinical implementation can be made. This will help implementing lung and 
diaphragm-protective ventilation approaches that can be applied in every ICU – not only 




PART 2 – NEW INSIGHTS ON THE IMPACT OF MECHANICAL VENTILATION 
ON THE RESPIRATORY PUMP
In chapter 13, we presented an approach to lung and diaphragm-protective ventilation. 
However, before implementing new approaches to mitigate the risks of diaphragm 
dysfunction, it is crucial to identify patterns of clinical management that may be favorable 
or deleterious to the respiratory muscle pump. Part 2 of this thesis sheds important 
light on this matter through sophisticated monitoring of breathing effort and respiratory 
mechanics.
Diaphragm disuse is common and mostly related to sedation practice, but not to se-
verity of illness
Whereas it is convincingly demonstrated that inspiratory over-assist may result in diaphragm 
disuse atrophy (chapters 2, 3 and 13), the duration of diaphragm inactivity after intubation and 
factors associated with this inactivity were yet uncertain. In a single-center study (chapter 15) 
we found that 49% (34/69) of invasively ventilated patients did not resume minimal levels 
of diaphragm activity within one day after intubation: the median time to resumption of 
diaphragm activity was 22 hours. Diaphragm activity was continuously measured with EAdi, 
starting directly after intubation, and EAdi resumption was defined as the beginning of 
the first continuous 24-hour period with a median EAdi >7 μV. The 7 μV threshold can be 
debated, since there is no consensus in the literature what a normal EAdi is. We defined this 
threshold mainly based on the correlation with physiological levels of diaphragm activity 
on ultrasound (chapter 15, [27]), and wanted to be conservative for detecting abnormally 
low diaphragm activity (e.g., healthy subjects usually show values above 10 µV [28]). In 
addition, we wanted to be cautious with the possibility of including lower amplitude cardiac 
activity-related artifacts (chapter 7a).
The result of late EAdi resumption (chapter 15) confirms that diaphragm disuse under 
mechanical ventilation is common. Sedation, controlled mechanical ventilation and age 
were the main accounting factors for late EAdi resumption, independent of illness severity. 
This is an important finding, since the usual belief is that severity implies more sedation and 
thus longer diaphragm inactivity. Our results do not support this hypothesis, and the fact 
that age is the strongest predictor of giving sedation (older patients receiving less sedation) 
reinforces the idea that this is related to the behavior of the clinical team and can potentially 
be modified. It also suggests that titrating sedation to generate diaphragm activity might 
prevent the development of diaphragm disuse atrophy. Of course, this must be balanced 
against several other competing factors including the need for lung-protective ventilation 
(chapter 13), especially during the first 72–96 hours following intubation where patients 
sometimes require heavy sedation with or without paralysis to optimize ventilation [29, 30]. 
In addition, we found that transition from controlled to assisted modes of ventilation does 
not imply direct EAdi resumption (chapter 15); this indeed suggests that ventilator over-
assistance is common and often unnoticed in modes such as pressure support ventilation 
[27] (chapter 10).
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Prerequisites for development of diaphragm longitudinal atrophy are present with 
the short-term application of PEEP
Today, the impact of expiratory assist (i.e., positive end-expiratory pressure (PEEP)) on the 
diaphragm is not taken into account in clinical decision-making, but may be of particular 
importance: application of PEEP is associated with diaphragm remodeling in rats and 
caudal diaphragm displacement in ICU patients [31]. Building upon these findings, we 
performed a unique combination of high-resolution magnetic resonance imaging (MRI) and 
physiological measurements (EMGdi, NME, twitch Pdi) in noninvasively ventilated healthy 
volunteers to study the short-term effects of PEEP on human diaphragm geometry and 
function (chapter 14). Other groups studied the effects of increases in lung volume on 
the diaphragm before [32–36]; however, employing active inspiration in these studies may 
have had a different impact on the diaphragm as compared to passive increases in lung 
volume with PEEP. PEEP-induced caudal diaphragm displacement resulted in shortening 
and thickening of the diaphragm muscle in the zone of apposition, and reduced diaphragm 
contractile efficiency (chapter 14). This sequence of events confirms that prerequisites for 
development of diaphragm longitudinal atrophy are present with the application of PEEP. 
If similar effects occur in ICU patients, the acute release of PEEP upon ventilator weaning 
could overstretch the longitudinally atrophied fibers to excessive sarcomere lengths, 
which could severely impact function. This might imply that a gradual (instead of acute) 
withdrawal of PEEP during weaning trials would be advisable under close monitoring of 
diaphragm function. Although much remains to be unraveled on a pre-clinical and clinical 
level, this study confirms the necessity to further explore this potentially new pathway for 
diaphragm weakness-related ventilator weaning failure.
Besides demonstrating the effects of PEEP on the diaphragm, we showed that it is 
feasible to apply MRI for diaphragm imaging. This is an exciting new field of study and 
future lines of research will be discussed later in this chapter.
Respiratory physiological parameters do not inform about ventilator liberation failure 
in brain-injured ICU patients
Whether breathing effort monitoring is of added clinical value outside of a mixed ICU 
population is less well studied. In chapter 16, we assessed ventilation liberation failure 
after a successful spontaneous breathing trial (SBT) in patients with brain injury, and the 
implications of respiratory muscle monitoring during this SBT. Ventilated brain-injured 
patients are of particular interest, since standardized weaning protocols are often lacking 
and liberation failure rate is generally much higher as compared to a medical-surgical 
ICU population (10-14%) [37, 38]. Brain injury often involves brainstem and/or cerebellar 
lesions, putting patients at risk of respiratory compromise by involving neural respiratory 
centers. Of the 46 patients that successfully completed an SBT (chapter 16), 37% 
required invasive ventilator support within 48 hours, and 61% within 7 days, which was 
indeed much higher than what has been reported for a mixed ICU population. Clinical 
characteristics did not differ between the liberations success and failure groups, and, in 




did not provide any predictive information on ventilator liberation failure. Immediate 
and expected changes occurred after the transition from pressure support ventilation 
to the SBT (increased respiratory rate, EAdi and inspiratory muscle pressure (Pmus)), 
but breathing pattern and respiratory effort remained stable thereafter. This indicates 
that liberation failure was likely not because of a limited cardiorespiratory physiological 
reserve, and it is debatable whether an SBT should be performed at all in brain-injured 
patients. Parameters related to neurological conditions (e.g., level of consciousness, 
visual pursuit, or swallowing function) are likely to provide more valuable information, 
however the Glasgow Coma Scale did not differ between success and failure groups 
(chapter 16) and the role of this parameter to predict extubation outcome remains 
controversial [41–44]. A large multicenter observational study aiming to provide a predictive 
score of successful extubation in neuro-ICU patients is currently being conducted [45].
Innovative ventilation solutions during a pandemic require monitoring of the safe 
delivery of ventilatory assist
During the coronavirus disease 2019 (COVID-19) wave in early 2020, a need for simple, 
efficient, and safe ventilation devices emerged to meet the unprecedented ventilator 
demands of patients, and to cope with extraordinary logistical challenges [46–48]. While 
being a research fellow in Toronto at that time, our team was highly motivated to explore 
whether the Oxylator device [49, 50] could be used reliably and safely in conditions of 
severe lung injury such as seen with the COVID-19-associated acute respiratory distress 
syndrome (ARDS). The Oxylator device is fist-sized, runs on compressed oxygen/air (no 
electricity required), and is pressure regulated. It was tested extensively on the bench and 
in a porcine model of lung injury, mimicking various clinical conditions (chapter 17). Key 
findings were that the device provided a very predictable and stable output: because it 
is pressure regulated, changes in compliance manifest as changes in respiratory timing 
and tidal volume (i.e., lower compliance = shorter inspiratory time = lower tidal volume). 
Therefore, it could be especially suitable for low compliant lungs. While the device does 
not provide any monitoring options, we found that external monitoring of respiratory 
timing allows the estimation of the delivered tidal volume, could guide setting PEEP, and 
helps with recognizing acute changes in respiratory mechanics. In addition, its short-term 
use resulted in ventilation and gas exchange comparable to conventional ventilation 
modes. We concluded that the Oxylator could be an efficient rescue solution for providing 
ventilatory support as a temporary bridge until an ICU ventilator becomes available – of 
course, one is not a replacement for the other, and the reliability of the Oxylator and safe 
patient monitoring should be verified in a clinical setting. This work also demonstrates the 
importance of extensive testing of ventilation solutions developed for situations of surge, 
since unconventional ventilation methods may do more harm than good.
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PART 3 – TREATMENT OF RESPIRATORY MUSCLE DYSFUNCTION 
DURING MECHANICAL VENTILATION: FOCUS ON THE EXPIRATORY 
MUSCLES
Preventing injury of the respiratory muscle pump under mechanical ventilation is a key 
priority, however (adjunctive) clinical strategies or pharmacological agents to treat or 
prevent respiratory muscle dysfunction are not yet available. In chapter 13, we discussed 
that functional electrical stimulation (FES, or “pacing”) of the respiratory muscles could 
be an interesting future technique in this regard, as it could generate muscle contraction in 
the absence of volitional efforts. Indeed, diaphragm pacing via transvenous phrenic nerve 
stimulation with a central line catheter could attenuate diaphragm type II fiber atrophy 
resulting from controlled mechanical ventilation [51]. That technique, however, is rather 
invasive, and its feasibility and safety in ICU patients during the acute phase of mechanical 
ventilation should be studied. Of note, diaphragm pacing is under investigation in difficult-
to-wean patients (ClinicalTrials.gov: NCT03096639 and NCT03783884), and it would be 
interesting to compare its performance to a less invasive alternative such as modulation of 
contractile activity through inspiratory muscle strength training, for instance. In contrast, FES 
strategies targeting the expiratory muscles are less well studied. This is surprising, as it can 
be performed noninvasively via surface electrodes placed over the abdominal wall. In Part 3 
of this thesis, we investigated whether expiratory muscle FES could be a novel technique to 
prevent expiratory muscle disuse (chapters 19 and 20). First, we summarized the physiology 
and pathophysiology of the expiratory muscles in critically ill patients (chapter 18), 
since the main reason for the limited attention that has been paid to this muscle group is 
that their role in the physiology of breathing is poorly understood.
Improved understanding of the role of the expiratory muscles is required to better 
design treatment strategies
The expiratory abdominal wall muscles are an essential component of the respiratory 
muscle pump. These muscles may be recruited in critically ill patients to maintain alveolar 
ventilation in situations of high respiratory loading and low inspiratory muscle capacity, or 
to counteract increased end-expiratory lung volume (EELV) (chapter 18). Expiratory muscle 
recruitment may have beneficial effects, including reduction in expiratory transpulmonary 
pressure and increases in inspiratory muscle capacity. Expiratory muscle recruitment results 
in reduced EELV and movement of the diaphragm to a more cranial position. Through these 
physiological effects, activation of the expiratory muscles was reasoned to be a potential 
confounding factor in studying the effects of PEEP on the diaphragm (chapter 14): it could 
affect the position and length of the diaphragm and thus its pressure generating capacity. 
In that study, we found that only a small fraction of subjects (3 out of 16) showed expiratory 
muscle recruitment and only at high PEEP levels, which did not influence study conclusions 
(chapter 14). It is currently unknown why only a subset of subjects recruited their expiratory 
muscles with higher PEEP, suggesting a complex interaction of the different respiratory 




In chapter 18, we also discussed that severe dysfunction of the expiratory muscles may 
develop in ICU patients, mostly identified as decreased maximal expiratory pressures or 
ineffective cough at the time of weaning, likely as a consequence of muscle disuse. This 
may result in respiratory complications such as pneumonia and atelectasis, and has been 
associated with adverse outcomes such as liberation failure and rehospitalization [6–9]. 
Risk factors for expiratory muscle weakness, and whether they are similar to the diaphragm, 
are largely unknown and need to be further studied.
Functional electrical stimulation is feasible and safe to maintain expiratory muscle 
activity under mechanical ventilation
Our multicenter pilot randomized clinical study confirmed the feasibility and safety of 
breath-synchronized expiratory muscle FES as a potential novel strategy to maintain 
expiratory muscle activity during the acute phase of mechanical ventilation. In the Holland 
study (chapter 20), we reported a high treatment compliance (91.1% of a total of 272 
30-minute sessions were completed), no FES-induced systemic inflammation within the 
first three days of using the technique, and no severe adverse events. Results were in 
line with the Australian study (chapter 19), a single-center study, which was conducted 
mainly in neuro-critically ill patients. Both studies did not have a robust physiological or 
clinical outcome parameter, since our main focus was feasibility: we first wanted to evaluate 
the device concepts and its practical use with respect to initial safety within a complex 
ICU environment. The design and conduct of the study using the prototype device was 
particularly helpful for understanding potential benefits and challenges of the intervention; 
the data and (user-)feedback have led to important device improvements and eventually 
CE marking [52]. Future studies are needed to determine the optimal protocol, timing 
and patient selection for improving ventilator liberation outcome. In addition, it would be 
interesting to explore to which extent this technique could be used simultaneously with 
diaphragm pacing (if feasible and safe in the critically ill).
At the time of designing both studies (chapters 19 and 20), we hypothesized that 
expiratory muscle FES could maintain (or potentially increase) muscle thickness as 
measured by ultrasound, while expecting that decreases in thickness would occur when 
muscle activity is not artificially elicited (as a result of disuse). However, it was yet unknown 
what the evolution is of expiratory muscle thickness during ICU stay, and our sample size 
was too small to draw any conclusions on this based on thickness changes occurring in 
the control group. Our recent longitudinal observational ultrasound study in 77 critically 
ill patients demonstrated that in the first week of ICU stay expiratory muscle thickness 
decreases in 22%, increases in 12%, and remains stable in 66% of ventilated patients [53]. 
In addition, changes in expiratory muscle thickness were not associated with changes in 
thickness of the diaphragm. This could suggest a different response of both muscle groups 
to mechanical ventilation and critical illness. A next study on the clinical effects of expiratory 
muscle FES should carefully consider these findings when designing study endpoints.
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ADDITIONAL FUTURE LINES OF RESEARCH
Next to the future perspectives that are addressed for the individual chapters of this thesis, 
this section outlines additional ongoing and future lines of research. I will focus on three 
topics: 1) improved physiological monitoring of respiratory drive and effort, 2) new imaging 
techniques for the diaphragm, and 3) approaches to facilitating lung and respiratory 
muscle-protective ventilation.
Physiological monitoring of respiratory drive and effort: next steps
EAdi could be a feasible modality to monitor diaphragm activity, mainly to identify patients 
at risk for disuse atrophy (chapter 15). However, the large individual variability in EAdi 
amplitudes makes it difficult to define safe upper levels of diaphragm activity, as well as 
to predict breathing effort based on EAdi amplitude solely using the NME as conversion 
factor (i.e., pressure (cmH2O) = EAdi (µV) x NME (cmH2O/µV)) [21]. We should also realize 
that a change in NME when measured as per Pmus/EAdi or Pawoccl/EAdioccl could indicate 
recruitment of accessory respiratory muscles, since EAdi is insensitive to recruitment of 
muscles other than the diaphragm. Therefore, obtaining the NME as per the Pdi to EAdi 
relationship reflects neuromechanical coupling of the diaphragm more accurately (as done in 
chapter 14). A next study should focus on better understanding the Pdi to EAdi relationship 
and the potential factors that could affect the shape of this relationship. If this could permit 
the development of a formula to convert EAdi parameters into pressure-derived variables 
specific to the diaphragm, we can better personalize EAdi-based titration of ventilatory 
assist. This is currently being studied by our group (ClinicalTrials.gov: NCT03580720).
In addition to the work presented in this thesis, other noninvasive monitoring alternatives 
based on airway pressure have recently emerged, including the pressure during a full breath 
end-expiratory occlusion (Pocc) [54] and during the first 100 ms of an occluded airway 
(P0.1) [55]. Pocc and P0.1 can be measured on most modern ventilators and could identify 
potentially injurious levels of respiratory muscle effort during spontaneous breathing, but 
cannot provide a precise estimate of the actual level of effort (Pmus or pressure-time 
product) [54–56]. Their main clinical utility would therefore be to serve as a feasible and 
rapid screening tool to identify patients at risk for excessive breathing effort and who would 
likely benefit from more advanced monitoring techniques.
There is an important role for the industry to make complex measurements based on 
esophageal and diaphragm manometry easier and continuously available at the bedside. 
Ideally, one needs a tightly integrated application that can automatically calculate parameters, 
verify its reliability, and suggest clinical interpretation in the complex context of the patient’s 
physiology. With the availability of continuous assessment of respiratory (muscle) effort 
in an extensively monitored environment such as the ICU, there lies a big opportunity for 
employing intelligent algorithms: I am confident that advanced time series analysis will help to 
better understand the impact of mechanical ventilation on the lungs and respiratory muscle 
pump, to detect unphysiological respiratory drive and patient-ventilator dyssynchronies, and 




Novel imaging techniques to study the (long-term) effects of mechanical ventilation 
and critical illness on the respiratory muscle pump
Besides physiological measurements, respiratory muscle imaging is rapidly gaining 
popularity. Ultrasound allows the clinician to rapidly diagnose and assess respiratory muscle 
dysfunction in critically ill patients and in patients with unexplained dyspnea. We developed 
and presented a point-of-care ultrasound approach in weaning failure patients in chapter 
11. In that narrative review, we also identified novel techniques for functional imaging that 
might offer new noninvasive methods for gauging diaphragm effort or quantification of 
diaphragm tissue properties. Other groups recently explored these techniques in healthy 
volunteers and ICU patients, which include tissue Doppler imaging [57], strain imaging 
[58, 59], quantification of echogenicity [60] and shear wave elastography [61–63]. Future 
studies should determine the optimal imaging protocols, patient selection, and clinical 
interpretation.
Although ultrasound is noninvasive, inexpensive and can be easily applied at the bedside, 
visualization of the complete diaphragm is rather impossible. In contrast, MRI enables a 
more complete and detailed assessment of diaphragm geometry and motion (chapter 14), 
but has never been applied to study the effects of critical illness and mechanical ventilation 
on the diaphragm. We recently confirmed the feasibility of diaphragm MRI in an ICU patient 
(unpublished work) and our interdisciplinary team has developed imaging protocols for 
advanced monitoring of diaphragm dysfunction and the long-term consequences in ICU 
survivors. We are currently exploring these promising avenues, with a particular focus on 
the impact of COVID-19 infection on the diaphragm (ClinicalTrials.gov: NCT04735757). 
This may provide novel insights into the histological differences in myopathic phenotypes 
between COVID-19 and matched control ICU patients that have been recently reported by 
our group [64].
Clinical strategies for lung and diaphragm-protective ventilation
Clinical trials testing new ventilation algorithms, sedation strategies and adjunctive 
therapies targeted at optimizing respiratory effort are required to confirm the benefit of 
a lung and diaphragm-protective ventilation approach (chapter 13). In this context, we 
recently confirmed that modulation of inspiratory support based on diaphragm effort to 
target a physiological range of breathing effort is feasible without compromising tidal 
volumes and lung stress (ClinicalTrials.gov: NCT03527797, [65]). Similarly, the clinical 
benefits of integration of breathing effort to sedation practice algorithms should be studied 
prospectively (chapter 15). It should be noted that in patients with excessive respiratory 
drive due to reasons not related to PaCO2 and ventilation, modulating ventilatory support 
or sedation likely does not reduce patient effort; instead, it could contribute to higher lung 
stress and strain. Preliminary findings from our group suggest that partial neuromuscular 
blockade (low-dose rocuronium) could be a feasible approach to achieving lung and 
diaphragm-protective ventilation targets in ARDS patients with excessive respiratory drive 
on partially-supported modes [66]. This could be an interesting compromise between total 
paralysis and injurious breathing efforts, balanced against the risks of developing dyspnea 
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and potential hemodynamic side effects. We are currently exploring the safety and efficacy 
of prolonged partial neuromuscular blockade and its feasibility under low levels of sedation 
(ClinicalTrials.gov: NCT03646266).
CONCLUSION
There are many opportunities for monitoring and assisting the respiratory muscle pump 
in critically ill patients, using innovative technology. Through adopting these modalities in 
clinical practice, the impact of mechanical ventilation on the lungs and diaphragm can be 
better understood, allowing the identification of target values and clinical strategies for 
personalized and safe mechanical ventilation. This thesis reflects an enormous international 
team effort towards facilitating lung and respiratory muscle-protective mechanical 
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I have stated this quite often in my thesis: the respiratory muscle pump is much more 
than just the diaphragm. It involves a complex and coordinated interplay between different 
muscle groups that are recruited in order to deliver the best possible output depending on 
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by a fantastic group of supervisors. I got the freedom to experiment, to struggle and to fail, 
to take on challenges that best fitted my research interests, and to be part of a winning 
team. I enjoyed every moment of it. 
Reflecting on this great journey while reading the proof print of this thesis, I realized 
that a PhD process could actually be compared to a proportional mode of ventilation: your 
output and personal growth is directly proportional to the effort you put into the process. 
It is also dependent on the level (and quality) of assist from your supervisors, and about 
avoiding putting an excessive amount of constant pressure on yourself. And once you realize 
that the level of assist that you need from your supervisors has gradually reduced over the 
years to a point where you can stand on your own two feet, then you know it is the right 
time to write this final chapter of acknowledgments. 
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koffiemok vrolijk door de gangen loopt, zelfs op elke maandagochtend. Dank voor je ‘geen 
woorden maar daden’-mentaliteit. Dank voor de bijna wekelijkse Skype sessies toen ik in 
Toronto zat, al was het soms alleen maar even om te peilen of ik het nog wel volhield daar 
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goede sfeer en gezellige borrels en etentjes. Ik heb enorm genoten van onze samenwerking 
en je begeleiding. We zijn intussen een sterk team en ik hoop dat er nog vele mooie jaren 
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mag gaan betekenen als jij voor mij hebt gedaan.
Mijn copromotoren dr. Angélique de Man en dr. Pieter Roel Tuinman. Dank voor 
de prettige en laagdrempelige samenwerking en begeleiding. Jullie stonden altijd klaar 
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Dank voor jullie oprechte interesse in mijn werk en voor de kritische vragen vanuit een 
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(92 meters) office building in the Dutch city of 
Groningen (build in 2008-2011, by UNStudio). 
I have selected this photo from my dad’s collection, 
as I think it perfectly fits the theme of my thesis for 
several reasons. The tree on the back of the cover 
represents the lung with its bronchus that continues to 
branch. The building itself symbolizes the diaphragm, 
located below the lung and with a dome shape. The 
building is further characterized by flowing lines, a 
symbol for the breathing pattern with its dynamics. 
Its solid structure symbolizes strength and the ability 
to bear high loads; to me, this represents the capacity 
of the diaphragm, but it also symbolizes technology 
and its role in supporting respiratory physiology. 
As a fun fact, after selecting this photo my dad told 
me that this building houses the office from DUO. 
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